,id,seq,len,pdb,comments,target,topology,nterm,cterm,mod,stereo,db
51,DRAMP00795,GIPCGESCVFIPCITAAIGCSCKSKVCYRN,30,None,"Function: Cliotide T1 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=7.1 µM) and cytotoxicity against HeLa Cells (IC50=0.6 µM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. ","[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC=1.1 µM), Pseudomonas aeruginosa ATCC 39018 (MIC=2.7 µM), Klebsiella pneumonia ATCC 13883 (MIC=4.7 µM).",Cyclic,Free,Free,"There are three disulfide bonds between Cys4 and Cys20, Cys8 and Cys22, Cys13 and Cys27.",L,DRAMP
52,DRAMP00798,GIPCGESCVFIPCITGAIGCSCKSKVCYRN,30,None,"Function: Cliotide T4 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=8.4 µM) and cytotoxicity against HeLa Cells (IC50=0.6 µM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. ","[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC=1.3 µM), Pseudomonas aeruginosa ATCC 39018 (MIC=1.9 µM), Klebsiella pneumonia ATCC 13883 (MIC=1.5 µM).",Cyclic,Free,Free,"There are three disulfide bonds between Cys4 and Cys20, Cys8 and Cys22, Cys13 and Cys27.",L,DRAMP
67,DRAMP01064,AWKLFDDGV,9,None,"Function: The synthetic peptide inhibits cell proliferation and induces apoptosis in cancer-derived cell lines Hep2 (IC50=1.5 mM) and HCT15 and, to a lesser extent, in non-cancerous NIH/3T3 cells. The mode of action is presumably an arrest in the G0/G1 phase. Antiproliferative, proapoptotic and DNA-binding activities are increased by acetylation at Ala-1 and Lys-3. Has a weak hemolytic activity against mouse erythrocytes. Has antibacterial activity. Antibacterial activity is decreased by acetylation. ","[Ref.21882228]Gram-positive bacteria: Staphylococcus epidermidis (MIC=60 µM), Bacillus subtilis (MIC=30 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=30 µM), EEscherichia coli strain ATCC 8739 (MIC=30 µM).",Linear,Free,Free,None,L,DRAMP
171,DRAMP03024,LKLKSIVSWAKKVL,14,None,Function: Mast cell degranulating peptide. Activates G proteins that couple to phospholipase C. Has hemolytic activity.,"[Ref.10667861] Gram-positive bacteria: Staphylococcus epidermidis ATTC 12228 (MIC=25 µM), Bacillus subtilis PCI 219 (MIC=25 µM), Enterococcus faecium EFMY-28 (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli NIHJ JC-2 (MIC=50 µM)",Linear,Free,Amidation,Free,L,DRAMP
327,DRAMP01607,GLFDIIKKIAESF,13,1VM5 resolved by NMR.,Function: Probably acts by disturbing membrane functions with its amphipathic structure. Aurein 1.2 is HIV active (Wang G et al. 2010 Antimicrob. Agents Chemother. (54) 1343-1346). Aurein 1.2 is also the smallest amphibian peptide to show both antibiotic and Anti-cancer activity. The aurein antibiotics show more activity towards Gram-positive than Gram-negative pathogens. Expressed by the skin dorsal glands.,"Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=8 μmol/L);##Gram-negative bacteria: Pasteurella multocida (MIC=100 μg/ml), Escherichia coli (MIC=8 μmol/L);##Fungi: Candida albicans (MIC=32 μmol/L)",Linear,Free,Amidation,Free,L,DRAMP
328,DRAMP01608,GLLDIVKKVVGAFGSL,16,None,"Function:Antimicrobial activity against Gram-positive bacteria. Probably acts by disturbing membrane functions with its amphipathic structure. The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=6 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=100 μg/ml)",Linear,Free,Amidation,Free,L,DRAMP
329,DRAMP01612,GLFDIVKKVVGAFGSL,16,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",Linear,Free,Amidation,Free,L,DRAMP
330,DRAMP01613,GLFDIAKKVIGVIGSL,16,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",Linear,Free,Amidation,Free,L,DRAMP
331,DRAMP01614,GLFDIVKKIAGHIAGSI,17,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml), Streptococcus uberis (MIC=100 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",Linear,Free,Amidation,Free,L,DRAMP
332,DRAMP01617,GLFDIVKKIAGHIASSI,17,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",Linear,Free,Amidation,Free,L,DRAMP
333,DRAMP01618,GLFDIVKKIAGHIVSSI,17,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 μg/ml)",Linear,Free,Amidation,Free,L,DRAMP
334,DRAMP01620,GLMSSIGKALGGLIVDVLKPKTPAS,25,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=100 μg/ml), Streptococcus uberis (MIC=50 μg/ml)",Linear,Free,Free,Free,L,DRAMP
420,DRAMP03571,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,37,2K6O resolved by NMR,Function:Antibacterial activity against the Gram-positive and Gram-negative bacteria. Has hemolytic activity.,[Ref.29859288] Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=25 ± 0 μg/ml);ESBL-producing Escherichia coli(MIC=33.3 ± 14.4μg/ml);NDM-1 producing Acinetobacter baumannii(MIC=20.8 ± 7.2 μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=133.3 ± 57.7μg/ml);##Fungi:Candida albicans (ATCC 90028)(MIC>400μg/ml),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
540,DRAMP01746,FVQWFSKFLGRIL,13,6GS5 resolved by NMR.,"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
567,DRAMP18494,FIHHIIGGLFSAGKAIHRLIRRRRR,25,5H2S,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. Has hemolytic activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=64 μg/ml; MBC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
583,DRAMP01107,GIGTKILGGVKTALKGALKELASTYAN,27,7OVZ,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity.
Toxic dose: LD50 is 8.2 mg/kg by intraperitoneal injection into mice.
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=19.5 µg/ml), Klebsiella pneumoniae (MIC=9 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=19.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=19.5 µg/ml), Bacillus megatherium (MIC=19.5 µg/ml), Bacillus dysenteriae (MIC=2.7 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3 µg/ml);##Virus: HIV-1 (IC50=15.5 µg/ml, EC50=21.4 µg/ml);##Cancer cell lines: C8166 (IC50=15.3 µg/ml), Molt-4 (IC50=24.3 µg/ml), BIU-87 (IC50=20.5 µg/ml), T24 (IC50=35.4 µg/ml).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
659,DRAMP02397,AVPDVAFNAYG,11,None,Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria and fungi in vitro. Has antibacterial activity.,"Gram-positive bacteria: Staphylococcus aureus (MIC=9.6 mg/L), Bacillus subtilis (MIC=76.8 mg/L), Micrococcus tetragenus (MIC=38.4 mg/L);##Gram-negative bacteria: Escherichia coli (MIC=76.8 mg/L), Vibrio parahaemolyticus (MIC=19.2 mg/L), Vibrio anguillarum (MIC=19.2 mg/L).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
693,DRAMP18372,CHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYM,34,None,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
750,DRAMP18367,GFGSKPLDSFGLNFF,15,None,Fuction: No activity against the Gram-negative bacteria. It showed dose dependent inhibition of A549 cancer cells.,Gram-positive bacteria: S. aureus and B. subtilis (MIC 30-35 ug/mL).,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
915,DRAMP03573,IGKEFKRIVQRIKDFLRNLVPRTES,25,2FCG resolved by NMR.,The slightly lower activity of LL-37(13-37) may result from the interference of the disordered regions with membrane binding of the peptide.,"Gram-negative bacterium: Escherichia coli K12 (MIC=80 µM).##Drug-resistant KBv cancer cells (LC50=39 µM), Drug-sensitive KB cancer cells (LC50=40 µM).",Cyclic,Free,Amidation,Disulfide bonds,L,DRAMP
916,DRAMP03574,FKRIVQRIKDFLRNLV,16,None,Antibacterial and anticancer assays found that LL-37(17-32) was more active than LL-37(13-37). ,"Gram-negative bacteria: Escherichia coli K12(MIC=20 µM).##Drug-resistant KBv cancer cells (LC50=30 µM), Drug-sensitive KB cancer cells (LC50=30 µM).",Cyclic,Free,Amidation,Disulfide bonds,L,DRAMP
935,DRAMP18366,GFGSKPIDSFGLSWL,15,None,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,Cyclic,Free,Free,"Form a lactam bond at position 1 and 8(Gly1, Asp8)",L,DRAMP
936,DRAMP03687,FLSLIPSLVGGSISAFK,17,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer activity against HI57 and H838.","[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=120 μM, MBC>160 μM);##Gram-negative bacteria : Escherichia coli(MIC=160 μM, MBC>160 μM);##Fungi : Candida albicans(MIC=160 μM, MBC>160 μM)",Linear,Free,Amidation,Free,L,DRAMP
937,DRAMP03688,FLGMIPGLIGGLISAFK,17,None,"Function: TsAP-2 was of high potency against the Gram-positive bacterium, Staphylococcus aureus and the yeast Candida albicans.",Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM).##Yeast: Candida albicans (MIC=10 µM). ,Linear,Free,Amidation,Free,L,DRAMP
956,DRAMP02926,KWCFRVCYRGICYRRCR,17,"1MA2, 1MA5, 6PIN, 1WO0, 1WO1, 2MDB, 2RTV resolved by NMR.","Function:  Significantly inhibits the growth of Gram-negative and Gram-positive bacteria, also anti-HIV activity may be due to the inhibition of virual adsorption to cells.
PTM: Contains two disulfide bonds 3-16; 7-12 and Arginine amide at R17.",No MICs found in DRAMP database,Cyclic,Free,Amidation (Arg17),"Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.",L,DRAMP
978,DRAMP03829,GLKKLLGKLLKKLGKLLLK,19,None,Function: GLK-19 showed a higher activity against Escherichia coli than human LL-37.,Gram-negative bacterium: Escherichia coli K12 (MIC=10 µM).,Linear,Free,Free,Free,L,DRAMP
1515,DRAMP00240,MRKEFHNVLSSGQLLADKRPARDYNRK,27,None,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
1572,DRAMP00301,DYPKLTFTTS,10,None,"Function: Significantly inhibits growth and induces an apoptotic response in HeLa cells through cell-cycle arrest at S-phase. Exhibits highly cytotoxic activities against cancer cell and non-cancer cell lines.
Subunit structure: Heterodimer of an A chain and a B chain, which are crosslinked by one or more disulfide bonds.
Toxic dose: LD50 values are 26.22 µg/kg by intraperitoneal injection and 43.11 mg/kg by intragingival injection into IRC strain mice.","Cancer cell lines: HeLa (IC50=0.15±0.08 nM), PC-12 (IC50=7.71±0.24 nM), MCF-7 (IC50=11.20±0.02 nM), K562 (IC50=15.80±0.09 nM).##Non-cancer cell lines: Vero (IC50=2.79±0.05 nM) and Madin-Darby canine kidney cells (IC50=3.92±0.01 nM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
1573,DRAMP00302,DETXTDEEFN,10,None,"Function: Significantly inhibits growth and induces an apoptotic response in HeLa cells through cell-cycle arrest at S-phase. Exhibits highly cytotoxic activities against cancer cell and non-cancer cell lines.
Subunit structure: Heterodimer of an A chain and a B chain, which are crosslinked by one or more disulfide bonds.
Toxic dose: LD50 values are 26.22 µg/kg by intraperitoneal injection and 43.11 mg/kg by intragingival injection into IRC strain mice.","Cancer cell lines: HeLa (IC50=0.15±0.08 nM), PC-12 (IC50=7.71±0.24 nM), MCF-7 (IC50=11.20±0.02 nM), K562 (IC50=15.80±0.09 nM).##Non-cancer cell lines: Vero (IC50=2.79±0.05 nM) and Madin-Darby canine kidney cells (IC50=3.92±0.01 nM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
1630,DRAMP00361,ITCPQVTQSLAPCVPYLISG,20,None,"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. Inhibits cell proliferation of cervical carcinoma cell line HeLa (IC50=2.74 µM), gastric carcinoma cell line MGC-7 (IC50=3.13 µM), esophageal carcinoma cell line Eca-109 (IC50=0.7 µM) and melanoma B16 cells (IC50=1.47 µM). Has antifungal activity. Induces caspase-dependent apoptosis in cell line Eca-109. Demonstrates inhibitory effect on HIV-1 reverse transcriptase (IC50=1.26 µM).
Biophysicochemical properties: pH dependence (Stable between pH 4 and 10); Temperature dependence (Thermostable. Retains antifungal activity between 4 degrees Celsius and 60 degrees Celsius. Activity reduced after 30 min at 80 degrees Celsius).","Fungi: Penicillium digitatum (IC50=37.5 µM), Alternaria alternata (IC50=1.5 µM), Rhizopus stolonifer (IC50=8.44 µM) and Magnaporthe grisea (IC50=12.19 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2022,DRAMP00767,GDACGETCFTGICFTAGCSCNPWPTCTRN,29,None,"IC50=9.8 µM, HD50=51.9 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys 4 and Cys18, Cys8 and Cys20,  Cys13 and Cys26 .",L,DRAMP
2023,DRAMP00768,GIPCAESCVWIPPCTITALMGCSCKNNVCYNN,32,None,"IC50=2.4 µM, HD50>25 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys 4 and Cys21, Cys8 and Cys23,  Cys13 and Cys28.",L,DRAMP
2024,DRAMP00769,GASCGETCFTGICFTAGCSCNPWPTCTRN,29,None,"IC50=9.8 µM, HD50=51.9 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys 4 and Cys18, Cys8 and Cys20,  Cys13 and Cys26 .",L,DRAMP
2025,DRAMP00770,GEYCGESCYLIPCFTPGCYCVSRQCVNKN,29,None,"IC50=5.0 µM, HD50>25 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys 4 and Cys18, Cys8 and Cys20,  Cys13 and Cys25 .",L,DRAMP
2026,DRAMP00771,GIACGESCVFLGCFIPGCSCKSKVCYFN,28,None,Function: Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=26 µM).,No MICs found in DRAMP database,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI .",L,DRAMP
2027,DRAMP00772,KLCGETCFKFKCYTPGCSCSYPFCK,25,None,Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=3.5 µM).,No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2028,DRAMP00773,GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,31,None,Function: Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=0.76 µM).,No MICs found in DRAMP database,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI .",L,DRAMP
2029,DRAMP00775,GIPCGESCVFIPCLTSAIDCSCKSKVCYRN,30,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines.,"Cancer cell lines: BGC-823 (IC50=1.75±0.05 µM), MM96L (IC50=4.91±0.04 µM), HeLa (IC50=15.5±0.06 µM).##Non-cancer cell line: HFF-1 (IC50=3.19±0.01 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2030,DRAMP00776,GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN,31,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi F.,"Cancer cell lines: BGC-823 (IC50=2.91±0.06 µM), MM96L (IC50=1.03±0.03 µM), HeLa (IC50=6.35±0.31 µM).##Non-Cancer cell line: HFF-1 (IC50=1.76±0.12 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2031,DRAMP00777,GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,31,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi G.,"Cancer cell lines: BGC-823 (IC50=2.91±0.06 µM), MM96L (IC50=1.03±0.03 µM), HeLa (IC50=6.35±0.31 µM)##Non-Cancer cell line: HFF-1 (IC50=1.76±0.12 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2032,DRAMP00778,GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,31,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi D.,"Cancer cell lines: MM96L (IC50=2.51±0.03 µM), HeLa (IC50=5.24±0.40 µM).##Non-Cancer cell line: HFF-1 (IC50=1.55±0.09 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2033,DRAMP00779,GIPCGESCVFIPCISSVIGCSCSSKVCYRN,30,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi E.,"Cancer cell lines: MM96L (IC50=2.51±0.03 µM), HeLa (IC50=5.24±0.40 µM).##Non-Cancer cell line: HFF-1 (IC50=1.55±0.09 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2034,DRAMP00780,GSIPCGESCVFIPCISSVIGCACKSKVCYKN,31,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines.,"Cancer cell lines: BGC-823 (IC50=1.75±0.05 µM), MM96L (IC50=4.91±0.04 µM), HeLa (IC50=15.5±0.06 µM).##Non-cancer cell line: HFF-1 (IC50=3.19±0.01 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2035,DRAMP00781,GLPVCGETCVGGTCNTPGCGCSWPVCTRN,29,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viba 15.,"Cancer cell lines: BGC-823 (IC50=1.32±0.15 µM), MM96L (IC50=3.10±0.06 µM), HeLa (IC50=10.21±0.43 µM).##Non-Cancer cell line: HFF-1 (IC50=2.38±0.09 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2036,DRAMP00782,GLPVCGETCVGGTCNTPGCACSWPVCTRN,29,None,Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Activity tested together with Viba 17.,"Cancer cell lines: BGC-823 (IC50=1.32±0.15 µM), MM96L (IC50=3.10±0.06 µM), HeLa (IC50=10.21±0.43 µM).##Non-Cancer cell line: HFF-1 (IC50=2.38±0.09 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2038,DRAMP00784,GLPVCGETCVGGTCNTPGCSCSWPVCTRN,29,None,"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against a variety of drug-resistant and drug-sensitive human tumor cell lines, and against primary chronic lymphocytic leukemia cells. Has weak cytotoxic activity against primary ovarian carcinoma cells or normal lymphocytes.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26.","Human tumor cell lines: RPMI-8226/s (IC50=3.24 µM), RPMI-8226/Dox40 (IC50=2.73 µM), RPMI-8226/LR-5 (IC50=3.19 µM), U-937GTB (IC50=6.35 µM), U-937Vcr (IC50=4.84 µM), ACHN (IC50=4.19 µM), CCRF-CEM (IC50=3.56 µM), CCRF-CEM/VM-1 (IC50=4.97 µM), NCI-H69 (IC50=4.88 µM), NCI-H69AR (IC50=4.89 µM).",Cyclic,No specific N-terminal,No specific C-terminal,Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.,L,DRAMP
2039,DRAMP00785,GLPVCGETCFGGTCNTPGCSCDPWPMCSRN,30,None,"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26.",No MICs found in DRAMP database,Cyclic,No specific N-terminal,No specific C-terminal,Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.,L,DRAMP
2040,DRAMP00786,GVPICGETCVGGTCNTPGCSCSWPVCTRN,29,None,"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2041,DRAMP00787,GLPICGETCVGGSCNTPGCSCSWPVCTRN,29,None,"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2042,DRAMP00788,GLPICGETCVGGTCNTPGCSCSWPVCTRN,29,None,"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against human lymphoma U-937 GTB and human myeloma RPMI-8226/s cell lines.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26.","[Ref.14987049]Human cancer cell lines: U-937 GTB (lymphoma) (IC50=4 µM), RPMI-8226/s (myeloma) (IC50=4 µM).##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=350 nM).",Cyclic,Cyclization (N termini to C termini),Cyclization (C termini to N termini),Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.,L,DRAMP
2043,DRAMP00789,GVPICGETCTLGTCYTAGCSCSWPVCTRN,29,2K7G resolved by NMR.,"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against a variety of drug-resistant and drug-sensitive human tumor cell lines.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26.","Human tumor cell lines: RPMI-8226/s (IC50=5.90 µM), RPMI-8226/Dox40 (IC50=3.14 µM), RPMI-8226/LR-5 (IC50=6.31 µM), U-937GTB (IC50=7.07 µM), U-937Vcr (IC50=7.45 µM), ACHN (IC50=2.63 µM), CCRF-CEM (IC50=7.13 µM), CCRF-CEM/VM-1 (IC50=7.15 µM), NCI-H69 (IC50=7.49 µM), NCI-H69AR (IC50=7.12 µM).",Cyclic,No specific N-terminal,No specific C-terminal,Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.,L,DRAMP
2044,DRAMP00790,GVPVCGETCFGGTCNTPGCSCDPWPVCSRN,30,None,"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-27.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2045,DRAMP00791,GLPVCGETCFGGTCNTPGCSCETWPVCSRN,30,None,"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-27.",No MICs found in DRAMP database,Cyclic,No specific N-terminal,No specific C-terminal,Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys27.,L,DRAMP
2049,DRAMP00796,GEFLKCGESCVQGECYTPGCSCDWPICKKN,30,None,Function: Cliotide T2 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. Cliotide T2 was relatively nonhemolytic (HD50>100 µM) .,"[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC>100 µM), Pseudomonas aeruginosa ATCC 39018 (MIC>100 µM), Klebsiella pneumonia ATCC 13883 (MIC>100 µM).",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI.",L,DRAMP
2050,DRAMP00797,GLPTCGETCTLGTCYVPDCSCSWPICMKN,29,2LAM,"Function: Cliotide T3 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=13.1 µM) and cytotoxicity against HeLa Cells (IC50=2.0 µM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. ","[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC>100 µM), Pseudomonas aeruginosa ATCC 39018 (MIC>100 µM), Klebsiella pneumonia ATCC 13883 (MIC>100 µM).",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI.",L,DRAMP
2172,DRAMP00924,PGLGFY,6,None,"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against human nasopharyngeal carcinoma.
PTM: This is a cyclic peptide.",Human nasopharyngeal carcinoma (IC50=17 nM).,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2581,DRAMP01609,GLFDIVKKVVGALGSL,16,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=12 μg/ml), Micrococcus luteus (MIC=25 μg/ml), , Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=100 μg/ml), Staphylococcus aureus (MIC=25 μg/ml)",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2582,DRAMP01610,GLFDIVKKVVGAIGSL,16,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml)",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2583,DRAMP01611,GLFDIVKKVVGTLAGL,16,None,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=25 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=25 μg/ml)",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2584,DRAMP01615,GLFDIVKKIAGHIA,14,None,"Function: 	  Has antimicrobial activity against L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2585,DRAMP01616,FDIVKKIAGHIAGSI,15,None,"Function: 	  Has antimicrobial activity against L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2586,DRAMP01619,FDIVKKIAGHIVSSI,15,None,"Function: 	  Antimicrobial activity against L.lactis, M.luteus, P.multocida, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2681,DRAMP02396,ACSAG,5,None,Function: Displays antimicrobial activity. The effects of EP5 on HeLa cells lead to the cancer cell's apoptosis and break down. ,No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2804,DRAMP01978,KLKNFAIGVAQSLLNKASCKLSGQC,25,None,"Function: Cytotoxicity towards malignant cells, including Jurkat (T-cell leukemia), BJAB (B-cell lymphoma), HT29/219, SW742 (colon carcinomas), L929 (fibrosarcoma), MCF-7 (breast adenocarcinoma), A549 (lung carcinoma), acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death. Does not show significant hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 19-25.","[Swiss_Prot Entry P85095]Cytotoxic to cancer cells, acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2852,DRAMP01111,SIGAKILGGVKTFFKGALKELASTYLQ,27,None,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. No amidation at the C-terminus.
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacterium: Klebsiella pneumoniae (MIC=3.6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.2 μg/ml), Bacillus megatherium (MIC=12 μg/ml), Bacillus dysenteriae (MIC=12 μg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=1.2 μg/ml), Aspergillus flavus IFFI 4015 (MIC=12 μg/ml), Penicillium uticale IFFI 2001 (MIC=12 μg/ml);##Virus: HIV-1 (IC50=34.4 μg/ml, EC50=39.8 μg/ml);##Cancer cell lines: C8166 (IC50=34.4 μg/ml).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2853,DRAMP01110,GIGGVLLSAGKAALKGLAKVLAEKYAN,27,2MHW resolved by NMR,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2.7 µg/ml), Klebsiella pneumoniae (MIC=15 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2.7 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=2.7 µg/ml), Bacillus megatherium (MIC=1.5 µg/ml), Bacillus dysenteriae (MIC=2.7 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=15 µg/ml);##Virus: HIV-1 (IC50=24.2 µg/ml, EC50=21.9 µg/ml);##Cancer cell lines: C8166 (IC50=24.2 µg/ml), Molt-4 (IC50=35.4 µg/ml).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
2854,DRAMP01109,GIGGKILSGLKTALKGAAKELASTYLH,27,6HZ2,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity. No amidation at the C-terminus.
Toxic dose: LD50 is 4.3 mg/kg by intraperitoneal injection into mice.
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.9 µg/ml), Klebsiella pneumoniae (MIC=3.1 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=1.5 µg/ml), Bacillus megatherium (MIC=0.9 µg/ml), Bacillus dysenteriae (MIC=0.9 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=15 µg/ml);##Virus: HIV-1 (IC50=11.4 µg/ml, EC50=1.5 µg/ml);##Cancer cell lines: C8166 (IC50=11.4 µg/ml), Molt-4 (IC50=25.2 µg/ml), BIU-87 (IC50=28 µg/ml), T24 (IC50=18 µg/ml).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
3082,DRAMP02472,LCPLDVLQLSSELLDIDGNEVEASRILSDITAFGGIRCPLTVVQSRGIGTIISSPYRFIAEGHPLSLKDMDGWFRVSDDEFNNYK,85,None,"Function: Has anticarcinogenic activity, prevents transformation of DMBA-treated JB6 cells. Has antipromoter activity, prevents promotion by tetradecanoyl phorbal acetate (TPA) in JB6 cells. Prevents tertiary butyl hydroperoxide-induced mutagenesis. Protects AT base pairs and shows antimutagenesis activity in TA102 and TA104 S.typhimurium mutagenesis tests. Inhibits paw edema formation induced by phospholipase A2 in Swiss Wistar mice. Prevents the release of arachidonate, the parent compound for the synthesis of prostaglandins and prostacyclins. Has antimalarial activity, kills P. falciparum. Has antivenom activity, nullifies the lethal effects of N.naja venom and inhibits phospholipase A2 present in N.naja venom. Has antifungal activity, inhibits cilia formation by A.niger. Is not toxic or allergenic.
Sequence similarities: Belongs to the protease inhibitor I3 (leguminous Kunitz-type inhibitor) family. [View classification]
Biophysicochemical properties: Temperature dependence (Stable for 7 days at room temperature and for 30 days at 4 degrees Celsius. Remains active after incubation at 100 degrees Celsius for 3 hours).
Caution: The order of the first peptide shown is Not found.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
3508,DRAMP02989,VNWKKVLGKIIKVAK,15,None,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.8 μM), S. aureus(MIC=14.3 μM);##Gram-negative bacteria: P. aeruginosa(MIC=15.8 μM), E. coli(MIC=1.7 μM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
3509,DRAMP02990,VNWKKILGKIIKVAK,15,None,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=9.0 μM);##Gram-negative bacteria: P. aeruginosa(MIC=14.4 μM), E. coli(MIC=1.4 μM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
3510,DRAMP02991,VNWKKILGKIIKVVK,15,None,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=3.9 μM);##Gram-negative bacteria: P. aeruginosa(MIC=18.7 μM), E. coli(MIC=1.4 μM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
3988,DRAMP18198,GFGSKPLDSFGLNFF,15,2N5C resolved by NMR,"Function: Active against Gram-positive strains, S. aureus and B. subtilis (MIC 30-35 ug/mL), and no activity against the Gram-negative bacteria. It also showed dose dependent inhibition of A549 cancer cells.",S. aureus and B. subtilis (MIC 30-35 ug/mL),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4218,DRAMP04130,FVDLKKIANIINSIFKK,17,None,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=20.97 µM), Bcap-37 (IC50=18.7 µM), MDA-MB-231 (IC50=66.4 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4219,DRAMP04131,FKDLKKIANIINSIFKK,17,None,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=44.7 µM), Bcap-37 (IC50=83.49 µM), MDA-MB-231 (IC50=894.7 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4220,DRAMP04132,FVKLKKIANIINSIFKK,17,None,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=15.54 µM), MDA-MB-231 (IC50=85.41 µM), Bcap-37 (IC50=18.9 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4221,DRAMP04133,FKKLKKIANIINSIFKK,17,None,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=27.72 µM), MDA-MB-231 (IC50=224.8 µM), Bcap-37 (IC50=25.04 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4222,DRAMP04134,FVKLKKILNIINSIFKK,17,None,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=9.01 µM), MDA-MB-231 (IC50=34.74 µM), Bcap-37 (IC50=10.52 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4223,DRAMP04135,FVKLKKILNIILSIFKK,17,None,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=11 µM), MDA-MB-231 (IC50=41.55 µM), Bcap-37 (IC50=9.39 µM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4250,DRAMP02126,FIGSALKVLAGVLPSIVSWVKQ,22,None,"Function: Peptide has cellular defense response,  inflammatory response, behavioral defense response, defense response to tumor cell,  defense response by callose deposition,  clearance of foreign intracellular nucleic acids, innate immune response, defense response by cell wall thickening, defense response to other organism, protein serine/threonine kinase inhibitor activity, calcium-dependent protein kinase inhibitor activity, protein tyrosine kinase inhibitor activity in GO analysis. Has hemolytic activity.
PTM: Glutamine amide at position 22.
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4634,DRAMP04654,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,29,None,"Function: Antimicrobial, Anticancer, Immunomodulatory and Antidiabetic activity.
As a cationic, amphipathic, α-helical, 29-residue,host defense peptide,  Hymenochirin-1B is the predominant pharmacological active component of four hymenochirins, which showed a wide range of biological activities, such as antimicrobial, anticancer, immunomodulatory, and antidiabetic activities. Surprisingly, we don't find the entry introducing Hymenochirin-1B in UniProt (2021-3-29).","[Ref.30789695] Cancer cell lines: A549 (IC50 = 15.22 ± 0.21 μM), HCT116 (IC50 = 12.76 ± 0.43 μM), HepG2 (IC50 = 8.07 ± 0.21 μM)",Linear,Free,Amidation,None,L,DRAMP
4743,DRAMP18147,LKCNKLVPLFYKTCPAGKNL,20,None,"Function: This three-finger cytotoxin has antiproliferative, cytotoxic and apoptotic activitieS. Both in vivo and in vitro experimental results suggests that this protein possess anticancer potential. Also shows neurotoxicity, cardiotoxicity and myotoxicity.",IC50=8.9 Î¼g/ml for U937 and 6.7 Î¼g/ml for K562,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4829,DRAMP18491,RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK,37,None,Function: Antimicrobial activity against Gram-positive and Gram-negative bacteria.,Gram-positive bacteria: Staphylococcus aureus (MIC= 1.81 ,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4837,DRAMP03575,FKRIVQRIKDFLR,13,2FBS resolved by NMR.,"Function: LL-37(17-29) became slightly less active than the longer ones, indicating that the truncated hydrophobic residues L31 and V32 also play a role in interaction with human cells. Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.","[Ref.16637646] Gram-negative bacterium: Escherichia coli K12(MIC=40 μM);##Drug-resistant KBv cancer cells (LC50=60 μM), Drug-sensitive KB cancer cells (LC50=57 μM).##[Ref.28178190]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=16 μM), S. faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=16 μM), Salmonella typhimurium ATCC 14028 (MIC=32 μM), Salmonella typhimurium ATCC 7731 (MIC=16 μM). [Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4869,DRAMP18517,KWKSFLKTFKSLKKTVLHTLLkAISS,26,None,Function: K14D against HeLa cells. D-Lysine replace L-Lysine at the position 14 on the polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=1.52±0.05 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4870,DRAMP18518,KWKSFLkTFKSLKkTVLHTLLKAISS,26,None,Function: K22D against HeLa cells. D-Lysine replace L-Lysine at the position 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=1.39±0.02 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4871,DRAMP18519,KWKSFLKTFKSLKkTVLHTLLkAISS,26,None,Function: K7D/K14D against HeLa cells. D-lysine replace L-Lysine at the position 7 and 14 on the polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=2.06±0.01 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4872,DRAMP18520,KWKSFLkTFKSLKkTVLHTLLkAISS,26,None,Function: K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 14 and 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=1.40±0.09 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4873,DRAMP18521,KWKSFLkTFkSLKkTVLHTLLkAISS,26,None,"Function: K7D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 7,14 and 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=4.45±0.19 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4874,DRAMP18522,KWKSFLkTFkSLKkTVLHTLLkAISS,26,None,"Function: K7D/K10D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 7,10,14 and 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=4.79±0.23 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4875,DRAMP18523,KWkSFLkTFkSLKkTVLHTLLkAISS,26,None,"Function: K3D/K7D/K10D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 3,7,10,14 and 22 on the polar face of peptide A12L/A20L. Weak hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=20.41±0.64 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4876,DRAMP18524,kWkSFLkTFkSLKkTVLHTLLkAISS,26,None,"Function: K1D/K3D/K7D/K10D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 1,3,7,10,14 and 22 on the polar face of peptide A12L/A20L. Weak hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=18.07±0.48 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4877,DRAMP18525,KWKSFLKTFKSLKKTVLHTLLKAISS,26,None,Function: L6D against HeLa cells. D-Leucine replace L-Leucine at the position 6 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=2.23±0.10 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4878,DRAMP18526,KWKSFLKTFKSLKKTVLHTLLKAISS,26,None,Function: L12D against HeLa cells. D-Leucine replace L-Leucine at the position 12 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=2.63±0.07 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4879,DRAMP18527,KWKSFLKTFKSLKKTVLHTLLKAISS,26,None,Function: L20D against HeLa cells. D-Leucine replace L-Leucine at the position 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=2.33±0.06 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4880,DRAMP18528,KWKSFlKTFKSlKKTVLHTLLKAISS,26,None,Function: L6D/L12D against HeLa cells. D-Leucine replace L-Leucine at the position 6 and 12 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=3.01±0.08 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4881,DRAMP18529,KWKSFLKTFKSlKKTVLHTlLKAISS,26,None,Function: L12D/L20D against HeLa cells. D-Leucine replace L-Leucine at the position 12 and 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=3.14±0.06 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4882,DRAMP18530,KWKSFlKTFKSlKKTVLHTlLKAISS,26,None,"Function: L6D/L12D/L20D against HeLa cells. D-Leucine replace L-Leucine at the position 6,12 and 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=7.80±0.26 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4883,DRAMP18531,KWKSFlKTFKSlKKTVlHTlLKAISS,26,None,"Function: L6D/L12D/L17D/L20D against HeLa cells. D-Leucine replace L-Leucine at the position 6,12,17 and 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=9.69±0.38 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
4884,DRAMP18532,KWKSFlKTFKSlKKTVlHTllKAISS,26,None,"Function: L6D/L12D/L17D/L20D/L21D against HeLa cells. D-Leucine replace L-Leucine at the position 6,12,17,20 and 21 on the non-polar face of peptide A12L/A20L. Weak hemolytic activity.",[Ref.22837667]Cancer cell: HeLa cell (IC50=12.88 ± 0.15 μmol/L),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
5014,DRAMP18658,FLPIVAKLLSGLL,13,None,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.Has hemolytic activity.","[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=2.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=4.0 μM), Enterococcus faecalis (MIC=8.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=16.0 μM);##Fungus: Candida albicans (MIC=4.0 μM).##Cancer cell lines: NCI-H157 (IC50=34.56 μM), U251MG (IC50=25.13 μM), PC-3 (IC50=38.56 μM), MDA-MB-435s (IC50=33.23 μM), HMEC-1 (IC50=58.62 μM).",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DRAMP
5145,DRAMP20829,RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK,37,None,Function: Anticancer activity against the human leukemia cells,"[Ref.28347740] Cancer cell lines: Leukemia cell lines K562 (IC50=349.5μM), Leukemia cell lines U937 (IC50=303.2μM), Leukemia cell lines THP-1 (IC50=228.5μM)",Linear,Free,Free,None,L,DRAMP
5146,DRAMP20830,RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK,37,None,Function: Anticancer activity against the human leukemia cells,"[Ref.28347740]  Cancer cell lines: Leukemia cell lines K562 (IC50=184.9μM), Leukemia cell lines U937 (IC50=223.9μM), Leukemia cell lines THP-1 (IC50=196.1μM)",Linear,Free,Free,None,L,DRAMP
5826,DRAMP29006,GLFAVIKKVASVIKGL,16,None,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.
A4K14-citropin 1.1 is a structurally optimized derivative of citropin-1.1 derived from amphibians' skin secreta peptide Citropin, which exhibits broad biological activities. Citropin-1.1 is Amphibian defense peptide with antibiotic and antimicrobial activity. Bowie and his team found that replacement of Asp4 and Gly14 with Ala and Lys (termed A4K14-CITROPIN 1.1) resulted in a more stable α-helix than Citropin on the C-terminal section, and it led to better biologicla activities","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 29.05 μM), A549 (IC50 = 14.97 μM), U87 (IC50 = 14.8 μM), MCF-7 (14.16 μM)",Linear,Acetylation,Amidation,None,L,DRAMP
5827,DRAMP29018,IKLSKKTKKNLKKVLKGAIKGAIAVAKMV,29,None,"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.30789695] Cancer cell lines: A549 (IC50 = 0.98 ± 0.11 μM), HCT116 (IC50 = 1.841 ± 0.34 μM), HepG2 (IC50 = 4.54 ± 0.25 μM)",Linear,Free,Amidation,None,L,DRAMP
5832,DRAMP29034,IKLSKETKDNLKKVLKGAIKGAIAVAKMV,29,None,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 6.25 μM), S. aureus ATCC 25923 (MIC = 6.25 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 1.6 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 12.5 μM), A. baumannii (MIC = 6.25 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 12.5 μM), P. aeruginosa (MIC = 25 μM), P.mirabilis (MIC > 100 μM).##[Ref.30789695] Cancer cell lines: A549 (IC50 = 2.35 ± 0.31 μM), HCT116 (IC50 = 8.09 ± 0.40 μM), HepG2 (IC50 = 4.28 ± 0.38 μM)",Linear,Free,Amidation,None,L,DRAMP
5834,DRAMP29036,IKLSPETKKNLKKVLKGAIKGAIAVAKMV,29,None,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 12.5 μM), P. aeruginosa (MIC = 25 μM), P.mirabilis (MIC > 100 μM).##[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.82 ± 0.23 μM), HCT116 (IC50 = 6.50 ± 0.32 μM), HepG2 (IC50 = 4.96 ± 0.43 μM).",Linear,Free,Amidation,None,L,DRAMP
5836,DRAMP29038,IKLSKETKKNLKKVLKGAIKGAIAVAKMV,29,None,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays","[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 6.25 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 1.6 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 12.5 μM), P.mirabilis (MIC > 100 μM).##[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.17 ± 0.23 μM), HCT116 (IC50 = 4.93 ± 0.51 μM), HepG2 (IC50 = 2.46 ± 0.32 μM).",Linear,Free,Amidation,None,L,DRAMP
5892,DRAMP29094,GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV,36,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,[Ref.32751755]Gram-positive bacteria:Bacillus megaterium(MIC=0.5 µg/mL); Bacillus subtilis(MIC=1.5 µg/mL); Corynebacterium glutamicum(MIC=1.5 µg/mL); Micrococcus luteus(MIC=8.0 µg/mL); Staphylococcus aureus(MIC=23.3 µg/mL);##Gram-negative bacteria:Escherichia coli(MIC=3.0 µg/mL); Pseudomonas aeruginosa(MIC=5.9 µg/mL);##Fungi: Rhodotorula sp(MIC=23.2 µg/mL);Aurobasidium pollulans(MIC=92.6 µg/mL); Candida albicans(MIC=46.3 µg/mL).##[Ref.31940927]Cancer:Human melanoma A2058(IC50=1.4 μM).,Cyclic,Free,Amidation,"Disulfide bond between Cys8 and Cys33, Cys12 and Cys29, Cys17 and Cys26; the 'Met' at position 10 is Methionine sulfoxide.",L,DRAMP
5893,DRAMP29095,GIKEMLCNMACAQTVCKKSGGPLCDTCQAACKALG,35,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,[Ref.31940927]Gram-positive bacteria:Corynebacterium glutamicum ATCC 13032(MIC=1.6 µM);Bacillus subtilis ATCC 23857(MIC=1.6 µM);Staphylococcus aureus ATCC 9144(MIC>100µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=12.5 µM);Pseudomonas aeruginosa ATCC 27853(MIC=25.0 µM);##Cancer:Human melanoma A2058(IC50=4.1 μM).,Cyclic,Free,Amidation,"Disulfide bond between Cys7 and Cys31, Cys11 and Cys27, Cys16 and Cys24; the 'Met' at position 5 and 9 is Methionine sulfoxide.",L,DRAMP
5899,DRAMP29101,GFKDLLKGAAKALVKAVLF,19,None,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=6 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM).##Cancer:human hepatoma‐derived cells HepG2 (LC50=9 µM).,Linear,Free,Amidation,None,L,DRAMP
5900,DRAMP29102,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,30,None,"Function:The microbial killing activity of Hc-CATH is executed through the disruption of cell membrane and lysis of bacterial cells. Antimicrobial activity of Hc-CATH in the presence of a high concentration of sodium chlorideIn addition is strong. Hc-CATH exhibited potent anti-inflammatory activity by inhibiting the LPS-induced production of nitric oxide (NO) and pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.","[Ref.26013823]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=2.34 µg/ml); Escherichia coli ATCC 25922(400 Mm NaCl,MIC=4.69 µg/ml); Escherichia coli 1(MIC=2.34 µg/ml);Escherichia coli 2(MIC=2.34 µg/ml); Escherichia coli 3(MIC=2.34 µg/ml); Escherichia coli 4(MIC=9.38 µg/ml); Shigella dysenteriae(MIC=0.59 µg/ml); Klebsiella pneumoniae 1(MIC=37.50 µg/ml); Klebsiella pneumoniae 2(MIC=4.69 µg/ml); Klebsiella pneumoniae 3(MIC=9.38 µg/ml); Klebsiella pneumoniae 4(MIC=9.38 µg/ml); Klebsiella pneumoniae 5(MIC=18.75 µg/ml); Klebsiella pneumoniae 6(MIC=37.50 µg/ml); Klebsiella pneumoniae 7(MIC=37.50 µg/ml); Klebsiella pneumoniae 8(MIC=75.00 µg/ml); Serratia marcescens(MIC>200 µg/ml); Klebsiella oxytoca(MIC=4.69 µg/ml); Proteus vulgaris(MIC>200 µg/ml); Proteus mirabilis(MIC=4.69 µg/ml); Acinetobacter baumannii 1(MIC>200 µg/ml); Acinetobacter baumannii 2(MIC>200 µg/ml); Stenotrophomonas maltophilia(MIC>200 µg/ml); Stenotrophomonas maltophilia 2(MIC=9.38 µg/ml); Pseudomonas aeruginosa ATCC 27853(MIC=18.75 µg/ml); Pseudomonas aeruginosa 1 (MIC=37.50 µg/ml ); Pseudomonas aeruginosa(MIC>200 µg/ml); Salmonella paratyphi A(MIC=4.69 µg/ml);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4.69 µg/ml); Staphylococcus aureus 1(MIC>200 µg/ml ); Staphylococcus aureus 2(MIC>200 µg/ml ); Staphylococcus aureus 3(MIC>200 µg/ml ); Staphylococcus aureus 4(MIC=4.69 µg/ml); Staphylococcus aureus 5(MIC=4.69 µg/ml); Bacillus cereus(MIC=9.38 µg/ml); Bacillus subtilis(MIC=75.00 µg/ml); Enterococcus faecium(MIC=37.50 µg/ml); Nocardia asteroides(MIC=9.38 µg/ml); Enterococcus faecalis(MIC>200 µg/ml); Staphylococcus epidermidis(MIC>200 µg/ml);##Fungi:Candida albicans 1(MIC=4.69 µg/ml); Candida albicans 2(MIC=4.69 µg/ml); Candida albicans 3(MIC=4.69 µg/ml); Candida albicans 4(MIC=4.69 µg/ml); Candida albicans 5(MIC=2.34 µg/ml); Candida albicans 6(MIC=2.34 µg/ml); Candida glabrata 1(MIC=2.34 µg/ml); Candida glabrata(MIC>200 µg/ml); Cryptococcus neoformans(MIC>200 µg/ml); Arcyria cinerea(MIC=9.38 µg/ml);##Pathogenic bacteria:Aeromonas sobria(MIC=2.34 µg/ml); Aeromonas hydrophila(MIC=2.34 µg/ml); Aeromonas veronii(MIC=2.34 µg/ml); Vibrio vulnificus(MIC=4.69 µg/ml ); Vibrio harveyi(MIC=9.38 µg/ml); Vibrio fluvialis(MIC=4.69 µg/ml); Vibrio alginolyticus(MIC=4.69 µg/ml); Vibrio parahaemolyticus(MIC=9.38 µg/ml); Vibrio splendidus(MIC=2.34 µg/ml); Vibrio anguillarum(MIC=18.75 µg/ml); Edwardsiella tarda(MIC=2.34 µg/ml).",Linear,Free,Free,None,L,DRAMP
5902,DRAMP29104,LNLKALLAVAKKIL,14,None,"Function:The peptide was tolerant in the presence of physiological salts.MP-C  lost antimicrobial activities after incubation with 20 μg/mL trypsin or chymotrypsin,indicating moderate protease resistance.","[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=2 µM); Staphylococcus aureus NCTC 10788(MBC=2 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=4 µM); Enterococcus faecalis NCTC 12697(MIC=8 µM); Enterococcus faecalis NCTC 12697(MBC=8 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=4 µM); Escherichia coli NCTC 10418(MBC=8 µM); Pseudomonas aeruginosa ATCC 27853(MIC=8 µM); Pseudomonas aeruginosa ATCC 27853(MBC=16 µM);    Fungi:Candida albicans NCTC 1467(MIC=4 µM); Candida albicans NCTC 1467(MBC=4 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=13.57 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=27.70 µM);Human prostate adenocarcinoma PC-3(IC50=6.29 µM);Human glioblastoma U251-MG(IC50=36.65 µM); Human breast adenocarcinoma MCF-7(IC50=25.27 µM).##[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacterial:Escherichia coli ATCC 25922(4.5 mM KCl and 0.004 mM FeCl3,MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(4.5 mM KCl,MIC=8 µM); Klebsiella pneumoniae ATCC 700603(MIC=8 µM); Escherichia coli ATCC 25922(NaCl/MgCl2=150mM/1mM,MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(NaCl/MgCl2=150mM/1mM,MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(0.004mM FeCl3,MIC=4 µM);Escherichia coli(Rifampin-resistant strain,MIC=4 µM).",Linear,Free,Amidation,None,L,DRAMP
5903,DRAMP29105,CLNLKALLAVAKKILC,16,None,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=32 µM); Staphylococcus aureus NCTC 10788(MBC=64 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=128 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=128 µM); Enterococcus faecalis NCTC 12697(MIC=128 µM); Enterococcus faecalis NCTC 12697(MBC=128 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=32 µM); Escherichia coli NCTC 10418(MBC=128 µM); Pseudomonas aeruginosa ATCC 27853(MIC=32 µM); Pseudomonas aeruginosa ATCC 27853(MBC>512 µM);##Fungi:Candida albicans NCTC 1467(MIC=32 µM); Candida albicans NCTC 1467(MBC=128 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=7.02 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=13.87 µM);Human prostate adenocarcinoma PC-3(IC50=13.87 µM);Human glioblastoma U251-MG(IC50=8.56 µM); Human breast adenocarcinoma MCF-7(IC50=13.66 µM).       ",Cyclic,Free,Amidation,Disulfide bond (Cys1-Cys16),L,DRAMP
5904,DRAMP29106,RKKRRQRRRLNLKALLAVAKKIL,23,None,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=4 µM); Staphylococcus aureus NCTC 10788(MBC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=8 µM); Enterococcus faecalis NCTC 12697(MIC=8 µM); Enterococcus faecalis NCTC 12697(MBC=16 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=2 µM); Escherichia coli NCTC 10418(MBC=2 µM); Pseudomonas aeruginosa ATCC 27853(MIC=4 µM); Pseudomonas aeruginosa ATCC 27853(MBC=4 µM);##Fungi:Candida albicans NCTC 1467(MIC=2 µM); Candida albicans NCTC 1467(MBC=2 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=2.79 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=3.86 µM);Human prostate adenocarcinoma PC-3(IC50=3.86 µM);Human glioblastoma U251-MG(IC50=3.36 µM); Human breast adenocarcinoma MCF-7(IC50=3.70 µM).     ",Linear,Free,Amidation,None,L,DRAMP
7726,DRAMP31568,KWKLFKKIGPGKFLHSAKKF,20,Not available,Not available,Tumor cells: Jurkat (IC50=75 µM); A549 (IC50>100 µM); K562 (IC50>100 µM); MDA-MB-361 (IC50>100 µM),Linear,Free,Amidation,None,L,DRAMP
7727,DRAMP31569,KWKFKKIPKFLHLAKKF,17,Not available,Not available,Tumor cells: K562 (IC50=3.5 µM); Jurkat (IC50=4 µM); MDA-MB-361 (IC50=8 µM),Linear,Free,Amidation,None,L,DRAMP
7728,DRAMP31570,PAWFKARRWAWRMKKLAA,18,Not available,Not available,Tumor cells: Meth A (IC50=144 µM); MT-1 (IC50>254 µM); HT-29 (IC50>440 µM),Linear,Free,Free,None,L,DRAMP
7729,DRAMP31571,PAWRKAFRWAWRMKKLAA,18,Not available,Not available,Tumor cells: HT-29 (IC50=141 µM); MT-1 (IC50=18 µM); Meth A (IC50=32 µM),Linear,Free,Free,None,L,DRAMP
7730,DRAMP31572,PAWFKARRWAWRMLKKAA,18,Not available,Not available,Tumor cells: MT-1 (IC50=16 µM); Meth A (IC50=31 µM); HT-29 (IC50=57 µM),Linear,Free,Free,None,L,DRAMP
7731,DRAMP31573,PAWRKAFRWAWRMLKKAA,18,Not available,Not available,Tumor cells: HT-29 (IC50=14 µM); A549 (IC50=3 ± 1 μM(pH=7.4); IC50=4 ± 1 μM(pH=5.5)); Meth A (IC50=6.6 µM); MT-1 (IC50=8 µM),Linear,Free,Free,None,L,DRAMP
7732,DRAMP31574,PAWRKAFRWAARMLKKAA,18,Not available,Not available,Tumor cells: Meth A (IC50=11 µM); MT-1 (IC50=12 µM); HT-29 (IC50=15 µM),Linear,Free,Free,None,L,DRAMP
7733,DRAMP31575,PAWRKAFRAAWRMLKKAA,18,Not available,Not available,Tumor cells: MT-1 (IC50=11 µM); HT-29 (IC50=16 µM); Meth A (IC50=16 µM),Linear,Free,Free,None,L,DRAMP
7734,DRAMP31576,PAWAKAFRAAARMKLKAA,18,Not available,Not available,Tumor cells: Meth A (IC50=110 µM); HT-29 (IC50=180 µM); MT-1 (IC50=87 µM),Linear,Free,Free,None,L,DRAMP
7735,DRAMP31577,PAWRKAARWAWRMLKKAA,18,Not available,Not available,Tumor cells: MT-1 (IC50=32 µM); Meth A (IC50=35 µM); HT-29 (IC50=52 µM),Linear,Free,Free,None,L,DRAMP
7736,DRAMP31578,PAARKAFRWAWRMLKKAA,18,Not available,Not available,Tumor cells: MT-1 (IC50=20 µM); Meth A (IC50=24 µM); HT-29 (IC50=35 µM),Linear,Free,Free,None,L,DRAMP
7737,DRAMP31579,PAARKAARWAWRMLKKGA,18,Not available,Not available,Tumor cells: Meth A (IC50=116 µM); HT-29 (IC50=248 µM); MT-1 (IC50=75 µM),Linear,Free,Free,None,L,DRAMP
7738,DRAMP31580,PAWRKAFRWAKRMLKKAA,18,Not available,Not available,Tumor cells: MT-1 (IC50=10 µM); HT-29 (IC50=25 µM); Meth A (IC50=7.9 µM),Linear,Free,Free,None,L,DRAMP
7739,DRAMP31581,PAWRKAFRKAWRMLKKAA,18,Not available,Not available,Tumor cells: MT-1 (IC50=12 µM); Meth A (IC50=14 µM); HT-29 (IC50=29 µM),Linear,Free,Free,None,L,DRAMP
7740,DRAMP31582,PAWRKARRWAWRMKKLAA,18,Not available,Not available,Tumor cells: Meth A (IC50=125 µM); MT-1 (IC50=141 µM); HT-29 (IC50=423 µM),Linear,Free,Free,None,L,DRAMP
7741,DRAMP31583,PAWRKARRWARRMKKLAA,18,Not available,Not available,Tumor cells: HT-29 (IC50=178 µM); Meth A (IC50=87 µM); MT-1 (IC50=92 µM),Linear,Free,Free,None,L,DRAMP
7742,DRAMP31584,GIGKFLHSAKKWGKAFVGQIMNC,23,Not available,Not available,Tumor cells: HeLa (30-40% viablity=100 µM ),Linear,Free,Amidation,None,L,DRAMP
7743,DRAMP31585,TRSSRAGLQWPVGRVHRLLRKGGC,24,Not available,Not available,Tumor cells: HeLa (80-90% viablity=100 µM ),Linear,Free,Amidation,None,L,DRAMP
7744,DRAMP31586,glfdvikkvasviggl,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Linear,Free,Amidation,None,D,DRAMP
7745,DRAMP31587,GLFDVIKAVASVIGGL,16,Not available,Not available,Tumor cells: Lung cancer group (NCI) (IC50=1 μM); Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
7746,DRAMP31588,GLFDVIKKVAAVIGGL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Linear,Free,Amidation,None,L,DRAMP
7747,DRAMP31589,GLFDVIKKVASVIKGL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Linear,Free,Amidation,None,L,DRAMP
7748,DRAMP31590,GLFDVIKKVASVIKKL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Linear,Free,Amidation,None,L,DRAMP
7749,DRAMP31591,GLFAVIKKVAAVIKKL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Linear,Free,Amidation,None,L,DRAMP
7750,DRAMP31592,GLFAVIKKVAAVIRRL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>10 μM),Linear,Free,Amidation,None,L,DRAMP
7751,DRAMP31593,GLFAVIKKVAKVIKKL,16,Not available,Not available,Tumor cells: Melanoma cancer group (NCI) (IC50=1 μM); Ovarian cancer group (NCI) (IC50=1 μM); Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Linear,Free,Amidation,None,L,DRAMP
7752,DRAMP31594,GLFKVIKKVASVIGGL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50>10 μM); Leukemia group (NCI) (IC50>10 μM),Linear,Free,Amidation,None,L,DRAMP
7753,DRAMP31595,GLFKVIKKVAKVIKKL,16,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>10 μM),Linear,Free,Amidation,None,L,DRAMP
7754,DRAMP31596,LGGIVSAVKKIVDFLG,16,Not available,Not available,Tumor cells: CNS cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Breast cancer group (NCI) (IC50>10 μM); Colon cancer group (NCI) (IC50>10 μM); Leukemia group (NCI) (IC50>10 μM); Ovarian cancer group (NCI) (IC50>10 μM),Linear,Free,Amidation,None,L,DRAMP
7755,DRAMP31597,KLllKLKlKlLK,12,Not available,Not available,Tumor cells: B16-F10 (LC50=100 µM); D122 (LC50>50 µM),Linear,Free,Free,l=D-Leucine; k=D-Lysine,Mix,DRAMP
7756,DRAMP31598,KLlRLLkkLlRLlLK,15,Not available,Not available,Tumor cells: B16-F10 (LC50=2.5 µM); D122 (LC50=4.5 µM),Linear,Free,Free,l=D-Leucine; k=D-Lysine,Mix,DRAMP
7757,DRAMP31599,AIGKFLHSAKKFGKAFVGEIMNS,23,Not available,Not available,Tumor cells: NCI-H735 (IC50=10.4 µM); NCI-H526 (IC50=11.7 µM); U-937 (IC50=16 µg/ml); RPMI-8402 (IC50=18 µg/ml); Raji (IC50=20 µg/ml); SSKT-1 (IC50=23 µg/ml); Daudi (IC50=30 µg/ml); MLA (IC50=34 µg/ml); K562 (IC50=40 µg/ml); CHP-100 (IC50=45 µg/ml); MCF-7 (IC50=49 µg/ml); PC-3 (IC50=53 µg/ml); NCI-H678 (IC50=6.23 µM); NCI-H889 (IC50=6.56 µM); NCI-H82 (IC50=7.28 µM); NCI-H841 (IC50=9.7 µM),Linear,Beta-alanine,Amidation,None,L,DRAMP
7758,DRAMP31600,LLAGLAANFLPTIICKISYKC,21,Not available,Not available,Tumor cells: A549 (IC50>100 µg/ml); Hep 3B (IC50>100 µg/ml); MCF-7 (IC50>100 µg/ml); PC-3 (IC50>100 µg/ml),Cyclic,Free,Amidation,None,L,DRAMP
7759,DRAMP31601,FAGLAANFLPTIICKISYKC,20,Not available,Not available,Tumor cells: A549 (IC50>100 µg/ml); Hep 3B (IC50>100 µg/ml); MCF-7 (IC50>100 µg/ml); PC-3 (IC50>100 µg/ml),Cyclic,Free,Amidation,None,L,DRAMP
7760,DRAMP31602,FLKLLKKLAAKFLPTIICKISYKC,24,Not available,Not available,Tumor cells: A549 (IC50=13.71 ± 2.12 µg/ml); MCF-7 (IC50=18.10 ± 2.13 µg/ml); Hep 3B (IC50=18.18 ± 3.31 µg/ml); PC-3 (IC50=18.63 ± 0.99 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7761,DRAMP31603,FLKLLKKLAAKFL,13,Not available,Not available,Tumor cells: PC-3 (IC50=13.27 ± 4.27 µg/ml); A549 (IC50=13.94 ± 3.96 µg/ml); Hep 3B (IC50=15.07 ± 1.59 µg/ml); MCF-7 (IC50=17.56 ± 6.23 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7762,DRAMP31604,FLGALFKALSKLL,13,Not available,Induce cell death via apoptosis,Tumor cells: PANC-1 (IC50=11 μM ); PC-3 (IC50=5.01±0.42 µg/ml); MCF-7 (IC50=5.25±0.63 µg/ml); Hep 3B (IC50=5.40 ± 0.91 µg/ml); A549 (IC50=8.01 ± 1.32 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7763,DRAMP31605,FLKLLAGLLKNFA,13,Not available,Not available,Tumor cells: A549 (IC50=24.58 ± 3.24 µg/ml); PC-3 (IC50=28.90 ± 5.19 µg/ml); Hep 3B (IC50=30.79 ± 3.11 µg/ml); MCF-7 (IC50=32.23 ± 9.12 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7764,DRAMP31606,KIFGSLAFL,9,Not available,Not available,"Tumor cells: N202.A2 (Animals immunized three times with DC pulsed with p369–377 or p773–782 peptide showed ~25–30% tumor growth inhibition, while two immunizations induced ~12–15% tumor growth inhibition and one injection)",Linear,Free,Free,None,L,DRAMP
7765,DRAMP31607,VMAGVGSPYV,10,Not available,"The low-avidity T cell repertoire for a self tumor antigen is functional, can be activated and expanded with the help of costimulation","Tumor cells: N202.A2 (Animals immunized three times with DC pulsed with p369–377 or p773–782 peptide showed ~25–30% tumor growth inhibition, while two immunizations induced ~12–15% tumor growth inhibition and one injection)",Linear,Free,Free,None,L,DRAMP
7766,DRAMP31608,FRKSKEKIGKEFKRIVQRIKDFLRNLV,27,Not available,Not available,Tumor cells: SAS-H1 (88 ± 7.2% cytotoxicity=40 mg/ml),Linear,Free,Free,None,L,DRAMP
7767,DRAMP31609,HHPHGHHPHGHHPHGHHPHG,20,Not available,Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities,Tumor cells: 3LL (The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48%); B16-F1 (The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48%),Linear,Acetylation,Amidation,None,L,DRAMP
7768,DRAMP31610,CVKVKVKVGSGVKVKVKVC,19,Not available,Not available,Tumor cells: THP-1 (IC50=45 µM),Cyclic,Acetylization,Amidation,None,L,DRAMP
7769,DRAMP31611,CWMSPRHLGTCGRKKRRQRRRPPQ,24,Not available,"CIGB-300 is a cyclic synthetic peptide that induces apoptosis in malignant cells, elicits antitumor activity in cancer animal models",Tumor cells: SiHa (IC50=135±10 µmol/L); HeLa (IC50=136±16  µmol/L); 3LL (IC50=143±4 µmol/L); A549 (IC50=171±12 µmol/L); Ca Ski (IC50=182±6  µmol/L); NCI-H82 (IC50=20±3 µmol/L); PC-3 (IC50=201±16 µmol/L); HL-60 (IC50=30±3 µmol/L); NCI-H125 (IC50=36±9  µmol/L); TC-1 (IC50=71±15  µmol/L); Jurkat (IC50=89±3  µmol/L),Cyclic,Free,Free,None,L,DRAMP
7770,DRAMP31612,GRKKRRQRRRGGWMWVTNLRTD,22,Not available,Enhances genotoxin-induced cytotoxicity in tumor cells,"Tumor cells: HeLa (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); H-Meso-1  (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); MCF-7 (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); U2OS (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone )",Linear,Free,Free,None,L,DRAMP
7771,DRAMP31613,ERRP,4,Not available,ERRP inhibits the growth of prostate cancer cells by attenuating EGFR signaling processes,Tumor cells: PC-3 (30% Cell viability at 5 µg/ml),Linear,Free,Free,None,L,DRAMP
7772,DRAMP31614,LW,2,Not available,Not available,Tumor cells: P388 (IC50=10.1 µg/ml),Linear,Free,Free,None,L,DRAMP
7773,DRAMP31615,HSHRDFQPVLHLVALNSPLSGGMRG,25,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (39% inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7774,DRAMP31616,MRGIRGADFQAFQQARAVGLAGTFR,25,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (19% inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7775,DRAMP31617,TFRAFLSSRLQDLYSIVRRADRAAV,25,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7776,DRAMP31618,AAVPIVNLKDELLFPSWEALFSGSE,25,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7777,DRAMP31619,GSEGPLKPGARIFSFDGKDVLRHPT,25,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (29% inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7778,DRAMP31620,HPTWPQKSVWHGSDPNGRRLTESY,24,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7779,DRAMP31621,ETWRTEAPSATGQASSLLGGRLLGQ,25,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7780,DRAMP31622,LGQSAASAHHAYIVLAIENSFMTASKKK,28,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Linear,Free,Free,None,L,DRAMP
7781,DRAMP31623,AXQNXXXPLXXVX,13,Not available,Not available,Tumor cells: CEM/VM-1 (40% inhibition at 1 µM); CEM-VLB (40% inhibition at 1 µM); CEM-WT (40% inhibition at 1 µM); CEM/VM-1 (44% inhibition at 1 µM); CEM-VLB (44% inhibition at 1 µM); CEM-WT (44% inhibition at 1 µM); CEM-WT (50% inhibition at 1 µM),Cyclic,,,X(2/13)=Leu(3-OH); X(5)=N(Me)xiIle; X(6)=Asn(3-OH); X(7/10)=xiThr; X(11)=Unk,L,DRAMP
7782,DRAMP31624,XXXFLXXLGXX,11,Not available,Not available,Tumor cells: CEM/VM-1 (No inhibition at 4 µM); CEM-VLB (No inhibition at 4 µM); CEM-WT (No inhibition at 4 µM),Cyclic,,,"X(1)=Abu(2,3-dehydro); X(2)=xiHyp; X(3/11)=Hse; X(6/7)=xiIle; X(10)=Unk",L,DRAMP
7783,DRAMP31625,MWKWFHNVLSSWQLLADKRPARDYNRK,27,Not available,Not available,Tumor cells: SNU-601 (IC50=37 µM); Jurkat (IC50=47 µM); OCI-AML-2 (IC50=50 µM); HL-60 (IC50=53 µM); MCF-7 (IC50=55 µM),Linear,Free,Free,None,L,DRAMP
7784,DRAMP31626,MWKWFHNVLSWWWLLADKRPARDYNRK,27,Not available,"Pep27anal2 can penetrate the plasma membrane, and then induce apoptosis in both caspase-and cytochrome c-independent manner",Tumor cells: MCF-7 (IC50<10 µM); HL-60 (IC50=20 µM); Jurkat (IC50=23 µM); SNU-601 (IC50=25 µM); OCI-AML-2 (IC50=29 µM),Linear,Free,Free,None,L,DRAMP
7785,DRAMP31627,MRKWFHNVLSSGQLLADKWPAWDYNRK,27,Not available,Not available,Tumor cells: MCF-7 (IC50=38 µM); Jurkat (IC50=50 µM); SNU-601 (IC50=50 µM); HL-60 (IC50=52 µM); OCI-AML-2 (IC50=67 µM),Linear,Free,Free,None,L,DRAMP
7786,DRAMP31628,MWKEFHNVLSSGQLLADKRWARWYNRW,27,Not available,Not available,Tumor cells: MCF-7 (IC50=29 µM); SNU-601 (IC50=37 µM); Jurkat (IC50=46 µM); OCI-AML-2 (IC50=50 µM); HL-60 (IC50=51 µM),Linear,Free,Free,None,L,DRAMP
7787,DRAMP31629,MWKWFHNVLSSGQLLADKWWAWWYNWW,27,Not available,Not available,Tumor cells: HL-60 (IC50>70 µM); Jurkat (IC50>70 µM); MCF-7 (IC50>70 µM); OCI-AML-2 (IC50>70 µM); SNU-601 (IC50>70 µM),Linear,Free,Free,None,L,DRAMP
7788,DRAMP31630,YSL,3,Not available,"Enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1β, TNF-α, and NO in vitro",Tumor cells: BEL-7402 (20.8% cytotoxic at 1 µg/ml); BEL-7402 (33.8% cytotoxic at 10 µg/ml); BEL-7402 (35.6% cytotoxic at 100 µg/ml); BEL-7402 (39.0% cytotoxic at 0.1 µg/ml); B16-F10 (49.4% cytotoxic at 0.1 µg/ml); B16-F10 (51.2% cytotoxic at 1 µg/ml); B16-F10 (53.0% cytotoxic at 10 µg/ml); B16-F10 (61.2% cytotoxic at 100 µg/ml),Linear,Free,Free,None,L,DRAMP
7789,DRAMP31631,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,34,Not available,Induce apoptosis in highly malignant NB-derived cell lines,Tumor cells: NGP (>50% apoptosis at 20 µM); SK-N-AS (0% apoptosis at 10 µM); SK-N-AS (10% apoptosis at 20 µM); IMR-5 (15% apoptosis at 10 µM); NGP (20% apoptosis at 10 µM); IMR-5 (20% apoptosis at 20 µM); NB69 (30% apoptosis at 10 µM); NGP (30% apoptosis at 50 µM); SK-N-AS (30% apoptosis at 50 µM); IMR-5 (50% apoptosis at 50 µM); NB69 (80% apoptosis at 20 µM); NB69 (80% apoptosis at 50 µM),Linear,Free,Free,rrrrrrrr=D-isomer homopolymer of eight arginine residues,Mix,DRAMP
7790,DRAMP31632,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,29,Not available,Induce apoptosis in highly malignant NB-derived cell lines,Tumor cells: IMR-5 (23% apoptosis at 10 µM); NB69 (25% apoptosis at 10 µM); IMR-5 (35% apoptosis at 20 µM); NGP (43% apoptosis at 10 µM); SK-N-AS (45% apoptosis at 20 µM); NGP (46% apoptosis at 20 µM); IMR-5 (55% apoptosis at 50 µM); SK-N-AS (65% apoptosis at 50 µM); NB69 (66% apoptosis at 20 µM); NB69 (68% apoptosis at 50 µM); NGP (79% apoptosis at 50 µM); SK-N-AS (8% apoptosis at 10 µM),Linear,Free,Free,rrrrrrrr=D-isomer homopolymer of eight arginine residues,Mix,DRAMP
7791,DRAMP31633,rrrrrrrrGEDIIRNIARHAAQVGASMDR,29,Not available,Induce apoptosis in highly malignant NB-derived cell lines,Tumor cells: IMR-5 (0% apoptosis at 10 µM); NGP (1% apoptosis at 10 µM); SK-N-AS (1% apoptosis at 10 µM); IMR-5 (1% apoptosis at 20 µM); NB69 (1% apoptosis at 20 µM); NB69 (2% apoptosis at 10 µM); NGP (2% apoptosis at 20 µM); SK-N-AS (2% apoptosis at 20 µM); IMR-5 (2% apoptosis at 50 µM); NGP (3% apoptosis at 50 µM); SK-N-AS (3% apoptosis at 50 µM); NB69 (5% apoptosis at 50 µM),Linear,Free,Free,rrrrrrrr=D-isomer homopolymer of eight arginine residues,Mix,DRAMP
7792,DRAMP31634,LKlLKKLlkKLLkLL,15,Not available,The exclusive selectivity of the peptide towards cancer derives from its specific binding to surface phosphatidylserine and the killing of the cancer cells via cytoplasmic membrane depolarization,Tumor cells: CL-1 (LC50=3 μmol/L); MDA-MB-231 (LC50=3 μmol/L); 22Rv1 (LC50=6 μmol/L),Linear,Free,Amidation,l=D-Leucine; k=D-Lysine,Mix,DRAMP
7793,DRAMP31635,YGGFM,5,Not available,lead to apoptosis,"Tumor cells: HBL (0.4% inhibition at 1μM, 1% inhibition at 10μM, 4.5% inhibition at 100μM, 10.8% inhibition at 1000μM); HT-29 (14% inhibition at 1μM, 15.9% inhibition at 10μM, 16.1% inhibition at 100μM, 19.3% inhibition at 1000μM); SW620 (18.9% inhibition at 1μM, 12.7% inhibition at 10μM, 15.3% inhibition at 100μM, 19.1% inhibition at 1000μM); HeLa (2.3% inhibition at 1μM, 11.4% inhibition at 10μM, 12% inhibition at 100μM, 22.3% inhibition at 1000μM); MCF-7 (3.6% inhibition at 1μM, 4.1% inhibition at 10μM, 7.6% inhibition at 100μM, 15.4% inhibition at 1000μM); CaCo-2 (4.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.4% inhibition at 100μM, 3.2% inhibition at 1000μM); HEp-2 (5.2% inhibition at 1μM, 4.5% inhibition at 10μM, 2.4% inhibition at 100μM, 3.3% inhibition at 1000μM)",Linear,Free,Free,None,L,DRAMP
7794,DRAMP31636,YX,2,Not available,lead to apoptosis,"Tumor cells: HeLa (10% inhibition at 10μM, 8.2% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.9% inhibition at 1μM, 16.5% inhibition at 10μM, 28.1% inhibition at 100μM, 58.2% inhibition at 1000μM); HEp-2 (14.2% inhibition at 1μM, 19.7% inhibition at 10μM, 24.9% inhibition at 100μM, 30.4% inhibition at 1000μM); MCF-7 (2.4% inhibition at 10μM, 7.5% inhibition at 1000μM); CaCo-2 (3.5% inhibition at 1μM, 22.7% inhibition at 10μM, 18.9% inhibition at 100μM, 26.4% inhibition at 1000μM); HBL (6.5% inhibition at 1μM, 14% inhibition at 10μM, 7.5% inhibition at 100μM, 14% inhibition at 1000μM); HT-29 (9.8% inhibition at 1μM, 1.6% inhibition at 10μM, 5.4% inhibition at 100μM, 26.5% inhibition at 1000μM)",Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7795,DRAMP31637,YX,2,Not available,lead to apoptosis,"Tumor cells: MCF-7 (1.1% inhibition at 10μM, 1.2% inhibition at 100μM, 17.8% inhibition at 1000μM); SW620 (10.5% inhibition at 1μM, 21.9% inhibition at 10μM, 11.8% inhibition at 100μM, 17.9% inhibition at 1000μM); CaCo-2 (3.7% inhibition at 1μM, 16.5% inhibition at 10μM, 8.4% inhibition at 100μM, 14.5% inhibition at 1000μM); HBL (3.9% inhibition at 10μM, 7.3% inhibition at 1000μM); HT-29 (4.9% inhibition at 1μM, 8.9% inhibition at 10μM, 3.4% inhibition at 100μM, 20.8% inhibition at 1000μM); HEp-2 (6.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.2% inhibition at 100μM, 21.2% inhibition at 1000μM); HeLa (7.5% inhibition at 1μM, 6.1% inhibition at 10μM, 3.1% inhibition at 100μM, 14.8% inhibition at 1000μM)",Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7796,DRAMP31638,YX,2,Not available,lead to apoptosis,"Tumor cells: HT-29 (0.7% inhibition at 1μM, 8.3% inhibition at 10μM, 10.5% inhibition at 100μM, 21.8% inhibition at 1000μM); MCF-7 (1.6% inhibition at 1μM, 2.6% inhibition at 10μM, 7.7% inhibition at 100μM, 18.7% inhibition at 1000μM); SW620 (10.7% inhibition at 1μM, 10% inhibition at 10μM, 9.4% inhibition at 100μM, 18.7% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); CaCo-2 (22.2% inhibition at 1μM, 21.4% inhibition at 10μM, 17.5% inhibition at 100μM, 16% inhibition at 1000μM); HBL (3% inhibition at 1μM, 4.7% inhibition at 10μM, 2.7% inhibition at 100μM, 7.3% inhibition at 1000μM); HeLa (7.2% inhibition at 1μM, 17.1% inhibition at 10μM, 11% inhibition at 100μM, 20.5% inhibition at 1000μM)",Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7797,DRAMP31639,YX,2,Not available,lead to apoptosis,"Tumor cells: HeLa (10% inhibition at 10μM, 8.2% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.9% inhibition at 1μM, 16.5% inhibition at 10μM, 28.1% inhibition at 100μM, 58.2% inhibition at 1000μM); HEp-2 (14.2% inhibition at 1μM, 19.7% inhibition at 10μM, 24.9% inhibition at 100μM, 30.4% inhibition at 1000μM); MCF-7 (2.4% inhibition at 10μM, 7.5% inhibition at 1000μM); CaCo-2 (3.5% inhibition at 1μM, 22.7% inhibition at 10μM, 18.9% inhibition at 100μM, 26.4% inhibition at 1000μM); HBL (6.5% inhibition at 1μM, 14% inhibition at 10μM, 7.5% inhibition at 100μM, 14% inhibition at 1000μM); HT-29 (9.8% inhibition at 1μM, 1.6% inhibition at 10μM, 5.4% inhibition at 100μM, 26.5% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,S )",L,DRAMP
7798,DRAMP31640,YX,2,Not available,lead to apoptosis,"Tumor cells: MCF-7 (1.1% inhibition at 10μM, 1.2% inhibition at 100μM, 17.8% inhibition at 1000μM); SW620 (10.5% inhibition at 1μM, 21.9% inhibition at 10μM, 11.8% inhibition at 100μM, 17.9% inhibition at 1000μM); CaCo-2 (3.7% inhibition at 1μM, 16.5% inhibition at 10μM, 8.4% inhibition at 100μM, 14.5% inhibition at 1000μM); HBL (3.9% inhibition at 10μM, 7.3% inhibition at 1000μM); HT-29 (4.9% inhibition at 1μM, 8.9% inhibition at 10μM, 3.4% inhibition at 100μM, 20.8% inhibition at 1000μM); HEp-2 (6.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.2% inhibition at 100μM, 21.2% inhibition at 1000μM); HeLa (7.5% inhibition at 1μM, 6.1% inhibition at 10μM, 3.1% inhibition at 100μM, 14.8% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,S )",L,DRAMP
7799,DRAMP31641,YX,2,Not available,lead to apoptosis,"Tumor cells: HT-29 (0.7% inhibition at 1μM, 8.3% inhibition at 10μM, 10.5% inhibition at 100μM, 21.8% inhibition at 1000μM); MCF-7 (1.6% inhibition at 1μM, 2.6% inhibition at 10μM, 7.7% inhibition at 100μM, 18.7% inhibition at 1000μM); SW620 (10.7% inhibition at 1μM, 10% inhibition at 10μM, 9.4% inhibition at 100μM, 18.7% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); CaCo-2 (22.2% inhibition at 1μM, 21.4% inhibition at 10μM, 17.5% inhibition at 100μM, 16% inhibition at 1000μM); HBL (3% inhibition at 1μM, 4.7% inhibition at 10μM, 2.7% inhibition at 100μM, 7.3% inhibition at 1000μM); HeLa (7.2% inhibition at 1μM, 17.1% inhibition at 10μM, 11% inhibition at 100μM, 20.5% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,S )",L,DRAMP
7800,DRAMP31642,YX,2,Not available,lead to apoptosis,"Tumor cells: HeLa (10% inhibition at 10μM, 8.2% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.9% inhibition at 1μM, 16.5% inhibition at 10μM, 28.1% inhibition at 100μM, 58.2% inhibition at 1000μM); HEp-2 (14.2% inhibition at 1μM, 19.7% inhibition at 10μM, 24.9% inhibition at 100μM, 30.4% inhibition at 1000μM); MCF-7 (2.4% inhibition at 10μM, 7.5% inhibition at 1000μM); CaCo-2 (3.5% inhibition at 1μM, 22.7% inhibition at 10μM, 18.9% inhibition at 100μM, 26.4% inhibition at 1000μM); HBL (6.5% inhibition at 1μM, 14% inhibition at 10μM, 7.5% inhibition at 100μM, 14% inhibition at 1000μM); HT-29 (9.8% inhibition at 1μM, 1.6% inhibition at 10μM, 5.4% inhibition at 100μM, 26.5% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,R )",L,DRAMP
7801,DRAMP31643,YX,2,Not available,lead to apoptosis,"Tumor cells: MCF-7 (1.1% inhibition at 10μM, 1.2% inhibition at 100μM, 17.8% inhibition at 1000μM); SW620 (10.5% inhibition at 1μM, 21.9% inhibition at 10μM, 11.8% inhibition at 100μM, 17.9% inhibition at 1000μM); CaCo-2 (3.7% inhibition at 1μM, 16.5% inhibition at 10μM, 8.4% inhibition at 100μM, 14.5% inhibition at 1000μM); HBL (3.9% inhibition at 10μM, 7.3% inhibition at 1000μM); HT-29 (4.9% inhibition at 1μM, 8.9% inhibition at 10μM, 3.4% inhibition at 100μM, 20.8% inhibition at 1000μM); HEp-2 (6.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.2% inhibition at 100μM, 21.2% inhibition at 1000μM); HeLa (7.5% inhibition at 1μM, 6.1% inhibition at 10μM, 3.1% inhibition at 100μM, 14.8% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,R )",L,DRAMP
7802,DRAMP31644,YX,2,Not available,lead to apoptosis,"Tumor cells: HT-29 (0.7% inhibition at 1μM, 8.3% inhibition at 10μM, 10.5% inhibition at 100μM, 21.8% inhibition at 1000μM); MCF-7 (1.6% inhibition at 1μM, 2.6% inhibition at 10μM, 7.7% inhibition at 100μM, 18.7% inhibition at 1000μM); SW620 (10.7% inhibition at 1μM, 10% inhibition at 10μM, 9.4% inhibition at 100μM, 18.7% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); CaCo-2 (22.2% inhibition at 1μM, 21.4% inhibition at 10μM, 17.5% inhibition at 100μM, 16% inhibition at 1000μM); HBL (3% inhibition at 1μM, 4.7% inhibition at 10μM, 2.7% inhibition at 100μM, 7.3% inhibition at 1000μM); HeLa (7.2% inhibition at 1μM, 17.1% inhibition at 10μM, 11% inhibition at 100μM, 20.5% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,R )",L,DRAMP
7803,DRAMP31645,YXG,3,Not available,lead to apoptosis,"Tumor cells: HBL (1.6% inhibition at 1μM, 2.9% inhibition at 10μM, 5.9% inhibition at 100μM, 17.9% inhibition at 1000μM); SW620 (13.6% inhibition at 1μM, 20.4% inhibition at 10μM, 14.4% inhibition at 100μM, 23.4% inhibition at 1000μM); CaCo-2 (2.2% inhibition at 1μM, 4.2% inhibition at 10μM, 6.4% inhibition at 100μM, 6.2% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); MCF-7 (21.2% inhibition at 100μM); HT-29 (5.4% inhibition at 1μM, 7.4% inhibition at 10μM, 9.5% inhibition at 100μM, 15.7% inhibition at 1000μM); HeLa (9.8% inhibition at 1μM, 7.3% inhibition at 10μM, 9.9% inhibition at 100μM, 28.2% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,S )",L,DRAMP
7804,DRAMP31646,YXG,3,Not available,lead to apoptosis,"Tumor cells: HBL (1.2% inhibition at 10μM, 3.3% inhibition at 100μM, 19.4% inhibition at 1000μM); HeLa (11% inhibition at 1μM, 11.7% inhibition at 10μM, 11.6% inhibition at 100μM, 28.2% inhibition at 1000μM); MCF-7 (15.6% inhibition at 100μM); SW620 (17% inhibition at 1μM, 13.5% inhibition at 10μM, 13.5% inhibition at 100μM, 25.3% inhibition at 1000μM); HEp-2 (4.6% inhibition at 1μM, 4.9% inhibition at 10μM, 12.6% inhibition at 100μM, 26.4% inhibition at 1000μM); HT-29 (7.6% inhibition at 1μM, 3.8% inhibition at 10μM, 12.4% inhibition at 100μM, 22.4% inhibition at 1000μM); CaCo-2 (8.1% inhibition at 1μM, 6.9% inhibition at 10μM, 8.1% inhibition at 100μM, 8.6% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,S )",L,DRAMP
7805,DRAMP31647,YXG,3,Not available,lead to apoptosis,"Tumor cells: HBL (1.6% inhibition at 1μM, 2.9% inhibition at 10μM, 5.9% inhibition at 100μM, 17.9% inhibition at 1000μM); SW620 (13.6% inhibition at 1μM, 20.4% inhibition at 10μM, 14.4% inhibition at 100μM, 23.4% inhibition at 1000μM); CaCo-2 (2.2% inhibition at 1μM, 4.2% inhibition at 10μM, 6.4% inhibition at 100μM, 6.2% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); MCF-7 (21.2% inhibition at 100μM); HT-29 (5.4% inhibition at 1μM, 7.4% inhibition at 10μM, 9.5% inhibition at 100μM, 15.7% inhibition at 1000μM); HeLa (9.8% inhibition at 1μM, 7.3% inhibition at 10μM, 9.9% inhibition at 100μM, 28.2% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,R )",L,DRAMP
7806,DRAMP31648,YXG,3,Not available,lead to apoptosis,"Tumor cells: HBL (1.2% inhibition at 10μM, 3.3% inhibition at 100μM, 19.4% inhibition at 1000μM); HeLa (11% inhibition at 1μM, 11.7% inhibition at 10μM, 11.6% inhibition at 100μM, 28.2% inhibition at 1000μM); MCF-7 (15.6% inhibition at 100μM); SW620 (17% inhibition at 1μM, 13.5% inhibition at 10μM, 13.5% inhibition at 100μM, 25.3% inhibition at 1000μM); HEp-2 (4.6% inhibition at 1μM, 4.9% inhibition at 10μM, 12.6% inhibition at 100μM, 26.4% inhibition at 1000μM); HT-29 (7.6% inhibition at 1μM, 3.8% inhibition at 10μM, 12.4% inhibition at 100μM, 22.4% inhibition at 1000μM); CaCo-2 (8.1% inhibition at 1μM, 6.9% inhibition at 10μM, 8.1% inhibition at 100μM, 8.6% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,R )",L,DRAMP
7807,DRAMP31649,YXGFM,5,Not available,lead to apoptosis,"Tumor cells: HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)",Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7808,DRAMP31650,YXGFM,5,Not available,lead to apoptosis,"Tumor cells: HEp-2 (13.7% inhibition at 1μM, 25.8% inhibition at 10μM, 34.7% inhibition at 100μM, 44.5% inhibition at 1000μM); HT-29 (16.2% inhibition at 1μM, 6.6% inhibition at 10μM, 5.1% inhibition at 100μM, 14.5% inhibition at 1000μM); CaCo-2 (17.7% inhibition at 1μM, 10.9% inhibition at 10μM, 12.1% inhibition at 100μM, 8.1% inhibition at 1000μM); HBL (2.4% inhibition at 1μM, 4.5% inhibition at 10μM, 11.4% inhibition at 100μM, 23.2% inhibition at 1000μM); SW620 (26.4% inhibition at 1μM, 13.1% inhibition at 10μM, 14.6% inhibition at 100μM, 38.4% inhibition at 1000μM); HeLa (8.5% inhibition at 1μM, 9.5% inhibition at 10μM, 15.4% inhibition at 100μM, 24.1% inhibition at 1000μM); MCF-7 (9.6% inhibition at 100μM, 29.9% inhibition at 100μM)",Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7809,DRAMP31651,YXGFM,5,Not available,lead to apoptosis,Not available,Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7810,DRAMP31652,YXGFM,5,Not available,lead to apoptosis,"Tumor cells: HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)",Linear,Free,Free,X=Cα -dialkylated glycine (Aaa2),L,DRAMP
7811,DRAMP31653,YXGFM,5,Not available,lead to apoptosis,"Tumor cells: HEp-2 (13.7% inhibition at 1μM, 25.8% inhibition at 10μM, 34.7% inhibition at 100μM, 44.5% inhibition at 1000μM); HT-29 (16.2% inhibition at 1μM, 6.6% inhibition at 10μM, 5.1% inhibition at 100μM, 14.5% inhibition at 1000μM); CaCo-2 (17.7% inhibition at 1μM, 10.9% inhibition at 10μM, 12.1% inhibition at 100μM, 8.1% inhibition at 1000μM); HBL (2.4% inhibition at 1μM, 4.5% inhibition at 10μM, 11.4% inhibition at 100μM, 23.2% inhibition at 1000μM); SW620 (26.4% inhibition at 1μM, 13.1% inhibition at 10μM, 14.6% inhibition at 100μM, 38.4% inhibition at 1000μM); HeLa (8.5% inhibition at 1μM, 9.5% inhibition at 10μM, 15.4% inhibition at 100μM, 24.1% inhibition at 1000μM); MCF-7 (9.6% inhibition at 100μM, 29.9% inhibition at 100μM)",Linear,Free,Free,X=Cα -dialkylated glycine (Aaa2),L,DRAMP
7812,DRAMP31654,YXGFM,5,Not available,lead to apoptosis,Not available,Linear,Free,Free,X=Cα -dialkylated glycine (Aaa2),L,DRAMP
7813,DRAMP31655,YGGFMX,6,Not available,lead to apoptosis,"Tumor cells: CaCo-2 (11.8% inhibition at 10μM, 47.0% inhibition at 1000μM); MCF-7 (2.2% inhibition at 1μM, 7.1% inhibition at 10μM, 6.9% inhibition at 100μM, 25.9% inhibition at 1000μM); HEp-2 (3.9% inhibition at 10μM, 45.0% inhibition at 1000μM); HBL (4.1% inhibition at 1μM, 70.7% inhibition at 10μM, 34.2% inhibition at 1000μM); HT-29 (9.2% inhibition at 1000μM); HeLa (9.3% inhibition at 1000μM)",Linear,Free,Free,X=Cαα -dialkylated glycine (Aaa1 ),L,DRAMP
7814,DRAMP31656,FLGALFKVASKVLPSVKCAITKKC,24,Not available,Not available,Tumor cells: HCT 116 (IC50=113.31 µg/ml); A498 (IC50=138.06 µg/ml); A549 (IC50=145.72 µg/ml); MCF-7 (IC50=183.74 µg/ml); MKN 45 (IC50=34.96 µg/ml); SK-OV-3 (IC50=38.28 µg/ml); NCI-H630 (IC50=41.85 µg/ml); PC-3 (IC50=43.64 µg/ml); SK-MEL-2 (IC50=47.47 µg/ml),Linear,Free,Free,None,L,DRAMP
7815,DRAMP31657,FLGALFKWASK,11,Not available,Not available,Tumor cells: NCI-H630 (IC50=129.54 µg/ml); MKN 45 (IC50=142.72 µg/ml); HCT 116 (IC50=144.37 µg/ml); SK-OV-3 (IC50=150.45 µg/m); PC-3 (IC50=174.15 µg/ml); MCF-7 (IC50=198.87 µg/ml); A498 (IC50=214.33 µg/ml); A549 (IC50=418.15 µg/ml),Linear,Free,Free,None,L,DRAMP
7816,DRAMP31658,FLGWLFKVASK,11,Not available,Not available,Tumor cells: A549 (IC50=106.27 µg/ml); PC-3 (IC50=123.81 µg/ml); HCT 116 (IC50=30.48 µg/ml); SK-MEL-2 (IC50=30.48 µg/ml); A498 (IC50=73.26 µg/ml); NCI-H630 (IC50=75.92 µg/ml); MCF-7 (IC50=77.29 µg/ml); MKN 45 (IC50=82.70 µg/ml); SK-OV-3 (IC50=92.15 µg/ml),Linear,Free,Free,None,L,DRAMP
7817,DRAMP31659,ALSKALSKALSKALSKALSKALSK,24,Not available,magainin 2 and synthetic analogues can rapidly and irreversibly lyse hematopoietic tumor and solid tumor ,Tumor cells: SSKT-1 (IC50=107 µg/ml); Daudi (IC50=115 µg/ml); RPMI-8402 (IC50=60 µg/ml); Raji (IC50=64 µg/ml); MLA (IC50=80 µg/ml); U-937 (IC50=97 µg/ml); K562 (IC50=98 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7818,DRAMP31660,AKSKAKSKAKSKAKSKAKSKAKSK,24,Not available,magainin 2 and synthetic analogues can rapidly and irreversibly lyse hematopoietic tumor and solid tumor ,Tumor cells: MLA (IC50=102 µg/ml); SSKT-1 (IC50=109 µg/ml); K562 (IC50=112 µg/ml); U-937 (IC50=123 µg/ml); Daudi (IC50=143 µg/ml); Raji (IC50=72 µg/ml); RPMI-8402 (IC50=83 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7819,DRAMP31661,KILRGVSKKIMRTFLRRILTGKK,23,Not available,Not available,Tumor cells: HeLa (Not active up to 100 µg/ml),Linear,Free,Free,None,L,DRAMP
7820,DRAMP31662,KILRGVSKKIMRTFLRRISKDILTGKK,27,Not available,Not available,Tumor cells: HeLa ((38.4±10.3)% Cytotoxicity=100 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7821,DRAMP31663,KILRGVSKKIMRTFLRRISKDILTGKK,27,Not available,Not available,Tumor cells: HeLa ((6.5±17.3)% Cytotoxicity=100 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7822,DRAMP31664,KILRGVSKKIMRTFLRRISKDILTGKK,27,Not available,Not available,Tumor cells: HeLa ((38.4±10.3)% Cytotoxicity=100 µg/ml),Linear,Free,Free,None,L,DRAMP
7823,DRAMP31665,KILRGVSKKIMRTFLRRISKDILTGKK,27,Not available,Not available,Tumor cells: HeLa ((6.5±17.3)% Cytotoxicity=100 µg/ml),Linear,Free,Free,None,L,DRAMP
7824,DRAMP31666,KISKKIMRTFLRRISKDILTGKK,23,Not available,Not available,Tumor cells: HeLa (Not active up to 100 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7825,DRAMP31667,VXLfPVXLfP,10,Not available,Not available,Tumor cells: HeLa (LC50=7.4 µM); A549 (LC50=7.5 µM),Cyclic,Free,Free,X=Orn; f=D-Phe,Mix,DRAMP
7826,DRAMP31668,fCYwOXXTKKrPKPfQwFwLXKKLMYPTYLKKfQWAVXHL,40,Not available,Not available,Tumor cells: Molt-4 (10.4 % inhibition of cell proliferation at 1 nM); KB (10.6 % inhibition of cell proliferation at 1 nM); PTC (14.2 % inhibition of cell proliferation at 10 nM); PTC (16.5 % inhibition of cell proliferation at 1 nM); PTC (16.8 % inhibition of cell proliferation at 100 nM); KB (18.2 % inhibition of cell proliferation at 10 nM); Molt-4 (18.7 % inhibition of cell proliferation at 10 nM); PTC (21.7 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (24.2 % inhibition of cell proliferation at 1 nM); PTC (27.9 % inhibition of cell proliferation at 10 µM); MCF-7 (28.2 % inhibition of cell proliferation at 10 nM); MCF-7 (29.7 % inhibition of cell proliferation at 1 nM); KB (30.7 % inhibition of cell proliferation at 100 nM); Molt-4 (34.7 % inhibition of cell proliferation at 100 nM); MCF-7 (35.3 % inhibition of cell proliferation at 100 nM); Mia PaCa-2 (37.8 % inhibition of cell proliferation at 10 nM); KB (43.1 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (48.2 % inhibition of cell proliferation at 100 nM); Molt-4 (54.3 % inhibition of cell proliferation at 1 µM); MCF-7 (59.4 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (59.6 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (84.5 % inhibition of cell proliferation at 10 µM); MCF-7 (85.4 % inhibition of cell proliferation at 10 µM); Molt-4 (94.5 % inhibition of cell proliferation at 10 µM); KB (98.3 % inhibition of cell proliferation at 10 µM),Cyclic,Free,Amidation,f=D-Phenylalanine; w=D-Tryptophan; O=Ornithine; X(6/21)==cycloleucine or 1-aminocyclopentane-1-carboxylic acid; X(7)=penicillamine; r=D-Arginine;  Aib=2-Aminoisobutyric acid,Mix,DRAMP
7827,DRAMP31669,LLGMIPLAISAISALSKL,18,Not available,Cytolytic,Tumor cells: Hep-G2 (LC50=35 μM),Linear,Free,Free,None,L,DRAMP
7828,DRAMP31670,FKCRRWQWRMKKLGAPSITCVR,22,1LFC,Pep1 may kill cancer cells by activating an apoptosis-inducing pathway,Tumor cells: HL-60 (IC50=77 µM),Linear,Free,Free,None,L,DRAMP
7829,DRAMP31671,RKAFRWAWRMLKKAAPSITCVR,22,Not available,mPep1 causes necrotic cell death by destroying cellular membrane structure ,Tumor cells: HL-60 (IC50=8 µM),Linear,Free,Free,None,L,DRAMP
7830,DRAMP31672,KAQIRAMECNIL,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
7831,DRAMP31673,KAQIRAMECNILGRKKRRQRRR,22,Not available,Tat-a5 could arrest cancer cells at G2/M phase and make them apoptotic; Tat-a5 would have the potential to inhibit tumor angiogenesis,Tumor cells: HCT 116 (~80% Cytotoxicity at 100 µM),Linear,Free,Free,None,L,DRAMP
7832,DRAMP31674,KKKFPWWWPFKKK,13,Not available,Not available,Tumor cells: MDA-MB-361 (IC50=80 µg/ml); A549 (IC50=90 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7833,DRAMP31675,KKKFPWWWPFKKKCKKKFPWWWPFKKKC,28,Not available,Not available,Tumor cells: MDA-MB-361 (IC50=10 µg/ml); A549 (IC50=15 µg/ml); A549 (IC50=17 µg/ml); MDA-MB-361 (IC50=17 µg/ml),Linear,Free,Amidation,None,L,DRAMP
7834,DRAMP31676,ETFSDLWKLL,10,Not available,"PNC-28 may be effective in treating human pancreatic cancer. The penetratin sequence appears to be responsible for the fundamental change in the mechanism of action, inducing rapid necrosis initiated by membrane pore formation.",Tumor cells: Mia PaCa-2 (100% Cytotoxicity=75μM),Linear,Free,Free,None,L,DRAMP
7835,DRAMP31677,YKQCHKKGGKKGSG,14,Not available,Not available,Tumor cells: HeLa (Not active up to 100 µM),Linear,Free,Amidation,None,L,DRAMP
7836,DRAMP31678,FVDLKKIANIINSIF,15,Not available,Not available,Tumor cells: MCF-7 (IC50=12 µM); MCF-7 (IC50=27.84 μM); MCF-7 (IC50=31.78 μM); MCF-7 (IC50=31.91 μM); MCF-7 (IC50=34.5 μM); HeLa (IC50=36.31 μM); BEL-7402 (IC50=36.9 μM); BEL-7402 (IC50=37.1 μM); BCaP-37 (IC50=37.33 μM); BCaP-37 (IC50=38.39 μM); BCaP-37 (IC50=38.5 μM); HeLa (IC50=38.96 μM); BEL-7402 (IC50=38.98 μM); BCaP-37 (IC50=39.42 μM); BEL-7402 (IC50=40.16 μM); HeLa (IC50=40.6 μM); HeLa (IC50=43.87 μM); SMMC-7721 (IC50=44.92 μM); SMMC-7721 (IC50=46.73 μM); SMMC-7721 (IC50=47.73 μM); SMMC-7721 (IC50=50.32 μM); A549 (IC50=52.09 μM); A549 (IC50=52.82 μM); A549 (IC50=53.12 μM); A549 (IC50=53.31 μM); MDA-MB-231 (IC50=54.95 μM); BGC-823 (IC50=55.16 μM); BGC-823 (IC50=56.47 μM); MDA-MB-231 (IC50=57.94 μM); LK-2 (IC50=58.32 μM); NCI-H446 (IC50=59.45 μM); MDA-MB-231 (IC50=60.38 μM); LK-2 (IC50=61.57 μM); BGC-823 (IC50=61.63 μM); LK-2 (IC50=61.73 μM); HO-8910 (IC50=62.84 μM); BGC-823 (IC50=63.2 μM); MDA-MB-231 (IC50=63.26 μM); LK-2 (IC50=63.4 μM); HO-8910 (IC50=64.75 μM); NCI-H446 (IC50=64.81 μM); NCI-H446 (IC50=65.29 μM); HO-8910 (IC50=66.55 μM); HO-8910 (IC50=66.68 μM); NCI-H446 (IC50=67.66 μM); HT-29 (IC50=88.91 μM); HT-29 (IC50>100 μM); HT-29 (IC50>100 μM); HT-29 (IC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
7837,DRAMP31679,ILPILSLIGGLL,12,Not available,Not available,Tumor cells: MCF-7 (IC50=56 µM),Linear,Free,Amidation,None,L,DRAMP
7838,DRAMP31680,FKCRRWQWRMKK,12,Not available,Peptides induce lysis of cancer cells through interactions with the plasma membrane,Tumor cells: Ramos (IC50=10 µM); Raji (IC50=13 µM); Kelly (IC50=141 ± 3 µM); HT-29 (IC50=148±8 µM); SU-DHL-4 (IC50=16 µM); KMS-5 (IC50=38 µM); FEMX-I (IC50=40±7 µM); U266B1 (IC50=55 µM); KMM-1 (IC50=57 µM); MT-1 (IC50>160 µM),Linear,Free,Free,None,L,DRAMP
7839,DRAMP31681,KAAKKAAKAAKKAAKAAKKAA,21,Not available,Peptides induce lysis of cancer cells through interactions with the plasma membrane,Tumor cells: FEMX-I (IC50=30±3 µM); HT-29 (IC50=55±14 µM),Linear,Free,Free,None,L,DRAMP
7840,DRAMP31682,IDWKKLLDAAKQIX,14,Not available,Not available,Tumor cells: PC-3 (IC50=20.3±1.0µM); HepG2 (IC50=21.2±0.8µM); EJ (IC50=21.6±1.2µM),Linear,Free,Amidation,X=Leu-S,L,DRAMP
7841,DRAMP31683,GFFGKRKEYFKKFGASFKRRFANLKKRL,28,Not available,Not available,Tumor cells: K562 (EC50>36 µM),Linear,Free,Amidation,None,L,DRAMP
7842,DRAMP31684,GKLIKKFGRKAISYAVKKARGKH,23,Not available,Not available,Tumor cells: K562 (EC50>36 µM),Linear,Free,Free,None,L,DRAMP
7843,DRAMP31685,GKMKEYFKKFGASFKRRFANLKKRL,25,Not available,Not available,Tumor cells: K562 (EC50>36 µM),Linear,Free,Amidation,None,L,DRAMP
7844,DRAMP31686,GLFGKLIKKFLRKAISYAVKKARGKH,26,Not available,Not available,Tumor cells: K562 (EC50=0.7 µM),Linear,Free,Free,None,L,DRAMP
7845,DRAMP31687,GLFGKLIKKKGRKAISYAVKKARGKH,26,Not available,Not available,Tumor cells: K562 (EC50=18 µM),Linear,Free,Free,None,L,DRAMP
7846,DRAMP31688,GLFGKLQKKFGRKAISYAVKKARGKH,26,Not available,Not available,Tumor cells: K562 (EC50=18 µM),Linear,Free,Free,None,L,DRAMP
7847,DRAMP31689,DDESSKPCCDQCACTKSNPPQCRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCKPSEDDKEN,71,Not available,Not available,Tumor cells: HT-29 (IC50=48.3±3.5µM),Cyclic,Free,Free,None,L,DRAMP
7848,DRAMP31690,ACDCRGDCFCGGGGIVRRADRAAVP,25,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 5µg/ml); B16-F10 (50% inhibition at 2.5µg/ml); B16-F10 (75% inhibition at 10µg/ml),Linear,Free,Free,None,L,DRAMP
7849,DRAMP31691,ACDCRGDCFCGGGGIVRRADRAAVP,25,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 2.5µg/ml); B16-F10 (42% inhibition at 5µg/ml); B16-F10 (52% inhibition at 10µg/ml),Linear,Free,Free,None,L,DRAMP
7850,DRAMP31692,ACDCRGDCFCGGGGIVRRADRAAVP,25,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 5µg/ml); B16-F10 (50% inhibition at 2.5µg/ml); B16-F10 (75% inhibition at 10µg/ml),Cyclic,Free,Free,None,L,DRAMP
7851,DRAMP31693,ACDCRGDCFCGGGGIVRRADRAAVP,25,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 2.5µg/ml); B16-F10 (42% inhibition at 5µg/ml); B16-F10 (52% inhibition at 10µg/ml),Cyclic,Free,Free,None,L,DRAMP
7852,DRAMP31694,IVRRADRAAVPGGGGACDCRGDCFC,25,Not available,Not available,Tumor cells: B16-F10 (60% inhibition at 11µg/ml),Linear,Free,Free,None,L,DRAMP
7853,DRAMP31695,LPFFPPVXPIIG,12,Not available,Not available,Tumor cells: L5178Y (ED50=0.39µM); HeLa (ED50=3.4µM); PC-12 (ED50=3.8µM),Cyclic,Free,Amidation,X=Daa,L,DRAMP
7854,DRAMP31696,VPVFPXPLF,9,Not available,Not available,Tumor cells: HeLa (ED50>9µM); L5178Y (ED50>9µM); PC-12 (ED50>9µM),Cyclic,Free,Amidation,X=Daa,L,DRAMP
7855,DRAMP31697,IIFPXPLXPINAI,13,Not available,Not available,Tumor cells: L5178Y (ED50=3.03µM),Cyclic,Free,Amidation,X(5)= 4-Hydroxyproline; X(8)=Daa,L,DRAMP
7856,DRAMP31698,VPVFPPLXPI,10,Not available,Not available,Tumor cells: L5178Y (ED50=0.48µM),Cyclic,Free,Amidation,X=Daa,L,DRAMP
7857,DRAMP31699,LPPPPLXPFFF,11,Not available,Not available,Tumor cells: L5178Y (ED50=0.41µM); HeLa (ED50=4.43µM); PC-12 (ED50>8µM),Cyclic,Free,Amidation,X=Daa,L,DRAMP
7858,DRAMP31700,CSSRTMHHC,9,Not available,Not available,Tumor cells: A2058 (30% viablity=100 µM); SK-MEL-28 (35-40% viablity=100 µM); B16-F10 (50% viablity=100 µM); HeLa (50% viablity=100 µM); MDA-MB-231 (55% viablity=100 µM); SK-MEL-25 (55-60% viablity=100 µM); HL-60 (90% viablity=100 µM),Cyclic,Free,Free,None,L,DRAMP
7859,DRAMP31701,KWKSFAKTFKSAKKTVAHTALKAISS,26,Not available,Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis,Tumor cells: A-375 (IC50>83.6 μmol/L); A549 (IC50>83.6 μmol/L); B16 (IC50>83.6 μmol/L); HeLa (IC50>83.6 μmol/L); MCF-7 (IC50>83.6 μmol/L); NCI-H1299 (IC50>83.6 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L),Linear,Acetylation,Amidation,None,L,DRAMP
7860,DRAMP31702,KWKSFLKTFKSAKKTVAHTAAKAISS,26,Not available,Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis,Tumor cells: NCI-H1299 (IC50=37.7 μmol/L); A-375 (IC50>83.6 μmol/L); A549 (IC50>83.6 μmol/L); B16 (IC50>83.6 μmol/L); HeLa (IC50>83.6 μmol/L); MCF-7 (IC50>83.6 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L),Linear,Acetylation,Amidation,None,L,DRAMP
7861,DRAMP31703,KWKSFLKTFKSAKKTVAHTALKAISS,26,Not available,Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis,Tumor cells: NCI-H1299 (IC50=16.4 μmol/L); A-375 (IC50>83.6 μmol/L); A549 (IC50>83.6 μmol/L); B16 (IC50>83.6 μmol/L); HeLa (IC50>83.6 μmol/L); MCF-7 (IC50>83.6 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L),Linear,Acetylation,Amidation,None,L,DRAMP
7862,DRAMP31704,KWKSFLKTFKSAKKTVLHTAAKAISS,26,Not available,Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis,Tumor cells: NCI-H1299 (IC50=15.6 μmol/L); A-375 (IC50=59.8 μmol/L); B16 (IC50=63.5 μmol/L); HeLa (IC50=64.7 μmol/L); MCF-7 (IC50=70.8 μmol/L); A549 (IC50=71 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L),Linear,Acetylation,Amidation,None,L,DRAMP
7863,DRAMP31705,KWKSFLKTFKSAKKTVLHTAAKAISS,26,Not available,Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis,,Linear,Acetylation,Amidation,None,L,DRAMP
7864,DRAMP31706,KWKSFAKTFKSAKKTVLHTALKAISS,26,Not available,Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis,Tumor cells: NCI-H1299 (IC50=14 μmol/L); A549 (IC50=53 μmol/L); HeLa (IC50=58.6 μmol/L); A-375 (IC50=58.7 μmol/L); MCF-7 (IC50=62.3 μmol/L); B16 (IC50=62.5 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L),Linear,Acetylation,Amidation,None,L,DRAMP
7865,DRAMP31707,YHWYGYTPQNVIGGGKLlLKlLKKLLKlLKKK,32,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=0.12 µM); MDA-MB-231 (IC50=0.46 µM),Linear,Free,Free,None,Mix,DRAMP
7866,DRAMP31708,VDKPPYLPRPRPPRXXYNX,19,Not available,Not available,Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml),Linear,Free,Amidation,X(15)=Orn; X(16)=L-tert-leucine; X(19)=Orn,L,DRAMP
7867,DRAMP31709,VDKPPYLPRPRPXRXIYNX,19,Not available,Not available,Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml),Linear,Free,Amidation,X(13)= 4-Hydroxyproline; X(15)= 4-Hydroxyproline; X(19)=Orn,L,DRAMP
7868,DRAMP31710,VDKPPYLPRPRPXRXXYNX,19,Not available,Not available,Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml),Linear,Free,Amidation,X(13)= 4-Hydroxyproline; X(15)= 4-Hydroxyproline; X(16)=L-tert-leucine; X(19)=Orn,L,DRAMP
7869,DRAMP31711,LTFEHYWAQLTS,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=0.29 µM);  -- (IC50 for MDMX-p53=1.6 µM),Linear,Free,Free,None,L,DRAMP
7870,DRAMP31712,LTFEHYWAQLTS,12,Not available,Inhibits MDM2-p53 Interaction,,Linear,Free,Free,None,L,DRAMP
7871,DRAMP31713,LTAEHYAAQATS,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2>100 µM);  -- (IC50 for MDMX-p53>100 µM),Linear,Free,Free,None,L,DRAMP
7872,DRAMP31714,QETFSDLWKLLP,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=4.7 µM);  -- (IC50 for MDMX-p53=30 µM),Linear,Free,Free,None,L,DRAMP
7873,DRAMP31715,PRAWEYWLRLME,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=0.57 µM),Linear,Free,Free,None,L,DRAMP
7874,DRAMP31716,PRFWEAWLRLME,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2>100 µM),Linear,Free,Free,None,L,DRAMP
7875,DRAMP31717,PRFWEYALRLME,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2>100 µM),Linear,Free,Free,None,L,DRAMP
7876,DRAMP31718,PRFWEYWLALME,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=0.02 µM),Linear,Free,Free,None,L,DRAMP
7877,DRAMP31719,PRFWEYWLRAME,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=1.14 µM),Linear,Free,Free,None,L,DRAMP
7878,DRAMP31720,PRFWEYWLRLAE,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=0.4 µM),Linear,Free,Free,None,L,DRAMP
7879,DRAMP31721,PRFWEYWLRLME,12,Not available,Inhibits MDM2-p53 Interaction,Tumor cells:  -- (IC50 for MDM2=0.01 µM);  -- (IC50 for MDMX-p53=0.12 µM),Linear,Free,Free,None,L,DRAMP
7880,DRAMP31722,WKKWXKKWK,9,Not available,Not available,Tumor cells: HL-60/ADR (IC50=10.5 ± 3.1 µM); MCF-7/mdr (IC50=11.0 ± 4.4 µM); A20 (IC50=16.0 ± 3.0 µM); IGROV-1 (IC50=19.6 ± 8.7 µM); AT84 (IC50=21.0 ± 1.7 µM); Kelly (IC50=28 ± 0 µM); IGROV-1/CDDP (IC50=6.4 ± 2.6 µM); MT-1 (IC50=73 ± 2 µM); HT-29 (IC50=75 ± 5 µM); HL-60 (IC50=8.0 ± 1.1 µM); K562 (IC50=8.2 ± 1.3 µM); MCF-7  (IC50=8.9 ± 2.8 µM); K562/Gleevec (IC50=9.0 ± 2.1 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
7881,DRAMP31723,XXWXXXWWX,9,Not available,Not available,Tumor cells: A20 (IC50=21.7 ± 2.5 µM); MT-1 (IC50=216 ± 36 µM); AT84 (IC50=23.0 ± 3.6 µM); HT-29 (IC50=248 ± 5 µM); Kelly (IC50=78 ± 7 µM),Linear,Free,Amidation,X(1/2/5/6/9)=ornithine; X(4)=Dip (Diphenylalanine),L,DRAMP
7882,DRAMP31724,XXWXXXWWX,9,Not available,Not available,Tumor cells: AT84 (IC50=14.3 ± 1.2 µM); A20 (IC50=8.3 ± 0.6 µM),Linear,Free,Amidation,X(1/2/5/6/9)=ornithine; X(4)=Dip (Diphenylalanine),L,DRAMP
7883,DRAMP31725,XXWXXXWWX,9,Not available,Not available,Tumor cells: AT84 (IC50=154 ± 29 µM); A20 (IC50=67.7 ± 13.2 µM),Linear,Free,Amidation,X(1/2/5/6/9)=ornithine; X(4)=Dip (Diphenylalanine),L,DRAMP
7884,DRAMP31726,GIPCGESCVFIPCLTSAIGCSCKSKVCYRN,30,Not available,Not available,Tumor cells: BGC-823 (IC50=1.75±0.05µM); HeLa (IC50=15.5±0.06µM); MM96L (IC50=4.91±0.04µM),Cyclic,Free,Free,None,L,DRAMP
7885,DRAMP31727,GSIPCGESCVFIPCISAIIGCSCSNKVCYKN,31,Not available,Not available,Tumor cells: MM96L (IC50=1.03±0.03µM); BGC-823 (IC50=2.91±0.06µM); HeLa (IC50=6.35±0.31µM),Cyclic,Free,Free,None,L,DRAMP
7886,DRAMP31730,AWXLFDDGV,9,Not available,Proapoptosis,Tumor cells: HEp-2 (IC50=0.8 mM); HCT 15 (IC50=1.0 mM),Linear,Acetylation,Free,X=Lys-Acetylation (Lysine with acetylation side group),L,DRAMP
7887,DRAMP31731,GVGSPYVSRLLGICL,15,Not available,Disrupting tumor-mediated mechanisms suppressing host immunity,Not available,Linear,Free,Free,None,L,DRAMP
7888,DRAMP31732,LIAHNQVRQV,10,Not available,Disrupting tumor-mediated mechanisms suppressing host immunity,Not available,Linear,Free,Free,None,L,DRAMP
7889,DRAMP31733,GIIKKIIIKKI,11,Not available,Not available,Tumor cells: HeLa (IC50=160 µM); HL-60 (IC50>500 µM),Linear,Free,Amidation,None,L,DRAMP
7890,DRAMP31734,GIIKKIIIKKIIIKKI,16,Not available,Not available,Tumor cells: HeLa (IC50=15 µM); HL-60 (IC50=25 µM),Linear,Free,Amidation,None,L,DRAMP
7891,DRAMP31735,GIIKKIIIKKIIIKKIIIKKI,21,Not available,Not available,Tumor cells: HL-60 (IC50=10 µM); HeLa (IC50=4 µM),Linear,Free,Amidation,None,L,DRAMP
7892,DRAMP31736,AAKKWAKAKWAKAKKWAKAA,20,Not available,Not available,Tumor cells: HT-29 (EC50>211 µM); Meth A (EC50>211 µM); MT-1 (EC50>211 µM),Linear,Free,Free,None,L,DRAMP
7893,DRAMP31737,AAWKWAWAKKWAKAKKWAKAA,21,Not available,Not available,Tumor cells: HT-29 (EC50=13 µM); MT-1 (EC50=16 µM); Meth A (EC50=9 µM),Linear,Free,Free,None,L,DRAMP
7894,DRAMP31738,AWKKWAKAWKWAKAKWWAKAA,21,Not available,Not available,Tumor cells: MT-1 (EC50=14 µM); Meth A (EC50=19 µM); HT-29 (EC50=23 µM),Linear,Free,Free,None,L,DRAMP
7895,DRAMP31739,KAAKKAWKAAKKAAKWWKKAA,21,Not available,Not available,Tumor cells: Meth A (EC50=155 µM); HT-29 (EC50=173 µM); MT-1 (EC50=68 µM),Linear,Free,Free,None,L,DRAMP
7896,DRAMP31740,KAAKKAWKAAKKAWKAAKKAA,21,Not available,Not available,Tumor cells: Meth A (EC50=15 µM); MT-1 (EC50=15 µM); HT-29 (EC50=21 µM),Linear,Free,Free,None,L,DRAMP
7897,DRAMP31741,KAAKKAWKAWKKAAKAAWKKAA,22,Not available,Not available,Tumor cells: MT-1 (EC50=128 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM),Linear,Free,Free,None,L,DRAMP
7898,DRAMP31742,KAAKKAWKWAKKAAKWAKKAA,21,Not available,Not available,Tumor cells: MT-1 (EC50=28 µM); Meth A (EC50=42 µM); HT-29 (EC50=67 µM),Linear,Free,Free,None,L,DRAMP
7899,DRAMP31743,KAAKKWAKAAKKAAKAWKKAA,21,Not available,Not available,Tumor cells: MT-1 (EC50=186 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM),Linear,Free,Free,None,L,DRAMP
7900,DRAMP31744,KAAKKWAKAWKKAAKAWKKAA,21,Not available,Not available,Tumor cells: MT-1 (EC50=173 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM),Linear,Free,Free,None,L,DRAMP
7901,DRAMP31745,KWWKKAAKAAKKAAKAAKKWA,21,Not available,Not available,Tumor cells: MT-1 (EC50=16 µM); Meth A (EC50=17 µM); HT-29 (EC50=31 µM),Linear,Free,Free,None,L,DRAMP
7902,DRAMP31746,IELLQARGGCX,11,Not available,Not available,Tumor cells: HL-60 (IC50=2.17 µM); NCI-H358 (IC50=4.63 mM),Linear,Free,Amidation,X(11)=Pemetrexed,L,DRAMP
7903,DRAMP31747,IELLQARGGCXGGRRRRRRRR,21,Not available,Not available,Tumor cells: NCI-H358 (IC50=2.19 µM); HL-60 (IC50=2.64 µM),Linear,Free,Amidation,X(11)=Pemetrexed,L,DRAMP
7904,DRAMP31748,RRRRRRRRGGCX,12,Not available,Not available,Tumor cells: HL-60 (IC50=6.24 µM); NCI-H358 (IC50=8.41 µM),Linear,Free,Amidation,X(12)=Pemetrexed,L,DRAMP
7905,DRAMP31750,AFGMALKLLKKVL,13,Not available,Not available,Tumor cells: SW480 (IC50=16 µM); HeLa (IC50=16±3 µM); CCRF-CEM (IC50=17 µM),Linear,Free,Amidation,None,L,DRAMP
7906,DRAMP31751,GFGMAXKLLKKVL,13,Not available,Not available,Tumor cells: SW480 (IC50=18 ± 1 µM); HeLa (IC50=8±2 µM); CCRF-CEM (IC50=9±2 µM),Linear,Free,Amidation,X(6)=AC6C=cyclohexyl-1-carboxylic acid,L,DRAMP
7907,DRAMP31752,GFGMALKXLKKVL,13,Not available,Not available,Tumor cells: CCRF-CEM (IC50=12±2 µM); SW480 (IC50=14 ± 1 µM); HeLa (IC50=7±1 µM),Linear,Free,Amidation,X(6)=AC6C=cyclohexyl-1-carboxylic acid,L,DRAMP
7908,DRAMP31753,GFGMALKLXKKVL,13,Not available,Not available,Tumor cells: CCRF-CEM (IC50=11 µM); SW480 (IC50=16 ± 1 µM); HeLa (IC50=8±2 µM),Linear,Free,Amidation,X(6)=AC6C=cyclohexyl-1-carboxylic acid,L,DRAMP
7909,DRAMP31754,gfgmalkllkkvl,13,Not available,Not available,Tumor cells: CCRF-CEM (IC50=11 µM); HeLa (IC50=12±4 µM); SW480 (IC50=19±2 µM),Linear,Free,Amidation,None,D,DRAMP
7910,DRAMP31755,GFGMALKLlKKVL,13,Not available,Not available,Tumor cells: HeLa (IC50=32±2 µM); CCRF-CEM (IC50=70 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,l=D-Leu,Mix,DRAMP
7911,DRAMP31756,GFGmALKLLKKVL,13,Not available,Not available,Tumor cells: HeLa (IC50=21±4 µM); CCRF-CEM (IC50=43±11 µM); SW480 (IC50=68±2 µM),Linear,Free,Amidation,m=D-Met,Mix,DRAMP
7912,DRAMP31757,GFGMaLKLLKKVL,13,Not available,Not available,Tumor cells: HeLa (IC50=15±5 µM); CCRF-CEM (IC50=29 µM); SW480 (IC50=49±9 µM),Linear,Free,Amidation,a=D-Ala,Mix,DRAMP
7913,DRAMP31758,GfGMALKLLKKVL,13,Not available,Not available,Tumor cells: CCRF-CEM (IC50=15 µM); SW480 (IC50=29±3 µM); HeLa (IC50=8±2 µM),Linear,Free,Amidation,f=D-Phe,Mix,DRAMP
7914,DRAMP31759,GFGMALXLLXXVL,13,Not available,Not available,Tumor cells: HeLa (IC50=10±1 µM); CCRF-CEM (IC50=25±3 µM); SW480 (IC50=35±4 µM),Linear,Free,Amidation,X=Ornithine,L,DRAMP
7915,DRAMP31760,GFGMALRLLRRVL,13,Not available,Not available,Tumor cells: SW480 (IC50=17±2 µM); CCRF-CEM (IC50=22±4 µM); HeLa (IC50=9±3 µM),Linear,Free,Amidation,None,L,DRAMP
7916,DRAMP31761,GFkMALKLLKKVL,13,Not available,Not available,Tumor cells: HeLa (IC50=15±6 µM); CCRF-CEM (IC50=16 µM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
7917,DRAMP31762,GFKMALKLLKKVL,13,Not available,Not available,Tumor cells: SW480 (IC50=13±3 µM); CCRF-CEM (IC50=14±4 µM); HeLa (IC50=8±1 µM),Linear,Free,Amidation,None,L,DRAMP
7918,DRAMP31763,GKFMSLLKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=34 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
7919,DRAMP31764,GKWKKILGHLIR,12,Not available,Not available,Tumor cells: HeLa (IC50> 100 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,L,DRAMP
7920,DRAMP31765,GKWKKILGKLIR,12,Not available,Not available,Tumor cells: HeLa (IC50=30±3 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,L,DRAMP
7921,DRAMP31766,GKWKSLLKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=14±2 µM); SW480 (IC50> 100 µM); CCRF-CEM (IC50>40 µM),Linear,Free,Amidation,None,L,DRAMP
7922,DRAMP31767,GKWLSLLKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=14±3 µM); SW480 (IC50=40 µM),Linear,Free,Amidation,None,L,DRAMP
7923,DRAMP31768,GKWMKLLKHILK,12,Not available,Not available,Tumor cells: SW480 (IC50=35±5 µM); HeLa (IC50=6±1 µM); CCRF-CEM (IC50>40 µM),Linear,Free,Amidation,None,L,DRAMP
7924,DRAMP31769,GMWSKLLGHLLR,12,Not available,Not available,Tumor cells: HeLa (IC50=14±2 µM); SW480 (IC50> 40 µM); CCRF-CEM (IC50>40 µM),Linear,Free,Amidation,None,L,DRAMP
7925,DRAMP31770,GTGLPMSERRKIMLMMR,17,Not available,Not available,Tumor cells: CCRF-CEM (IC50=32 µM); HeLa (IC50> 100 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,L,DRAMP
7926,DRAMP31771,KMWSKILGHLIR,12,Not available,Not available,Tumor cells: HeLa (IC50=35±3 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,L,DRAMP
7927,DRAMP31772,KNWKKXLKKXIKXVK,15,Not available,Not available,Tumor cells: HeLa (IC50=11±7 µM); CCRF-CEM (IC50=25±4 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,X=Aib=1-amino-isobutyric acid,L,DRAMP
7928,DRAMP31773,KNWKKILGKIIKVVK,15,Not available,Not available,Tumor cells: CCRF-CEM (IC50=9 µM); HeLa (IC50=9±4 µM),Linear,Free,Amidation,None,L,DRAMP
7929,DRAMP31774,KNWKKILKKIIKVVK,15,Not available,Not available,Tumor cells: HeLa (IC50=3 µM); CCRF-CEM (IC50=7±2 µM),Linear,Free,Amidation,None,L,DRAMP
7930,DRAMP31775,LFGMALKLLKKVL,13,Not available,Not available,Tumor cells: SW480 (IC50=11±1 µM); CCRF-CEM (IC50=22 µM); HeLa (IC50=9±2 µM),Linear,Free,Amidation,None,L,DRAMP
7931,DRAMP31776,NKWKKILGKIIKVVK,15,Not available,Not available,Tumor cells: SW480 (IC50=37 µM); HeLa (IC50=5±2 µM); CCRF-CEM (IC50=5±3 µM),Linear,Free,Amidation,None,L,DRAMP
7932,DRAMP31777,VNFKKLLGKLLKVVK,15,Not available,Not available,Tumor cells: SW480 (IC50=42 µM); HeLa (IC50=7±1 µM); CCRF-CEM (IC50=9±3 µM),Linear,Free,Amidation,None,L,DRAMP
7933,DRAMP31778,VNXKKLLGKLLKVVK,15,Not available,Not available,Tumor cells: HeLa (IC50=6±1 µM),Linear,Free,Amidation,X=Nal=3-(1-naphthyl)alanine,L,DRAMP
7934,DRAMP31779,VNWKKXLGKXIKXVK,15,Not available,Not available,Tumor cells: SW480 (IC50=28 µM); HeLa (IC50=3±1 µM); CCRF-CEM (IC50=8±2 µM),Linear,Free,Amidation,X=Aib=1-amino-isobutyric acid,L,DRAMP
7935,DRAMP31780,VNWKKIILGKIIKVVK,16,Not available,Not available,Tumor cells: CCRF-CEM (IC50=4±1 µM); SW480 (IC50=48 µM); HeLa (IC50=8±1 µM),Linear,Free,Amidation,None,L,DRAMP
7936,DRAMP31781,vnwkkilgkiikvvk,15,Not available,Not available,Tumor cells: SW480 (IC50=20 µM); CCRF-CEM (IC50=5±2 µM); HeLa (IC50=6±2 µM),Linear,Free,Amidation,None,D,DRAMP
7937,DRAMP31782,VNWKKVLAKIIKVVK,15,Not available,Not available,Tumor cells: SW480 (IC50=13 µM); CCRF-CEM (IC50=4±1 µM); SW480 (IC50=5±1 µM),Linear,Free,Amidation,None,L,DRAMP
7938,DRAMP31783,VNWKKILGKIKKVVK,15,Not available,Not available,Tumor cells: CCRF-CEM (IC50=18 µM); HeLa (IC50=7±1 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
7939,DRAMP31784,VNWKKLLGKLLKVVK,15,Not available,Not available,Tumor cells: SW480 (IC50=15 µM); HeLa (IC50=4 µM); CCRF-CEM (IC50=6 µM),Linear,Free,Amidation,None,L,DRAMP
7940,DRAMP31785,vnwkkllgkllkvvk,15,Not available,Not available,Tumor cells: SW480 (IC50=20 µM); CCRF-CEM (IC50=4 µM); HeLa (IC50=4±2 µM),Linear,Free,Amidation,None,D,DRAMP
7941,DRAMP31786,VNWKKVLGKVVKVVK,15,Not available,Not available,Tumor cells: HeLa (IC50=13±2 µM); CCRF-CEM (IC50=18 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,L,DRAMP
7942,DRAMP31787,VNWXXILGXIIXVVX,15,Not available,Not available,Tumor cells: SW480 (IC50=20 µM); HeLa (IC50=3±1 µM); CCRF-CEM (IC50=5±2 µM),Linear,Free,Amidation,X=Ornithine,L,DRAMP
7943,DRAMP31788,VNWRRILGRIIRVVR,15,Not available,Not available,Tumor cells: HeLa (IC50=9 µM),Linear,Free,Amidation,None,L,DRAMP
7944,DRAMP31789,VYWKKILGKIIKVVK,15,Not available,Not available,Tumor cells: SW480 (IC50=30 µM); HeLa (IC50=5±1 µM); CCRF-CEM (IC50=6 µM),Linear,Free,Amidation,None,L,DRAMP
7945,DRAMP31790,KVKVKVKVpPTKVKVKVK,18,Not available,Not available,Tumor cells: A549 (IC50=4.9±0.6µM); MDA-MB-436 (IC50=5.6±0.5µM); KB (IC50=6.3±0.7µM); MCF-7 (IC50=8.1±0.8µM),Linear,Free,Free,p=D-Pro,Mix,DRAMP
7946,DRAMP31791,kvkvkvkvPptkvkvkvk,18,Not available,Not available,Tumor cells: MDA-MB-436 (IC50=3.2±0.4µM); A549 (IC50=3.2±0.6µM); KB (IC50=4.5±0.5µM); MCF-7 (IC50=4.7±0.4µM),Linear,Free,Free,k=D-Lys; v=D-Val; p=D-Pro; t=D-Thr,Mix,DRAMP
7947,DRAMP31792,KVKVKVKVPPTKVKVKVK,18,Not available,Not available,Tumor cells: A549 (IC50>100µM); KB (IC50>100µM); MCF-7 (IC50>100µM); MDA-MB-436 (IC50>100µM),Linear,Free,Free,None,L,DRAMP
7948,DRAMP31793,GIPCAESCVWIPCTITALMGCSCKNNVCYNN,31,Not available,Not available,Tumor cells: HeLa (IC50=2.4 μM),Cyclic,Free,Free,None,L,DRAMP
7949,DRAMP31794,GIPCAESCVWIPCTITALXGCSCKNNVCYNN,31,Not available,Not available,Tumor cells: HeLa (IC50>15 μM),Cyclic,Free,Free,X=MetO (Methionine sulfoxide),L,DRAMP
7950,DRAMP31795,IPCGESCVWIPCISGXFGCSCKDKVCYS,28,Not available,Not available,Tumor cells: HeLa (IC50>15 μM),Cyclic,Free,Free,X=MetO (Methionine sulfoxide),L,DRAMP
7951,DRAMP31796,PLLQATLGGGS,11,Not available,Not available,Tumor cells: B16-F10 (IC50=1 µM),Linear,Free,Free,None,L,DRAMP
7952,DRAMP31797,LLRHVVKILEKYL,13,Not available,A membrane-disturbing action seems to be the major mechanism for cell death,Tumor cells: MEC (24.15Inhibition ratio at 50 µg/ml); HL-7702(L-02) (37.22 Inhibition ratio at 50 µg/ml); A549 (45.62 Inhibition ratio at 50 µg/ml); BGC-823 (48.19 Inhibition ratio at 50 µg/ml); Hep-G2 (50.90 Inhibition ratio at 50 µg/ml); HeLa (52.32 Inhibition ratio at 50 µg/ml); SMMC-7721 (52.77 Inhibition ratio at 50 µg/ml); SW1116 (57.62 Inhibition ratio at 50 µg/ml),Linear,Free,Free,None,L,DRAMP
7953,DRAMP31798,LLRHVVKILSKYL,13,Not available,A membrane-disturbing action seems to be the major mechanism for cell death,Tumor cells: MEC (27.99 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (37.00 Inhibition ratio at 50 µg/ml); A549 (50.64 Inhibition ratio at 50 µg/ml); BGC-823 (50.85 Inhibition ratio at 50 µg/ml); Hep-G2 (55.98 Inhibition ratio at 50 µg/ml); HeLa (56.81 Inhibition ratio at 50 µg/ml); SMMC-7721 (59.37 Inhibition ratio at 50 µg/ml); SW1116 (62.73 Inhibition ratio at 50 µg/ml),Linear,Free,Free,None,L,DRAMP
7954,DRAMP31799,RGDLLRHVVKILEKYL,16,Not available,A membrane-disturbing action seems to be the major mechanism for cell death,Tumor cells: MEC (19.76 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (36.25 Inhibition ratio at 50 µg/ml); A549 (47.26Inhibition ratio at 50 µg/ml); Hep-G2 (60.22 Inhibition ratio at 50 µg/ml); BGC-823 (62.49 Inhibition ratio at 50 µg/ml); SMMC-7721 (70.39 Inhibition ratio at 50 µg/ml); SW1116 (72.69 Inhibition ratio at 50 µg/ml); HeLa (73.09 Inhibition ratio at 50 µg/ml),Linear,Free,Free,None,L,DRAMP
7955,DRAMP31800,RGDLLRHVVKILSKYL,16,Not available,A membrane-disturbing action seems to be the major mechanism for cell death,Tumor cells: MEC (29.33 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (38.13 Inhibition ratio at 50 µg/ml); A549 (52.50 Inhibition ratio at 50 µg/ml); Hep-G2 (73.07 Inhibition ratio at 50 µg/ml); BGC-823 (73.705 Inhibition ratio at 50 µg/ml); HeLa (78.045 Inhibition ratio at 50 µg/ml); SW1116 (81.465 Inhibition ratio at 50 µg/ml); SMMC-7721 (86.175 Inhibition ratio at 50 µg/ml),Linear,Free,Free,None,L,DRAMP
7956,DRAMP31801,PDEDAINDALNKVCSTGRRQRSICKQLLKK,30,Not available,Lyse cancer cells,Tumor cells: SNU-1 (<100% cell viability at 5 µM); SNU-1 (<40% cell viability at 50 µM); U-937 (<60% cell viability at 50 µM); SW480 (>100% cell viability at 5 µM); U-937 (100% cell viability at 5 µM); SW480 (60% cell viability at 50 µM),Linear,Free,Free,None,L,DRAMP
7957,DRAMP31802,PDEDAINNALNKVCSTGRRQRSICKQLLKK,30,Not available,Lyse cancer cells,Tumor cells: SNU-1 (<100% cell viability at 5 µM); SNU-1 (<20% cell viability at 50 µM); U-937 (<40% cell viability at 50 µM); SW480 (100% cell viability at 5 µM); U-937 (100% cell viability at 5 µM); SW480 (40% cell viability at 50 µM),Linear,Free,Free,None,L,DRAMP
7958,DRAMP31803,KWKSFLKTFKSlKKTVLHTLLKAISS,26,Not available,Not available,Tumor cells: HeLa (IC50=2.63±0.07 µmol/L),Linear,Acetylation,Amidation,None,Mix,DRAMP
7959,DRAMP31804,KWKSFLKTFKSLKKTVLHTlLKAISS,26,Not available,Not available,Tumor cells: HeLa (IC50=2.33±0.06 µmol/L),Linear,Acetylation,Amidation,None,Mix,DRAMP
7960,DRAMP31805,KWKSFlKTFKSLKKTVLHTLLKAISS,26,Not available,Not available,Tumor cells: HeLa (IC50=2.23±0.10 µmol/L),Linear,Acetylation,Amidation,None,Mix,DRAMP
7961,DRAMP31806,GLFGKLIKKFARKAISYAVKKARGKH,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
7962,DRAMP31807,KKWXWKK,7,Not available,Not available,Tumor cells: Ramos (IC50=10±2 μM); Ramos (IC50=22±5 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7963,DRAMP31808,KKWXWKK,7,Not available,Not available,Tumor cells: Ramos (IC50=11±2 μM); Ramos (IC50=23±3 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7964,DRAMP31809,KKWXWKK,7,Not available,Not available,Tumor cells: Ramos (IC50=10±2 μM); Ramos (IC50=22±5 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7965,DRAMP31810,KKWXWKK,7,Not available,Not available,Tumor cells: Ramos (IC50=11±2 μM); Ramos (IC50=23±3 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7966,DRAMP31811,KKXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=15±2 μM); Ramos (IC50=92±2 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7967,DRAMP31812,KKXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=157±30 μM); Ramos (IC50=16±5 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7968,DRAMP31813,KKXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=15±2 μM); Ramos (IC50=92±2 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7969,DRAMP31814,KKXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=157±30 μM); Ramos (IC50=16±5 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7970,DRAMP31815,KWXKK,5,Not available,Not available,Tumor cells: Ramos (IC50=12.6±0.6 μM); Ramos (IC50=99±15 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7971,DRAMP31816,KWXKK,5,Not available,Not available,Tumor cells: Ramos (IC50=20±2 μM); Ramos (IC50=226±21 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7972,DRAMP31817,KWXKK,5,Not available,Not available,Tumor cells: Ramos (IC50=12.6±0.6 μM); Ramos (IC50=99±15 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7973,DRAMP31818,KWXKK,5,Not available,Not available,Tumor cells: Ramos (IC50=20±2 μM); Ramos (IC50=226±21 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7974,DRAMP31819,KWXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=1.71±0.6 μM); Ramos (IC50=7.9±0.3 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7975,DRAMP31820,KWXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=26±2 μM); Ramos (IC50=8±1 μM),Cyclic,lactam,lactam,X=2-Nal-CH2-,L,DRAMP
7976,DRAMP31821,KWXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=1.71±0.6 μM); Ramos (IC50=7.9±0.3 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7977,DRAMP31822,KWXWKK,6,Not available,Not available,Tumor cells: Ramos (IC50=26±2 μM); Ramos (IC50=8±1 μM),Cyclic,lactam,lactam,X=p-CF3-Bzl-,L,DRAMP
7978,DRAMP31823,FLGALFHALSKLL,13,Not available,Induced cell tissue damage through a new cell lysis mechanism ,Tumor cells: A549 (IC50=28 µM); PANC-1 (IC50=57 μM ),Linear,Free,Free,None,L,DRAMP
7979,DRAMP31824,FLGALFKALSHLL,13,Not available,Induced cell tissue damage through a new cell lysis mechanism ,Tumor cells: A549 (IC50=32 µM); PANC-1 (IC50=77 μM ),Linear,Free,Free,None,L,DRAMP
7980,DRAMP31825,RRRRRNWMWC,10,Not available,Not available,Tumor cells: J774A.1 (IC50=12 µM); MDA-MB-231 (IC50=16 µM); LNCaP (IC50=23 µM); HuT 102 (IC50=25 µM); LNCaP (IC50=28 µM); MDA-MB-231 (IC50=29 µM); HuT 102 (IC50=36 µM); HuT 102 (IC50=37 µM); HuT 102 (IC50=39 µM); MDA-MB-231 (IC50=39 µM); LNCaP (IC50=44 µM); J774A.1 (IC50=47 µM); HuT 102 (IC50=93 µM),Linear,Free,Amidation,None,L,DRAMP
7981,DRAMP31826,RRRRRWCMNW,10,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=10 µM); MDA-MB-231 (IC50=12 µM); J774A.1 (IC50=17 µM); MDA-MB-231 (IC50=18 µM); J774A.1 (IC50=26 µM); LNCaP (IC50=26 µM); HuT 102 (IC50=36 µM); HuT 102 (IC50=38 µM); HuT 102 (IC50=43 µM); HuT 102 (IC50=43 µM); HuT 102 (IC50=45 µM); LNCaP (IC50=8 µM); LNCaP (IC50=9 µM),Linear,Free,Amidation,None,L,DRAMP
7982,DRAMP31827,PPPEE,5,Not available,Not available,Tumor cells: AZ-97 (Inhibition at 24-28 g/l),Linear,Free,Amidation,None,L,DRAMP
7983,DRAMP31828,RYLGYL,6,Not available,Not available,Tumor cells: AZ-97 (Inhibition at 12-15 g/l),Linear,Free,Amidation,None,L,DRAMP
7984,DRAMP31829,YPFPG,5,Not available,Not available,Tumor cells: AZ-97 (Inhibition at 9-11 g/l),Linear,Free,Amidation,None,L,DRAMP
7985,DRAMP31830,CLBKKLFKKILKKL,14,Not available,Not available,Tumor cells: MCF-7 (IC50=12.0 ± 2.7 µM); CAPAN-1 (IC50=13.7 ± 2.4 µM); E42/02 (IC50>>100 µM); E42/02 (IC50>>100 µM); E42/02 (IC50>>100 µM); E42/02 (IC50>>100 µM),Linear,Free,Amidation,None,L,DRAMP
7986,DRAMP31831,RWRWRWX,7,Not available,Not available,Tumor cells: HT-29 (IC50=4.5µM); MCF-7 (IC50=4.7µM),Linear,Free,Amidation,X=Lysine with Octanoylated side group,L,DRAMP
7987,DRAMP31832,YGRKKRRQRRRREADFFWSLCTA,23,Not available,Not available,"Tumor cells: LNCaP (At 20 μM,  about 30% Trypan blue-negative cells); PC-3-TR (At 20 μM,  about 30% Trypan blue-negative cells); RS4;11 (At 20 μM, 10.4% Trypan blue-negative cells); MV4-11 (At 20 μM, 10.8% Trypan blue-negative cells); HCT 115 (At 20 μM, 40% Trypan blue-negative cells); K562 (At 20 μM, 7.7% Trypan blue-negative cells); PC-3 (At 20 μM, about 50% Trypan blue-negative cells); HCT 116 (At 20 μM, about 70% Trypan blue-negative cells)",Linear,Free,Free,None,L,DRAMP
7988,DRAMP31833,GIIKKIIKKI,10,Not available,"In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.",Tumor cells: HL-60 (100% Cytotoxicity at 5 µM Approx); HeLa (99% Cytotoxicity at 4 µM Approx),Linear,Free,Amidation,None,L,DRAMP
7989,DRAMP31834,GIIKKIIKKIIKKI,14,Not available,"In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.",Tumor cells: HL-60 (90% Cytotoxicity at 5 µM Approx); HeLa (95% Cytotoxicity at 4 µM Approx),Linear,Free,Amidation,None,L,DRAMP
7990,DRAMP31835,GIIKKIIKKIIKKIIKKI,18,Not available,"In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.",Tumor cells: HL-60 (70% Cytotoxicity at 5 µM Approx); HeLa (80% Cytotoxicity at 4 µM Approx),Linear,Free,Amidation,None,L,DRAMP
7991,DRAMP31836,CREKAKKLFKKILKKL,16,Not available,Not available,Tumor cells: MCF-7 (IC50=74.7±8.8µM); CAPAN-1 (IC50=76.2±0.8µM),Linear,Free,Amidation,None,L,DRAMP
7992,DRAMP31837,RRLFRRILRRL,11,Not available,Not available,Tumor cells: MCF-7 (IC50=148.2±8.8µM); CAPAN-1 (IC50=97.0±15.4µM),Linear,Free,Amidation,None,L,DRAMP
7993,DRAMP31838,RLGDGCTR,8,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=2.06 μg/mL),Cyclic,Free,Free,None,L,DRAMP
7994,DRAMP31839,FFGRLKSVWSAVKHGWKAAKSR,22,Not available,Not available,Tumor cells: MCF-7 (IC50=45-50µM),Linear,Free,Free,None,L,DRAMP
7995,DRAMP31840,HGFQWPGSWTWENGKWTWKGAYQFLKGGGGSRRRRRRRRR,40,Not available,"With the addition of a cell-penetrating motif, the resulting APTSTAT3-9R aptide was able to suppress the viability and proliferation of cancer cells by blocking STAT3 phosphorylation, thereby inhibiting STAT3 downstream signaling.",Tumor cells: A549 (IC50=10-20 μmol/L),Linear,Free,Free,None,L,DRAMP
7996,DRAMP31841,KKCKFFCKVKKKIKSIGFQIPIVSIPFK,28,Not available,Not available,Tumor cells: PC-3 (At 200 µg/ml induced 2.5% cell death); HepG2 (At 200 µg/ml induced 4.3% cell death),Linear,Free,Free,None,L,DRAMP
7997,DRAMP31842,KAQXQKQAW,9,Not available,Not available,Tumor cells: FEMX-I (IC50>350 µM),Linear,Free,Amidation,X=Dip=diphenylalanine,L,DRAMP
7998,DRAMP31843,TKPRKTKPRKTKPRKTKPR,19,Not available,Not available,Tumor cells: BGC-823 (67.2% maximum inhibitory rate at 8 mg/kg); Hep-G2 (69.6% maximum inhibitory rate at 8 mg/kg); HT-29 (70% maximum inhibitory rate at 8 mg/kg),Linear,Free,Free,None,L,DRAMP
7999,DRAMP31844,ESFSDWWKLLAE,12,Not available,target the p53–MDM4 interaction,Tumor cells: MCF-7 (IC50=27 µM),Linear,Free,Free,None,L,DRAMP
8000,DRAMP31845,ETFADWWKLLAE,12,Not available,target the p53–MDM5 interaction,Tumor cells: MCF-7 (IC50=8.7 µM),Linear,Free,Free,None,L,DRAMP
8001,DRAMP31846,ETFSDWWKLLAE,12,Not available,target the p53–MDM2 interaction,Tumor cells: MCF-7 (IC50=16.3 µM),Linear,Free,Free,None,L,DRAMP
8002,DRAMP31847,LTFSDWWKLLAE,12,Not available,target the p53–MDM3 interaction,Tumor cells: MCF-7 (IC50=15.1 µM),Linear,Free,Free,None,L,DRAMP
8003,DRAMP31848,KILRGVAKKIMRTFLRRISKDILTGKK,27,Not available,Not available,Tumor cells: HCT 116 (Cell viability >40% at 12.5μM approx); HROC40 (Cell viability >45% at 12.5μM approx); HROC107 (Cell viability >50% at 12.5μM approx); HCT 116 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC18 (Cell viability >55% at 12.5μM approx); HROC24 (Cell viability >55% at 12.5μM approx); HROC32 (Cell viability >55% at 12.5μM approx); HROC24 (Cell viability >60% at 25μM approx); HROC32 (Cell viability >60% at 25μM approx); HROC40 (Cell viability >60% at 25μM approx); HROC60 (Cell viability >70% at 12.5μM approx); HROC113 (Cell viability >80% at 12.5μM approx),Linear,Free,Amidation,None,L,DRAMP
8004,DRAMP31849,KILRGVAKKIMRTFLRRILTGKK,23,Not available,Not available,Tumor cells: HCT 116 (Cell viability >50% at 12.5μM approx); HCT 116 (Cell viability >50% at 12.5μM approx.); HROC40 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC24 (Cell viability >60% at 25μM approx); HROC107 (Cell viability >70% at 12.5μM approx); HROC113 (Cell viability >70% at 12.5μM approx); HROC24 (Cell viability >70% at 12.5μM approx); HROC60 (Cell viability >70% at 12.5μM approx); HROC18 (Cell viability >75% at 12.5μM approx); HROC32 (Cell viability >85% at 12.5μM approx); HROC40 (Cell viability >85% at 12.5μM approx); HROC32 (Cell viability=50% at 12.5μM approx.),Linear,Free,Amidation,None,L,DRAMP
8005,DRAMP31850,KILRGVAKKIMRTFLRRISKKILTGKK,27,Not available,Not available,Tumor cells: HCT 116 (Cell viability >40% at 12.5μM approx); HROC24 (Cell viability >50% at 25μM approx); HROC40 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC18 (Cell viability >55% at 12.5μM approx); HROC24 (Cell viability >55% at 12.5μM approx); HROC60 (Cell viability >60% at 12.5μM approx); HROC107 (Cell viability >65% at 12.5μM approx); HROC113 (Cell viability >65% at 12.5μM approx); HROC32 (Cell viability >80% at 12.5μM approx); HROC40 (Cell viability >80% at 12.5μM approx); HCT 116 (Cell viability=50% at 12.5μM approx.); HROC32 (Cell viability=50% at 12.5μM approx.),Linear,Free,Amidation,None,L,DRAMP
8006,DRAMP31851,MICYSHKTPQPSATITCEEKTCYKKSVRKLPAIVAGRGCGCPSKEMLVAIHCCRSDKCNE,60,Not available,Not available,Tumor cells: A549 (LC50=106±5 μg/mL  ); HT-29 (LC50>300 μg/mL); MDA-MB-231 (LC50>300 μg/mL),Linear,Free,Free,None,L,DRAMP
8007,DRAMP31852,RICYSHKLLQAKTTKTCEENSCYKRSLPKIPLIIIGRGCGCPLTLPFLRIKCCTSDKCN,59,Not available,Not available,Tumor cells: HT-29 (LC50=110±4 μg/mL); A549 (LC50=56±4 μg/mL); MDA-MB-231 (LC50=62±2 μg/mL),Linear,Free,Free,None,L,DRAMP
8008,DRAMP31853,LKLSPKTKDTLKKVLKGAIKGAIAIASMA,29,Not available,Not available,Tumor cells: A549 (LC50=1.2±0.2 μM); HT-29 (LC50=12.3±4.7 μM); MDA-MB-231 (LC50=3.1±0.2 μM),Linear,Free,Amidation,None,L,DRAMP
8009,DRAMP31854,LKLSPKTKKTLKKVLKGAIKGAIAIASMA,29,Not available,Not available,Tumor cells: A549 (LC50=0.9±0.3 μM); MDA-MB-231 (LC50=2.4±0.1 μM); HT-29 (LC50=3.9±0.4 μM),Linear,Free,Amidation,None,L,DRAMP
8010,DRAMP31855,LKLSPKTKkTLKKVLKGAIKGAIAIASMA,29,Not available,Not available,Tumor cells: A549 (LC50=2.5±0.3 μM); MDA-MB-231 (LC50=5.4±0.4 μM); HT-29 (LC50=6.3±1.9 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8011,DRAMP31856,GIFPIFAKLLGKVIKVASSLISKGRTE,27,Not available,Not available,Tumor cells: HT-29 (LC50=11.5±2.6 μM); A549 (LC50=6.0±0.6 μM); MDA-MB-231 (LC50=6.2±0.6 μM),Linear,Free,Free,None,L,DRAMP
8012,DRAMP31857,IKIPSFFRNILKKVGKEAVSLIAGALKQS,29,Not available,Not available,Tumor cells: A549 (LC50=2.5±0.2 μM); MDA-MB-231 (LC50=6.6±0.3 μM); HT-29 (LC50=9.5±1.3 μM),Linear,Free,Free,None,L,DRAMP
8013,DRAMP31858,VKRFKKFFRKLKKAV,15,Not available,Not available,Tumor cells: K562 (IC50=8.6 µM); MCF-7 (IC50=8.9 µM),Linear,Free,Amidation,None,L,DRAMP
8014,DRAMP31859,VKRFKKFFRKLKKDV,15,Not available,Not available,Tumor cells: MCF-7 (IC50=19.9 µM); K562 (IC50=44.7 µM),Linear,Free,Amidation,None,L,DRAMP
8015,DRAMP31860,VKRFKKFFRKLKKEV,15,Not available,Not available,Tumor cells: K562 (IC50=36.6 µM); MCF-7 (IC50=38.9 µM),Linear,Free,Amidation,None,L,DRAMP
8016,DRAMP31861,VKRFKKFFRKLKKFV,15,Not available,Not available,Tumor cells: MCF-7 (IC50=1.3 µM); K562 (IC50=3.7 µM),Linear,Free,Amidation,None,L,DRAMP
8017,DRAMP31862,VKRFKKFFRKLKKGV,15,Not available,Not available,Tumor cells: K562 (IC50=14.8 µM); MCF-7 (IC50=15.8 µM),Linear,Free,Amidation,None,L,DRAMP
8018,DRAMP31863,VKRFKKFFRKLKKHV,15,Not available,Not available,Tumor cells: K562 (IC50=10.5 µM); MCF-7 (IC50=5.0 µM),Linear,Free,Amidation,None,L,DRAMP
8019,DRAMP31864,VKRFKKFFRKLKKKV,15,Not available,Not available,Tumor cells: K562 (IC50=5.5 µM); K562/Adr (IC50=5.5 µM); MCF-7 (IC50=8.3 µM); MCF-7/ADM (IC50=8.6 µM),Linear,Free,Amidation,None,L,DRAMP
8020,DRAMP31865,VKRFKKFFRKLKKLV,15,Not available,Not available,Tumor cells: K562 (IC50=1.1 µM); K562/Adr (IC50=3.3. µM); MCF-7 (IC50=3.6 µM); MCF-7/ADM (IC50=4.4 µM),Linear,Free,Amidation,None,L,DRAMP
8021,DRAMP31866,VKRFKKFFRKLKKQV,15,Not available,Not available,Tumor cells: MCF-7 (IC50=14.5 µM); K562 (IC50=16.2 µM),Linear,Free,Amidation,None,L,DRAMP
8022,DRAMP31867,VKRFKKFFRKLKKRV,15,Not available,Not available,Tumor cells: MCF-7 (IC50=5.5 µM); K562 (IC50=8.7 µM),Linear,Free,Amidation,None,L,DRAMP
8023,DRAMP31868,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Linear,Free,Amidation,None,L,DRAMP
8024,DRAMP31869,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Linear,Free,Amidation,None,L,DRAMP
8025,DRAMP31870,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Linear,Free,Amidation,None,L,DRAMP
8026,DRAMP31871,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Linear,Free,Amidation,None,L,DRAMP
8027,DRAMP31872,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Linear,Free,Amidation,None,L,DRAMP
8028,DRAMP31873,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Linear,Free,Amidation,None,L,DRAMP
8029,DRAMP31874,VKRFKKFFRKLKKTV,15,Not available,Not available,Tumor cells: K562 (IC50=17.0 µM); MCF-7 (IC50=19.1 µM),Linear,Free,Amidation,None,L,DRAMP
8030,DRAMP31875,VKRFKKFFRKLKKVV,15,Not available,Not available,Tumor cells: MCF-7 (IC50=4.9 µM); K562 (IC50=5.0 µM),Linear,Free,Amidation,None,L,DRAMP
8031,DRAMP31876,WKX,3,Not available,Not available,Tumor cells: MM1.S (25% Inhibition=10µM),Linear,Picolinoyl,Free,X=MET-Boro,L,DRAMP
8032,DRAMP31877,IKWKRWWWR,9,Not available,Not available,Tumor cells: HeLa (IC50>200µg/ml),Linear,Free,Amidation,None,L,DRAMP
8033,DRAMP31878,IWKRWWWKR,9,Not available,Not available,Tumor cells: HeLa (IC50=199µg/ml),Linear,Free,Amidation,None,L,DRAMP
8034,DRAMP31879,KKRWWWWWR,9,Not available,Not available,Tumor cells: HeLa (IC50=131µg/ml),Linear,Free,Amidation,None,L,DRAMP
8035,DRAMP31880,KWWKIWRWR,9,Not available,Not available,Tumor cells: HeLa (IC50=173µg/ml),Linear,Free,Amidation,None,L,DRAMP
8036,DRAMP31881,KWWRWRRWW,9,Not available,Not available,Tumor cells: HeLa (IC50=106µg/ml),Linear,Free,Amidation,None,L,DRAMP
8037,DRAMP31882,RIWKIWWKR,9,Not available,Not available,Tumor cells: HeLa (IC50>200µg/ml),Linear,Free,Amidation,None,L,DRAMP
8038,DRAMP31883,RKRWWWWFR,9,Not available,Not available,Tumor cells: HeLa (IC50=97µg/ml),Linear,Free,Amidation,None,L,DRAMP
8039,DRAMP31884,RLWKRWWIR,9,Not available,Not available,Tumor cells: HeLa (IC50>200µg/ml),Linear,Free,Amidation,None,L,DRAMP
8040,DRAMP31885,RWKKWWRWL,9,Not available,Not available,Tumor cells: HeLa (IC50=37µg/ml),Linear,Free,Amidation,None,L,DRAMP
8041,DRAMP31886,RWKRWWRWI,9,Not available,Not available,Tumor cells: HeLa (IC50=47µg/ml),Linear,Free,Amidation,None,L,DRAMP
8042,DRAMP31887,GLFDIWAWWRWRR,13,Not available,Not available,Tumor cells: A549 (IC50>250µg/ml),Linear,Free,Amidation,None,L,DRAMP
8043,DRAMP31888,GLFDIWKKLRWRR,13,Not available,Not available,Tumor cells: A549 (IC50=97.0±9.8µg/ml),Linear,Free,Amidation,None,L,DRAMP
8044,DRAMP31889,GLFDIWKKWRWRR,13,Not available,Not available,Tumor cells: A549 (IC50=93.3±5.1µg/ml),Linear,Free,Amidation,None,L,DRAMP
8045,DRAMP31890,GLFDIWKWWRWRR,13,Not available,Not available,Tumor cells: A549 (IC50=56.0±9.3µg/ml),Linear,Free,Amidation,None,L,DRAMP
8046,DRAMP31891,GLFDKWAWWRWRR,13,Not available,Not available,Tumor cells: A549 (IC50=215.3±19.7µg/ml),Linear,Free,Amidation,None,L,DRAMP
8047,DRAMP31892,RTRCRfLRRC,10,Not available,Not available,Tumor cells: PC-12 (IC50=225µg/ml),Cyclic,C9,Amidation,f=D-Phe,Mix,DRAMP
8048,DRAMP31893,RTRCXfLRXC,10,Not available,Not available,Tumor cells: PC-12 (IC50=595µg/ml),Cyclic,C9,Amidation,X=diaminobutyrate; f=D-Phe,Mix,DRAMP
8049,DRAMP31894,RTXCXfLRXC,10,Not available,Not available,Tumor cells: PC-12 (IC50=629µg/ml),Cyclic,C9,Amidation,X=diaminobutyrate; f=D-Phe,Mix,DRAMP
8050,DRAMP31895,GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD,32,Not available,induce apoptosis and inhibit proliferation and migration of prostate cancer cells,Tumor cells: PC-3 (IC50=2.24 μM); DU145 (IC50=3.32 μM); LNCaP (IC50=5.03 μM),Linear,Free,Free,None,L,DRAMP
8051,DRAMP31896,GAVPCGETCVYLPCITPDIGCSCQNKVCYRD,31,Not available,induce apoptosis and inhibit proliferation and migration of prostate cancer cells,Tumor cells: PC-3 (IC50=2.65 μM); DU145 (IC50=3.11 μM); LNCaP (IC50=4.31 μM),Linear,Free,Free,None,L,DRAMP
8052,DRAMP31897,GTSCGETCVLLPCLSSVLGCTCQNKRCYKD,30,Not available,induce apoptosis and inhibit proliferation and migration of prostate cancer cells,Tumor cells: LNCaP (IC50=0.21 μM); DU145 (IC50=0.55 μM); PC-3 (IC50=0.76 μM),Linear,Free,Free,None,L,DRAMP
8053,DRAMP31898,KGIRDWLRGFNKLRKWFLRLIKGL,24,Not available,Not available,Tumor cells: SW480 (IC50=60 mg/ml),Linear,Free,Free,None,L,DRAMP
8054,DRAMP31899,KRKLYKWFAHLIKGL,15,Not available,Not available,Tumor cells: CaCo-2 (IC50=50 mg/ml); SW480 (IC50=50 mg/ml),Linear,Free,Free,None,L,DRAMP
8055,DRAMP31900,LRLLDRWLRLFNRLLRWLRLLRGL,24,Not available,Not available,Tumor cells: SW480 (IC50=100 mg/ml),Linear,Free,Free,None,L,DRAMP
8056,DRAMP31901,LRRLDRWLRLFNRLRRWFLRLLRGL,25,Not available,Not available,Tumor cells: SW480 (IC50=110 mg/ml),Linear,Free,Free,None,L,DRAMP
8057,DRAMP31902,RLWRLAWRLYRLWRLTL,17,Not available,Not available,Tumor cells: SW480 (IC50=70 mg/ml),Linear,Free,Free,None,L,DRAMP
8058,DRAMP31903,RLYRLYFRLYRLWRRLTL,18,Not available,Not available,Tumor cells: SW480 (IC50=60 mg/ml),Linear,Free,Free,None,L,DRAMP
8059,DRAMP31904,HXLLPPVXPLFG,12,Not available,Not available,Tumor cells: L5178Y (ED50=2.92µM); THP-1 (IC50>100µM; IC90>100µM),Cyclic,Free,Amidation,X(2)= 4-Hydroxyproline; X(8)=Daa,L,DRAMP
8060,DRAMP31905,IXIILPPLXPII,12,Not available,Not available,Tumor cells: L5178Y (ED50=4.14µM); HeLa (ED50>8µM); PC-12 (ED50>8µM); THP-1 (IC50=5µM; IC90=30µM),Cyclic,Free,Amidation,X(2)= 4-Hydroxyproline; X(9)=Daa,L,DRAMP
8061,DRAMP31906,IXVILPPLXPIFG,13,Not available,Not available,Tumor cells: L5178Y (ED50=3.61µM); THP-1 (IC50=30µM; IC90=50µM),Cyclic,Free,Amidation,X(2)= 4-Hydroxyproline; X(9)=Daa,L,DRAMP
8062,DRAMP31907,FWQRRIRRWRRFWQRRIRRWRR,22,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: A-375 (LC50=9.3±0.8 µM ); SBcl-2 (LC50=9.4±0.5 µM ),Linear,Free,Amidation,None,L,DRAMP
8063,DRAMP31908,PFWRIRIRRPRRIRIRWFP,19,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: SBcl-2 (LC50=10.4±0.7 µM ); A-375 (LC50=23.3±1.7 µM ),Linear,Free,Amidation,None,L,DRAMP
8064,DRAMP31909,PFWRRRIRIRRRRIRIRRRWFP,22,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: SBcl-2 (LC50=5.0±0.4 µM ); A-375 (LC50=61.8±0.1 µM ),Linear,Free,Amidation,None,L,DRAMP
8065,DRAMP31910,RWKRINRQWFFWQRNIRKWR,20,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: SBcl-2 (LC50=16.0±0.5 µM ); A-375 (LC50=21.0±1.2 µM ),Linear,Free,Amidation,None,L,DRAMP
8066,DRAMP31911,WWRRWWRRWRRWWRRWWR,18,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: A-375 (LC50=13.9±0.4 µM ); SBcl-2 (LC50=4.6±0.2 µM ),Linear,Free,Amidation,None,L,DRAMP
8067,DRAMP31912,GKPICGETCFKGKCYTPGCTCSYPICKKD,29,Not available,Not available,Tumor cells: HeLa (CC50=18.73±1.82µM); MM96L (CC50=2.04±0.26µM),Cyclic,Free,Free,None,L,DRAMP
8068,DRAMP31913,GKPICGETCFKGKCYTPGCTCSYPICKKN,29,Not available,Not available,Tumor cells: HeLa (CC50=18.73±1.82µM); MM96L (CC50=2.04±0.26µM),Cyclic,Free,Free,None,L,DRAMP
8069,DRAMP31914,GKPTCGETCFKGKCYTPGCTCSYPLCKKD,29,Not available,Not available,Tumor cells: MM96L (CC50=1.30±0.44µM); HeLa (CC50=19.26±1.37µM),Cyclic,Free,Free,None,L,DRAMP
8070,DRAMP31915,GKYTCGETCFKGKCYTPGCTCSYPICKKD,29,Not available,Not available,Tumor cells: MM96L (CC50=2.09±0.18µM); HeLa (CC50=9.83±0.78µM),Cyclic,Free,Free,None,L,DRAMP
8071,DRAMP31916,GLPTCGETCFKGKCYTPGCSCSYPICKKD,29,Not available,Not available,Tumor cells: MM96L (CC50=1.58±0.48µM); HeLa (CC50=11.42±1.00µM),Cyclic,Free,Free,None,L,DRAMP
8072,DRAMP31917,GLPTCGETCFKGKCYTPGCSCSYPICKKN,29,Not available,Not available,Tumor cells: MM96L (CC50=1.58±0.48µM); HeLa (CC50=11.42±1.00µM),Cyclic,Free,Free,None,L,DRAMP
8073,DRAMP31918,GLPTCGETCTLGKCNTPKCTCNWPICYKD,29,Not available,Not available,Tumor cells: MM96L (CC50=21.94±1.90µM); HeLa (CC50=36.92±3.25µM),Cyclic,Free,Free,None,L,DRAMP
8074,DRAMP31919,GLPTCGETCTLGKCNTPKCTCNWPICYKN,29,Not available,Not available,Tumor cells: MM96L (CC50=21.94±1.90µM); HeLa (CC50=36.92±3.25µM),Cyclic,Free,Free,None,L,DRAMP
8075,DRAMP31920,FKKLKKLFSKLWNWK,15,Not available,Not available,Tumor cells: HeLa (IC50=3.5±0.03 μM); SGC-7901 (IC50=5.2±0.14 μM); B16 (IC50=6.1±0.02 μM); Hep-G2 (IC50=7.7±0.23 μM),Linear,Acetylation,Amidation,None,L,DRAMP
8076,DRAMP31921,FKKLKKLFSKLWNWK,15,Not available,Not available,Tumor cells: NCI-H460 (IC50=13.3 µM); BGC-823 (IC50=14.1 µM); A549 (IC50=14.8 µM); MCF-7 (IC50=15.7 µM); MDA-MB-231 (IC50=22.9 µM),Linear,Acetylation,Amidation,None,L,DRAMP
8077,DRAMP31922,FKKLKKLFSKLWNWKRKKRRQRRR,24,Not available,Not available,Tumor cells: HeLa (IC50=1.8±0.02 μM); B16 (IC50=3.5±0.03 μM); SGC-7901 (IC50=4.8±0.08 μM); Hep-G2 (IC50=5.8±0.36 μM),Linear,Acetylation,Amidation,None,L,DRAMP
8078,DRAMP31923,fkklkklfsklwnwk,15,Not available,Not available,Tumor cells: SGC-7901 (IC50=10.42±0.30 μM ); B16 (IC50=19.16±0.38 μM ); PC-3 (IC50=21.38±0.56 μM ); BGC-823 (IC50=8.65 ±0.38 μM ),Linear,Free,Free,None,L,DRAMP
8079,DRAMP31924,fkklkklfsklwnwk,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
8080,DRAMP31925,KRFKKFFKKVKKSV,14,Not available,Not available,Tumor cells: HeLa S3 (IC50=1 µM); THP-1 (IC50=25 µM); U-937 (IC50=6.25 µM),Linear,Free,Amidation,None,L,DRAMP
8081,DRAMP31926,KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF,34,Not available,Not available,Tumor cells: HeLa S3 (IC50 < 1 µM ); U-937 (IC50 < 1 µM ); THP-1 (IC50=1.56 µM ); HL-60 (IC50>12.5 µM ); Jurkat E6.1 (IC50>12.5 µM ),Linear,Free,Free,None,Mix,DRAMP
8082,DRAMP31927,YGFVMPRSGLWFR,13,Not available,Not available,Tumor cells: A549 (IC50=104.05 μg/mL); Hep-G2 (IC50=188.23 μg/mL); SGC-7901 (IC50=247.32 μg/mL); HT-29 (IC50=446.72 μg/mL),Linear,Free,Free,None,L,DRAMP
8083,DRAMP31928,CTLEW,5,Not available,Not available,Tumor cells: HeLa (IC50=0.60±0.17 mg/mL ); CaCo-2 (IC50=0.65±0.42 mg/mL ),Linear,Free,Free,None,L,DRAMP
8084,DRAMP31929,GIFPIFAKLLGKVIKVASSLISKGRTK,27,Not available,Not available,Tumor cells: A549 (IC50=2.5±0.5µM); MDA-MB-231 (IC50=4.3±0.2µM); HT-29 (IC50=5.6±0.4µM),Linear,Free,Free,k=D-Lys,L,DRAMP
8085,DRAMP31930,IKIPSFFRNILKKVGKkAVSLIAGALKQS,29,Not available,Not available,Tumor cells: HT-29 (IC50=11±2µM); A549 (IC50=2.1±0.7µM); MDA-MB-231 (IC50=3.6±0.5µM),Linear,Free,Free,k=D-Lys,Mix,DRAMP
8086,DRAMP31931,FFSMIPKIAGGIASLVKNL,19,Not available,Not available,Tumor cells: U-251MG (IC50=1.8µM); PC-3 (IC50=2.9µM); NCI-H460 (IC50=4.3µM),Linear,Free,Amidation,None,L,DRAMP
8087,DRAMP31932,IRKLKSWKWLRWL,13,Not available,Not available,Tumor cells: A549 (Not active up to 170 µM),Linear,Free,Free,None,L,DRAMP
8088,DRAMP31933,KLLKLLKKLLKLLK,14,Not available,Not available,Tumor cells: HeLa (IC50=3.3±0.4 μM ),Linear,Free,Amidation,None,L,DRAMP
8089,DRAMP31934,KLLKLLKLKKLLKL,14,Not available,Not available,Tumor cells: HeLa (IC50=34.5±1.6 μM),Linear,Free,Amidation,None,L,DRAMP
8090,DRAMP31935,RLLRLLRLRRLLRL,14,Not available,Not available,Tumor cells: HeLa (IC50=4.3±0.2 μM); MCF-7 (IC50=4.5±0.3 μM); A549 (IC50=4.8±0.6 μM),Linear,Free,Amidation,None,L,DRAMP
8091,DRAMP31936,RLLRLLRRLLRLLR,14,Not available,Not available,Tumor cells: MCF-7 (IC50=2.5±0.3 μM ); HeLa (IC50=3.7±0.1 μM); A549 (IC50=4.3±0.2 μM ),Linear,Free,Amidation,None,L,DRAMP
8092,DRAMP31937,FKIGGFIKKLWRSKLA,16,Not available," ZXR-1 could internalize into cells by endocytosis, target on mitochondria, and induce cell apoptosis",Tumor cells: Hep-G2 (IC50=141.7±12.2 µM); SACC-83 (IC50=27.9±7.7 µM); HeLa (IC50=62.6±8.4 µM); PC-3 (IC50=69.1±1.6 µM); Huh-7 (IC50=77.9±0.9 µM),Linear,Free,Free,None,L,DRAMP
8093,DRAMP31938,FKIGGFIKKLWRSLLA,16,Not available,ZXR-2 could cause cell membrane lysis,Tumor cells: PC-3 (IC50=14.2±0.5 µM); PC-3 (IC50=14.8±1.6 μM ); Hep-G2 (IC50=7.5±1.2 µM); HeLa (IC50=8.1±1.6 µM); HeLa (IC50=8.1±1.6 μM ); Huh-7 (IC50=8.4±1.1 µm); SACC-83 (IC50=9.9±1.7 µM),Linear,Free,Free,None,L,DRAMP
8094,DRAMP31939,XIXIXIXRPVYXPRPRPPHPRL,22,Not available,Not available,Tumor cells: HeLa (IC50>600µg/ml),Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,DRAMP
8095,DRAMP31940,XIXIXRPVYXPRPRPPHPRL,20,Not available,Not available,Tumor cells: HeLa (IC50>600µg/ml),Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,DRAMP
8096,DRAMP31941,XWXWXRPVYXPRPRPPHPRL,20,Not available,Not available,Tumor cells: HeLa (IC50=640±150µg/ml),Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,DRAMP
8097,DRAMP31942,XWXWXWXRPVYXPRPRPPHPRL,22,Not available,Not available,Tumor cells: HeLa (IC50=230 ± 90µg/ml),Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,DRAMP
8098,DRAMP31943,KWKSFLKTFKSAEKTVLHTALKAISS,26,Not available,Not available,Tumor cells: A549 (IC50=109.68µM); SGC-7901 (IC50=92.04µM),Linear,Acetylation,Amidation,None,L,DRAMP
8099,DRAMP31944,ATCETPSKHFNGLCIRSSNCASVCHGEHFTDGRCQGVRRRCMCLKPC,47,Not available,PaDef defensin from avocado (Persea americana) fruit is cytotoxic to MCF-7 cells via the induction of mitochondrial apoptosis,Tumor cells: MCF-7 (IC 50=141.62 μg/mL  ); K562 (IC50=97.3 μg/mL (18.65 μM)),Linear,Free,Free,None,L,DRAMP
8100,DRAMP31945,TSLDASIWAMMQNA,14,Not available,P144 induced an upregulation of SMAD7 and downregulation of SKI through inhibition of the TGF-β pathway.,Tumor cells: U-87MG ATCC (IC50=16.34±1.47 µg/mL); A172 (IC50=21.96±3.68 µg/mL ),Linear,Free,Free,None,L,DRAMP
8101,DRAMP31946,RECKTESHRFKGPCITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,47,Not available,Not available,Tumor cells: U-937 (22.2±2.4% Cell death=10µM),Cyclic,Free,Free,None,L,DRAMP
8102,DRAMP31947,RECKTESNTFPGICITKPPCRKACISEKFSGGDCSKILRRCLCTKPC,47,Not available,Not available,Tumor cells: U-937 (20.0±1.4% Cell death=10µM),Cyclic,Free,Free,None,L,DRAMP
8103,DRAMP31948,RECKTESNTFPGICITKPPCRKACISEKFTDGHCRGFRRRCLCTKPC,47,Not available,Not available,Tumor cells: U-937 (13.7±8.1% Cell death=10µM),Cyclic,Free,Free,None,L,DRAMP
8104,DRAMP31949,RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCFCTRPC,47,Not available,Not available,Tumor cells: U-937 (43.1±7.2% Cell death=10µM),Cyclic,Free,Free,None,L,DRAMP
8105,DRAMP31950,RECKTESNTFPGICITKPPCRKACLTEGFTDGHCSKILRRCLCTKPC,47,Not available,Not available,Tumor cells: U-937 (44.6±8.5% Cell death=10µM),Cyclic,Free,Free,None,L,DRAMP
8106,DRAMP31951,RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC,47,Not available,Not available,Tumor cells: U-937 (5.9±1.3% Cell death=10	µM),Cyclic,Free,Free,None,L,DRAMP
8107,DRAMP31952,RTCESQSNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,47,Not available,Not available,Tumor cells: U-937 (7.9±2.4% Cell death=10µM),Cyclic,Free,Free,None,L,DRAMP
8108,DRAMP31953,MQFITDLIKKAVDFFKGLFDNK,22,Not available,Not available,Tumor cells: Jurkat (LD50=5.39µM),Linear,Free,Free,None,L,DRAMP
8109,DRAMP31954,MQFITDLIKKAVDVFKGLFGNK,22,Not available,Not available,Tumor cells: Jurkat (LD50=8.79µM),Linear,Free,Free,None,L,DRAMP
8110,DRAMP31955,GIKHILFMAKTKLPRATCTAEIKENCDRKK,30,Not available,Not available,Tumor cells: A549 (Not active up to 500µg/ml),Linear,Free,Free,None,L,DRAMP
8111,DRAMP31956,KREDFLDQIIRDFRNFIYQKYRRLRDEFRKLRDILSG,37,Not available,Not available,Tumor cells: A549 (Not active up to 500µg/ml),Linear,Free,Free,None,L,DRAMP
8112,DRAMP31957,KRIGLIRLIGKILRGLRRLG,20,Not available,Not available,Tumor cells: A549 (Not active up to 500 µg/ml),Linear,Free,Free,None,L,DRAMP
8113,DRAMP31958,TFKRKNGSRKNGHRPGGYSLIALGNKKVLKAPYMESI,37,Not available,Not available,Tumor cells: A549 (Not active up to 500µg/ml),Linear,Free,Free,None,L,DRAMP
8114,DRAMP31959,CGRRKRRRGCRRDSDCPGACICRYwKVCGSGSDGGV,36,Not available,Not available,Tumor cells: HT-29 (IC50=40.12±0.13 μM); MCF-7 (IC50=45.01±0.16 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,w=D-Tryptophane,Mix,DRAMP
8115,DRAMP31960,CPKILKKCRRDSDCPGACICRGNGYCGRRKRRRG,34,Not available,Not available,Tumor cells: HT-29 (IC50=52.89±0.11 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8116,DRAMP31961,CPKILKKCRRDSDCPGACICRGNGYCGSGSDGGV,34,2PO8,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8117,DRAMP31962,CPKILKKCRRDSDCPGACICRGNGYCRFwKTW,32,Not available,Not available,Tumor cells: HT-29 (IC50=58.89±0.09 μM); MCF-7 (IC50=70.61±0.11 μM); PC-3 (IC50=83.55±0.20 μM),Cyclic,Free,Free,w=D-Tryptophane,Mix,DRAMP
8118,DRAMP31963,CPKILKKCRRDSDCPGACICRGNGYCYHLNQPF,33,Not available,Not available,Tumor cells: HT-29 (IC50=35.22±0.08 μM); PC-3 (IC50=39.11±0.07 μM); MCF-7 (IC50=53.44±0.14 μM),Cyclic,Free,Free,None,L,DRAMP
8119,DRAMP31964,CPKILKKCRRDSDCPGACICRYwKVCGSGSDGGV,34,Not available,Not available,Tumor cells: HT-29 (IC50=74.13±0.07 μM); PC-3 (IC50=85.44±0.08 μM); MCF-7 (IC50>100 μM),Cyclic,Free,Free,w=D-Tryptophane,Mix,DRAMP
8120,DRAMP31965,CPKILKKCRRDSDCPGACICRYwKVCGYHLNQPFG,35,Not available,Not available,Tumor cells: HT-29 (IC50=19.75±0.07 μM); PC-3 (IC50=35.44±0.13 μM); MCF-7 (IC50>100 μM),Cyclic,Free,Free,w=D-Tryptophane,Mix,DRAMP
8121,DRAMP31966,CRRKRRRCRRDSDCPGACICRGNGYCGSGSDGGV,34,Not available,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8122,DRAMP31967,CRRKRRRICFPDGR,14,Not available,Not available,Tumor cells: MCF-7 (IC50=28.72±0.15 μM); HT-29 (IC50=82.27±0.13 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8123,DRAMP31968,CTKSIPPICFPDGR,14,2AB9,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8124,DRAMP31969,CTKSIPPICRFwKTW,15,Not available,Not available,Tumor cells: HT-29 (IC50=43.29±0.04 μM); MCF-7 (IC50=55.13±0.07 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,w=D-Tryptophane,Mix,DRAMP
8125,DRAMP31970,CTKSIPPICRRKRRR,15,Not available,Not available,Tumor cells: MCF-7 (IC50=41.84±0.07 μM); HT-29 (IC50>100 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8126,DRAMP31971,CTKSIPPICYHLNQPF,16,Not available,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
8127,DRAMP31972,CTKSIPPICYwKV,13,Not available,Not available,Tumor cells: HT-29 (IC50=45.38±0.03 μM); MCF-7 (IC50=46.07±0.05 μM); PC-3 (IC50>100 μM),Cyclic,Free,Free,w=D-Tryptophane,Mix,DRAMP
8128,DRAMP31973,RFwKTW,6,Not available,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Linear,Free,Free,w=D-Tryptophane,Mix,DRAMP
8129,DRAMP31974,RRKRRR,6,Not available,Not available,Tumor cells: MCF-7 (IC50=83.51±0.46 μM); HT-29 (IC50>100 μM); PC-3 (IC50>100 μM),Linear,Free,Free,None,L,DRAMP
8130,DRAMP31975,YHLNQPF,7,Not available,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Linear,Free,Free,None,L,DRAMP
8131,DRAMP31976,YwKV,4,Not available,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Linear,Free,Free,w=D-Tryptophane,Mix,DRAMP
8132,DRAMP31977,FKAGGFIKKLWRSLLA,16,Not available,Not available,Tumor cells: PC-3 (IC50=58.4±13.7 μM); HeLa (IC50=73.9±13.6 μM),Linear,Free,Free,None,L,DRAMP
8133,DRAMP31978,FKIGGFAKKLWRSLLA,16,Not available,Not available,Tumor cells: PC-3 (IC50=43.6±7.9 μM); HeLa (IC50=52.0±5.8 μM),Linear,Free,Free,None,L,DRAMP
8134,DRAMP31979,FKIGGFIKKAWRSLLA,16,Not available,Not available,Tumor cells: PC-3 (IC50=74.9±13.3 μM); HeLa (IC50=93.5±19.4 μM),Linear,Free,Free,None,L,DRAMP
8135,DRAMP31980,FKIGGFIKKLWRSALA,16,Not available,Not available,Tumor cells: PC-3 (IC50=35.5±3.9 μM); HeLa (IC50=54.4±3.0 μM),Linear,Free,Free,None,L,DRAMP
8136,DRAMP31981,FKIGGFIKKLWRSLAA,16,Not available,Not available,Tumor cells: PC-3 (IC50=22.0±2.6 μM); HeLa (IC50=28.0±4.6 μM),Linear,Free,Free,None,L,DRAMP
8137,DRAMP31982,FIGAIARLLSK,11,Not available,BmKn-2 exerts selective cytotoxic effects on human oral cancer cells by inducting apoptosis via a p53-dependent intrinsic apoptotic pathway. BmKn-2 peptide originally derived from a natural source shows great promise as a candidate treatment for oral cancer,Tumor cells: HSC-4 (IC50=97 μg/mL),Linear,Free,Free,None,L,DRAMP
8138,DRAMP31983,RYRRKKKMKKALQYIKLLKE,20,Not available,Not available,Tumor cells: HeLa (Not active up to 44 µg/ml); HepG2 (Not active up to 44 µg/ml),Linear,Free,Free,None,L,DRAMP
8139,DRAMP31984,XXXVXAaXXXX,11,Not available,Not available,Tumor cells: CaCo-2 (0% Killing=12µM; 20% Killing=17µM); Huh-7 (0% Killing=8µM; 50% Killing=17µM),Cyclic,Free,Free,X(1)=alpha-Aminobutyrate; X(2)=Sarcosine; X(3)=METH-Leu; X(5)=METH-Leu; X(7)=D-Ala; X(8)=METH-Leu; X(9)=METH-Leu; X(10)=METH-Val; X(11)=N-methyl-(4R)-4-[(E)-but-2-enyl]-4-methyl-L-threonyl,Mix,DRAMP
8140,DRAMP31985,ASVVNKLTGGVAGLLK,16,Not available,Not available,Tumor cells: NB4 (IC50=11.479µM); MKN 45 (IC50=4.686µM),Linear,Free,Free,None,L,DRAMP
8141,DRAMP31986,FASGIAGMAGKLF,13,Not available,Not available,Tumor cells: THP-1 (IC50>60µM); HepG2 (IC50>600µM),Linear,Free,Amidation,None,L,DRAMP
8142,DRAMP31987,ALlVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8143,DRAMP31988,lLWVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8144,DRAMP31989,WAlVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8145,DRAMP31990,WIlVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8146,DRAMP31991,WLaVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8147,DRAMP31992,WLIVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(6)=D-Orn,Mix,DRAMP
8148,DRAMP31993,WLlANx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8149,DRAMP31994,WLlIIx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8150,DRAMP31995,WLlINx,6,Not available,Not available,Tumor cells: HepG2 (IC50=50µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8151,DRAMP31996,WLlISx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8152,DRAMP31997,WLlIXx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8153,DRAMP31998,WLlVAx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8154,DRAMP31999,WLlVxx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,l=D-Leu; x(5)=D-Orn; x(6)=D-Orn,Mix,DRAMP
8155,DRAMP32000,WLxIxx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(3)=D-4-Cl-Phe; x(5)=D-Orn; x(6)=D-Orn,Mix,DRAMP
8156,DRAMP32001,WLxVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50=60µM),Cyclic,Free,Free,x(3)=D-4-Cl-Phe; x(6)=D-Orn,Mix,DRAMP
8157,DRAMP32002,WLxVXx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(3)=METH-Leu; x(5)=METH-Asn; x(6)=D-Orn,Mix,DRAMP
8158,DRAMP32003,WxlVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(2)=D-4-Cl-Phe; l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8159,DRAMP32004,WXlVXx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(2)=METH-Leu; l=D-Leu; x(5)=METH-Asn; x(6)=D-Orn,Mix,DRAMP
8160,DRAMP32005,WXlXNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(2)=METH-Leu; l=D-Leu; x(5)=METH-Val; x(6)=D-Orn,Mix,DRAMP
8161,DRAMP32006,xLlVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50>100µM),Cyclic,Free,Free,x(1)=D-4-Cl-Phe; l=D-Leu; x(6)=D-Orn,Mix,DRAMP
8162,DRAMP32007,KKLFKKILKAL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=21.4±2.7µM); MCF-7 (IC50=23.2±2.4µM); K562 (IC50=27.4±3.5µM); K562/ADM (IC50=31.3±4.0µM),Linear,Free,Amidation,None,L,DRAMP
8163,DRAMP32008,KKLFKKILKDL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=70.7±6.3µM); K562 (IC50=76.3±5.4µM); MCF-7 (IC50=77.9±6.7µM); K562/ADM (IC50=82.5±6.8µM),Linear,Free,Amidation,None,L,DRAMP
8164,DRAMP32009,KKLFKKILKEL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=79.5±6.9µM); MCF-7 (IC50=83.2±6.7µM); K562 (IC50=89.4±7.3µM); K562/ADM (IC50>100µM),Linear,Free,Amidation,None,L,DRAMP
8165,DRAMP32010,KKLFKKILKGL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=30.3±4.2µM); MCF-7 (IC50=33.5±3.3µM); K562 (IC50=34.5±4.0µM); K562/ADM (IC50=36.8±3.9µM),Linear,Free,Amidation,None,L,DRAMP
8166,DRAMP32011,KKLFKKILKHL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=10.2±1.7µM); K562 (IC50=7.6±1.8µM); MCF-7 (IC50=8.6±1.3µM); K562/ADM (IC50=9.9±1.4µM),Linear,Free,Amidation,None,L,DRAMP
8167,DRAMP32012,KKLFKKILKIL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=21.3±2.1µM); MCF-7 (IC50=21.5±1.9µM); K562 (IC50=23.7±2.3µM); K562/ADM (IC50=24.6±1.6µM),Linear,Free,Amidation,None,L,DRAMP
8168,DRAMP32013,KKLFKKILKLL,11,Not available,Not available,Tumor cells: MCF-7 (IC50=6.6±1.4µM); MCF-7/ADM (IC50=7.3±0.7µM); K562 (IC50=7.7±1.4µM); K562/ADM (IC50=9.3±1.7µM),Linear,Free,Amidation,None,L,DRAMP
8169,DRAMP32014,KKLFKKILKQL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=53.3±4.5µM); MCF-7 (IC50=53.6±4.2µM); K562 (IC50=57.6±3.9µM); K562/ADM (IC50=58.3±6.2µM),Linear,Free,Amidation,None,L,DRAMP
8170,DRAMP32015,KKLFKKILKRL,11,Not available,Not available,Tumor cells: MCF-7/ADM (IC50=57.3±4.5µM); MCF-7 (IC50=59.4±2.9µM); K562 (IC50=60.8±5.3µM); K562/ADM (IC50=71.2±4.7µM),Linear,Free,Amidation,None,L,DRAMP
8171,DRAMP32016,KKLFKKILKTL,11,Not available,Not available,Tumor cells: K562 (IC50=32.2±2.2µM); MCF-7/ADM (IC50=33.7±3.9µM); MCF-7 (IC50=36.9±4.0µM); K562/ADM (IC50=39.5±3.7µM),Linear,Free,Amidation,None,L,DRAMP
8172,DRAMP32017,FRRFFKWFRRFFKFF,15,Not available,Not available,Tumor cells: Hep-G2 (IC50=2.5 μM); MDA-MB-231 (IC50=3.15 μM); HeLa (IC50=4.9 μM); DLD-1 (IC50=6.7 μM),Linear,Free,Free,None,L,DRAMP
8173,DRAMP32018,FRRFFKWFRRPFKFF,15,Not available,Not available,Tumor cells: HeLa (IC50=11 μM); DLD-1 (IC50=12.9 μM); Hep-G2 (IC50=4.8 μM); MDA-MB-231 (IC50=7.0 μM),Linear,Free,Free,None,L,DRAMP
8174,DRAMP32019,FRRFFKWPRRFFKFF,15,Not available,Not available,Tumor cells: HeLa (IC50=10.5 μM); DLD-1 (IC50=10.8 μM); Hep-G2 (IC50=4.2 μM); MDA-MB-231 (IC50=6.4 μM),Linear,Free,Free,None,L,DRAMP
8175,DRAMP32020,FRRFFKWPRRPFKFF,15,Not available,Not available,Tumor cells: Hep-G2 (IC50=15 μM); HeLa (IC50=18.9 μM); DLD-1 (IC50=22 μM); MDA-MB-231 (IC50=27 μM),Linear,Free,Free,None,L,DRAMP
8176,DRAMP32021,FRRPFKWFRRFFKFF,15,Not available,Not available,Tumor cells: Hep-G2 (IC50=2.5 μM); MDA-MB-231 (IC50=6.3 μM); HeLa (IC50=7.7 μM); DLD-1 (IC50=9.4 μM),Linear,Free,Free,None,L,DRAMP
8177,DRAMP32022,FRRPFKWPRRFFKFF,15,Not available,Not available,Tumor cells: HeLa (IC50=13.8 μM); DLD-1 (IC50=15.3 μM); MDA-MB-231 (IC50=15.4 μM); Hep-G2 (IC50=5 μM),Linear,Free,Free,None,L,DRAMP
8178,DRAMP32023,KKLFKKILKY,10,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: K562 (IC50=73.7±6.1 μM); MCF-7 (IC50=77.3±5.6 μM); MCF-7/ADM (IC50=97.3±11.4 μM); K562/Adr (IC50>100 μM),Linear,Free,Free,None,L,DRAMP
8179,DRAMP32024,KKLFKKILKYLK,12,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7 (IC50=15.7±1.5 μM); K562 (IC50=17.9±1.4 μM); MCF-7/ADM (IC50=18.2±1.3 μM); K562/Adr (IC50=19.1±2.1 μM),Linear,Free,Free,None,L,DRAMP
8180,DRAMP32025,KKLFKKILKYLKK,13,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7 (IC50=30.8±3.4 μM); K562 (IC50=33.6±4.2 μM); MCF-7/ADM (IC50=36.1±6.7 μM); K562/Adr (IC50=39.6±5.7 μM),Linear,Free,Free,None,L,DRAMP
8181,DRAMP32026,KKLFKKILKYLKKL,14,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7 (IC50=25.3±3.2 μM); MCF-7/ADM (IC50=28.4±3.1 μM); K562 (IC50=47.4±12.5 μM); K562/Adr (IC50>100 μM),Linear,Free,Free,None,L,DRAMP
8182,DRAMP32027,KLKKLFKKILKY,12,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7/ADM (IC50=30.6±5.7 μM); MCF-7 (IC50=38.3±2.5 μM); K562 (IC50=60.7±5.4 μM); K562/Adr (IC50=83.7±5.3 μM),Linear,Free,Free,None,L,DRAMP
8183,DRAMP32028,LKKLFKKILKY,11,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7/ADM (IC50=10.9±1.2 μM); MCF-7 (IC50=7.6±1.4 μM); K562 (IC50=7.7±1.2 μM); K562/Adr (IC50=8.1±0.9 μM),Linear,Free,Free,None,L,DRAMP
8184,DRAMP32029,LKKLFKKILKYL,12,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7 (IC50=5.9±0.2 μM); MCF-7/ADM (IC50=6.3±0.4 μM); K562 (IC50=6.6±0.5 μM); K562/Adr (IC50=7.7±0.4 μM),Linear,Free,Free,None,L,DRAMP
8185,DRAMP32030,LKKLFKKILKYLK,13,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: K562 (IC50=26.5±1.5 μM); MCF-7 (IC50=27.3±2.4 μM); MCF-7/ADM (IC50=28.2±2.7 μM); K562/Adr (IC50=28.3±2.3 μM),Linear,Free,Free,None,L,DRAMP
8186,DRAMP32031,LKKLFKKILKYLKK,14,Not available,"disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis",Tumor cells: MCF-7 (IC50=18.4±1.5  μM); K562 (IC50=19.2±2.3 μM); MCF-7/ADM (IC50=20.7±1.6 μM); K562/Adr (IC50=22.7±2.3 μM),Linear,Free,Free,None,L,DRAMP
8187,DRAMP32032,KAKAKAVSRSARAGLQFPVGRIHRHLK,27,Not available,Not available,Tumor cells: HeLa (Not active up to 100 µg/ml),Linear,Free,Free,None,L,DRAMP
8188,DRAMP32033,IIGPVLGLIGKALGGLL,17,Not available,Not available,Tumor cells: SK-HEP-1 (IC50=0.99 μM); Huh-7 (IC50=1.81 μM); Hep-G2 (IC50=2.88 μM),Linear,Free,Amidation,None,L,DRAMP
8189,DRAMP32034,kwfrvyrGiyrrr,13,Not available,Not available,Tumor cells: A549 (IC50=9.814µM),Linear,Free,Amidation,k=D-Lys; w=D-Trp; f=D-Phe; r=D-Arg; v=D-Val; y=D-Tyr; i=D-Ile,Mix,DRAMP
8190,DRAMP32035,rrryiGryvrfwk,13,Not available,Not available,Tumor cells: A549 (IC50=90.16µM),Linear,Free,Amidation,k=D-Lys; w=D-Trp; f=D-Phe; r=D-Arg; v=D-Val; y=D-Tyr; i=D-Ile,Mix,DRAMP
8191,DRAMP32036,RRRYIGRYVRFWK,13,Not available,Not available,Tumor cells: A549 (IC50=12100µM),Linear,Free,Amidation,None,L,DRAMP
8192,DRAMP32037,LVKRFKKFFRKLKKSVLL,18,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.3±0.3 μM); K562/ADM (IC50=12.9±0.3 μM); K562 (IC50=15.1±1.1 μM); HeLa (IC50=6.5±0.3 μM); MCF-7 (IC50=7.0±0.2 μM),Linear,Free,Amidation,None,L,DRAMP
8193,DRAMP32038,LVRRFRRFFRRLRRSVLL,18,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=14.3±0.2 μM); HeLa (IC50=4.2±0.8 μM); MCF-7 (IC50=5.9±0.1 μM); K562 (IC50=6.9±0.2 μM); K562/ADM (IC50=7.6±0.3 μM),Linear,Free,Amidation,None,L,DRAMP
8194,DRAMP32039,VKRFKKFFLKLKSV,14,Not available,Not available,Tumor cells: HeLa (IC50=15.4±0.1 μM); MCF-7 (IC50=22.5±3.3 μM); K562 (IC50=24.4±3.3 μM); K562/ADM (IC50=54.8±6.1 μM); MCF-7/Taxol (IC50=65.2±4.2 μM),Linear,Free,Amidation,None,L,DRAMP
8195,DRAMP32040,VKRFKKFFRKLKKSVL,16,Not available,Not available,Tumor cells: MCF-7 (IC50=12.7±2.5 μM); K562/ADM (IC50=19.3±0.8 μM); K562 (IC50=26.5±0.9 μM); MCF-7/Taxol (IC50=31.1±5.1 μM); HeLa (IC50=9.8±1.5 μM),Linear,Free,Amidation,None,L,DRAMP
8196,DRAMP32041,VKRFKKFFRKLKKSVLL,17,Not available,Not available,Tumor cells: HeLa (IC50=10.2±0.8 μM); MCF-7 (IC50=10.5±1.2 μM); K562 (IC50=20.4±3.3 μM); K562/ADM (IC50=20.7±1.1 μM); MCF-7/Taxol (IC50=30.2±2.4 μM),Linear,Free,Amidation,None,L,DRAMP
8197,DRAMP32042,VKRFKLFFRKLKSV,14,Not available,Not available,Tumor cells: HeLa (IC50=16.5±0.4 μM); MCF-7 (IC50=31.1±2.2 μM); K562 (IC50=33.4±1.1 μM); MCF-7/Taxol (IC50=43.6±1.1 μM); K562/ADM (IC50=55.6±3.3 μM),Linear,Free,Amidation,None,L,DRAMP
8198,DRAMP32043,VRRFRLFFRRLRRSV,15,Not available,Not available,Tumor cells: MCF-7 (IC50=11.5±0.5 μM); HeLa (IC50=19.0±1.1 μM); K562/ADM (IC50=23.2±1.7 μM); MCF-7/Taxol (IC50=35.7±1.5 μM); K562 (IC50=9.46±0.5 μM),Linear,Free,Amidation,None,L,DRAMP
8199,DRAMP32044,VRRFRRFFLRLRRSV,15,Not available,Not available,Tumor cells: HeLa (IC50=13.5±1.4 μM); MCF-7 (IC50=16.2±3.8 μM); MCF-7/Taxol (IC50=21.5±2.7 μM); K562 (IC50=25.6±3.3 μM); K562/ADM (IC50=43.5±4.2 μM),Linear,Free,Amidation,None,L,DRAMP
8200,DRAMP32045,VRRFRRFFRRLRRSV,15,Not available,Not available,Tumor cells: HeLa (IC50=10.7±0.5 μM); MCF-7 (IC50=16.9±2.1 μM); K562 (IC50=17.9±0.2 μM); K562/ADM (IC50=22.7±0.5 μM); MCF-7/Taxol (IC50=40.6±5.1 μM),Linear,Free,Amidation,None,L,DRAMP
8201,DRAMP32046,VRRFRRFFRRLRRSVL,16,Not available,Not available,Tumor cells: K562/ADM (IC50=10.5±0.7 μM); MCF-7/Taxol (IC50=16.8±0.8 μM); K562 (IC50=20.4±0.7 μM); HeLa (IC50=3.3±1.1 μM); MCF-7 (IC50=7.5±0.9 μM),Linear,Free,Amidation,None,L,DRAMP
8202,DRAMP32047,VRRFRRFFRRLRRSVLL,17,Not available,Not available,Tumor cells: K562/ADM (IC50=10.3±0.3 μM); MCF-7/Taxol (IC50=15.1±1.0 μM); MCF-7 (IC50=3.8±0.4 μM); HeLa (IC50=7.9±0.9 μM); K562 (IC50=8.5±1.1 μM),Linear,Free,Amidation,None,L,DRAMP
8203,DRAMP32048,GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Tumor cells: U-937/GTB (IC50>>80µM),Cyclic,Free,Free,None,L,DRAMP
8204,DRAMP32049,GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Tumor cells: U-937/GTB (IC50>>32µM),Cyclic,Free,Free,None,L,DRAMP
8205,DRAMP32050,GLPVCGETCTLGTCSTQGCTCSWPICKRN,29,Not available,Not available,Tumor cells: U-937/GTB (IC50>>40µM),Cyclic,Free,Free,None,L,DRAMP
8206,DRAMP32051,FpFw,4,Not available,Not available,Tumor cells: PC-3 (IC50=16.5±0.7 µM),Cyclic,Lactam,Lactam,p=D-Proline; w=D-Tryptophane,Mix,DRAMP
8207,DRAMP32052,FpFW,4,Not available,Not available,Tumor cells: PC-3 (IC50=10.1±0.9 µM),Cyclic,Lactam,Not available,p=D-Proline,Mix,DRAMP
8208,DRAMP32053,FLGAIAQALTSLLGKL,16,Not available,Not available,Tumor cells: HT-29 (LC50=100 μM); MDA-MB-231 (LC50=40 μM); A549 (LC50=45 μM),Linear,Free,α-amidated residue at the C-terminus,α-amidated residue at the C-terminus,L,DRAMP
8209,DRAMP32054,IVPFLLGMVPKLVCLITKKC,20,Not available,Not available,Tumor cells: A549 (LC50=18 μM); HT-29 (LC50=18 μM); MDA-MB-231 (LC50=8 μM),Linear,Free,Free,None,L,DRAMP
8210,DRAMP32055,GXRRLXYKQRXVTYXRGR,18,Not available,Not available,Tumor cells: K562 (CC50=1.4±0.2µM); MCF-7 (CC50=37.5±3.3µM); HL-60 (CC50=38.5±4.8µM); MM96L (CC50=4.6±0.2µM); CRL-1739 (CC50=51.0±4.6µM); HeLa (CC50>64µM),Cyclic,Free,Free,X=Se-Cys,L,DRAMP
8211,DRAMP32056,KXRRYXYRQRXVTYXRGR,18,Not available,Not available,Tumor cells: MM96L (CC50=2.3±0.2µM); MCF-7 (CC50=29.0±3.7µM); HL-60 (CC50=33.3±7.4µM); HeLa (CC50=36.2±2.8µM); CRL-1739 (CC50=46.2±7.6µM); K562 (CC50=6.4±0.6µM),Cyclic,Free,Free,X=Se-Cys,L,DRAMP
8212,DRAMP32057,RRGLFKKLRRKIKKGFKKIFKRLPPVGVGVSIPLAGRR,38,Not available,Not available,Tumor cells: BGC-823 (26±0.9% Cell death=200µg/ml); BGC-823 (58±1.5% Cell death=200µg/ml); BGC-823 (58±1.5% Cell death=200µg/ml),Linear,Free,Free,None,L,DRAMP
8213,DRAMP32058,WDPYFAGVKKLTKAILAVRA,20,Not available,Not available,Tumor cells: MEC-7 (EC50=(50-100)µM); MEC-7 (Not active up to 100 µM),Linear,Free,Amidation,None,L,DRAMP
8214,DRAMP32059,WGKFFAGVKKLTKAILAVRA,20,Not available,Not available,Tumor cells: MEC-7 (EC50=25µM),Linear,Free,Amidation,None,L,DRAMP
8215,DRAMP32060,WDPYFAGVKKLTKAILGEIA,20,Not available,Not available,Tumor cells: MEC-7 (Not active up to 100 µM),Linear,Free,Amidation,None,L,DRAMP
8216,DRAMP32061,WGKFFAGVKKLTKAILGEIA,20,Not available,Not available,Tumor cells: MEC-7 (EC50=25µM),Linear,Free,Amidation,None,L,DRAMP
8217,DRAMP32062,IKKILSKIKKLLK,13,Not available,Not available,Tumor cells: MCF-7 (IC50=23 μM ); MCF-7 (IC50=31 μM ); MCF-7 (IC50=34 μM ); MCF-7 (IC50=38 μM ),Linear,Free,Free,None,L,DRAMP
8218,DRAMP32063,FLSLIPAAISAVSALANHF,19,Not available,Not available,Tumor cells: MCF-7 (LD50=24.05µM); MDA-MB-435S (LD50=28.48µM); U-251MG (LD50=34.67µM); HCT 116 (LD50=36.64µM); NCI-H157 (LD50=37.61µM); PC-3 (LD50=37.96µM),Linear,Free,Amidation,None,L,DRAMP
8219,DRAMP32064,FLSLIPKIAGGIAALAKHL,19,Not available,Not available,Tumor cells: NCI-H157 (IC50=6.73µM),Linear,Free,Amidation,None,L,DRAMP
8220,DRAMP32065,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8221,DRAMP32066,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8222,DRAMP32067,XXLXAXX,7,Not available,Not available,Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8223,DRAMP32068,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8224,DRAMP32069,XXLXAXX,7,Not available,Not available,Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8225,DRAMP32070,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8226,DRAMP32071,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8227,DRAMP32072,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8228,DRAMP32073,XXLXAXX,7,Not available,Not available,Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8229,DRAMP32074,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8230,DRAMP32075,XXLXAXX,7,Not available,Not available,Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8231,DRAMP32076,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8232,DRAMP32077,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8233,DRAMP32078,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8234,DRAMP32079,XXLXAXX,7,Not available,Not available,Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8235,DRAMP32080,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8236,DRAMP32081,XXLXAXX,7,Not available,Not available,Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8237,DRAMP32082,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8238,DRAMP32083,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8239,DRAMP32084,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8240,DRAMP32085,XXLXAXX,7,Not available,Not available,Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8241,DRAMP32086,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8242,DRAMP32087,XXLXAXX,7,Not available,Not available,Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8243,DRAMP32088,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu,L,DRAMP
8244,DRAMP32089,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8245,DRAMP32090,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8246,DRAMP32091,XXLXAXX,7,Not available,Not available,Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8247,DRAMP32092,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8248,DRAMP32093,XXLXAXX,7,Not available,Not available,Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8249,DRAMP32094,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8250,DRAMP32095,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8251,DRAMP32096,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8252,DRAMP32097,XXLXAXX,7,Not available,Not available,Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8253,DRAMP32098,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8254,DRAMP32099,XXLXAXX,7,Not available,Not available,Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8255,DRAMP32100,XXLXAXX,7,Not available,Not available,Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM),Cyclic,Free,Free,X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu,L,DRAMP
8256,DRAMP32101,FTVAXFI,7,Not available,Not available,Tumor cells: HepG2 (IC50=192µg/ml); MCF-7 (IC50=280µg/ml),Cyclic,Acetylation,Free,X=dehydrobutyrine,L,DRAMP
8257,DRAMP32102,NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,33,Not available,Not available,Tumor cells: A549 (Not active up to 200 µm),Linear,Free,Free,None,L,DRAMP
8258,DRAMP32103,FKARRWQWRMKKLGAFKARRWQWRMKKLGAKX,32,Not available,Not available,Tumor cells: MDA-MB-468 (IC50=11 μM); MDA-MB-231 (IC50=31 μM),Linear,Free,Free,X=Ahx,L,DRAMP
8259,DRAMP32104,FKARRWQWRMKKLGAFKARRWQWRMKKLGAKXC,33,Not available,Not available,Tumor cells: MDA-MB-468 (IC50=5 μM); MDA-MB-231 (IC50=9 μM),Tetrameric,Free,Free,X=Ahx,L,DRAMP
8260,DRAMP32105,RRWQWRRRWQWRKX,14,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=130 μM); MDA-MB-468 (IC50>100 μM),Linear,Free,Free,X=Ahx,L,DRAMP
8261,DRAMP32106,RRWQWRRRWQWRKXC,15,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=15 μM); MDA-MB-468 (IC50=6 μM),Tetrameric,Free,Free,X=Ahx,L,DRAMP
8262,DRAMP32107,RWQWRMKKLGRWQWRMKKLGKX,22,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=14 μM); MDA-MB-468 (IC50=5 μM),Linear,Free,Free,X=Ahx,L,DRAMP
8263,DRAMP32108,RWQWRMKKLGRWQWRMKKLGKXC,23,Not available,Not available,Tumor cells: MDA-MB-468 (IC50=2 μM); MDA-MB-231 (IC50=6 μM),Tetrameric,Free,Free,X=Ahx,L,DRAMP
8264,DRAMP32109,CFKARRWQWRMKKLGAXC,18,Not available,Not available,Tumor cells: MDA-MB-231 (IC50>88 μM); MDA-MB-468 (IC50>88 μM),Linear,Free,Free,X=Ahx,L,DRAMP
8265,DRAMP32110,CRRWQWRXC,9,Not available,Not available,Tumor cells: MDA-MB-231 (IC50>200 μM); MDA-MB-468 (IC50>200 μM),Cyclic,Free,Free,X=Ahx,L,DRAMP
8266,DRAMP32111,RWQWRMKKLG,10,Not available,Not available,Tumor cells: MDA-MB-231 (IC50>103 μM); MDA-MB-468 (IC50>103 μM),Linear,Free,Free,None,L,DRAMP
8267,DRAMP32112,CRWQWRMKKLGXC,13,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=7 μM); MDA-MB-468 (IC50>107 μM),Linear,Free,Free,X=Ahx,L,DRAMP
8268,DRAMP32113,GFGCPFNARRCHRHCRSIRRRAGYCAGRLRLTCTCVR,37,Not available,Not available,Tumor cells: A549 (Not active up to 20 µM); K562 (Not active up to 20 µM); THP-1 (Not active up to 20 µM),Cyclic,Free,Free,None,L,DRAMP
8269,DRAMP32114,GFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCY,36,Not available,Not available,Tumor cells: A549 (Not active up to 20 µM); K562 (Not active up to 20 µM); THP-1 (Not active up to 20 µM),Cyclic,Free,Free,None,L,DRAMP
8270,DRAMP32115,ALWKEVLKNAGKAALNEINNLVQ,23,Not available,Not available,Tumor cells: MCF-7 (IC50=0.69µM); PC-3 (IC50=11.8µM); NCI-H157 (IC50=2.01µM); U-251MG (IC50=2.36µM); MDA-MB-435S (IC50=9.94µM),Linear,Free,Amidation,None,L,DRAMP
8271,DRAMP32116,GIGSAILSAGKSIIKGLAKGLAEHF,25,Not available,Not available,Tumor cells: SK-HEP-1 (IC50=0.76µM); HepG2 (IC50=3.75µM); Huh-7 (IC50=3.91µM),Linear,Free,Amidation,None,L,DRAMP
8272,DRAMP32117,GIGSAILSAGKSIIKGLAKGLA,22,Not available,Not available,Tumor cells: Hep-G2 (IC50=0.76 μM); SK-HEP-1 (IC50=3.75 μM); Huh-7 (IC50=3.91 μM),Linear,Free,Amidation,None,L,DRAMP
8273,DRAMP32118,IIGPVLGLVGKALGGLL,17,Not available,Not available,Tumor cells: Hep-G2 (IC50=3.61 μM); SK-HEP-1 (IC50=8.08 μM); Huh-7 (IC50=8.42 μM),Linear,Free,Amidation,None,L,DRAMP
8274,DRAMP32119,FLSLIPKIATGIAALAKHL,19,Not available,Not available,Tumor cells: NCI-H157 (IC50=2.85µM),Linear,Free,Amidation,None,L,DRAMP
8275,DRAMP32120,HLRRINKLLTRIGLYRHAFG,20,Not available,Not available,Tumor cells: HepG2 (Not active up to 128 µg/ml),Linear,Free,Free,None,L,DRAMP
8276,DRAMP32121,LPRRNRWSKIWKKVVTVFS,19,Not available,Not available,Tumor cells: HepG2 (IC50=45.9µg/ml),Linear,Free,Free,None,L,DRAMP
8277,DRAMP32122,NRFTARFRRTPWRLCLQFRQ,20,Not available,Not available,Tumor cells: HepG2 (IC50=24.4µg/ml),Linear,Free,Free,None,L,DRAMP
8278,DRAMP32123,RLLSLIRKLIT,11,Not available,Not available,Tumor cells: MCF-7 (IC50=50.0 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8279,DRAMP32124,SFLSLIRKLIT,11,Not available,Not available,Tumor cells: MCF-7 (IC50=50.0 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8280,DRAMP32125,SLLPLIRKLIT,11,Not available,Not available,Tumor cells: MCF-7 (IC50=25.0 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8281,DRAMP32126,SLLSLFRKLI,10,Not available,Not available,Tumor cells: MCF-7 (IC50=50.0 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8282,DRAMP32127,SLLSLFRKLIT,11,Not available,Not available,Tumor cells: MCF-7 (IC50>50 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8283,DRAMP32128,SLLSLIRKLIW,11,Not available,Not available,Tumor cells: MCF-7 (IC50=25.0 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8284,DRAMP32129,SLLSLIRLLIT,11,Not available,Not available,Tumor cells: MCF-7 (IC50>50 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8285,DRAMP32130,FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA,45,Not available,Not available,Tumor cells: N2a (65.6% Killing=20µM); A549 (73.5% Killing=20µM),Linear,Free,Free,None,L,DRAMP
8286,DRAMP32131,CIKPHQGQHICNDE,14,Not available,Not available,Tumor cells: 4T1 (IC50=0.61 μM); U-87MG ATCC (IC50=0.92 μM),Cyclic,Free,Free,None,L,DRAMP
8287,DRAMP32132,GALKGCWTKSIPPKPCK,17,Not available,Not available,Tumor cells: HCT 116 (IC50=35.4 μM); DLD-1 (IC50=50.1 μM ); DKs-8 (IC50=9.8 μM ),Linear,Free,Amidation,None,L,DRAMP
8288,DRAMP32133,GIMDTVKNAAKNLAGQLLDKLK ,23,Not available,Not available,Tumor cells: U-251MG (IC50=104.10 μM); MCF-7 (IC50=109.30 μM); PC-3 (IC50=283.90 μM); NCI-H157 (IC50=843.40 μM); MDA-MB-435S (IC50=872.70 μM),Linear,Free,Free,None,Mix,DRAMP
8289,DRAMP32134,GIMDTVKNAAKNLAGQLLDKLKCKITAC ,29,Not available,Not available,Tumor cells: MDA-MB-435S (IC50=15.44 μM); U-251MG (IC50=16.14 μM); MCF-7 (IC50=20.19 μM); PC-3 (IC50=5.79 μM); NCI-H157 (IC50=5.90 μM),Linear,Free,Free,None,Mix,DRAMP
8290,DRAMP32135,GIMDTVKNAAKNLAGQLLDKLKCSITAC,28,Not available,Not available,Tumor cells: MDA-MB-435S (IC50=179.00 μM); U-251MG (IC50=278.30 μM); MCF-7 (IC50=316.90 μM); NCI-H157 (IC50=58.18 μM); PC-3 (IC50=792.60 μM),Linear,Free,Free,None,L,DRAMP
8291,DRAMP32136,GCRLYGFKFHGCG,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=20.1 µM),Cyclic,Free,Free,None,L,DRAMP
8292,DRAMP32137,GCRLYGFKIFGCG,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=26.8 µM),Cyclic,Free,Free,None,L,DRAMP
8293,DRAMP32138,GCRLYGFKIHGCG,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=30.4 µM),Cyclic,Free,Free,None,L,DRAMP
8294,DRAMP32139,GCRLYGFKIWGG,12,Not available,Not available,Tumor cells: Hep-G2 (IC50=19.4 µM),Cyclic,Free,Free,None,L,DRAMP
8295,DRAMP32140,GCRLYGFKWHGCG,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=72.9 µM),Cyclic,Free,Free,None,L,DRAMP
8296,DRAMP32141,GCRVYGFKIHGCG,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=38.9 µM),Cyclic,Free,Free,None,L,DRAMP
8297,DRAMP32142,PMKKLKLALRLAAKIAPVW,19,Not available,Not available,Tumor cells: HT-29 (Not active up to 100 µM); MCF-7 (Not active up to 100 µM); PC-3 (Not active up to 100 µM),Linear,Free,Free,None,L,DRAMP
8298,DRAMP32143,IWLTALKFLGKNLGKLAKQQLAKL,24,Not available,Not available,Tumor cells: U-373MG ATCC (IC50=20.94±5.18 μM ); U-87MG ATCC (IC50=29.20±7.96 μM); SH-SY5Y (IC50=93.80±2.17 μM ),Linear,Free,Free,None,L,DRAMP
8299,DRAMP32144,HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK,38,Not available,Not available,Tumor cells: NCI-H460 (IC50=14.97 ± 1.16 µM ),Linear,Free,Free,None,L,DRAMP
8300,DRAMP32145,RRGCFRVCYRGFCFQRCR,18,Not available,Not available,Tumor cells: HL-60 (IC50=2.5±0.1 μM); HeLa (IC50=6.0±0.2 μM); A549 (IC50=7.3±0.5 μM); SK-BR-3 (IC50=9.9±0.1 μM),Linear,Free,Free,None,L,DRAMP
8301,DRAMP32146,FKKLKKLFSKLWNWK,15,Not available,Not available,Tumor cells: HeLa (IC50=3.5±0.03 μM); SGC-7901 (IC50=5.2±0.14 μM); B16 (IC50=6.1±0.02 μM); Hep-G2 (IC50=7.7±0.23 μM),Linear,Free,Free,None,L,DRAMP
8302,DRAMP32147,FKKLKKLFSKLWNWK,15,Not available,Not available,Tumor cells: NCI-H460 (IC50=13.3 µM); BGC-823 (IC50=14.1 µM); A549 (IC50=14.8 µM); MCF-7 (IC50=15.7 µM); MDA-MB-231 (IC50=22.9 µM),Linear,Free,Free,None,L,DRAMP
8303,DRAMP32148,FKKLKKLFSKLWNWKCRGDKGPDC,24,Not available,Not available,Tumor cells: A549 (IC50=14.3 µM); MCF-7 (IC50=14.8 µM); NCI-H460 (IC50=15.2 µM); BGC-823 (IC50=18.5 µM); MDA-MB-231 (IC50=22.5 µM),Linear,Free,Free,None,L,DRAMP
8304,DRAMP32149,FKKLKKLFSKLWNWKGGCRGDKGPDC,26,Not available,Not available,Tumor cells: NCI-H460 (IC50=12.9 µM); BGC-823 (IC50=14.8 µM); MDA-MB-231 (IC50=15.2 µM); MCF-7 (IC50=15.8 µM); A549 (IC50=21.6 µM),Linear,Free,Free,None,L,DRAMP
8305,DRAMP32150,FKKLKKLFSKLWNWKGGRGD,20,Not available,Not available,Tumor cells: A549 (IC50=11.1 µM); MCF-7 (IC50=11.8 µM); BGC-823 (IC50=15.7 µM); NCI-H460 (IC50=19.5 µM); MDA-MB-231 (IC50=27 µM),Linear,Free,Free,None,L,DRAMP
8306,DRAMP32151,FKKLKKLFSKLWNWKRGD,18,Not available,Not available,Tumor cells: BGC-823 (IC50=10.8 µM); MCF-7 (IC50=11.8 µM); NCI-H460 (IC50=14.6 µM); MDA-MB-231 (IC50=15.6 µM); A549 (IC50=8.4 µM),Linear,Free,Free,None,L,DRAMP
8307,DRAMP32152,GRFKRFRKKLKRLWHKVGPFVGPILHY,27,Not available,Not available,Tumor cells: HL-60 (IC50=3.39±0.15 μM); B16-F1 (IC50=4.82±1.01 μM); SK-BR-3 (IC50=5.63±1.05 μM); A431 (IC50=6.49±0.09 μM),Linear,Free,Free,None,L,DRAMP
8308,DRAMP32153,RQCKAESNTFTGICIAKPPCRKACIREKFTDGHCSKVLRRCLCTKRC,47,Not available,Not available,Tumor cells: HeLa (IC50=0.70±0.07 μM); MM170 (IC50=0.87±0.04 μM); PC-3 (IC50=2.86±0.14 μM),Linear,Free,Free,None,L,DRAMP
8309,DRAMP32154,RQCKAESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,47,Not available,Not available,Tumor cells: HeLa (IC50=1.35±0.06 μM); MM170 (IC50=1.75±0.06 μM); PC-3 (IC50=6.31±0.099 μM),Linear,Free,Free,None,L,DRAMP
8310,DRAMP32155,RQCKRESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,47,Not available,Not available,Tumor cells: PC-3 (IC50=12.41±0.14 μM); MM170 (IC50=3.27±0.12 μM); HeLa (IC50=3.32±0.09 μM),Linear,Free,Free,None,L,DRAMP
8311,DRAMP32156,WEQKIEELLKKAEEQQKKNEEELKKLEKC,29,Not available,Not available,Tumor cells: TZM-bl (50% Cytotoxicity=12.34µM); C8166 (50% Cytotoxicity=19.19µM); MT-4 (50% Cytotoxicity=19.65µM); U-937 (50% Cytotoxicity=9.97µM),Linear,Acetylation,Chol-NH2,None,L,DRAMP
8312,DRAMP32157,NGVQPKYKWWKWWKKWW,17,Not available,"KT2 interacts with the plasma membrane and is then internalized into cells. Moreover, the KT2 peptide increases membrane permeability and induces cytotoxicity against cancer cells through DNA condensation, the increase of apoptotic factor protein levels, and autophagy suppression.",Tumor cells: A431 (34% Cytotoxicity=10 µM); HCT 116 (IC50=50 µM); MDA-MB-231 (Not active up to 10 µM),Linear,Free,Amidation,None,L,DRAMP
8313,DRAMP32158,KWCVYAYVKVKGVLVKYKKCW,21,Not available,Not available,Tumor cells: K562 (IC50=7.7 µM),Cyclic,Free,Free,None,L,DRAMP
8314,DRAMP32159,INLKKLAARIKKKI,14,Not available,Not available,Tumor cells: HT-29 (IC50>100 µM); MCF-7 (IC50>100 µM); PC-3 (IC50>100 µM),Linear,Free,Amidation,None,L,DRAMP
8315,DRAMP32160,KILKRLAAKIKKIL,14,Not available,Not available,Tumor cells: HT-29 (IC50>100 µM); MCF-7 (IC50>100 µM); PC-3 (IC50>100 µM),Linear,Free,Amidation,None,L,DRAMP
8316,DRAMP32161,LP,2,Not available,Not available,Tumor cells: MDA-MB-468 (IC50=67.4 μM); MDA-MB-231 (IC50=73.4 μM),Cyclic,Lactam,Lactam,Lactam,L,DRAMP
8317,DRAMP32162,RFRPPIRRPPIRPPFWP,17,Not available,Not available,Tumor cells: MEC-1 (19% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8318,DRAMP32163,RFRPPIRRPPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8319,DRAMP32164,RFRPPIRRPPIRPPFYW,17,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8320,DRAMP32165,RFRRPIRRPPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (9% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8321,DRAMP32166,RFRRPIRRPPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (32% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8322,DRAMP32167,RFRRPIRRRPIRPPFWR,17,Not available,Not available,Tumor cells: MEC-1 (10% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8323,DRAMP32168,RFRRPIRRRPIRPPFYP,17,Not available,Not available,Tumor cells: MEC-1 (Not active up to 32 µM),Linear,Free,Free,None,L,DRAMP
8324,DRAMP32169,RFRRPIRRRPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (13% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8325,DRAMP32170,RFRRPIRRRPIRPPWYR,17,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8326,DRAMP32171,RFRWPIRRPPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (Not active up to 32 µM),Linear,Free,Free,None,L,DRAMP
8327,DRAMP32172,RFRWPIRRPPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (7% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8328,DRAMP32173,RFRWPIRRRPIRPPFWR,17,Not available,Not available,Tumor cells: MEC-1 (20% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8329,DRAMP32174,RFRWPIRRRPIRPPFYP,17,Not available,Not available,Tumor cells: MEC-1 (2% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8330,DRAMP32175,RFRWPIRRRPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (16% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8331,DRAMP32176,RFRWPIRRRPIRPPFYW,17,Not available,Not available,Tumor cells: MEC-1 (22% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8332,DRAMP32177,RFRWPIRRRPIRPPWYR,17,Not available,Not available,Tumor cells: MEC-1 (28% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8333,DRAMP32178,RRRRPIRRRPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (Not active up to 32 µM),Linear,Free,Free,None,L,DRAMP
8334,DRAMP32179,RRRRPIRRRPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8335,DRAMP32180,RRRRPIRRRPIRPPWYR,17,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8336,DRAMP32181,RRRRPWRRRPIRPPFYW,17,Not available,Not available,Tumor cells: MEC-1 (23% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8337,DRAMP32182,RWRPPIRRPPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (25% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8338,DRAMP32183,RWRRPIRRPPIRPPFYP,17,Not available,Not available,Tumor cells: MEC-1 (16% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8339,DRAMP32184,RWRRPIRRPPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (11% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8340,DRAMP32185,RWRRPIRRPPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (17% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8341,DRAMP32186,RWRRPIRRRPIRPPFWR,17,Not available,Not available,Tumor cells: MEC-1 (4% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8342,DRAMP32187,RWRRPIRRRPIRPPFYP,17,Not available,Not available,Tumor cells: MEC-1 (1% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8343,DRAMP32188,RWRRPIRRRPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (1% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8344,DRAMP32189,RWRRPIRRRPIRPPFYW,17,Not available,Not available,Tumor cells: MEC-1 (19% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8345,DRAMP32190,RWRRPIRRRPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (9% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8346,DRAMP32191,RWRRPIRRRPIRPPWYR,17,Not available,Not available,Tumor cells: MEC-1 (9% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8347,DRAMP32192,RWRRPWRRRPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (22% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8348,DRAMP32193,RWRWPIRRPPIRPPFYP,17,Not available,Not available,Tumor cells: MEC-1 (8% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8349,DRAMP32194,RWRWPIRRPPIRPPFYR,17,Not available,Not available,Tumor cells: MEC-1 (14% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8350,DRAMP32195,RWRWPIRRPPIRPPWYP,17,Not available,Not available,Tumor cells: MEC-1 (10% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8351,DRAMP32196,RWRWPIRRRPIRPPFWR,17,Not available,Not available,Tumor cells: MEC-1 (27% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8352,DRAMP32197,RWRWPIRRRPIRPPWYR,17,Not available,Not available,Tumor cells: MEC-1 (41% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8353,DRAMP32198,KSCFRVCYRGICYRRCRG,18,Not available,Not available,Tumor cells: MDA-MB-435S (CC50=18.9±0.9 µM ); MM96L (CC50=2.0±0.1 µM ); K562 (CC50=2.7±0.2 µM ); HeLa (CC50=22.5±2.1 µM ); HT-144 (CC50=3.0±0.2 µM ); WM164 (CC50=3.9±0.2 µM ),Cyclic,Free,Free,None,L,DRAMP
8354,DRAMP32199,KWCFKVCYKGICYKKCKG,18,Not available,Not available,Tumor cells: HeLa (CC50=13.4±1.9 µM ); K562 (CC50=2.5±0.1 µM ); MDA-MB-435S (CC50=3.5±0.4 µM ); WM164 (CC50=4.3±0.3 µM ),Cyclic,Free,Free,None,L,DRAMP
8355,DRAMP32200,KWCFRVCSRGSCYRRCRG,18,Not available,Not available,Tumor cells: HeLa (CC50>32 µM ); K562 (CC50>32 µM ); MDA-MB-435S (CC50>32 µM ); MM96L (CC50>32 µM ); WM164 (CC50>32 µM ); HT-144 (CC50>64 µM ),Cyclic,Free,Free,None,L,DRAMP
8356,DRAMP32201,KWCFRVCYRGFCYRRCRK,18,Not available,Not available,Tumor cells: MM96L (CC50=1.3±0.1 µM ); K562 (CC50=1.9±0.1 µM ); WM164 (CC50=2.9±0.2 µM ); HT-144 (CC50=3.2±0.1 µM ); HeLa (CC50=5.1±0.3 µM ),Cyclic,Free,Free,None,L,DRAMP
8357,DRAMP32202,KWCFRVCYRGICYRRCRG,18,Not available,Not available,Tumor cells: MM96L (CC50=1.3±0.1 µM ); HT-144 (CC50=1.4±0.1µM ); K562 (CC50=2.0±0.1 µM ); WM164 (CC50=2.7±0.1 µM ); MDA-MB-435S (CC50=2.7±0.3 µM ); MCF-7 (CC50=6.4±0.6 µM ); HeLa (CC50=6.7±0.6 µM ),Cyclic,Free,Free,None,L,DRAMP
8358,DRAMP32203,KWCFRVCYRGICYRRCRK,18,6PIN##1WO0##1MA2,Not available,Tumor cells: MM96L (CC50=1.0±0.1 µM ); K562 (CC50=1.7±0.1 µM ); WM164 (CC50=2.7±0.2 µM ); HT-144 (CC50=3.2±0.1 µM ); HeLa (CC50=6.7±1.1 µM ),Cyclic,Free,Free,None,L,DRAMP
8359,DRAMP32204,KWCFRVCYRGICYRRCSG,18,1WO0##1MA2,Not available,Tumor cells: HT-144 (CC50=1.2±0.1 µM ); MM96L (CC50=1.8±0.1 µM ); WM164 (CC50=1.8±0.1 µM ); HeLa (CC50=12.2±0.4 µM ); MDA-MB-435S (CC50=4.5±0.3 µM ),Cyclic,Free,Free,None,L,DRAMP
8360,DRAMP32205,KWCFRVCYRGICYSRCRG,18,Not available,Not available,Tumor cells: MM96L (CC50=1.7±0.1 µM ); HT-144 (CC50=2.3±0.2 µM ); WM164 (CC50=2.7±0.1 µM ); MDA-MB-435S (CC50=3.5±0.3 µM ); HeLa (CC50=7.5±0.3 µM ),Cyclic,Free,Free,None,L,DRAMP
8361,DRAMP32206,KWCFRVCYSGICYRRCRG,18,Not available,Not available,Tumor cells: MDA-MB-435S (CC50=5.3±0.6 µM ),Cyclic,Free,Free,None,L,DRAMP
8362,DRAMP32207,KWCFRVCYSGICYSRCSG,18,Not available,Not available,Tumor cells: WM164 (CC50=11.1±0.9 µM ); HT-144 (CC50=11.8±0.9 µM ); K562 (CC50=4.8±0.3 µM ),Cyclic,Free,Free,None,L,DRAMP
8363,DRAMP32208,KWCSRVCYRGICSRRCRG,18,Not available,Not available,Tumor cells: K562 (CC50=13.2±0.9 µM ); MM96L (CC50=17.3±1.0 µM ); HT-144 (CC50=27.8±2.2 µM ); WM164 (CC50=28.2±2.0 µM ); HeLa (CC50>32 µM ); MCF-7 (CC50>32 µM ); MDA-MB-435S (CC50>64 µM ),Cyclic,Free,Free,None,L,DRAMP
8364,DRAMP32209,SRSCLIVCQRLF,12,Not available,Not available,Tumor cells: THP-1 (Not active up to 300 µg/ml),Cyclic,Free,Amidation,None,L,DRAMP
8365,DRAMP32210,AWWRRTVAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>100µM),Linear,Free,Amidation,None,L,DRAMP
8366,DRAMP32211,GAWRRTVAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8367,DRAMP32212,GWARRTVAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8368,DRAMP32213,GWWARTVAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8369,DRAMP32214,GWWRATVAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8370,DRAMP32215,GWWRRTAAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8371,DRAMP32216,GWWRRTVAAVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8372,DRAMP32217,GWWRRTVAKVAK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Free,None,L,DRAMP
8373,DRAMP32218,GWWRRTVAKVRK,12,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8374,DRAMP32219,GWWRRTVAKVRNAGRK,16,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Amidation,None,L,DRAMP
8375,DRAMP32220,GWWRRTVDKVRNAGRK,16,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Linear,Free,Free,None,L,DRAMP
8376,DRAMP32221,SNGYRPAYRPAYRPSYRP,18,Not available,Not available,Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM),Linear,Free,Amidation,None,L,DRAMP
8377,DRAMP32222,SNVYRPPPYRPVYRPLRRPGYRP,23,Not available,Not available,Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM),Linear,Free,Amidation,None,L,DRAMP
8378,DRAMP32223,FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH,31,Not available,Not available,Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM),Linear,Free,Free,None,L,DRAMP
8379,DRAMP32224,GIKEXLCNMACAQTVCKKSGGPLCDTCQAACKALG,35,Not available,Not available,Tumor cells: A2058 (IC50=27.4 µM),Cyclic,Free,Amidation,X=MET-OXD,L,DRAMP
8380,DRAMP32225,GIKEXLCNXACAQTVCKKSGGPLCDTCQAACKALG,35,Not available,Not available,Tumor cells: A2058 (IC50>50.0 µM),Cyclic,Free,Amidation,X=MET-OXD,L,DRAMP
8381,DRAMP32226,GPKTKAACKXACKLATCGKKPGGWKCKLCELGCDAV,36,Not available,Not available,Tumor cells: A2058 (IC50=1.4 µM),Cyclic,Free,Amidation,X=MET-OXD,L,DRAMP
8382,DRAMP32227,ILPWKWPWWPWKK,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.5 µM),Linear,Free,Amidation,None,L,DRAMP
8383,DRAMP32228,RAWVAWR,7,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8384,DRAMP32229,CLBCREKAKKLFKKILKKL,19,Not available,Not available,Tumor cells: CAPAN-1 (IC50=33.0 ± 1.0 µM); MCF-7 (IC50=35.2 ± 1.8 µM); 22Rv1 (LC50=50 µM); CL1 (LC50>100 µM),Linear,Free,Amidation,None,L,DRAMP
8385,DRAMP32230,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.6 µM),Linear,Free,Amidation,X=Agb=(S)-2-amino-4 guanidinobutyric acid,L,DRAMP
8386,DRAMP32231,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≤ 6.5 µM),Linear,Free,Amidation,X=Agb=(S)-2-amino-4 guanidinobutyric acid,L,DRAMP
8387,DRAMP32232,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,X=Agb=(S)-2-amino-4 guanidinobutyric acid,L,DRAMP
8388,DRAMP32233,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=13.3 µM),Linear,Free,Amidation,X=Agb=(S)-2-amino-4 guanidinobutyric acid,L,DRAMP
8389,DRAMP32234,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.6 µM),Linear,Free,Amidation,"X=Dab=2,4-diaminobutyric acid",L,DRAMP
8390,DRAMP32235,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≤ 6.5 µM),Linear,Free,Amidation,"X=Dab=2,4-diaminobutyric acid",L,DRAMP
8391,DRAMP32236,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,"X=Dab=2,4-diaminobutyric acid",L,DRAMP
8392,DRAMP32237,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=13.3 µM),Linear,Free,Amidation,"X=Dab=2,4-diaminobutyric acid",L,DRAMP
8393,DRAMP32238,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.6 µM),Linear,Free,Amidation,"X=Dap=2,3-diaminopropionic acid",L,DRAMP
8394,DRAMP32239,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≤ 6.5 µM),Linear,Free,Amidation,"X=Dap=2,3-diaminopropionic acid",L,DRAMP
8395,DRAMP32240,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,"X=Dap=2,3-diaminopropionic acid",L,DRAMP
8396,DRAMP32241,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=13.3 µM),Linear,Free,Amidation,"X=Dap=2,3-diaminopropionic acid",L,DRAMP
8397,DRAMP32242,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.6 µM),Linear,Free,Amidation,X=hArg=homo-arginine,L,DRAMP
8398,DRAMP32243,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≤ 6.5 µM),Linear,Free,Amidation,X=hArg=homo-arginine,L,DRAMP
8399,DRAMP32244,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,X=hArg=homo-arginine,L,DRAMP
8400,DRAMP32245,VXXFPWWWPFLXX,13,Not available,Not available,Tumor cells: Jurkat (IC50=13.3 µM),Linear,Free,Amidation,X=hArg=homo-arginine,L,DRAMP
8401,DRAMP32246,VKKFAWWWAFLKK,13,Not available,Not available,Tumor cells: Jurkat (IC50=14.5 µM),Linear,Free,Amidation,None,L,DRAMP
8402,DRAMP32247,VKKFAWWWPFLKK,13,Not available,Not available,Tumor cells: Jurkat (IC50=27.6 µM),Linear,Free,Amidation,None,L,DRAMP
8403,DRAMP32248,VKKFPWWWAFLKK,13,Not available,Not available,Tumor cells: Jurkat (IC50=15.1 µM),Linear,Free,Amidation,None,L,DRAMP
8404,DRAMP32249,VKKFPWWWPFLKK,13,Not available,Not available,Tumor cells: Jurkat (IC50=11.5 µM),Linear,Free,Amidation,None,L,DRAMP
8405,DRAMP32250,VOOFPWWWPFLOO,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≤ 6.5 µM),Linear,Free,Amidation,O=Ornithine,L,DRAMP
8406,DRAMP32251,VRRFAWWWPFLRR,13,2I1H,Not available,Tumor cells: Jurkat (IC50=16.2 µM),Linear,Free,Amidation,None,L,DRAMP
8407,DRAMP32252,VRRFPXXXPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.6 µM),Linear,Free,Amidation,X=bTA=β-3-benzothienyl-1-Ala,L,DRAMP
8408,DRAMP32253,VRRFPXXXPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=44.8 µM),Linear,Free,Amidation,X=bTA=β-3-benzothienyl-1-Ala,L,DRAMP
8409,DRAMP32254,VRRFPXXXPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=9.6 µM),Linear,Free,Amidation,X=HTrp=5-hydroxytryptophan; bTA,L,DRAMP
8410,DRAMP32255,VRRFPXXXPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=44.8 µM),Linear,Free,Amidation,X=HTrp=5-hydroxytryptophan; bTA,L,DRAMP
8411,DRAMP32256,VRRFPXWWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=16.1 µM),Linear,Free,Amidation,X=HTrp=5-hydroxytryptophan; bTA,L,DRAMP
8412,DRAMP32257,VRRFPAAAPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8413,DRAMP32258,VRRFPAAWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8414,DRAMP32259,VRRFPAWAPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8415,DRAMP32260,VRRFPAWWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=36.5 µM),Linear,Free,Amidation,None,L,DRAMP
8416,DRAMP32261,VRRFPWXWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=15.1 µM),Linear,Free,Amidation,X=HTrp=5-hydroxytryptophan; bTA,L,DRAMP
8417,DRAMP32262,VRRFPWAAPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8418,DRAMP32263,VRRFPWAWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=48.2 µM),Linear,Free,Amidation,None,L,DRAMP
8419,DRAMP32264,VRRFPWWXPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=10.7 µM),Linear,Free,Amidation,X=HTrp=5-hydroxytryptophan; bTA,L,DRAMP
8420,DRAMP32265,VRRFPWWAPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=22.8 µM),Linear,Free,Amidation,None,L,DRAMP
8421,DRAMP32266,VRRFPWWWAFLRR,13,2I1I,Not available,Tumor cells: Jurkat (IC50=6.8 µM),Linear,Free,Amidation,None,L,DRAMP
8422,DRAMP32267,VRRFPWWYPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=12.0 µM),Linear,Free,Amidation,None,L,DRAMP
8423,DRAMP32268,VRRFPWYWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=11.4 µM),Linear,Free,Amidation,None,L,DRAMP
8424,DRAMP32269,VRRFPWYYPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=25.6 µM),Linear,Free,Amidation,None,L,DRAMP
8425,DRAMP32270,VRRFPYWWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=19.3 µM),Linear,Free,Amidation,None,L,DRAMP
8426,DRAMP32271,VRRFPYWYPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=35.4 µM),Linear,Free,Amidation,None,L,DRAMP
8427,DRAMP32272,VRRFPYYWPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50=32.2 µM),Linear,Free,Amidation,None,L,DRAMP
8428,DRAMP32273,VRRFPYYYPFLRR,13,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8429,DRAMP32274,RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK,37,Not available,Not available,Tumor cells: HepG2 (20% Killing=100	µg/ml),Linear,Free,Free,None,L,DRAMP
8430,DRAMP32275,GFLKKIGKKLEGAVQRTRDATIQTIAVAQAAANVAATAKQ,40,Not available,Not available,Tumor cells: HepG2 (Not active up to 1655 µg/ml),Linear,Free,Amidation,None,L,DRAMP
8431,DRAMP32276,GFLKKVGKKLEGASDLTRDATIQTIAVAQAAANVAATAKQ,40,Not available,Not available,Tumor cells: HepG2 (Not active up to 1622 µg/ml),Linear,Free,Amidation,None,L,DRAMP
8432,DRAMP32277,GWLRDFGKRIERTGQNIRDATIQTIGIAQEAANVAATLK,39,Not available,Not available,Tumor cells: HepG2 (Not active up to 535 µg/ml),Linear,Free,Amidation,None,L,DRAMP
8433,DRAMP32278,QFNMQGGGSPRQGFDVNANARFPIWQSQNARNSVHGTASYAQHLGGPYGNSRPNFGGGLQFT,62,Not available,Not available,Tumor cells: HepG2 (Not active up to 1330 µg/ml),Linear,Free,Free,None,L,DRAMP
8434,DRAMP32279,GFPCGESCVYIPCFTAAIGCSCKSKVCYKN,30,Not available,Not available,Tumor cells: K562 (CC50=0.52±0.03 µM ); MCF-7 (CC50=0.75±0.05 µM ); HeLa (CC50=0.88±0.05 µM ),Cyclic,Free,Free,None,L,DRAMP
8435,DRAMP32280,GIPCAESCVYIPCTVTALLGCSCSDKVCYN,30,Not available,Not available,Tumor cells: K562 (CC50=1.54±0.08 µM ); HeLa (CC50=2.00±0.04 µM ); MCF-7 (CC50=3.34±0.28 µM ),Cyclic,Free,Free,None,L,DRAMP
8436,DRAMP32281,GTHPCQETCVTSTRCSTQGCHCNWPICFKN,30,Not available,Not available,Tumor cells: HeLa (CC50>8 µM ),Cyclic,Free,Free,None,L,DRAMP
8437,DRAMP32282,GVPCGESCVYIPCFTGIINCSCRDKVCYNN,30,Not available,Not available,Tumor cells: HeLa (CC50=2.64±0.09 µM ); K562 (CC50=2.85±0.09 µM ); MCF-7 (CC50=3.73±0.25 µM ),Cyclic,Free,Free,None,L,DRAMP
8438,DRAMP32283,SIPCAESCVWIPCTVTALLGCSCSDKVCYN,30,Not available,Not available,Tumor cells: K562 (CC50=1.16±0.03 µM ); HeLa (CC50=1.34±0.04 µM ); MCF-7 (CC50=2.36±0.16 µM ),Cyclic,Free,Free,None,L,DRAMP
8439,DRAMP32284,ALWKDMLKGIGKLAGKAALGAVKTLV,26,Not available,Not available,Tumor cells: NCI-H157 (IC50=1.55 μM); U-251MG (IC50=2.47 μM); MCF-7 (IC50=2.92 μM); PC-3 (IC50=4.15 μM),Linear,Free,Free,None,L,DRAMP
8440,DRAMP32285,FIQHLIPLIPHAIQGIKDIF,20,Not available,Not available,Tumor cells: NCI-H460 (IC50=1.67 μM); NCI-H838 (IC50=10.3 μM); U-251MG (IC50=13.20 μM ); NCI-H157 (IC50=21.54 μM); LNCaP (IC50=3.79 μM); NCI-H23 (IC50=4.52 μM),Linear,Free,Amidation,None,L,DRAMP
8441,DRAMP32286,GLLKRIKXLL,10,Not available,Not available,Tumor cells: HeLa (30% Killing=256	µM),Linear,Free,Amidation,X(8)=Beta-Ala,L,DRAMP
8442,DRAMP32287,XLLKRIKTLL,10,Not available,Not available,Tumor cells: HeLa (20% Killing=256	µM),Linear,Free,Amidation,X(1)=Beta-Ala,L,DRAMP
8443,DRAMP32288,XXGXGXXXA,9,Not available,Not available,Tumor cells: HCT 116 (IC50=0.02µM); MDA-MB-435 (IC50=0.022µM); NCI-H460 (IC50=0.063µM); N2a (IC50>1.0µM),Cyclic,Free,Free,"X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate",L,DRAMP
8444,DRAMP32289,XXGXGXXXA,9,Not available,Not available,Tumor cells: HCT 116 (IC50=0.016µM); NCI-H460 (IC50=0.094µM); MDA-MB-435 (IC50=0.23µM); N2a (IC50>1.0µM),Cyclic,Free,Free,"X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate",L,DRAMP
8445,DRAMP32290,XXGXGXXXA,9,Not available,Not available,Tumor cells: HCT 116 (IC50=0.02µM); MDA-MB-435 (IC50=0.022µM); NCI-H460 (IC50=0.063µM); N2a (IC50>1.0µM),Linear,Free,Free,"X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate",L,DRAMP
8446,DRAMP32291,XXGXGXXXA,9,Not available,Not available,Tumor cells: HCT 116 (IC50=0.016µM); NCI-H460 (IC50=0.094µM); MDA-MB-435 (IC50=0.23µM); N2a (IC50>1.0µM),Linear,Free,Free,"X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate",L,DRAMP
8447,DRAMP32292,RKIKRYLRRMI,11,Not available,Not available,Tumor cells: HeLa (10% Killing=600	µg/ml),Linear,Free,Free,None,L,DRAMP
8448,DRAMP32293,RKIKVYLPRMK,11,Not available,Not available,Tumor cells: HeLa (10% Killing=572	µg/ml),Linear,Free,Free,None,L,DRAMP
8449,DRAMP32294,GIFSKLAGKKIKNLLISGLKG,21,Not available,Not available,Tumor cells: A549 (50% Cell death=150 µM),Linear,Free,Amidation,None,L,DRAMP
8450,DRAMP32295,GIFSKLAGKKIKNlLIsGLKG,21,Not available,Not available,Tumor cells: A549 (10% Cell death=150 µM),Linear,Free,Amidation,l=D-Leu; s=D-Ser,Mix,DRAMP
8451,DRAMP32296,GIFSKLAGKKLKNLLISG,18,Not available,Not available,Tumor cells: A549 (20% Killing=64 µM),Linear,Free,Amidation,None,L,DRAMP
8452,DRAMP32297,FIFLPIFRRPVS,12,Not available,Not available,Tumor cells: HepG2 (50.5% Killing=32µg/ml),Linear,Free,Free,None,L,DRAMP
8453,DRAMP32298,GLISTIWNTASNVAGTLTDSVKCKFKKC,28,Not available,Not available,Tumor cells: HepG2 (80.3% Killing=32µg/ml),Linear,Free,Free,None,L,DRAMP
8454,DRAMP32299,SLFSLIKAGAKFLGKNMLKQGPQYPACKVSKDSENVNWKS,40,Not available,Not available,Tumor cells: HepG2 (95.3% Killing=32µg/ml),Linear,Free,Free,None,L,DRAMP
8455,DRAMP32300,FALGAVTKVLPKLFCLITRKC,21,Not available,Not available,Tumor cells: HCT 116 (IC50=2.599 μM); NCI-H157 (IC50=3.37 μM); MDA-MB-435S (IC50=3.47 μM); PC-3 (IC50=5.87 μM),Linear,Free,Free,None,L,DRAMP
8456,DRAMP32301,FALGAVTCLIRTKCKVLPKLF,21,Not available,Not available,Tumor cells: PC-3 (IC50=186.9 μM); MDA-MB-435S (IC50=214.7 μM); NCI-H157 (IC50=278.9 μM); HCT 116 (IC50=342.8 μM),Linear,Free,Free,None,L,DRAMP
8457,DRAMP32302,FALGAVTKVLYKLFCLITRKC,21,Not available,Not available,Tumor cells: MDA-MB-435S (IC50=2.243 μM); NCI-H157 (IC50=2.811 μM); HCT 116 (IC50=3.583 μM); PC-3 (IC50=5.425 μM),Linear,Free,Free,None,L,DRAMP
8458,DRAMP32303,GFQKVKAQAATCNHTVMA,18,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/2 signaling and mitochondrial events.",Tumor cells: MCF-7 (IC50>131.0 µM ); MCF-7/G11-TR1 (IC50>131.0 µM ); MCF-7/G11-TR5 (IC50>131.0 µM ); MDA-MB-231 (IC50>131.0 µM ); MDA-MB-468 (IC50>131.0 µM ); SK-BR-3 (IC50>131.0 µM ); T-47D  (IC50>131.0 µM ); ZR-75-1 (IC50>131.0 µM ),Linear,Free,Free,None,L,DRAMP
8459,DRAMP32304,GFQKAKAKALACLAKALA,18,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/18 signaling and mitochondrial events.",Tumor cells: MDA-MB-468 (IC50=135.6±9.3 µM); SK-BR-3 (IC50=43.5±11.5 µM); MCF-7/G11-TR5 (IC50=56.4±5.0 µM); ZR-75-1 (IC50=58.9±2.0 µM); MCF-7 (IC50=61.8±3.9 µM); MCF-7/G11-TR1 (IC50=61.8±5.1 µM); T-47D  (IC50=78.5±20.9 µM); MDA-MB-231 (IC50=83.7±20.1 µM),Linear,Free,Free,None,L,DRAMP
8460,DRAMP32305,GFQKVKAQALTCLHTVMA,18,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/10 signaling and mitochondrial events.",Tumor cells: MCF-7 (IC50>128.5 µM); MCF-7/G11-TR1 (IC50>128.5 µM); MCF-7/G11-TR5 (IC50>128.5 µM); MDA-MB-231 (IC50>128.5 µM); MDA-MB-468 (IC50>128.5 µM); SK-BR-3 (IC50>128.5 µM); T-47D  (IC50>128.5 µM); ZR-75-1 (IC50>128.5 µM),Linear,Free,Free,None,L,DRAMP
8461,DRAMP32306,GIGKAIAKAIACIAKAIA,18,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/34 signaling and mitochondrial events.",Tumor cells: T-47D  (IC50 >148.5 µM); ZR-75-1 (IC50=10.1±1.8 µM); MCF-7/G11-TR1 (IC50=10.8±2.0 µM); MCF-7 (IC50=16.0±1.6 µM); MCF-7/G11-TR5 (IC50=16.1±4.9 µM); MDA-MB-468 (IC50=16.6±1.5 µM); SK-BR-3 (IC50=18.1±4.7 µM); MDA-MB-231 (IC50=18.6±2.4 µM),Linear,Free,Free,None,L,DRAMP
8462,DRAMP32307,GLGKALAKALACLAKALA,18,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/26 signaling and mitochondrial events.",Tumor cells: MDA-MB-468 (IC50=12.4±1.4 µM); T-47D  (IC50=17.5±6.5 µM); MCF-7/G11-TR5 (IC50=3.8±0.3 µM); ZR-75-1 (IC50=5.2±1.0 µM); MCF-7 (IC50=5.9±0.5 µM); MCF-7/G11-TR1 (IC50=6.2±0.8 µM); MDA-MB-231 (IC50=7.2±0.8 µM); SK-BR-3 (IC50=7.2±1.0 µM),Linear,Free,Free,None,L,DRAMP
8463,DRAMP32308,FLPALAGIAGLLGKIF,16,Not available,Not available,Tumor cells: THP-1 (45% Killing=12.5µM; 96% Killing=25µM),Linear,Free,Amidation,None,L,DRAMP
8464,DRAMP32309,FIGTLIPLALGALTKLFK,18,Not available,Not available,Tumor cells: B16-F10 (IC50=10.5 µM (0.020 g/L)); HeLa (IC50=11.1 µM (0.021 g/L)); MCF-7 (IC50=13.7 µM (0.026 g/L)),Linear,Free,Free,None,L,DRAMP
8465,DRAMP32310,CKKKC,5,Not available,Not available,Tumor cells: HeLa (IC50=25.5±2.9	µg/ml),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8466,DRAMP32311,CKKKRC,6,Not available,Not available,Tumor cells: HeLa (IC50=30.4±2.5µg/ml),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8467,DRAMP32312,CKKRKC,6,Not available,Not available,Tumor cells: HeLa (IC50=21.9±4.5µg/ml),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8468,DRAMP32313,CRKKKC,6,Not available,Not available,Tumor cells: HeLa (IC50=38.8±4.4µg/ml),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8469,DRAMP32314,KKKR,4,Not available,Not available,Tumor cells: HeLa (IC50=3.6±0.5µg/ml),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8470,DRAMP32315,KKRK,4,Not available,Not available,Tumor cells: HeLa (IC50=6.2±2.7µg/ml),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8471,DRAMP32316,RKKK,4,Not available,Not available,Tumor cells: HeLa (IC50=8.4±1.7µg/ml),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
8472,DRAMP32317,WRRRYRRWRRRRRWRRRPRR,20,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=5.02±1.04 µM),Linear,Free,Amidation,None,L,DRAMP
8473,DRAMP32318,RRIPFWPIPLRWQWPPPWFPPSFPIPRISRKR,32,Not available,Not available,Tumor cells: MEC-1 (80% killing=32μM),Linear,Free,Free,None,L,DRAMP
8474,DRAMP32319,RRIPFWPPNLPGPRRPPWFLPDFRIPRIPRKR,32,Not available,Not available,Tumor cells: MEC-1 (40% Killing=32µM),Linear,Free,Free,None,L,DRAMP
8475,DRAMP32320,RRIRFPFPPFPWQWPPAGFPTFHIPRIPRKQ,31,Not available,Not available,Tumor cells: MEC-1 (32% killing=32μM),Linear,Free,Free,None,L,DRAMP
8476,DRAMP32321,RRIRFRPPRLPRPRPRPWIPPRFPFPRIPGKR,32,Not available,Not available,Tumor cells: MEC-1 (95% killing=32μM),Linear,Free,Free,None,L,DRAMP
8477,DRAMP32322,RRIRIRPPRLPRPRPRPWFPPRFPIPRIPGKR,32,Not available,Not available,Tumor cells: MEC-1 (90% killing=32μM),Linear,Free,Free,None,L,DRAMP
8478,DRAMP32323,KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ,34,Not available,Not available,Tumor cells: TZM-bl (IC50=40.16µg/ml),Linear,Free,Free,None,L,DRAMP
8479,DRAMP32324,KRWHWWRRHWVVW,13,Not available,Not available,Tumor cells: OVCAR-3 (IC50=14.2 µM); A549 (IC50=36.2 µM); NCI/ADR-RES (IC50=85.6 µM); T24 (IC50>100 µM),Linear,Free,Amidation,None,L,DRAMP
8480,DRAMP32325,LWKRWVGVWRKWL,13,Not available,Not available,Tumor cells: A549 (IC50=11.9 µM); NCI/ADR-RES (IC50=14.0 µM); T24 (IC50=15.3 µM); OVCAR-3 (IC50=8.6 µM),Linear,Free,Amidation,None,L,DRAMP
8481,DRAMP32326,RWGKWFKKNSHLS,13,Not available,Not available,Tumor cells: A549 (IC50>100 µM); NCI/ADR-RES (IC50>100 µM); OVCAR-3 (IC50>100 µM); T24 (IC50>100 µM),Linear,Free,Amidation,None,L,DRAMP
8482,DRAMP32327,WKWLKKWIK,9,Not available,Not available,Tumor cells: OVCAR-3 (IC50=51.1 µM),Linear,Free,Amidation,None,L,DRAMP
8483,DRAMP32328,WKWLKKWIK,9,Not available,Not available,Tumor cells: THP-1 (IC50=24.3 µM),Linear,Free,Amidation,None,L,DRAMP
8484,DRAMP32329,CGAISLAKLQINES,14,Not available,Not available,Tumor cells: CT26 (IC50=80.7±6.9 µM),Linear,Free,Free,None,L,DRAMP
8485,DRAMP32330,CGAISLAPKAQIKES,15,Not available,Not available,Tumor cells: CT26 (IC50=19.2±2.3 µM),Linear,Free,Free,None,L,DRAMP
8486,DRAMP32331,CGAISLAPKLQIKES,15,Not available,Not available,Tumor cells: CT26 (IC50=93.5±10.7 µM),Linear,Free,Free,None,L,DRAMP
8487,DRAMP32332,GAISAPKLQIND,12,Not available,Not available,Tumor cells: CT26 (IC50=4.4±0.4 µM),Linear,Free,Free,None,L,DRAMP
8488,DRAMP32333,GAISLAKLQINeG,13,Not available,Not available,Tumor cells: CT26 (IC50=0.71±0.22 µM),Cyclic,Acetylization,Amidation,"C,N-terminal lactam peptide; e=D-Glutamic acid",Mix,DRAMP
8489,DRAMP32334,GAISLAPKLQINE,13,Not available,Not available,Tumor cells: CT26 (IC50=5.6±0.15 µM),Linear,Free,Free,None,L,DRAMP
8490,DRAMP32335,GAISLAPKLQINe,13,Not available,Not available,Tumor cells: CT26 (IC50=1.56±0.35 µM),Linear,Free,Free,e=D-Glutamic acid,Mix,DRAMP
8491,DRAMP32336,OLeu-V-NMeLeu-FL,16,Not available,"MSSV inhibited the proliferation of both bladder cancer 5637 and T24 cells, which was attributed to the G1-phase cell cycle arrest, apoptosis induction, and alteration of mitogen-activated protein kinases (MAPKs) and protein kinase b (AKT) signaling pathways.",Tumor cells: 5637 (IC50=20 μg/mL); T24 (IC50=20 μg/mL),Cyclic,,,OLeu=leucic acid component; NMeLeu=N-methylleucine; ,Mix,DRAMP
8492,DRAMP32337,VKLRSLLCS,9,Not available,"VS-9 could induce apoptosis and upregulate mRNA levels of caspase 3, caspase 8, caspase 9, and Bax while downregulating Bcl-2, Bcl-xL, and Bcl-w.",Tumor cells: Molt-4 (IC50=0.84 mM ); K562 (IC50=1.57 mM ),Linear,Free,Free,None,L,DRAMP
8493,DRAMP32338,DVNFLLHKIYGNIRY,15,Not available,Not available,Tumor cells: EC109 (49.01% decrease=50μg/mL); HepG2  (53.26% decrease=50μg/mL); HeLa (70.30% decrease=50μg/mL); EJ (78.44% decrease=50μg/mL),Linear,Free,Free,None,L,DRAMP
8494,DRAMP32339,FFPLIAGLAARFLPKIFCSITKRC,24,Not available,Not available,Tumor cells: SW480 (IC50=10.37±0.40 µM ); MDA-MB-231 (IC50=5.44±0.33 µM ); A549 (IC50=5.81±0.23 µM ); HCT 116 (IC50=5.87±0.15 µM ); B16-F10 (IC50=6.65±0.33 µM ); SMMC-7721 (IC50=6.87±0.51 µM ),Linear,Free,Free,None,L,DRAMP
8495,DRAMP32340,CIIKKIIKKIIKK,13,Not available,Not available,Tumor cells: HCT 116 (IC50=29±6 µM); HeLa (IC50=47±5 µM),Linear,Free,Free,None,L,DRAMP
8496,DRAMP32341,CIIKKIIKKIIKKII,15,Not available,Not available,Tumor cells: HeLa (IC50=2.7±0.5 µM); HCT 116 (IC50=7.7±0.2 µM),Linear,Free,Free,None,L,DRAMP
8497,DRAMP32342,CIIRRIIRRIIRR,13,Not available,Not available,Tumor cells: HCT 116 (IC50>100 µM); HeLa (IC50>100 µM),Linear,Free,Free,None,L,DRAMP
8498,DRAMP32343,CLLKKLLKKLLKK,13,Not available,Not available,Tumor cells: HCT 116 (IC50=23±2 µM); HeLa (IC50=83±9 µM),Linear,Free,Free,None,L,DRAMP
8499,DRAMP32344,CLLRRLLRRLLRR,13,Not available,Not available,Tumor cells: HCT 116 (IC50=15.6±1.0 µM); HeLa (IC50=26.7±1.3 µM),Linear,Free,Free,None,L,DRAMP
8500,DRAMP32345,KKRKKKAFALKFVVDLI,17,Not available,"PCC-1 induces cell proliferation inhibition, apoptosis, and cell cycle arrest by downregulating Sp1 expression in the melanoma cell lines SK-MEL-28 and G361.",Tumor cells: SK-MEL-28 (IC50=50.8 µM); G-361 (IC50=57.8 µM),Linear,Free,Amidation,None,L,DRAMP
8501,DRAMP32346,VTFVLIAAK,9,Not available,Not available,Tumor cells: HT-29 (IC50=114.9±1.5 µM),Linear,Free,Free,None,L,DRAMP
8502,DRAMP32347,IKIKIKIKIKIK,12,Not available,Not available,Tumor cells: HCT 116 (IC50=32.7±4.5 µM); HeLa (IC50=8.9±2.1 µM),Linear,Free,Free,None,L,DRAMP
8503,DRAMP32348,IKIRIKIRIKIR,12,Not available,Not available,Tumor cells: HeLa (IC50=14.5±2.3 µM); HCT 116 (IC50=20.9±2.0 µM),Linear,Free,Free,None,L,DRAMP
8504,DRAMP32349,IRIKIRIKIRIK,12,Not available,Not available,Tumor cells: HeLa (IC50=15.5±1.2 µM); HCT 116 (IC50=30.1±5.2 µM),Linear,Free,Free,None,L,DRAMP
8505,DRAMP32350,LKLKLKLKLKLK,12,Not available,Not available,Tumor cells: HCT 116 (IC50=14.5±1.3 µM); HeLa (IC50=17.7±6.5 µM),Linear,Free,Free,None,L,DRAMP
8506,DRAMP32351,LKLRLKLRLKLR,12,Not available,Not available,Tumor cells: HCT 116 (IC50>40 µM); HeLa (IC50>40 µM),Linear,Free,Free,None,L,DRAMP
8507,DRAMP32352,LRLKLRLKLRLK,12,Not available,Not available,Tumor cells: HCT 116 (IC50>40 µM); HeLa (IC50>40 µM),Linear,Free,Free,None,L,DRAMP
8508,DRAMP32353,LRLRLRLRLRLR,12,Not available,Not available,Tumor cells: HCT 116 (IC50=31.8±2.9  µM); HeLa (IC50>40 µM),Linear,Free,Free,None,L,DRAMP
8509,DRAMP32354,FLPLLISALTSLFPKLGK,18,Not available,"In IL6Rα-overexpressing cancer cells, SSTP1 induces apoptosis at low concentration through JNK pathway, without causing significant membrane disruption.",Tumor cells: HSC-4 (IC50=10.22 μM); MDA-MB-231 (IC50=4.5 μM),Linear,Free,Free,None,L,DRAMP
8510,DRAMP32355,GYFCESCRKIIQKLEDMVGPQPNEDTVTQAASQVCDKLKILRGLCKKIMRSFLRRISWDILTGKKPQAICVDIKICKE,78,Not available,Not available,Tumor cells: YAC-1 (LC90=50 µg/ml),Cyclic,Free,Free,None,L,DRAMP
8511,DRAMP32356,GEILCNLCTGLINTLENLLTTKRKRQQ,27,Not available,Not available,Tumor cells: U-937 (LC=50 µM); Jurkat (LC50=8 µM),Linear,Free,Amidation,None,L,DRAMP
8512,DRAMP32357,GFIATLCTKVLDFGIDKLIQLIEDK,25,Not available,Not available,Tumor cells: Jurkat (LC50=60 µM); U-937 (LC50=80 µM),Linear,Free,Free,None,L,DRAMP
8513,DRAMP32358,GIGKFLKKAKKFAKAFVKIINN,22,Not available,A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.,Tumor cells: A549 (IC50=10 µM),Linear,Free,Amidation,None,L,DRAMP
8514,DRAMP32359,gigkflkkakkfakafvkiinn,22,Not available,A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.,Tumor cells: A549 (IC50=6 µM),Linear,Free,Amidation,None,D,DRAMP
8515,DRAMP32360,KWKLFKKIGIGAVLKVLKKG,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=3.4 µM); NCI-H128 (IC50=3.5 µM); NCI-H146 (IC50=4.5 µM),Linear,Free,Amidation,None,L,DRAMP
8516,DRAMP32361,KWKLFKKIGIGKFLHSATTF,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=36.2 µM); NCI-H128 (IC50=37.9 µM); NCI-H146 (IC50=47.7 µM),Linear,Free,Amidation,None,L,DRAMP
8517,DRAMP32362,KWKLFKKIGIGAFLHSAKKF,20,Not available,Not available,Tumor cells: NCI-H146 (IC50=10.9 µM); NCI-H128 (IC50=9.3 µM); NCI-H69 (IC50=9.3 µM),Linear,Free,Amidation,None,L,DRAMP
8518,DRAMP32363,KWKLFKKIGIGKFLHLAKKF,20,Not available,Not available,Tumor cells: NCI-H128 (IC50=1.3 µM); NCI-H69 (IC50=1.9 µM); NCI-H146 (IC50=2.8 µM),Linear,Free,Amidation,None,L,DRAMP
8519,DRAMP32364,KWKLFKKIGIGAFLHLAKKF,20,Not available,Not available,Tumor cells: NCI-H128 (IC50=2.9 µM); NCI-H69 (IC50=2.9 µM); NCI-H146 (IC50=3.2 µM),Linear,Free,Amidation,None,L,DRAMP
8520,DRAMP32365,KWKLFKKIGIGKFKLAKKF,19,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 µM); NCI-H128 (IC50=2 µM); NCI-H146 (IC50=3.1 µM),Linear,Free,Amidation,None,L,DRAMP
8521,DRAMP32366,KWKLFAKIGIGKFLHLAKKF,20,Not available,Not available,Tumor cells: NCI-H128 (IC50=2.4 µM); NCI-H146 (IC50=2.4 µM); NCI-H69 (IC50=3.1 µM),Linear,Free,Amidation,None,L,DRAMP
8522,DRAMP32367,KWKKFLKIGIGKFLHLAKKF,20,Not available,Not available,Tumor cells: NCI-H146 (IC50=1.8 µM); NCI-H128 (IC50=2.3 µM); NCI-H69 (IC50=2.6 µM),Linear,Free,Amidation,None,L,DRAMP
8523,DRAMP32368,RQSHFANAQP,10,Not available,"the bioactive peptide combined the DNA binding domain of p53 protein by hydrogen bonds, induced the expression of p53 protein and facilitated its stability so that it inhibited the cell proliferation.",Tumor cells: MDA-MB-231 (EC50=1.50 μmol/mL); MCF-7 (EC50=2.38 μmol/mL ),Linear,Free,Free,None,L,DRAMP
8524,DRAMP32369,WPP,3,Not available,Not available,Tumor cells: PC-3 (IC50=1.99 mg/mL ); HeLa (IC50=2.54 mg/mL ); DU145 (IC50=2.80 mg/mL); NCI-H1299 (IC50=3.3 mg/mL ),Linear,Free,Free,None,L,DRAMP
8525,DRAMP32370,SLPQNIPPLTQTPVVVPPF,19,Not available,Not available,"Tumor cells: HT-29 (Antiproliferative acitivity (%)=38.55±1.75%,  Peptide concentration 3 mg/mL)",Linear,Free,Free,None,L,DRAMP
8526,DRAMP32371,YQEPVLGPVRGPFPIIV,17,Not available,Not available,"Tumor cells: HT-29 (Antiproliferative acitivity (%)=41.49±2.18%,  Peptide concentration 3 mg/mL)",Linear,Free,Free,None,L,DRAMP
8527,DRAMP32372,XXMXIVVKVLKYLX,14,Not available,Not available,Tumor cells: HT-29 (IC50=1.40±0.09 µg/mL); SW1990 (IC50=13.40±0.08 µg/mL); SMMC-7721 (IC50=13.81±0.31 µg/mL); SW480 (IC50=17.15±0.97 µg/mL); EC109 (IC50=2.13±0.23 µg/mL); A498 (IC50=2.33±0.49 µg/mL); DU145 (IC50=2.56±0.23 µg/mL); HeLa (IC50=2.60±0.24 µg/mL); A431 (IC50=2.75±0.07 µg/mL); PANC-1 (IC50=3.11±0.49 µg/mL); KB (IC50=3.14±0.07 µg/mL); HeLa S3 (IC50=3.16±0.45 µg/mL); EC9706 (IC50=3.23±0.16 µg/mL); A-375 (IC50=4.16±0.15 µg/mL); MDA-MB-231 (IC50=4.16±0.27 µg/mL); SK-OV-3 (IC50=4.26±0.25 µg/mL); MCF-7 (IC50=4.94±0.28 µg/mL); A549 (IC50=5.54±0.55 µg/mL); BGC-823 (IC50=5.68±0.25 µg/mL); SGC-7901 (IC50=5.73±0.21 µg/mL); Tca8113 (IC50=5.82±0.25 µg/mL); K562 (IC50=5.86±0.66 µg/mL); PC-3M (IC50=6.17±0.24 µg/mL); A2780 (IC50=7.40±0.36 µg/mL); HCT 116 (IC50=7.67±0.57 µg/mL); Hep-G2 (IC50=9.84±0.39 µg/mL),Linear,Free,Free,X(1)=Hmp=2-hydroxy-3-methylpentanoic acid; X(2)=Aba=2-amino-2-butenoic acid; X(4)=Ornithine; X(14)=valinol,L,DRAMP
8528,DRAMP32373,INKKI,5,Not available,By apoptosis via  mitochondrial pathway in a caspase-independent manner,Tumor cells: MCF-7 (IC50=3.07 μg/mL); T-47D  (IC50=3.26 μg/mL); MDA-MB-231 (IC50=3.53 μg/mL ); MCF-7 (IC50=3.78  µg/mL),Linear,Free,Free,None,L,DRAMP
8529,DRAMP32374,GIKCRFCCGCCTPGICGVCCRF,22,Not available,Not available,Tumor cells: MCF-7 (IC50=20 μg/mL ),Linear,Free,Free,None,L,DRAMP
8530,DRAMP32375,GLFDIVKGIKSLF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=72.00±4.51 µg/mL),Linear,Free,Free,None,L,DRAMP
8531,DRAMP32376,GLFDIVKKIKSLF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=63.00±5.00 µg/mL),Linear,Free,Free,None,L,DRAMP
8532,DRAMP32377,GLFDIVKKLKSLF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=53.17±1.69 µg/mL),Linear,Free,Free,None,L,DRAMP
8533,DRAMP32378,GLFDIWKGIKSLF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=102.33±1.45 µg/mL),Linear,Free,Free,None,L,DRAMP
8534,DRAMP32379,GLFDRVKKRKSLF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50>256 µg/mL),Linear,Free,Free,None,L,DRAMP
8535,DRAMP32380,ILGKIVKKLVSDF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=152.17±7.73 µg/mL),Linear,Free,Free,None,L,DRAMP
8536,DRAMP32381,ILGKIWKGIVSDF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50=191.67±12.02 µg/mL),Linear,Free,Free,None,L,DRAMP
8537,DRAMP32382,ILGKIWKGLVSDF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50>256 µg/mL),Linear,Free,Free,None,L,DRAMP
8538,DRAMP32383,ILGKIWKKLVSDF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50>256 µg/mL),Linear,Free,Free,None,L,DRAMP
8539,DRAMP32384,ILGKRWKGRVSDF,13,Not available,Not available,Tumor cells: Hep-G2 (IC50>256 µg/mL),Linear,Free,Free,None,L,DRAMP
8540,DRAMP32385,YALPAG,6,Not available,Not available,Tumor cells: PC-3 (IC50=71.2 μM (42.0 mg/mL)),Linear,Free,Free,None,L,DRAMP
8541,DRAMP32386,YALPAR,6,Not available,Not available,Tumor cells: PC-3 (IC50=19.0 μM (13.1 mg/mL)),Linear,Free,Free,None,L,DRAMP
8542,DRAMP32387,YALRAH,6,Not available,Not available,Tumor cells: PC-3 (IC50=11.1 μM (8.1 mg/mL)),Linear,Free,Free,None,L,DRAMP
8543,DRAMP32388,VWLSALKFIGKHLAKHQLSKL,21,Not available,Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction,Tumor cells: HCT 116 (IC50=70.79 µg/mL ),Linear,Free,Free,None,L,DRAMP
8544,DRAMP32405,KWKVFKKIEKKWKVFKKIEKAGPKWKVFKKIEK,33,2IGR,Not available,Tumor cells: NCI-H520 (IC50=22.7±0.2	 µM); NCI-H661 (IC50=35.9±0.2	 µM); CCRF-CEM (IC50=4.4±0.3 µM); AGS (IC50=5.6±0.5 µM); HL-60 (IC50=6.7±1.1 µM),Linear,Free,Amidation,None,L,DRAMP
8545,DRAMP32444,XPAXXFXPAXXLXXLXXLX,19,Not available,Not available,Tumor cells: BEL-7402 (IC50=1.98 μM); BGC-823 (IC50=2.11 μM); A549 (IC50=2.30 μM); A2780 (IC50>10 μM); HCT 8 (IC50>10 μM),Linear,Acetylation,Aminoethanol,X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,DRAMP
8546,DRAMP32445,XPAXXFXPAXXLXXLXXLX,19,Not available,Not available,Tumor cells: BGC-823 (IC50=1.03 μM); BEL-7402 (IC50=1.94 μM); A549 (IC50=2.08 μM); A2780 (IC50=3.79 μM); HCT 8 (IC50=5.93 μM),Linear,Acetylation,Aminoethanol,X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,DRAMP
8547,DRAMP32446,XPAXXFXPAXXLXXLXXLX,19,Not available,Not available,Tumor cells: BEL-7402 (IC50=1.98 μM); BGC-823 (IC50=2.11 μM); A549 (IC50=2.30 μM); A2780 (IC50>10 μM); HCT 8 (IC50>10 μM),Linear,Acetylation,Aminoethanol,X(1/4/5/17)=Aib=1-amino-isobutyric acid; X(7/13/16)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,DRAMP
8548,DRAMP32447,XPAXXFXPAXXLXXLXXLX,19,Not available,Not available,Tumor cells: BGC-823 (IC50=1.03 μM); BEL-7402 (IC50=1.94 μM); A549 (IC50=2.08 μM); A2780 (IC50=3.79 μM); HCT 8 (IC50=5.93 μM),Linear,Acetylation,Aminoethanol,X(1/4/5/17)=Aib=1-amino-isobutyric acid; X(7/13/16)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,DRAMP
8549,DRAMP32448,GAVPCGESCVYLPCLTTVVGCSCQNSVCYHN,31,Not available,Not available,Tumor cells: BxPC-3 (IC50=1.03 μM); PANC-1 (IC50=1.08 μM); Capan-2 (IC50=1.21 μM); MOH-1 (IC50=1.32 μM),Cyclic,Free,Free,None,L,DRAMP
8550,DRAMP32449,GAVPCGETCVYLPCITAAIGCSCQNKVCYRD,31,Not available,Not available,Tumor cells: Capan-2 (IC50=1.85 μM); PANC-1 (IC50=1.97 μM); MOH-1 (IC50=2.10 μM); BxPC-3 (IC50=2.33 μM),Cyclic,Free,Free,None,L,DRAMP
8551,DRAMP32450,GIPCGESCAFLPCLTSLLGCTCQNKVCYRD,30,Not available,Not available,Tumor cells: MOH-1 (IC50=1.88 μM); PANC-1 (IC50=1.95 μM); Capan-2 (IC50=2.14 μM); BxPC-3 (IC50=3.11 μM),Cyclic,Free,Free,None,L,DRAMP
8552,DRAMP32451,GISCAETCVLLPCLSSVIGCTCQNKRCYKN,30,Not available,Not available,Tumor cells: MOH-1 (IC50=0.33 μM); PANC-1 (IC50=0.36 μM); Capan-2 (IC50=0.45 μM); BxPC-3 (IC50=0.68 μM),Cyclic,Free,Free,None,L,DRAMP
8553,DRAMP32452,GNPCGESCVYLPCITTVVGCSCQNSVCYHN,30,Not available,Not available,Tumor cells: MOH-1 (IC50=1.14 μM); Capan-2 (IC50=1.32 μM); BxPC-3 (IC50=1.54 μM); PANC-1 (IC50=2.01 μM),Cyclic,Free,Free,None,L,DRAMP
8554,DRAMP32453,AIMSSLMKKLAAHIAK,16,Not available,Not available,Tumor cells: A549 (IC50=19.72±0.38 µmol/L); Hep-G2 (IC50=30.78±0.24 µmol/L); HCT 116 (IC50=47.25±0.33 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8555,DRAMP32454,GAMSSLMKKLAAHIAK,16,Not available,Not available,Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=39.57±0.12 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8556,DRAMP32455,GIASSLMKKLAAHIAK,16,Not available,Not available,Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=28.97±0.27 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8557,DRAMP32457,GIMASLMKKLAAHIAK,16,Not available,Not available,Tumor cells: Hep-G2 (IC50=10.66±0.25 µmol/L); HCT 116 (IC50=18.50±0.22 µmol/L); A549 (IC50=6.01±0.15 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8558,DRAMP32459,GIMSALMKKLAAHIAK,16,Not available,Not available,Tumor cells: HCT 116 (IC50=12.75±0.26 µmol/L); A549 (IC50=5.32±0.47 µmol/L); Hep-G2 (IC50=7.57±0.18 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8559,DRAMP32460,GIMSSAMKKLAAHIAK,16,Not available,Not available,Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8560,DRAMP32461,GIMSSLAKKLAAHIAK,16,Not available,Not available,Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=28.32±0.28 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8561,DRAMP32463,GIMSSLMAKLAAHIAK,16,Not available,Not available,Tumor cells: A549 (IC50=15.17±0.34 µmol/L); Hep-G2 (IC50=17.09±0.26 µmol/L); HCT 116 (IC50=19.81±0.20 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8562,DRAMP32465,GIMSSLMKALAAHIAK,16,Not available,Not available,Tumor cells: A549 (IC50=4.75±0.33 µmol/L); HCT 116 (IC50=7.22±0.21 µmol/L); Hep-G2 (IC50=8.04±0.27 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8563,DRAMP32466,GIMSSLMKKAAAHIAK,16,Not available,Not available,Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8564,DRAMP32468,GIMSSLMKKLAAAIAK,16,Not available,Not available,Tumor cells: A549 (IC50=5.18±0.37 µmol/L); Hep-G2 (IC50=7.35±0.34 µmol/L); HCT 116 (IC50=7.99±0.22 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8565,DRAMP32469,GIMSSLMKKLAAHAAK,16,Not available,Not available,Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8566,DRAMP32470,GIMSSLMKKLAAHIAA,16,Not available,Not available,Tumor cells: A549 (IC50=11.84±0.17 µmol/L); HCT 116 (IC50=16.80±0.34 µmol/L); Hep-G2 (IC50=16.84±0.28 µmol/L),Linear,Free,Amidation,None,L,DRAMP
8567,DRAMP32764,GLPVCGETCFGGTCNTPGCSCXTWPVCSRN,30,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,X=Glu-methylation,L,DRAMP
8568,DRAMP32765,GLPVCGETCFGGTCNTPGCSCXTWPVCSRN,30,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,X=Glu-methylation,L,DRAMP
8569,DRAMP32766,GLPVCGETCFGGTCNTPGCSCXTWPVCSRN,30,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,X=Glu-ethylation,L,DRAMP
8570,DRAMP32767,GLPVCGETCFGGTCNTPGCSCXTWPVCSRN,30,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,X=Glu-ethylation,L,DRAMP
8571,DRAMP32768,GYPICGESCVGGTCNTPGCSCSWPVCTTN,29,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,None,L,DRAMP
8572,DRAMP32769,GLPICGETCVGGTCNTPGCFCTWPVCTRN,29,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,None,L,DRAMP
8573,DRAMP32770,GLPVCGETCFTGSCYTPGCSCNWPVCNRN,29,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,None,L,DRAMP
8574,DRAMP32771,GLPVCGETCVGGTCNTPGCSCSWPVCFRN,29,Not available,Not available,Tumor cells: BEL-7402 (IC50>10 µg/ml),Cyclic,Free,Free,None,L,DRAMP
8575,DRAMP32772,GTLPCGESCVWIPCISSVVGCACKSKVCYKD,31,Not available,Not available,Tumor cells: BEL-7402 (IC50=5.36 µg/ml),Cyclic,Free,Free,None,L,DRAMP
8576,DRAMP32773,GRKKRRQRRRPQSKRKKNKKGKRK,24,Not available,Not available,Tumor cells: KG-1a (~45%Cellular viability=105 µM),Linear,Acetylation,Amidation,None,L,DRAMP
8577,DRAMP32774,YADAIFTNSYRKVLGQLSARKLLQDIMSR,29,Not available,Not available,Tumor cells: HCT 15 (~40%Inhibition=5 µM),Linear,Phenylacetyl 12-aminododecanoyl,Amidation,None,L,DRAMP
8578,DRAMP32775,YADAIFTXSYRKVLGQLSARKLLQDIMSR,29,Not available,Not available,Tumor cells: LNCaP (~90%Inhibition=5 µM),Linear,Free,Free,X=N-methyl Ala,L,DRAMP
8579,DRAMP32776,YADAIFTAXXHKVLGQLSAHKLLQDIMSR,29,Not available,Not available,Tumor cells: LNCaP (~88%Inhibition=5 µM),Linear,Free,Free,X(9)=homoArg; X(10)=Tyr methyl ether,L,DRAMP
8580,DRAMP32777,FLPLLLAGLPSFLCLVFKKC,20,Not available,Not available,Tumor cells: MCF-7 (IC50=302.1 µM),Cyclic,Free,Free,None,L,DRAMP
8581,DRAMP32778,FLPKLLAGLPSFLCLVFKKC,20,Not available,Not available,Tumor cells: MCF-7 (IC50=41.6 µM),Cyclic,Free,Free,None,L,DRAMP
8582,DRAMP32779,FLPLLLAGLPKFLCLVFKKC,20,Not available,Not available,Tumor cells: MCF-7 (IC50=310.6 µM),Cyclic,Free,Free,None,L,DRAMP
8583,DRAMP32780,KRWRWRW,7,Not available,Not available,Tumor cells: HT-29 (IC50=4.3 µM),Linear,C8,Free,None,L,DRAMP
8584,DRAMP32781,NIlLWG,6,Not available,Not available,Tumor cells: Hep-G2 (IC50=606.8 µM),Cyclic,Free,Free,l=D-Leu,Mix,DRAMP
8585,DRAMP32782,NVlLWX,6,Not available,Not available,Tumor cells: Hep-G2 (IC50=137.6 µM),Cyclic,Free,Free,l=D-Leu; X=Orn,Mix,DRAMP
8586,DRAMP32783,NGWLLI,6,Not available,Not available,Tumor cells: Hep-G2 (IC50>100 µM),Cyclic,Free,Free,None,L,DRAMP
8587,DRAMP32784,XGNIlL,6,Not available,Not available,Tumor cells: Hep-G2 (IC50>100 µM),Cyclic,Free,Free,X=N-formyl-kynurenine; l=D-Leu,Mix,DRAMP
8588,DRAMP32785,XGNIlL,6,Not available,Not available,Tumor cells: Hep-G2 (IC50>100 µM),Cyclic,Free,Free,X=N-formyl-kynurenine; l=D-Leu,Mix,DRAMP
8589,DRAMP32786,XGNIlL,6,Not available,Not available,Tumor cells: Hep-G2 (IC50>100 µM),Cyclic,Free,Free,X=kynurenine; l=D-Leu,Mix,DRAMP
8590,DRAMP32787,XGNIlL,6,Not available,Not available,Tumor cells: Hep-G2 (IC50>100 µM),Cyclic,Free,Free,X=kynurenine; l=D-Leu,Mix,DRAMP
8591,DRAMP32788,fxisfSSxFSVix,13,Not available,Not available,Tumor cells: HT-29 (LC=64 µg/ml),Linear,C10,Free,f=D-Phe; x=D-Orn; i=D-Ile; s=D-Ser,Mix,DRAMP
8592,DRAMP32789,fxisfSSxFSViX,13,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,f=D-Phe; x=D-Orn; i=D-Ile; s=D-Ser; X=Orn,Mix,DRAMP
8593,DRAMP32790,fxiswSSxWSViX,13,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C10,Free,f=D-Phe; x=D-Orn; i=D-Ile; s=D-Ser; w=D-Trp; X=Orn,Mix,DRAMP
8594,DRAMP32791,fxisvSSxVSViX,13,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C10,Free,f=D-Phe; x=D-Dab; i=D-Ile; s=D-Ser; v=D-Val; X=Dab,Mix,DRAMP
8595,DRAMP32792,kLGvPLKRK,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,k=D-Lys; v=D-Val ,Mix,DRAMP
8596,DRAMP32793,kSGxKHKKK,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,k=D-Lys; x=D-Orn,Mix,DRAMP
8597,DRAMP32794,aLGvPLKRK,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,a=D-Ala; x=D-Orn,Mix,DRAMP
8598,DRAMP32795,kLGvALKRK,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,k=D-Lys; v=D-Val ,Mix,DRAMP
8599,DRAMP32796,kLGvPLARK,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,k=D-Lys; v=D-Val ,Mix,DRAMP
8600,DRAMP32797,kLGvPLKAK,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,k=D-Lys; v=D-Val ,Mix,DRAMP
8601,DRAMP32798,kLGvPLKRA,9,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,k=D-Lys; v=D-Val ,Mix,DRAMP
8602,DRAMP32799,WEXWtIW,7,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,t=D-Thr; X=Orn,Mix,DRAMP
8603,DRAMP32800,WyTxXxTwxWXY,12,Not available,Not available,Tumor cells: HT-29 (LC=64 µg/ml),Linear,C14OH,Free,y=D-TYR; x(4/6)=D-Orn; w=D-Trp; x(9)=D-Dab; X=Orn,Mix,DRAMP
8604,DRAMP32801,XrIRL,5,Not available,Not available,Tumor cells: HT-29 (LC=64 µg/ml),Linear,C14OH,Free,X=Orn; r=D-Arg,Mix,DRAMP
8605,DRAMP32802,sRxRtLxTTnGT,12,Not available,Not available,Tumor cells: HT-29 (LC>128 µg/ml),Linear,C14OH,Free,s=D-Ser; x=D-Dab; t=D=Thr; n=D-Asn,Mix,DRAMP
8606,DRAMP32803,GKEFKRIVWLSKTAKKL,17,Not available,Not available,Tumor cells: Hep-G2 (Not active up to 128 µM),Linear,Free,Amidation,None,L,DRAMP
8607,DRAMP32804,GKEFKRIVKWPWWPWRR,17,Not available,Not available,Tumor cells: Hep-G2 (87.5% Killing=128µM),Linear,Free,Amidation,None,L,DRAMP
8608,DRAMP32805,GKEFKRIVGRIYRLCCR,17,Not available,Not available,Tumor cells: Hep-G2 (80% Killing=128µM),Linear,Free,Amidation,None,L,DRAMP
8609,DRAMP32806,KKIGQKIKNFFQKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50>50µM),Linear,Free,Free,None,L,DRAMP
8610,DRAMP32807,KKIWQKIKNFFQKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50>50µM),Linear,Free,Free,None,L,DRAMP
8611,DRAMP32808,KRIWQKIKNFFQKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50>50µM),Linear,Free,Free,None,L,DRAMP
8612,DRAMP32809,KKIWQRIKNFFQKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50=50µM),Linear,Free,Free,None,L,DRAMP
8613,DRAMP32810,KKIWQKIRNFFQKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50>50µM),Linear,Free,Free,None,L,DRAMP
8614,DRAMP32811,KKIWQKIKRFFQKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50>50µM),Linear,Free,Free,None,L,DRAMP
8615,DRAMP32812,KKIWQKIKNFFRKL,14,Not available,Not available,Tumor cells: Hep-G2 (EC50>50µM),Linear,Free,Free,None,L,DRAMP
8616,DRAMP32813,FLSLIPKAISAVSALANHF,19,Not available,Not available,Tumor cells: U-251MG (LD50=33.65 µM),Linear,Free,Amidation,None,L,DRAMP
8617,DRAMP32814,FLSLIPKAISAISALANHF,19,Not available,Not available,Tumor cells: U-251MG (LD50=36.46 µM),Linear,Free,Amidation,None,L,DRAMP
8618,DRAMP32815,FLSLIPKAISAISALINHF,19,Not available,Not available,Tumor cells: U-251MG (LD50=10.85 µM),Linear,Free,Amidation,None,L,DRAMP
8619,DRAMP32816,FLSLIPKIISAISALINHF,19,Not available,Not available,Tumor cells: U-251MG (LD50=9.547 µM),Linear,Free,Amidation,None,L,DRAMP
8620,DRAMP32817,FLSLIPKIISAISALIKHF,19,Not available,Not available,Tumor cells: U-251MG (LD50=4.059 µM),Linear,Free,Amidation,None,L,DRAMP
8621,DRAMP32818,WFGKLYRGKTKVVKKVKGLLKG,22,Not available,Not available,Tumor cells: SH-SY5Y (0% Killing=64 µM),Linear,Free,Free,None,L,DRAMP
8622,DRAMP32819,QLGKKKHRRRPSKKKRHW,18,Not available,Not available,Tumor cells: MDA-MB-231 (5%Killing=100 µM),Linear,Free,Free,None,L,DRAMP
8623,DRAMP32820,QLGRRRHRRRPSRRRRHW,18,Not available,Not available,Tumor cells: MDA-MB-231 (25%Killing=100 µM),Linear,Free,Free,None,L,DRAMP
8624,DRAMP32821,AAVALLPAVLLALLAPMPFSTGKRIMLGE,29,Not available,Not available,Tumor cells: OCI-AML3 (Not active up to 100 µM),Linear,Free,Free,None,L,DRAMP
8625,DRAMP32822,AAVALLPAVLLALLAPQLGKKKHRRRPSKKKRHW,34,Not available,Not available,Tumor cells: HCT 116-/-p53 (30%Killing=10 µM),Linear,Free,Free,None,L,DRAMP
8626,DRAMP32823,LTVSPWYGCGQLGKKKHRRRPSKKKRHW,28,Not available,Not available,Tumor cells: OPM-2 (30%Killing=50 µM),Linear,Free,Free,None,L,DRAMP
8627,DRAMP32824,LTVSPWYGCGQLGRRRHRRRPSRRRRHW,28,Not available,Not available,Tumor cells: MDA-MB-231 (78%Killing=10 µM; 100%Killing=50 µM),Linear,Free,Free,None,L,DRAMP
8628,DRAMP32825,MPFSTGKRIMLGE,13,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 100 µM),Linear,Free,Free,None,L,DRAMP
8629,DRAMP32826,LTVSPWYGCGMPFSTGKRIMLGE,23,Not available,Not available,Tumor cells: OPM-2 (0%Killing=50 µM),Linear,Free,Free,None,L,DRAMP
8630,DRAMP32827,LTVSPWYGCGKLAKLAKKLAKLAK,24,Not available,Not available,Tumor cells: OPM-2 (78%Killing=10 µM; 100%Killing=50 µM),Linear,Free,Free,None,L,DRAMP
8631,DRAMP32828,AAVALLPAVLLALLAPQLGRRRHRRRPSRRRRHW,34,Not available,Not available,Tumor cells: HCT 116-/-p53 (100%Killing=10 µM),Linear,Free,Free,None,L,DRAMP
8632,DRAMP32829,AAVALLPAVLLALLAPQLGKKILAARPSKKKRHW,34,Not available,Not available,Tumor cells: HCT 116-/-p53 (65%Killing=10 µM; 100%Killing=50 µM),Linear,Free,Free,None,L,DRAMP
8633,DRAMP32830,ALFGILKKAFGKILTIFAGLPGVV,24,Not available,Not available,Tumor cells: A549 (EC50=8.6 μM),Linear,Free,Amidation,None,L,DRAMP
8634,DRAMP32831,GLGDFIKAIAKHLGPLIGILPSKLKVAA,28,Not available,Not available,Tumor cells: A549 (EC50=11.3 μM),Linear,Free,Amidation,None,L,DRAMP
8635,DRAMP32832,GLKDPLKSVAKHLVK,15,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8636,DRAMP32833,GLVMLVKKAGLT,12,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8637,DRAMP32834,IIFGVIKALSG,11,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8638,DRAMP32835,FLGPTIGKIAKFILKHIVGLGDAALV,26,Not available,Not available,Tumor cells: A549 (EC50=10.7 μM),Linear,Free,Amidation,None,L,DRAMP
8639,DRAMP32836,GIVTILKGAVGVILGGL,17,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8640,DRAMP32837,GLFKIISGIA,10,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8641,DRAMP32838,GLGMIAHGV,9,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8642,DRAMP32839,GLWKILKKGA,10,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8643,DRAMP32840,GLFAILKKLVNLVG,14,Not available,Not available,Tumor cells: A549 (EC50=4.6 μM),Linear,Free,Amidation,None,L,DRAMP
8644,DRAMP32841,GLFKIISKLAKKA,13,Not available,Not available,Tumor cells: A549 (EC50=36.3 μM),Linear,Free,Amidation,None,L,DRAMP
8645,DRAMP32842,GLPLFLKKLGSAV,13,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8646,DRAMP32843,GLWGVIKALGGHVG,14,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8647,DRAMP32844,GLLALLGELAEHLGSKI,17,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8648,DRAMP32845,GTFAIIQ,7,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8649,DRAMP32846,GDGDIMKGIAGH,12,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8650,DRAMP32847,GLPQIISKVVKT,12,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8651,DRAMP32848,GIKKWLHSAKKFGKKFVKKIXNS,23,Not available,Not available,Tumor cells: PANC-1 (EC50=9.1±3 µM(pH=7.4)),Linear,Free,Amidation,X=Nle,L,DRAMP
8652,DRAMP32849,GIKXWLHSAKKFGXKFVKKIXNS,23,Not available,Not available,Tumor cells: PANC-1 (EC50=14.7±0.6 µM(pH=7.4)),Linear,Free,Amidation,X(4/14)=Dap; X(21)=Nle,L,DRAMP
8653,DRAMP32850,GIKXWLHSAXKFGXKFVKXIXNS,23,Not available,Not available,Tumor cells: PANC-1 (EC50=35.7±0.7 µM(pH=7.4)),Linear,Free,Amidation,X(4/10/14/19)=Dap; X(21)=Nle,L,DRAMP
8654,DRAMP32851,GIKXWLHSAXXFGXKFVXXIXNS,23,Not available,Not available,Tumor cells: PANC-1 (EC50=55±1.8 µM(pH=7.4)),Linear,Free,Amidation,X(4/10/11/14/18/19)=Dap; X(21)=Nle,L,DRAMP
8655,DRAMP32852,GIXXWLHSAXXFGXXFVXXIXNS,23,Not available,Not available,Tumor cells: PANC-1 (EC50=61.4±1.7 µM(pH=7.4)),Linear,Free,Amidation,X(3/4/10/11/14/15/18/19)=Dap; X(21)=Nle,L,DRAMP
8656,DRAMP32853,LAANFLPQILCKIARKC,17,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Cyclic,Free,Amidation,None,L,DRAMP
8657,DRAMP32854,KIAGLAANFLPQILCKIARKC,21,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Cyclic,Free,Amidation,None,L,DRAMP
8658,DRAMP32855,WIAGLAANFLPQILCKIARKC,21,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Linear,Free,Amidation,None,L,DRAMP
8659,DRAMP32856,RIAGLAANFLPQILCKIARKC,21,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Linear,Free,Amidation,None,L,DRAMP
8660,DRAMP32857,HIAGLAANFLPQILCKIARKC,21,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Linear,Free,Amidation,None,L,DRAMP
8661,DRAMP32858,liaGlaanflpqilckiarkc,21,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Cyclic,Free,Amidation,None,D,DRAMP
8662,DRAMP32859,AIIKKIIKKIIKKI,14,Not available,Not available,Tumor cells: Jurkat (IC50=25 µM),Linear,Free,Amidation,None,L,DRAMP
8663,DRAMP32860,EIIKKIIKKIIKKI,14,Not available,Not available,Tumor cells: Jurkat (IC50=23 µM),Linear,Free,Amidation,None,L,DRAMP
8664,DRAMP32861,KIIKKIIKKIIKKI,14,Not available,Not available,Tumor cells: Jurkat (IC50=20 µM),Linear,Free,Amidation,None,L,DRAMP
8665,DRAMP32862,VIIKKIIKKIIKKI,14,Not available,Not available,Tumor cells: Jurkat (IC50=15 µM),Linear,Free,Amidation,None,L,DRAMP
8666,DRAMP32863,GIIKKIIKKIIKKA,14,Not available,Not available,Tumor cells: Jurkat (IC50>40 µM),Linear,Free,Amidation,None,L,DRAMP
8667,DRAMP32864,GIIKKIIKKIIKKE,14,Not available,Not available,Tumor cells: Jurkat (IC50>40 µM),Linear,Free,Amidation,None,L,DRAMP
8668,DRAMP32865,GIIKKIIKKIIKKK,14,Not available,Not available,Tumor cells: Jurkat (IC50>40 µM),Linear,Free,Amidation,None,L,DRAMP
8669,DRAMP32866,GIIKKIIKKIIKKV,14,Not available,Not available,Tumor cells: Jurkat (IC50=15 µM),Linear,Free,Amidation,None,L,DRAMP
8670,DRAMP32867,KLWKKIEKLIKKLLTSIR,18,Not available,Not available,Tumor cells: MCF-7 (EC50=47±3 µM),Linear,Free,Amidation,None,L,DRAMP
8671,DRAMP32868,YIWARAERVWLWWGKFLSL,19,Not available,Not available,Tumor cells: MCF-7 (EC50=56±3 µM),Linear,Free,Amidation,None,L,DRAMP
8672,DRAMP32869,DLFKQLQRLFLGILYCLYKIW,21,Not available,Not available,Tumor cells: MCF-7 (EC50=47±4 µM),Linear,Free,Amidation,None,L,DRAMP
8673,DRAMP32870,AIKKFGPLAKIVAKV,15,Not available,Not available,Tumor cells: MCF-7 (EC50=95±4 µM),Linear,Free,Amidation,None,L,DRAMP
8674,DRAMP32871,RWNGRIIKGFYNLVKIWKDLKG,22,Not available,Not available,Tumor cells: MCF-7 (EC50=42±4 µM),Linear,Free,Amidation,None,L,DRAMP
8675,DRAMP32872,KVWKIKKNIRRLLHGIKRGWKG,22,Not available,Not available,Tumor cells: MCF-7 (EC50=34±4 µM),Linear,Free,Amidation,None,L,DRAMP
8676,DRAMP32873,GFWARIGKVFAAVKNL,16,Not available,Not available,Tumor cells: MCF-7 (EC50=101±4 µM),Linear,Free,Amidation,None,L,DRAMP
8677,DRAMP32874,AFLYRLTRQIRPWWRWLYKW,20,Not available,Not available,Tumor cells: MCF-7 (EC50=45.5±0.8 µM),Linear,Free,Amidation,None,L,DRAMP
8678,DRAMP32875,RIWGKHSRYIKIVKRLIQ,18,Not available,Not available,Tumor cells: MCF-7 (EC50=50±10 µM),Linear,Free,Amidation,None,L,DRAMP
8679,DRAMP32876,QIWHKIRKLWQIIKDGF,17,Not available,Not available,Tumor cells: MCF-7 (EC50=16.1±0.3 µM),Linear,Free,Amidation,None,L,DRAMP
8680,DRAMP32877,RPFTRAQWFAIQHISPRTIAMRAINNYRWR,30,Not available,Not available,Tumor cells: Hep-G2 (IC50=74.43±1.91 µM),Linear,Free,Free,None,L,DRAMP
8681,DRAMP32878,RPFIRAQWFAIQHISPRTIAMRAINNYRWR,30,Not available,Not available,Tumor cells: Hep-G2 (IC50=95.78±6.37 µM),Linear,Free,Free,None,L,DRAMP
8682,DRAMP32879,RPFTRAQIFAIQHISPRTIAMRAINNYRWR,30,Not available,Not available,Tumor cells: Hep-G2 (IC50=171.55±1.23 µM),Linear,Free,Free,None,L,DRAMP
8683,DRAMP32880,RPFTRAQWFAIIHISPRTIAMRAINNYRWR,30,Not available,Not available,Tumor cells: Hep-G2 (IC50=59.64±6.17 µM),Linear,Free,Free,None,L,DRAMP
8684,DRAMP32881,MRGENMSEGNRPEGTPHGLRSTPARELPIPAFLEPAR,37,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
8685,DRAMP32882,GTTCYCGKTIGIYWFGKYSCPTNRGYTGSCPYFLGICCYPVD,42,Not available,"APETx4 is able to selectively inhibit the human ether-à-go-go channel (hEag1 or KV10.1), which a cancer-relevant voltage-gated potassium channel that is overexpressed in a majority of human tumors. ",Tumor cells: MDA-MB-435S (KV10.1 Expression Level: Moderate),Linear,Free,Free,None,L,DRAMP
8686,DRAMP32883,EGKLSSNDTEGGLCKEFLHPSKVDLPR,27,Not available,"SOR-C13 and SOR-C27, derived from the C-terminus of soricidin, are high-affinity antagonists of human TRPV6 channels that are up-regulated in a number of cancers",Tumor cells: HeLa (~95%Inhibition=100 µM),Linear,Free,Free,None,L,DRAMP
8687,DRAMP32884,KEFLHPSKVDLPR,13,Not available,"SOR-C13 and SOR-C27, derived from the C-terminus of soricidin, are high-affinity antagonists of human TRPV6 channels that are up-regulated in a number of cancers",Tumor cells: HeLa (~18%Inhibition=100 µM),Linear,Free,Free,None,L,DRAMP
8688,DRAMP32885,NEPCDSDGDCCTSSEQCISTGSKYFC,26,Not available,As a drug delivery system targeting cancer cell nucleus using CPP-Ts’s nuclear-targeting property.,Tumor cells: DU145 (Sub peptide was internalized and directed to the intranuclear region.),Linear,Free,Free,None,L,DRAMP
8689,DRAMP32886,GKWMSFLKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=23±3 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8690,DRAMP32887,gkwmsllkhilk,12,Not available,Not available,Tumor cells: HeLa (IC50=12 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,D,DRAMP
8691,DRAMP32888,GKwMSLLKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=15±3 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,w=D-Trp,Mix,DRAMP
8692,DRAMP32889,GKWMSLLKHIWK,12,Not available,Not available,Tumor cells: HeLa (IC50=14±2 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8693,DRAMP32890,GKWMSLLKHWLK,12,Not available,Not available,Tumor cells: HeLa (IC50=16±4 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8694,DRAMP32891,GKWMSLLKKILK,12,Not available,Not available,Tumor cells: SW480 (IC50=38±6 µM); HeLa (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8695,DRAMP32892,GKWMSLWKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=30±5 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8696,DRAMP32893,GKWMTLLKHILK,12,Not available,Not available,Tumor cells: HeLa (IC50=13±3 µM); SW480 (IC50> 60 µM),Linear,Free,Amidation,None,L,DRAMP
8697,DRAMP32894,GKWSKILGHLIR,12,Not available,Not available,Tumor cells: HeLa (IC50=43±14 µM); SW480 (IC50> 100 µM); CCRF-CEM (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8698,DRAMP32895,GKWSKILGKLIR,12,Not available,Not available,Tumor cells: HeLa (IC50=22±3 µM); CCRF-CEM (IC50> 40 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8699,DRAMP32896,GMWKKILGHLIR,12,Not available,Not available,Tumor cells: SW480 (IC50=44±5 µM); HeLa (IC50=9±1 µM); CCRF-CEM (IC50> 40 µM),Linear,Free,Amidation,None,L,DRAMP
8700,DRAMP32897,GMWKKILGKLIR,12,Not available,Not available,Tumor cells: HeLa (IC50=13±2 µM); SW480 (IC50> 60 µM),Linear,Free,Amidation,None,L,DRAMP
8701,DRAMP32898,GMWSKILGHLIk,12,Not available,Not available,Tumor cells: HeLa (IC50=15±1 µM); SW480 (IC50> 100 µM),Linear,Free,Amidation,None,Mix,DRAMP
8702,DRAMP32899,gmwskilghlir,12,Not available,Not available,Tumor cells: HeLa (IC50=15±3 µM); SW480 (IC50> 40 µM),Linear,Free,Amidation,None,D,DRAMP
8703,DRAMP32900,GMWSkILGHLIR,12,Not available,Not available,Tumor cells: HeLa (IC50> 100 µM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8704,DRAMP32901,GMWSKILGHLKR,12,Not available,Not available,Tumor cells: HeLa (IC50> 100 µM),Linear,Free,Amidation,None,L,DRAMP
8705,DRAMP32902,GMWSKILGKLIR,12,Not available,Not available,Tumor cells: CCRF-CEM (IC50=30±10 µM); HeLa (IC50=9±1 µM); SW480 (IC50> 50 µM),Linear,Free,Amidation,None,L,DRAMP
8706,DRAMP32903,GMWSKILKHLIR,12,Not available,Not available,Tumor cells: SW480 (IC50=18±2 µM); HeLa (IC50=4±2 µM),Linear,Free,Amidation,None,L,DRAMP
8707,DRAMP32904,CVRRFPWWYPFLRRC,15,Not available,Not available,Tumor cells: Jurkat (IC50=12.3 µM),Cyclic,Free,Amidation,None,L,DRAMP
8708,DRAMP32905,FRVTXRTKXXKG,12,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,X=HTrp=5-hydroxytryptophan,L,DRAMP
8709,DRAMP32906,GALFLGFLGAAGSTMGAWSQPKKKRKV,27,Not available,Not available,Tumor cells: Jurkat (IC50=15.8 µM),Linear,Free,Cysteamidation,None,L,DRAMP
8710,DRAMP32907,FPVTWKWWKWWKG,13,Not available,Not available,Tumor cells: Jurkat (IC50=10.0 µM),Linear,Free,Amidation,None,L,DRAMP
8711,DRAMP32908,FRVTWRTKWWKG,12,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8712,DRAMP32909,GIGKWLHSAKKFGKAFVGEIMNS,23,Not available,Not available,Tumor cells: Jurkat (IC50=16.8 µM),Linear,Free,Amidation,None,L,DRAMP
8713,DRAMP32910,FPVTWRWWRWWRG,13,Not available,Not available,Tumor cells: Jurkat (IC50=12.0  µM),Linear,Free,Amidation,None,L,DRAMP
8714,DRAMP32911,FRWWHR,6,Not available,Not available,Tumor cells: Jurkat (IC50 ≥ 65 µM),Linear,Free,Amidation,None,L,DRAMP
8715,DRAMP32912,GIGRWLHSARRFGRAFVGEIMNS,23,Not available,Not available,Tumor cells: Jurkat (IC50=16.8 µM),Linear,Free,Amidation,None,L,DRAMP
8716,DRAMP32913,CHHNLTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (19 ± 2.82% Inhibition=160 μM); HeLa (4.5 ± 0.1.4% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8717,DRAMP32914,CHHNLTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (4 ± 1.4% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8718,DRAMP32915,CHHNLTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (19 ± 2.82% Inhibition=160 μM); HeLa (4.5 ± 0.1.4% Inhibition=160 μM),Linear,Free,Free,None,L,DRAMP
8719,DRAMP32916,CHHNLTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (4 ± 1.4% Inhibition=160 μM),Linear,Free,Free,None,L,DRAMP
8720,DRAMP32917,CAHNLTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (16.5 ± 2.12% Inhibition=160 μM); HeLa (30 ± 2.82% Inhibition=160 μM); HeLa (32.0 ± 4.2% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8721,DRAMP32918,CHANLTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (28 ± 5.5% Inhibition=160 μM); HeLa (46 ± 4.2% Inhibition=160 μM); HeLa (51 ± 1.4% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8722,DRAMP32919,CHHALTHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (48.0 ± 2.82% Inhibition=160 μM); HeLa (62.5 ± 4.9% Inhibition=160 μM); HeLa (66.5 ± 2.12% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8723,DRAMP32920,CHHNATHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (19 ± 4.2% Inhibition=160 μM); HeLa (2 ± 1.5% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8724,DRAMP32921,CHHNLAHAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (19 ± 4.2% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8725,DRAMP32922,CHHNLTAAC,9,Not available,PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.,Tumor cells: HeLa (20 ± 1.4% Inhibition=160 μM); HeLa (4.5 ± 2.13% Inhibition=160 μM),Cyclic,Free,Free,None,L,DRAMP
8726,DRAMP32923,KAaK,4,Not available,Not available,Not available,Linear,Cholesterol,Amidation,k=D-Lys,Mix,DRAMP
8727,DRAMP32924,XFLGTLVNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=40 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8728,DRAMP32925,HXLGTLVNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=55 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8729,DRAMP32926,HFXGTLVNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=40 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8730,DRAMP32927,HFLXTLVNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=25 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8731,DRAMP32928,HFLGXLVNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=40 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8732,DRAMP32929,HFLGTXVNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8733,DRAMP32930,HFLGTLXNLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=22 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8734,DRAMP32931,HFLGTLVXLAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=10 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8735,DRAMP32932,HFLGTLVNXAKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=75 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8736,DRAMP32933,HFLGTLVNLXKKIL,14,Not available,Not available,Tumor cells: HepG2 (LC50=10 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8737,DRAMP32934,HFLGTLVNLAKKXL,14,Not available,Not available,Tumor cells: HepG2 (LC50=90 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8738,DRAMP32935,HFLGTLVNLAKKIX,14,Not available,Not available,Tumor cells: HepG2 (LC50=130 µM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
8739,DRAMP32936,KYLNFAKWLKGANLAKYANA,20,Not available,Not available,Tumor cells: AGS (IC50>500 µM),Linear,Free,Free,None,L,DRAMP
8740,DRAMP32937,ILKKLLSTAAGLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=100 μM),Linear,Free,Amidation,None,L,DRAMP
8741,DRAMP32938,ILGKLLKTAAGLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=35 μM),Linear,Free,Amidation,None,L,DRAMP
8742,DRAMP32939,ILGKLLkTAAGLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50>100 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8743,DRAMP32940,ILGKLLSTAAKLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=20 μM),Linear,Free,Amidation,None,L,DRAMP
8744,DRAMP32941,ILGKLLSTAAkLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=28 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8745,DRAMP32942,ILGKLLSTAAGLLKNL,16,Not available,Not available,Tumor cells: A549 (LC50=30 μM),Linear,Free,Amidation,None,L,DRAMP
8746,DRAMP32943,ILGKLLSTAAGLLSKL,16,Not available,Not available,Tumor cells: A549 (LC50=13 μM); HepG2 (LC50=17 μM); MDA-MB-231 (LC50=18 μM); HT-29 (LC50=32 μM),Linear,Free,Amidation,None,L,DRAMP
8747,DRAMP32944,ILGKLLSTAAGLLSkL,16,Not available,Not available,Tumor cells: HT-29 (LC50=125 μM); A549 (LC50=75 μM); MDA-MB-231 (LC50=80 μM); HepG2 (LC50=90 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8748,DRAMP32945,ILGKLLKTAAKLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=20 μM),Linear,Free,Amidation,None,L,DRAMP
8749,DRAMP32946,ILGKLLkTAAkLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=65 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8750,DRAMP32947,ILGKLLSTAAKLLSKL,16,Not available,Not available,Tumor cells: MDA-MB-231 (LC50=10 μM); HT-29 (LC50=18 μM); A549 (LC50=6 μM); HepG2 (LC50=8 μM),Linear,Free,Amidation,None,L,DRAMP
8751,DRAMP32948,ILGKLLSTAAkLLSKL,16,Not available,Not available,Tumor cells: A549 (LC50=15 μM); MDA-MB-231 (LC50=20 μM); HepG2 (LC50=26 μM); HT-29 (LC50=28 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8752,DRAMP32949,ILGKLLSWAAGLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=12 μM),Linear,Free,Amidation,None,L,DRAMP
8753,DRAMP32950,ILGKLLSTWAGLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=21 μM),Linear,Free,Amidation,None,L,DRAMP
8754,DRAMP32951,ILGKLLSTAWGLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=7 μM),Linear,Free,Amidation,None,L,DRAMP
8755,DRAMP32952,ILGKLLSTAWkLLSNL,16,Not available,Not available,Tumor cells: A549 (LC50=17 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8756,DRAMP32953,ILGKLLSTAWGLLSKL,16,Not available,Not available,Tumor cells: A549 (LC50=6 μM),Linear,Free,Amidation,None,L,DRAMP
8757,DRAMP32954,ILGKLLSTAWALLSkL,16,Not available,Not available,Tumor cells: A549 (LC50=20 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8758,DRAMP32955,ILGKLLSTAWkLLSkL,16,Not available,Not available,Tumor cells: A549 (LC50=17 μM),Linear,Free,Amidation,k=D-Lys,Mix,DRAMP
8759,DRAMP32956,KLKLKFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8760,DRAMP32957,KKKKKFLLLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8761,DRAMP32958,KKKKLFKLLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8762,DRAMP32959,KKKLKFKLLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8763,DRAMP32960,KKLKKFKLLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8764,DRAMP32961,KLKKKFKLLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (4 ± 0.11% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8765,DRAMP32962,LKKKKFKLLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8766,DRAMP32963,KKKKLFLKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (4 ± 0.07% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8767,DRAMP32964,KKKLKFLKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (2 ± 0.08% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8768,DRAMP32965,KKLKKFLKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (22 ± 0.08% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8769,DRAMP32966,KLKKKFLKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (14 ± 0.05% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8770,DRAMP32967,LKKKKFLKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (13 ± 0.05% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8771,DRAMP32968,KKKLLFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (9 ± 0.11% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8772,DRAMP32969,KKLKLFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (25 ± 0.03% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8773,DRAMP32970,KLKKLFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (27 ± 0.11% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8774,DRAMP32971,LKKKLFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (8 ± 0.21% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8775,DRAMP32972,KKKKLFLLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (6 ± 0.10% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8776,DRAMP32973,KKKLKFLLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (23 ± 0.08% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8777,DRAMP32974,KKLKKFLLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (11 ± 0.08% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8778,DRAMP32975,KLKKKFLLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (17 ± 0.10% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8779,DRAMP32976,LKKKKFLLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (9 ± 0.09% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8780,DRAMP32977,KKKLLFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (14 ± 0.15% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8781,DRAMP32978,KKLKLFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (9 ± 0.06% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8782,DRAMP32979,KLKKLFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (17 ± 0.05% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8783,DRAMP32980,LKKKLFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (5 ± 0.24% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8784,DRAMP32981,KKLLKFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (19 ± 0.01% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8785,DRAMP32982,LKKLKFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (12 ± 0.02% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8786,DRAMP32983,KLLKKFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (7 ± 0.08% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8787,DRAMP32984,LKLKKFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (4 ± 0.07% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8788,DRAMP32985,LLKKKFKLKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (8 ± 0.03% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8789,DRAMP32986,KKKLLFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (22 ± 0.06% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8790,DRAMP32987,KKLKLFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (15 ± 0.20% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8791,DRAMP32988,KLKKLFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (18 ± 0.18% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8792,DRAMP32989,LKKKLFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (3 ± 0.15% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8793,DRAMP32990,KKLLKFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (29 ± 0.05% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8794,DRAMP32991,KLKLKFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8795,DRAMP32992,LKKLKFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8796,DRAMP32993,KLLKKFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8797,DRAMP32994,LKLKKFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (7 ± 0.17% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8798,DRAMP32995,LLKKKFLKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (12 ± 0.19% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8799,DRAMP32996,KKLLLFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (19 ± 0.09% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8800,DRAMP32997,KLKLLFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (11 ± 0.22% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8801,DRAMP32998,LKKLLFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8802,DRAMP32999,KLLKLFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (28 ± 0.05% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8803,DRAMP33000,LKLKLFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (1 ± 0.26% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8804,DRAMP33001,LLKKLFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (2 ± 0.13% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8805,DRAMP33002,KLLLKFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (20 ± 0.26% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8806,DRAMP33003,LKLLKFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (16 ± 0.31% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8807,DRAMP33004,LLKLKFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (16 ± 0.15% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8808,DRAMP33005,LLLKKFKKKQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (5 ± 0.24% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8809,DRAMP33006,KKLLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (50 ± 0.10% Growth inhibition=40 μM; IC50=31.2 ± 5 μM); HeLa (IC50=22.5 ± 0 μM); A431 (IC50=28.0 ± 3 μM); PANC-1 (IC50=32.5 ± 11 μM); HepG2 (IC50=32.5 ± 4 μM),Cyclic,Free,Free,None,L,DRAMP
8810,DRAMP33007,KLKLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (23 ± 0.17% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8811,DRAMP33008,LKKLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (13 ± 0.08% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8812,DRAMP33009,KLLKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (95 ± 0.01% Growth inhibition=40 μM; IC50=22.0 ± 0 μM); PANC-1 (IC50=18.5 ± 8 μM); HepG2 (IC50=20.5 ± 6 μM); A431 (IC50=21.5 ± 8 μM); HeLa (IC50=23.0 ± 3 μM),Cyclic,Free,Free,None,L,DRAMP
8813,DRAMP33010,LKLKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (59 ± 0.08% Growth inhibition=40 μM; IC50=40.0 ± 7 μM); HeLa (IC50=24.5 ± 0.7 μM); HepG2 (IC50=34.5 ± 2 μM); A431 (IC50=35.0 ± 7 μM); PANC-1 (IC50=51.0 ± 6 μM),Cyclic,Free,Free,None,L,DRAMP
8814,DRAMP33011,LLKKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (60 ± 0.07% Growth inhibition=40 μM; IC50=40.7 ± 3 μM); HeLa (IC50=38.5 ± 4 μM); HepG2 (IC50=44.0 ± 3 μM); PANC-1 (IC50=44.5 ± 0.7 μM); A431 (IC50=47.5 ± 4 μM),Cyclic,Free,Free,None,L,DRAMP
8815,DRAMP33012,KLLLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (88 ± 0.01% Growth inhibition=40 μM; IC50=32.2 ± 7 μM); A431 (IC50=24.5 ± 0.7	 μM); HeLa (IC50=30.5 ± 12 μM); PANC-1 (IC50=41.5 ± 11 μM); HepG2 (IC50=42.2 ± 2 μM),Cyclic,Free,Free,None,L,DRAMP
8816,DRAMP33013,KKKLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (22 ± 0.09% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8817,DRAMP33014,LLLKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (14 ± 0.01% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8818,DRAMP33015,LKKKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (Not active up to 40 μM),Cyclic,Free,Free,None,L,DRAMP
8819,DRAMP33016,LKLLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (20 ± 0.05% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8820,DRAMP33017,KKLKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (70 ± 0.01% Growth inhibition=40 μM; IC50=32.5 ± 0.5 μM); HeLa (IC50=29.5 ± 2 μM); PANC-1 (IC50=40.0 ± 3 μM); HepG2 (IC50=46.0 ± 3 μM); A431 (IC50=50.0 ± 10 μM),Cyclic,Free,Free,None,L,DRAMP
8821,DRAMP33018,LLKLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (18 ± 0.09% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8822,DRAMP33019,KLKKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (56 ± 0.06% Growth inhibition=40 μM; IC50=53.2 ± 13 μM); HeLa (IC50=35.0 ± 1 μM); A431 (IC50=49.5 ± 6 μM); PANC-1 (IC50=57.5 ± 6 μM); HepG2 (IC50>60 μM),Cyclic,Free,Free,None,L,DRAMP
8823,DRAMP33020,LLLLKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (11 ± 0.27% Growth inhibition=40 μM),Cyclic,Free,Free,None,L,DRAMP
8824,DRAMP33021,KKKKKFKKLQ,10,Not available,Not available,Tumor cells: MDA-MB-231 (63 ± 0.02% Growth inhibition=40 μM; IC50=40.5 ± 9 μM); A431 (IC50=35.5 ± 2 μM); PANC-1 (IC50=43.5 ± 0.7 μM); HepG2 (IC50=46.0 ± 8 μM); HeLa (IC50=54.0 ± 6 μM),Cyclic,Free,Free,None,L,DRAMP
8825,DRAMP33022,RIIDLLWRVWRPQKPKFVTVWVR,23,Not available,Not available,Tumor cells: Jurkat (IC50=19 µM); SNU-601 (IC50=28 µM),Linear,Free,Amidation,None,L,DRAMP
8826,DRAMP33023,RIIDLLWRVRRPWKPKFVTVWVR,23,Not available,Not available,Tumor cells: Jurkat (IC50=20 µM); SNU-601 (IC50=30 µM),Linear,Free,Amidation,None,L,DRAMP
8827,DRAMP33024,RIIDLLWRVRRPQWPKFVTVWVR,23,Not available,Not available,Tumor cells: Jurkat (IC50=29 µM); SNU-601 (IC50=39 µM),Linear,Free,Amidation,None,L,DRAMP
8828,DRAMP33025,RIIDLLWRVRRPWWPKFVTVWVR,23,Not available,Not available,Tumor cells: Jurkat (IC50=23 µM); SNU-601 (IC50=37 µM),Linear,Free,Amidation,None,L,DRAMP
8829,DRAMP33026,RIIDLLWRVWRPWKPKFVTVWVR,23,Not available,Not available,Tumor cells: Jurkat (IC50=16 µM); SNU-601 (IC50=21 µM),Linear,Free,Amidation,None,L,DRAMP
8830,DRAMP33027,RIIDLLWRVWRPWWPKFVTVWVR,23,Not available,Not available,Tumor cells: SNU-601 (IC50=10 µM); Jurkat (IC50=11 µM),Linear,Free,Amidation,None,L,DRAMP
8831,DRAMP33028,GKKLKKIGQKIKNFFQKL,18,Not available,Not available,Tumor cells: Jurkat (IC50=20 µM); A549 (IC50=25 µM); K562 (IC50=34 µM),Linear,Free,Free,None,L,DRAMP
8832,DRAMP33029,GEKLKKIGKKIKNFFQKL,18,Not available,Not available,Tumor cells: Jurkat (IC50=66 µM); K562 (IC50=85 µM); A549 (IC50=88 µM),Linear,Free,Free,None,L,DRAMP
8833,DRAMP33030,GEKLKKIGQKIKKFFQKL,18,Not available,Not available,Tumor cells: K562 (IC50=100 µM); Jurkat (IC50=78 µM); A549 (IC50=93 µM),Linear,Free,Free,None,L,DRAMP
8834,DRAMP33031,GEKLKKIGQKIKNFFKKL,18,Not available,Not available,Tumor cells: A549 (IC50>100 µM); Jurkat (IC50>100 µM); K562 (IC50>100 µM),Linear,Free,Free,None,L,DRAMP
8835,DRAMP33032,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8836,DRAMP33033,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8837,DRAMP33034,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8838,DRAMP33035,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8839,DRAMP33036,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8840,DRAMP33037,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8841,DRAMP33038,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8842,DRAMP33039,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8843,DRAMP33040,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8844,DRAMP33041,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8845,DRAMP33042,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8846,DRAMP33043,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8847,DRAMP33044,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8848,DRAMP33045,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8849,DRAMP33046,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8850,DRAMP33047,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8851,DRAMP33048,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8852,DRAMP33049,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8853,DRAMP33050,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8854,DRAMP33051,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8855,DRAMP33052,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8856,DRAMP33053,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8857,DRAMP33054,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8858,DRAMP33055,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8859,DRAMP33056,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8860,DRAMP33057,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8861,DRAMP33058,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8862,DRAMP33059,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8863,DRAMP33060,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8864,DRAMP33061,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8865,DRAMP33062,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8866,DRAMP33063,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8867,DRAMP33064,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8868,DRAMP33065,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8869,DRAMP33066,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8870,DRAMP33067,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8871,DRAMP33068,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8872,DRAMP33069,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8873,DRAMP33070,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8874,DRAMP33071,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8875,DRAMP33072,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8876,DRAMP33073,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8877,DRAMP33074,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8878,DRAMP33075,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8879,DRAMP33076,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50>256 µM),Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8880,DRAMP33077,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=64 µM),Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8881,DRAMP33078,GLLxRIkTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8882,DRAMP33079,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8883,DRAMP33080,GLLxRIkTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8884,DRAMP33081,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8885,DRAMP33082,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8886,DRAMP33083,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8887,DRAMP33084,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8888,DRAMP33085,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8889,DRAMP33086,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8890,DRAMP33087,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys,Mix,DRAMP
8891,DRAMP33088,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8892,DRAMP33089,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8893,DRAMP33090,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8894,DRAMP33091,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8895,DRAMP33092,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8896,DRAMP33093,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8897,DRAMP33094,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys,Mix,DRAMP
8898,DRAMP33095,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8899,DRAMP33096,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8900,DRAMP33097,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8901,DRAMP33098,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8902,DRAMP33099,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8903,DRAMP33100,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8904,DRAMP33101,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys,Mix,DRAMP
8905,DRAMP33102,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8906,DRAMP33103,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8907,DRAMP33104,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8908,DRAMP33105,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8909,DRAMP33106,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8910,DRAMP33107,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8911,DRAMP33108,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys,Mix,DRAMP
8912,DRAMP33109,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8913,DRAMP33110,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8914,DRAMP33111,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8915,DRAMP33112,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8916,DRAMP33113,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8917,DRAMP33114,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8918,DRAMP33115,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys,Mix,DRAMP
8919,DRAMP33116,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8920,DRAMP33117,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8921,DRAMP33118,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8922,DRAMP33119,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8923,DRAMP33120,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8924,DRAMP33121,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8925,DRAMP33122,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys,Mix,DRAMP
8926,DRAMP33123,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8927,DRAMP33124,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8928,DRAMP33125,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=128 µM),Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8929,DRAMP33126,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=16 µM),Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8930,DRAMP33127,GLLkRIxTLL,10,Not available,Not available,Tumor cells: HeLa  (IC50=8 µM),Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8931,DRAMP33128,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8932,DRAMP33129,GLLkRIxTLL,10,Not available,Not available,Not available,Linear,Free,Amidation,x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys,Mix,DRAMP
8933,DRAMP33130,RLLRLIRKLII,11,Not available,Not available,Tumor cells: MCF-7 (EC50=11±1 μM); A549 (EC50=21±1 μM); Jurkat (EC50=39±1 μM); 1205Lu (EC50=9±1 μM),Linear,Free,Amidation,None,L,DRAMP
8934,DRAMP33131,RLLRLIRKLIL,11,Not available,Not available,Tumor cells: A549 (EC50=14±1 μM); Jurkat (EC50=25±1 μM); 1205Lu (EC50=7±1 μM); MCF-7 (EC50=9±1 μM),Linear,Free,Amidation,None,L,DRAMP
8935,DRAMP33132,LLLLLIRKLIK,11,Not available,Not available,Tumor cells: MCF-7 (EC50=11±1 μM); 1205Lu (EC50=16±1 μM); A549 (EC50=22±1 μM); Jurkat (EC50=25±1 μM),Linear,Free,Amidation,None,L,DRAMP
8936,DRAMP33133,YLLYLIRKLIL,11,Not available,Not available,Tumor cells: MCF-7 (EC50=13±1 μM); 1205Lu (EC50=14±1 μM); Jurkat (EC50=22±1 μM); A549 (EC50=29±1 μM),Linear,Free,Amidation,None,L,DRAMP
8937,DRAMP33134,RLLRLIRKLIR,11,Not available,Not available,Tumor cells: MCF-7 (EC50=14±1 μM); 1205Lu (EC50=16±1 μM); A549 (EC50=27±1 μM); Jurkat (EC50=27±1 μM),Linear,Free,Amidation,None,L,DRAMP
8938,DRAMP33135,QLLQLIRKLII,11,Not available,Not available,Tumor cells: 1205Lu (EC50=21±1 μM); MCF-7 (EC50=22±1 μM); A549 (EC50=29±1 μM); Jurkat (EC50=35±1 μM),Linear,Free,Amidation,None,L,DRAMP
8939,DRAMP33136,QLLQLIRKLIM,11,Not available,Not available,Tumor cells: 1205Lu (EC50=24±1 μM); A549 (EC50=33±1 μM); MCF-7 (EC50=33±1 μM); Jurkat (EC50=46±1 μM),Linear,Free,Amidation,None,L,DRAMP
8940,DRAMP33137,MLLMLIRKLIL,11,Not available,Not available,Tumor cells: MCF-7 (EC50=16±1 μM); 1205Lu (EC50=31±1 μM); Jurkat (EC50=31±1 μM); A549 (EC50=58±1 μM),Linear,Free,Amidation,None,L,DRAMP
8941,DRAMP33138,QLLQLIRKLIR,11,Not available,Not available,Tumor cells: 1205Lu (EC50=38±1 μM); MCF-7 (EC50=53±1 μM); A549 (EC50=60±1 μM); Jurkat (EC50=75±1 μM),Linear,Free,Amidation,None,L,DRAMP
8942,DRAMP33139,QLLQLIRKLIK,11,Not available,Not available,Tumor cells: 1205Lu (EC50=39±1 μM); MCF-7 (EC50=50-100 μM); A549 (EC50=54±1 μM); Jurkat (EC50=69±1 μM),Linear,Free,Amidation,None,L,DRAMP
8943,DRAMP33140,QLLQLIRKLIY,11,Not available,Not available,Tumor cells: 1205Lu (EC50=29±1 μM); MCF-7 (EC50=50-100 μM); Jurkat (EC50=58±1 μM); A549 (EC50=61±1 μM),Linear,Free,Amidation,None,L,DRAMP
8944,DRAMP33141,LLLQLIRKLIL,11,Not available,Not available,Tumor cells: MCF-7 (EC50=10±1 μM); 1205Lu (EC50=12±1 μM); A549 (EC50=30±1 μM); Jurkat (EC50=53±1 μM),Linear,Free,Amidation,None,L,DRAMP
8945,DRAMP33142,TLLLLIRKLIL,11,Not available,Not available,Tumor cells: 1205Lu (EC50=16±1 μM); Jurkat (EC50=30±1 μM); MCF-7 (EC50=38±1 μM); A549 (EC50=79±1 μM),Linear,Free,Amidation,None,L,DRAMP
8946,DRAMP33143,RLLLLIRKLIL,11,Not available,Not available,Tumor cells: 1205Lu (EC50=18±1 μM); MCF-7 (EC50=24±1 μM); A549 (EC50=35±1 μM); Jurkat (EC50=40±1 μM),Linear,Free,Amidation,None,L,DRAMP
8947,DRAMP33144,LLLLLIRKLIL,11,Not available,Not available,Tumor cells: MCF-7 (EC50=25±1 μM); 1205Lu (EC50=48±1 μM); Jurkat (EC50=50±1 μM); A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8948,DRAMP33145,QLLLLIRKLIL,11,Not available,Not available,Tumor cells: Jurkat (EC50=39±1 μM); 1205Lu (EC50=44±1 μM); MCF-7 (EC50=63±1 μM); A549 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8949,DRAMP33146,QLLLLIRKLIV,11,Not available,Not available,Tumor cells: 1205Lu (EC50=53±1 μM); MCF-7 (EC50=77±1 μM); A549 (EC50>100 μM); Jurkat (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8950,DRAMP33147,CLLLLIRKLIL,11,Not available,Not available,Tumor cells: 1205Lu (EC50=76±1 μM); A549 (EC50>100 μM); Jurkat (EC50>100 μM); MCF-7 (EC50>100 μM),Linear,Free,Amidation,None,L,DRAMP
8951,DRAMP33148,WKWLKKWIK,9,Not available,Not available,Tumor cells: OVCAR-3 (IC50=51.1 µM),Linear,Free,Free,None,L,DRAMP
8952,DRAMP33149,WKWLKKWIK,9,Not available,Not available,Tumor cells: THP-1 (IC50=24.3 µM),Linear,Free,Free,None,L,DRAMP
8953,DRAMP33150,WRKFWKYLK,9,Not available,Not available,Tumor cells: THP-1 (IC50=47.3 µM),Linear,Free,Free,None,L,DRAMP
8954,DRAMP33151,RLWWWWRRK,9,Not available,Not available,Tumor cells: THP-1 (IC50=87 µM),Linear,Free,Free,None,L,DRAMP
8955,DRAMP33152,KWKWWWRKI,9,Not available,Not available,Tumor cells: THP-1 (IC50=90.4 µM),Linear,Free,Free,None,L,DRAMP
8956,DRAMP33153,RIRRWKFRW,9,Not available,Not available,Tumor cells: THP-1 (IC50=182.5 µM),Linear,Free,Free,None,L,DRAMP
8957,DRAMP33154,RLKRWWKFL,9,Not available,Not available,Tumor cells: THP-1 (IC50=48 µM),Linear,Free,Free,None,L,DRAMP
8958,DRAMP33155,RRWWRWVVW,9,Not available,Not available,Tumor cells: THP-1 (IC50=179.1 µM),Linear,Free,Free,None,L,DRAMP
8959,DRAMP33156,WFKMRWWGR,9,Not available,Not available,Tumor cells: THP-1 (IC50=189.3 µM),Linear,Free,Free,None,L,DRAMP
8960,DRAMP33157,KFKWWRMLI,9,Not available,Not available,Tumor cells: THP-1 (IC50=49 µM),Linear,Free,Free,None,L,DRAMP
8961,DRAMP33158,RWRWWWRVY,9,Not available,Not available,Tumor cells: THP-1 (IC50=171.5 µM),Linear,Free,Free,None,L,DRAMP
8962,DRAMP33159,LKRRWKWWI,9,Not available,Not available,Tumor cells: THP-1 (IC50=186.7 µM),Linear,Free,Free,None,L,DRAMP
8963,DRAMP33160,RRRIKIRWY,9,Not available,Not available,Tumor cells: THP-1 (IC50=190.2 µM),Linear,Free,Free,None,L,DRAMP
8964,DRAMP33161,RLWWKIWLK,9,Not available,Not available,Tumor cells: THP-1 (IC50=192.8 µM),Linear,Free,Free,None,L,DRAMP
8965,DRAMP33162,KRRWRIWLV,9,Not available,Not available,Tumor cells: THP-1 (IC50=195.1 µM),Linear,Free,Free,None,L,DRAMP
8966,DRAMP33163,FFIYVWRRR,9,Not available,Not available,Tumor cells: THP-1 (IC50=190.8 µM),Linear,Free,Free,None,L,DRAMP
8967,DRAMP33164,IRMRIRVLL,9,Not available,Not available,Tumor cells: THP-1 (IC50=219 µM),Linear,Free,Free,None,L,DRAMP
8968,DRAMP33165,RWWRKIWKW,9,Not available,Not available,Tumor cells: THP-1 (IC50=177.3 µM),Linear,Free,Free,None,L,DRAMP
8969,DRAMP33166,RWWIRIRWH,9,Not available,Not available,Tumor cells: THP-1 (IC50=181.8 µM),Linear,Free,Free,None,L,DRAMP
8970,DRAMP33167,RRRWWKLMM,9,Not available,Not available,Tumor cells: THP-1 (IC50=94 µM),Linear,Free,Free,None,L,DRAMP
8971,DRAMP33168,LRRWIRIRW,9,Not available,Not available,Tumor cells: THP-1 (IC50=189.1 µM),Linear,Free,Free,None,L,DRAMP
8972,DRAMP33169,RKFRWWVIR,9,Not available,Not available,Tumor cells: THP-1 (IC50=190.2 µM),Linear,Free,Free,None,L,DRAMP
8973,DRAMP33170,WKIVFWWRR,9,Not available,Not available,Tumor cells: THP-1 (IC50=186 µM),Linear,Free,Free,None,L,DRAMP
8974,DRAMP33171,RQRRVVIWW,9,Not available,Not available,Tumor cells: THP-1 (IC50=197.2 µM),Linear,Free,Free,None,L,DRAMP
8975,DRAMP33172,RRWRVIVKW,9,Not available,Not available,Tumor cells: THP-1 (IC50=197.2 µM),Linear,Free,Free,None,L,DRAMP
8976,DRAMP33173,RLWRIVVIRVKR,12,Not available,Not available,Tumor cells: THP-1 (IC50=138.4 µM),Linear,Free,Free,None,L,DRAMP
8977,DRAMP33174,RLRRIVVIRVFR,12,Not available,Not available,Tumor cells: THP-1 (IC50=158.8 µM),Linear,Free,Free,None,L,DRAMP
8978,DRAMP33175,RKWKIKWYW,9,Not available,Not available,Tumor cells: THP-1 (IC50=183.8 µM),Linear,Free,Free,None,L,DRAMP
8979,DRAMP33176,YRLRVKWKW,9,Not available,Not available,Tumor cells: THP-1 (IC50=191.9 µM),Linear,Free,Free,None,L,DRAMP
8980,DRAMP33177,WKWRVRVTI,9,Not available,Not available,Tumor cells: THP-1 (IC50=206 µM),Linear,Free,Free,None,L,DRAMP
8981,DRAMP33178,RTKKWIVWI,9,Not available,Not available,Tumor cells: THP-1 (IC50=208.3 µM),Linear,Free,Free,None,L,DRAMP
8982,DRAMP33179,KRKKRFKWW,9,Not available,Not available,Tumor cells: THP-1 (IC50=188 µM),Linear,Free,Free,None,L,DRAMP
8983,DRAMP33180,VXLfPFfNQY,10,Not available,Not available,Tumor cells: A549 (LC50=14 µM); HeLa (LC50=21 µM),Cyclic,Free,Free,X=Orn; f=D-Phe,Mix,DRAMP
8984,DRAMP33181,VKLfPFfNQY,10,Not available,Not available,Tumor cells: A549 (LC50=12 µM); HeLa (LC50=15 µM),Cyclic,Free,Free,f=D-Phe,Mix,DRAMP
8985,DRAMP33182,VXLfPWfNQY,10,Not available,Not available,Tumor cells: A549 (LC50=12 µM); HeLa (LC50=17 µM),Cyclic,Free,Free,X=Orn; f=D-Phe,Mix,DRAMP
8986,DRAMP33183,VKLfPWfNQY,10,Not available,Not available,Tumor cells: A549 (LC50=24 µM); HeLa (LC50=28 µM),Cyclic,Free,Free,f=D-Phe,Mix,DRAMP
8987,DRAMP33184,VXLfPWwNQY,10,Not available,Not available,Tumor cells: A549 (LC50=12 µM); HeLa (LC50=13 µM),Cyclic,Free,Free,X=Orn; f=D-Phe,Mix,DRAMP
8988,DRAMP33185,VKLfPWwNQY,10,Not available,Not available,Tumor cells: A549 (LC50=12 µM); HeLa (LC50=16 µM),Cyclic,Free,Free,f=D-Phe,Mix,DRAMP
8989,DRAMP33186,FLPILASLAAKFGPKLFXLVTKKX,24,Not available,Not available,Tumor cells: HepG2 (LC50=4 μM ); MDA-MB-231 (LC50=7 μM ),Cyclic,Free,Free,X=Allylglycine,L,DRAMP
8990,DRAMP33187,FLPILASLAAKFGPKLFXLVTKKX,24,Not available,Not available,Not available,Cyclic,Free,Free,X=Allylglycine,L,DRAMP
8991,DRAMP33188,FLPILASLAAKFGPKLFXLVTKKX,24,Not available,Not available,Tumor cells: HepG2 (LC50=4 μM ); MDA-MB-231 (LC50=7 μM ),Cyclic,Free,Free,X=Allylglycine,L,DRAMP
8992,DRAMP33189,FLPILASLAAKFGPKLFXLVTKKX,24,Not available,Not available,Not available,Cyclic,Free,Free,X=Allylglycine,L,DRAMP
8993,DRAMP33190,FLPILASLAAKFGPKLFSLVTKKS,24,Not available,Not available,Tumor cells: HepG2 (LC50=10 μM ); MDA-MB-231 (LC50=13 μM ),Cyclic,Free,Free,None,L,DRAMP
8994,DRAMP33191,GQSQWRDVCRNFMRR,15,Not available,Not available,Tumor cells: Jurkat (Not active at 20 µM),Linear,Free,Free,None,L,DRAMP
8995,DRAMP33192,FLSLIPHIVSGVASLAKHF,19,Not available,Not available,Tumor cells: THP-1 (IC50=22.5 µM),Linear,Free,Amidation,None,L,DRAMP
8996,DRAMP33193,FLSMIPHIVSGVAALAKHL,19,Not available,Not available,Tumor cells: THP-1 (IC50=23 µM),Linear,Free,Amidation,None,L,DRAMP
8997,DRAMP33194,KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC,47,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=0.82±0.14 µM),Cyclic,Free,Free,None,L,DRAMP
8998,DRAMP33195,GFSSIFRGVAKFASKGLGKKLAKLGVKLVACKISKQC,37,Not available,Not available,Tumor cells: A549 (LC50=3 μM ),Linear,Free,Free,None,L,DRAMP
8999,DRAMP33196,GFSSIFRGVAKFASKGLGKDLAKLGVDLVASKISKQS,37,Not available,Not available,Tumor cells: A549 (LC50=26 μM ),Linear,Free,Free,None,L,DRAMP
9000,DRAMP33197,RGVAKFASKGLGKDLAKLGVDLVACKISKQC,31,Not available,Not available,Tumor cells: A549 (LC50>100 μM ),Cyclic,Free,Free,None,L,DRAMP
9001,DRAMP33198,KPPPWVPV,8,Not available,Not available,Tumor cells: DU145 (~25% Cell death=10 µM); PC-3 (~25% Cell death=10 µM); LNCaP (~50% Cell death=10 µM),Linear,Free,Free,None,L,DRAMP
9002,DRAMP33199,GIPCGESCVYIPCTVTALLGCSCKDKVCYKN,31,Not available,Not available,Tumor cells: A549 (IC50=0.78 µM ),Cyclic,Free,Free,None,L,DRAMP
9003,DRAMP33200,GSVIKCGESCLLGKCYTPGCTCSRPICKKD,30,Not available,Not available,Tumor cells: A549 (IC50=9.59 µM ),Cyclic,Free,Free,None,L,DRAMP
9004,DRAMP33201,GSAIRCGESCLLGKCYTPGCTCDRPICKKN,30,Not available,Not available,Tumor cells: A549 (IC50>10 µM ),Cyclic,Free,Free,None,L,DRAMP
9005,DRAMP33202,GNPANPLNLKKHHGVFCDVCKALVEGGEKVGDDDLDAWLDVNIGTLCWTMLLPLHHECEEELKKVKKELKKDIENKDSPDKACKDVDLC,89,Not available,Not available,Tumor cells: Jurkat (Low active up to 10 µM ),Cyclic,Free,Free,None,L,DRAMP
9006,DRAMP33203,GSHGAFCHLCEDLIKDGKEAGDVALDVWLDEEIGSRCKDFGVLASECFKELKVAEHDIWEAIDQEIPEDKTCKEAKLC,78,Not available,Not available,Tumor cells: Jurkat (Low active up to 10 µM ),Cyclic,Free,Free,None,L,DRAMP
9007,DRAMP33204,RRQRRTSKLMKRGGKLAKLAKKLAKLAKLAK,31,Not available,It is possible that the DP1 fusion peptide can be used to facilitate an immune response against tumor antigens by triggering massive apoptosis within tumors,Tumor cells: Clinical isolate 22B (LC50<50 μM ); Clinical isolate 4129 (LC50<50 μM ); MCA 205 (LC50<50 μM ),Linear,Free,Free,None,L,DRAMP
9008,DRAMP33205,KRIIQRILSRNS,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9009,DRAMP33206,KRIHPRLTRSIR,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9010,DRAMP33207,PPRLRKRRQLNM,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9011,DRAMP33208,PIRRRKKLRRLK,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9012,DRAMP33209,MHKRPTTPSRKM,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9013,DRAMP33210,klaklakklaklak,14,Not available,Not available,Tumor cells: HepG2 (LD50>256 µg/ml; 12% Killing=250 µg/ml),Linear,Free,Free,None,D,DRAMP
9014,DRAMP33211,Cklaklakklaklak,15,Not available,Not available,Tumor cells: HepG2 (LD50>256 µg/ml; 32% Killing=250 µg/ml),Linear,Free,Free,k=D-Lys; l=D-Leu; a=D-Ala,Mix,DRAMP
9015,DRAMP33212,klaklakklaklakC,15,Not available,Not available,Tumor cells: HepG2 (LD50=192 µg/ml),Linear,Free,Free,k=D-Lys; l=D-Leu; a=D-Ala,Mix,DRAMP
9016,DRAMP33213,GLWNSIKIAGKKLFVNVLDKIR,22,Not available,Not available,Tumor cells: HCT 116 (IC50=128.89 μM); NCI-H838 (IC50=25.25 μM); U-251MG (IC50=40.58 μM); H157 (IC50=9.36 μM),Linear,Free,Amidation,None,L,DRAMP
9017,DRAMP33214,XLPICGETCVLGTCYTPGCRCQYPICVR,28,Not available,Not available,Tumor cells: HeLa  (IC50=4.1 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9018,DRAMP33215,XLPICGETCVLGRCYTPNCRCQYPICVR,28,Not available,Not available,Tumor cells: HeLa  (IC50=6 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9019,DRAMP33216,XAFCGETCLLGKCYTPGCSCHTGICLK,27,Not available,Not available,Tumor cells: HeLa  (IC50>10 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9020,DRAMP33217,XAFCGETCLLGTCYTPGCRCTAGICLK,27,Not available,Not available,Tumor cells: HeLa  (IC50>10 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9021,DRAMP33218,XLPICGETCVLGTCYTPGCSCAYPICAR,28,Not available,Not available,Tumor cells: HeLa  (IC50=10 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9022,DRAMP33219,XLPICGETCVLGTCYTPGCSCAYPICVR,28,Not available,Not available,Tumor cells: HeLa  (IC50=5.7 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9023,DRAMP33220,XAFCGETCVLGTCYTPGCSCNFGICLK,27,Not available,Not available,Tumor cells: HeLa  (IC50=7.7 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9024,DRAMP33221,XDCGETCVLGTCYTPGCSCSAYPLCV,26,Not available,Not available,Tumor cells: HeLa  (IC50>10 µM),Cyclic,Free,Free,X=PYA (Pyroglutamic acid),L,DRAMP
9025,DRAMP33222,FLGALFHALSHLL,13,Not available,Not available,Tumor cells: PANC-1 (IC50>120 μM ); A549 (IC50>160 μM ),Linear,Free,Free,None,L,DRAMP
9026,DRAMP33223,FLGALWKALSKLL,13,Not available,Not available,Tumor cells: A549 (IC50=9 μM ); PANC-1 (IC50=9 μM ),Linear,Free,Free,None,L,DRAMP
9027,DRAMP33224,FLGALWHALSKLL,13,Not available,Not available,Tumor cells: A549 (IC50=22 μM ); PANC-1 (IC50=39 μM ),Linear,Free,Free,None,L,DRAMP
9028,DRAMP33225,FLGALWKALSHLL,13,Not available,Not available,Tumor cells: A549 (IC50=31 μM ); PANC-1 (IC50=54 μM ),Linear,Free,Free,None,L,DRAMP
9029,DRAMP33226,FLGALWHALSHLL,13,Not available,Not available,Tumor cells: A549 (IC50=59 μM ); PANC-1 (IC50>120 μM ),Linear,Free,Free,None,L,DRAMP
9030,DRAMP33227,PAWHHAFHWAWRMLKKAA,18,Not available,Not available,Tumor cells: A549 (IC50=19 ± 3 μM(pH=7.4); IC50=10 ± 2 μM(pH=5.5)),Linear,Free,Free,None,L,DRAMP
9031,DRAMP33228,PAWRKAFRWAWHMLHHAA,18,Not available,Not available,Tumor cells: A549 (IC50=12 ± 2 μM(pH=7.4); IC50=7 ± 2 μM(pH=5.5)),Linear,Free,Free,None,L,DRAMP
9032,DRAMP33229,PAWRHAFHWAWHMLHKAA,18,Not available,Not available,Tumor cells: A549 (IC50>80 μM(pH=7.4); IC50=12 ± 2 μM(pH=5.5)),Linear,Free,Free,None,L,DRAMP
9033,DRAMP33230,GLFAVIHKVASVIGGL,16,Not available,Not available,Tumor cells: A549 (IC50=56±3 μM(pH=7.4); IC50=44±3 μM(pH=5.5)),Linear,Free,Free,None,L,DRAMP
9034,DRAMP33231,GLFAVIKHVASVIGGL,16,Not available,Not available,Tumor cells: A549 (IC50=97 ± 4 μM(pH=7.4); IC50=61±3 μM(pH=5.5)),Linear,Free,Free,None,L,DRAMP
9035,DRAMP33232,GLFAVIHHVASVIGGL,16,Not available,Not available,Tumor cells: A549 (IC50=156 ± 7 μM(pH=7.4); IC50=36 ± 2 μM(pH=5.5)),Linear,Free,Free,None,L,DRAMP
9036,DRAMP33241,KRKILILIKRK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM ),Linear,Free,Free,None,L,DRAMP
9037,DRAMP33242,KRKILILILIL,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM ),Linear,Free,Free,None,L,DRAMP
9038,DRAMP33243,ILILILILKRK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9039,DRAMP33244,KRKILILIGSG,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9040,DRAMP33245,GSGILILIKRK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9041,DRAMP33246,KRKSGSGSKRK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9042,DRAMP33247,KRKRKILILIKRK,13,Not available,Not available,Tumor cells: U-937 (LD50=36 µm),Linear,Free,Free,None,L,DRAMP
9043,DRAMP33248,RKRKILILIKRK,12,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9044,DRAMP33249,RKILILIKRK,10,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9045,DRAMP33250,KILILIKRK,9,Not available,Not available,Tumor cells: U-937 (LD50=58 µM),Linear,Free,Free,None,L,DRAMP
9046,DRAMP33251,ILILIKRK,8,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9047,DRAMP33252,LILIKRK,7,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9048,DRAMP33253,ILIKRK,6,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9049,DRAMP33254,LIKRK,5,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9050,DRAMP33255,KRKILILIKRKRK,13,Not available,Not available,Tumor cells: U-937 (LD50=61 µM),Linear,Free,Free,None,L,DRAMP
9051,DRAMP33256,KRKILILIKRKR,12,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9052,DRAMP33257,KRKILILIKR,10,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9053,DRAMP33258,KRKILILIK,9,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9054,DRAMP33259,KRKILILI,8,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9055,DRAMP33260,KRKILIL,7,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9056,DRAMP33261,KRKILI,6,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9057,DRAMP33262,KRKIL,5,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9058,DRAMP33263,KRKILILILIKRK,13,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9059,DRAMP33264,KRKLILIKRK,10,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9060,DRAMP33265,KRKILIKRK,9,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9061,DRAMP33266,KRKLIKRK,8,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9062,DRAMP33267,KRKIKRK,7,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9063,DRAMP33268,KRKKRK,6,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9064,DRAMP33269,KRKGKRK,7,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9065,DRAMP33270,KRKGSGKRK,9,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9066,DRAMP33271,RKRKLILILIKRKR,14,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9067,DRAMP33272,KRKLILKRILIKRK,14,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9068,DRAMP33273,RKLILKRKRILIKR,14,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9069,DRAMP33274,KLILKRKRKRILIK,14,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9070,DRAMP33275,LILKRKRKRKRILI,14,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9071,DRAMP33276,RRRIIIIIRRR,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9072,DRAMP33277,KKKIIIIIKKK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9073,DRAMP33278,RRRLLLLLRRR,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9074,DRAMP33279,KKKLLLLLKKK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9075,DRAMP33280,RRRVVVVVRRR,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9076,DRAMP33281,KKKVVVVVKKK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9077,DRAMP33282,RRRFFFFFRRR,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9078,DRAMP33283,KKKFFFFFKKK,11,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9079,DRAMP33284,KKKIIIIIIKKK,12,Not available,Not available,Tumor cells: U-937 (LD50>64 µM),Linear,Free,Free,None,L,DRAMP
9080,DRAMP33285,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9081,DRAMP33286,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9082,DRAMP33287,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9083,DRAMP33288,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9084,DRAMP33289,XGLXGGLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9085,DRAMP33290,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9086,DRAMP33291,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9087,DRAMP33292,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9088,DRAMP33293,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9089,DRAMP33294,XGLXGGLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9090,DRAMP33295,XGLXGKLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=2 μM); T67 (EC50=4 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9091,DRAMP33296,XGLXGKLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9092,DRAMP33297,XGLXGKLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9093,DRAMP33298,XGLXGKLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=2 μM); T67 (EC50=4 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9094,DRAMP33299,XGLXGKLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9095,DRAMP33300,XGLXGKLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9096,DRAMP33301,XRLXGGLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=4 μM); T67 (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9097,DRAMP33302,XRLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (EC50=9 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9098,DRAMP33303,XRLXGGLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=4 μM); T67 (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9099,DRAMP33304,XRLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (EC50=9 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9100,DRAMP33305,XGLXGGLXRIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=5 μM); T67 (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9101,DRAMP33306,XGLXKKLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=10 μM); T67 (EC50=7 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9102,DRAMP33307,XGLXKKLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=10 μM); HeLa  (EC50=6 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9103,DRAMP33308,XGLXKKLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=10 μM); T67 (EC50=7 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9104,DRAMP33309,XGLXKKLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=10 μM); HeLa  (EC50=6 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9105,DRAMP33310,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9106,DRAMP33311,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9107,DRAMP33312,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9108,DRAMP33313,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9109,DRAMP33314,XGLXGGLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9110,DRAMP33315,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9111,DRAMP33316,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9112,DRAMP33317,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9113,DRAMP33318,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9114,DRAMP33319,XGLXGGLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9115,DRAMP33320,XGLLGGLXGIX,11,Not available,Not available,Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9116,DRAMP33321,XGLLGGLXGIX,11,Not available,Not available,Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9117,DRAMP33322,XGLLGGLXGIX,11,Not available,Not available,Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9118,DRAMP33323,XGLLGGLXGIX,11,Not available,Not available,Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9119,DRAMP33324,XGLXGGLLGIX,11,Not available,Not available,Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1)=TOAC; X(4)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
9120,DRAMP33325,GFKDLLKKAAKALVKTVLF,19,Not available,Not available,Tumor cells: HepG2 (LC50=8 µM),Linear,Free,Amidation,None,L,DRAMP
9121,DRAMP33326,GFKDLLKGAKKALVKTVLF,19,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Linear,Free,Amidation,None,L,DRAMP
9122,DRAMP33327,GFKDLLKGAAKALKKTVLF,19,Not available,Not available,Tumor cells: HepG2 (LC50=200 µM),Linear,Free,Amidation,None,L,DRAMP
9123,DRAMP33328,GFKDLLKGAAKALVKTVKF,19,Not available,Not available,Tumor cells: HepG2 (LC50=200 µM),Linear,Free,Amidation,None,L,DRAMP
9124,DRAMP33329,GFKDLLKkAAKALVKTVLF,19,Not available,Not available,Tumor cells: HepG2 (LC50=15 µM),Linear,Free,Amidation,None,Mix,DRAMP
9125,DRAMP33330,GFKDLLKGAkKALVKTVLF,19,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Linear,Free,Amidation,None,Mix,DRAMP
9126,DRAMP33331,GFKDLLKGAAKALkKTVLF,19,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Linear,Free,Amidation,None,Mix,DRAMP
9127,DRAMP33332,GFKDLLKGAAKALVKTVkF,19,Not available,Not available,Tumor cells: HepG2 (LC50=140 µM),Linear,Free,Amidation,None,Mix,DRAMP
9128,DRAMP33355,NGRKACLNPASPIVKKIIEKMLNS,24,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9129,DRAMP33356,NGKKACLNPASPMVQKIIEKIL,22,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9130,DRAMP33357,NGKEICLDPEAPFLKKVIQKILD,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9131,DRAMP33358,NGKQVCLDPEAPFLKKVIQKILDS,24,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9132,DRAMP33359,DGRKICLDPDAPRIKKIVQKKL,22,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9133,DRAMP33360,DGRELCLDPKENWVQRVVEKFLK,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9134,DRAMP33361,KILRGVSKKIMRTFLRR,17,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9135,DRAMP33362,KKIMRTFLRR,10,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9136,DRAMP33363,KKIMRTFLRRISKDILTGKK,20,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9137,DRAMP33364,KKIMRTFLRRISKKILTGKK,20,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9138,DRAMP33365,KILRGVSKKIMRRISKDILTGKK,23,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9139,DRAMP33366,KILGVSKKIMRRISKDILTGKK,22,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9140,DRAMP33367,KISKKIMRTFLRRILTGKK,19,Not available,Not available,Tumor cells: HeLa  (21.1 ± 4.0% Cytotoxicity=100 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9141,DRAMP33368,KILRGVSKKIMRRILTGKK,19,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9142,DRAMP33369,RILRGVSRRIMRRILTGRR,19,Not available,Not available,Tumor cells: HeLa  (6.6 ± 7.9% Cytotoxicity=100 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9143,DRAMP33370,KILRGVSKRILTGKK,15,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9144,DRAMP33371,KILGVSKRILTGKK,14,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9145,DRAMP33372,KISKKIMRTFLRR,13,Not available,Not available,Tumor cells: HeLa  (6.4 ± 3.0% Cytotoxicity=100 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9146,DRAMP33373,ISKRILTGKK,10,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9147,DRAMP33374,KISKRILTGKK,11,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Linear,Free,Amidation,None,L,DRAMP
9148,DRAMP33375,CLB,3,Not available,Not available,Tumor cells: CAPAN-1 (IC50=129.0 ± 35.5 µM); MCF-7 (IC50=73.7 ± 4.5 µM),Linear,Free,Amidation,None,L,DRAMP
9149,DRAMP33376,CLBCREKA,8,Not available,Not available,Tumor cells: CAPAN-1 (IC50>200 µM); MCF-7 (IC50>200 µM),Linear,Free,Amidation,None,L,DRAMP
9150,DRAMP33377,KWKKLLKKLLKLLKKLLK,18,Not available,Not available,Tumor cells: A549 (IC50=0.6 µM); SK-OV-3 (IC50=0.6 µM); SK-MEL-2 (IC50=0.7 µM),Linear,Free,Amidation,None,L,DRAMP
9151,DRAMP33378,KWKKLLKKXLKLLKKLLK,18,Not available,Not available,Tumor cells: SK-OV-3 (IC50=1.7 µM); A549 (IC50=2 µM); SK-MEL-2 (IC50=2.1 µM),Linear,Free,Amidation,X=NAla,L,DRAMP
9152,DRAMP33379,KWKKLLKKLXKLLKKLLK,18,Not available,Not available,Tumor cells: SK-OV-3 (IC50=0.9 µM); A549 (IC50=1 µM); SK-MEL-2 (IC50=1.3 µM),Linear,Free,Amidation,X=NAla,L,DRAMP
9153,DRAMP33380,KWKKLLKKLLXLLKKLLK,18,Not available,Not available,Tumor cells: SK-OV-3 (IC50=0.5 µM); A549 (IC50=0.6 µM); SK-MEL-2 (IC50=0.6 µM),Linear,Free,Amidation,X=NAla,L,DRAMP
9154,DRAMP33381,KWKKLLKKXLKLXKKLLK,18,Not available,Not available,Tumor cells: SK-OV-3 (IC50=31.9 µM); SK-MEL-2 (IC50=38.7 µM); A549 (IC50=75.5 µM),Linear,Free,Amidation,X=NAla,L,DRAMP
9155,DRAMP33382,KWKKLLXKLLXLLKKLLK,18,Not available,Not available,Tumor cells: SK-OV-3 (IC50=0.7 µM); A549 (IC50=1 µM); SK-MEL-2 (IC50=1.1 µM),Linear,Free,Amidation,X=NAla,L,DRAMP
9156,DRAMP33383,RGDfX,5,Not available,Not available,Tumor cells: M21 (IC50 (Cilengitide inhibited integrin-mediated binding to vitronectin) =0.4 µM); UCLA-P3 (IC50 (Cilengitide inhibited integrin-mediated binding to vitronectin) =0.4 µM),Cyclic,Free,Free,f=D-Phe,Mix,DRAMP
9157,DRAMP33384,FQNRRMKWKK,10,Not available,Not available,Tumor cells: HeLa WT (50% Cytotoxicity= μM ),Linear,Free,Amidation,None,L,DRAMP
9158,DRAMP33385,WRRRRRRRR,9,Not available,Not available,Tumor cells: HeLa WT (50% Cytotoxicity=442 ± 66.7 μM ),Linear,Free,Amidation,None,L,DRAMP
9159,DRAMP33386,GFXGXKKXGXFXGXGKKXKKKK,22,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.9 μM ); RL (IC50=2 μM ); UACC-62 (IC50=2.6 μM ); A498 (IC50=3 μM ); COLO 205 (IC50=5.4 μM ); MCF-7  (IC50=6.2 μM ); A549 (IC50=7.2 μM ); Mia PaCa-2 (IC50=7.3 μM ); CFPAC-1 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ),Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9160,DRAMP33387,GFXGXRXGXFXGXGRXRRRR,20,Not available,Not available,Tumor cells: RL (IC50=1.1 μM ); NCI-H69 (IC50=2 μM ); CFPAC-1 (IC50=2.6 μM ); Mia PaCa-2 (IC50=5 μM ); A498 (IC50=5.6 μM ); IGROV-1 (IC50=6 μM ); A549 (IC50=6.4 μM ); DLD-1 (IC50=6.4 μM ); UACC-62 (IC50=6.4 μM ); COLO 205 (IC50=6.6 μM ); MCF-7  (IC50=7 μM ); PC-3 (IC50=7.4 μM ),Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9161,DRAMP33388,GFXGXRXGXFXGXGRXRRRR,20,Not available,Not available,Tumor cells: RL (IC50=3.7 μM); NCI-H69 (IC50=7.1 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9162,DRAMP33389,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM),Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine),L,DRAMP
9163,DRAMP33390,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM),Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine),L,DRAMP
9164,DRAMP33391,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine),L,DRAMP
9165,DRAMP33392,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM),Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid),L,DRAMP
9166,DRAMP33393,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM),Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid),L,DRAMP
9167,DRAMP33394,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid),L,DRAMP
9168,DRAMP33395,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM),Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid),L,DRAMP
9169,DRAMP33396,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM),Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid),L,DRAMP
9170,DRAMP33397,GFXGXXXGXFXGXGXXXXXX,20,Not available,Not available,Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid),L,DRAMP
9171,DRAMP33398,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,DRAMP
9172,DRAMP33399,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,DRAMP
9173,DRAMP33400,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,DRAMP
9174,DRAMP33401,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,DRAMP
9175,DRAMP33402,GFXGXRXGXFXGXGRXRRRR,20,Not available,Not available,Tumor cells: RL (IC50=1.1 μM ); NCI-H69 (IC50=2 μM ); CFPAC-1 (IC50=2.6 μM ); Mia PaCa-2 (IC50=5 μM ); A498 (IC50=5.6 μM ); IGROV-1 (IC50=6 μM ); A549 (IC50=6.4 μM ); DLD-1 (IC50=6.4 μM ); UACC-62 (IC50=6.4 μM ); COLO 205 (IC50=6.6 μM ); MCF-7  (IC50=7 μM ); PC-3 (IC50=7.4 μM ),Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,DRAMP
9176,DRAMP33403,GFXGXRXGXFXGXGRXRRRR,20,Not available,Not available,Tumor cells: RL (IC50=3.7 μM); NCI-H69 (IC50=7.1 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,DRAMP
9177,DRAMP33404,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,DRAMP
9178,DRAMP33405,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,DRAMP
9179,DRAMP33406,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,DRAMP
9180,DRAMP33407,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,DRAMP
9181,DRAMP33408,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,DRAMP
9182,DRAMP33409,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,DRAMP
9183,DRAMP33410,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,DRAMP
9184,DRAMP33411,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,DRAMP
9185,DRAMP33412,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9186,DRAMP33413,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9187,DRAMP33414,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9188,DRAMP33415,GFXGXKXGXFXGXGKXKKKK,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9189,DRAMP33416,KKKKGFXGXKXGXFXGXGKX,20,Not available,Not available,Tumor cells: NCI-H69 (IC50=2.2 μM); RL (IC50=3.7 μM); A498 (IC50=4.2 μM); UACC-62 (IC50=6.4 μM); COLO 205 (IC50=6.7 μM); A549 (IC50=7.2 μM); MCF-7  (IC50=7.3 μM); CFPAC-1 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM),Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,DRAMP
9190,DRAMP33417,KKWWKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=31.0 ± 1.0 µM); A20 (IC50=37.3 ± 1.5 µM),Linear,Free,Amidation,,L,DRAMP
9191,DRAMP33418,KKXWKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=36.7 ± 9.5 µM); A20 (IC50=51.7 ± 6.5 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9192,DRAMP33419,KKXWKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=13.0 ± 1.0 µM); IGROV-1 (IC50=13.4 ± 1.6 µM); AT84 (IC50=17.7 ± 3.1 µM); HL-60 (IC50=6.1 ± 1.8 µM); IGROV-1/CDDP (IC50=6.6 ± 2.6 µM); MCF-7  (IC50=6.8 ± 2.8 µM); HL-60/ADR (IC50=7.0 ± 3.7 µM); K562 (IC50=7.2 ± 0.4 µM); K562/Gleevec (IC50=7.9 ± 2.9 µM); MCF-7/mdr (IC50=8.4 ± 2.7 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9193,DRAMP33420,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9194,DRAMP33421,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9195,DRAMP33422,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9196,DRAMP33423,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9197,DRAMP33424,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9198,DRAMP33425,KKWWKKXWK,9,Not available,Not available,Tumor cells: A20 (IC50=12.3 ± 1.5 µM); AT84 (IC50=25.3 ± 4.2 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9199,DRAMP33426,KKWXKKWXK,9,Not available,Not available,Tumor cells: A20 (IC50=12 µM); AT84 (IC50=15.0 ± 1.0 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9200,DRAMP33427,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9201,DRAMP33428,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9202,DRAMP33429,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9203,DRAMP33430,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9204,DRAMP33431,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9205,DRAMP33432,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM),Linear,Free,Amidation,X=1-Nal (1-naphthylalanine),L,DRAMP
9206,DRAMP33433,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM),Linear,Free,Amidation,X=1-Nal (1-naphthylalanine),L,DRAMP
9207,DRAMP33434,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM),Linear,Free,Amidation,X=1-Nal (1-naphthylalanine),L,DRAMP
9208,DRAMP33435,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM),Linear,Free,Amidation,X=1-Nal (1-naphthylalanine),L,DRAMP
9209,DRAMP33436,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM),Linear,Free,Amidation,X=1-Nal (1-naphthylalanine),L,DRAMP
9210,DRAMP33437,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM),Linear,Free,Amidation,X=2-Nal (2-naphthylalanine),L,DRAMP
9211,DRAMP33438,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM),Linear,Free,Amidation,X=2-Nal (2-naphthylalanine),L,DRAMP
9212,DRAMP33439,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM),Linear,Free,Amidation,X=2-Nal (2-naphthylalanine),L,DRAMP
9213,DRAMP33440,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM),Linear,Free,Amidation,X=2-Nal (2-naphthylalanine),L,DRAMP
9214,DRAMP33441,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM),Linear,Free,Amidation,X=2-Nal (2-naphthylalanine),L,DRAMP
9215,DRAMP33442,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM),Linear,Free,Amidation,X=9-Ath (9-anthracenylalanine),L,DRAMP
9216,DRAMP33443,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM),Linear,Free,Amidation,X=9-Ath (9-anthracenylalanine),L,DRAMP
9217,DRAMP33444,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM),Linear,Free,Amidation,X=9-Ath (9-anthracenylalanine),L,DRAMP
9218,DRAMP33445,KKWXKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM),Linear,Free,Amidation,X=9-Ath (9-anthracenylalanine),L,DRAMP
9219,DRAMP33446,KKWXKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM),Linear,Free,Amidation,X=9-Ath (9-anthracenylalanine),L,DRAMP
9220,DRAMP33447,KKXWKKWWK,9,Not available,Not available,Tumor cells: AT84 (IC50=36.7 ± 9.5 µM); A20 (IC50=51.7 ± 6.5 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9221,DRAMP33448,KKXWKKWWK,9,Not available,Not available,Tumor cells: A20 (IC50=13.0 ± 1.0 µM); IGROV-1 (IC50=13.4 ± 1.6 µM); AT84 (IC50=17.7 ± 3.1 µM); HL-60 (IC50=6.1 ± 1.8 µM); IGROV-1/CDDP (IC50=6.6 ± 2.6 µM); MCF-7  (IC50=6.8 ± 2.8 µM); HL-60/ADR (IC50=7.0 ± 3.7 µM); K562 (IC50=7.2 ± 0.4 µM); K562/Gleevec (IC50=7.9 ± 2.9 µM); MCF-7/mdr (IC50=8.4 ± 2.7 µM),Linear,Free,Amidation,X=Bip (Biphenylalanine),L,DRAMP
9222,DRAMP33449,kkxwkkwwk,9,Not available,Not available,Tumor cells: AT84 (IC50=11.3 ± 1.2 µM); IGROV-1 (IC50=14.3 ± 5.3 µM); MCF-7  (IC50=4.6 ± 1.1 µM); MCF-7/mdr (IC50=4.9 ± 1.6 µM); HL-60/ADR (IC50=4.9 ± 3.7 µM); HL-60 (IC50=6.1 ± 3.4 µM); IGROV-1/CDDP (IC50=6.6 ± 2.7 µM); K562 (IC50=7.4 ± 0.1 µM); K562/Gleevec (IC50=7.6 ± 1.3 µM); A20 (IC50=8.3 ± 1.5 µM),Linear,Free,Amidation,X=D-Bip (D-Biphenylalanine),D,DRAMP
9223,DRAMP33450,XXWXXXWWX,9,Not available,Not available,Tumor cells: A20 (IC50=21.7 ± 2.5 µM); MT-1 (IC50=216 ± 36 µM); AT84 (IC50=23.0 ± 3.6 µM); HT-29 (IC50=248 ± 5 µM); Kelly (IC50=78 ± 7 µM),Linear,Free,Amidation,"X=Dab ((S)-2,4-diaminobutyric acid)",L,DRAMP
9224,DRAMP33451,XXWXXXWWX,9,Not available,Not available,Tumor cells: AT84 (IC50=14.3 ± 1.2 µM); A20 (IC50=8.3 ± 0.6 µM),Linear,Free,Amidation,"X=Dab ((S)-2,4-diaminobutyric acid)",L,DRAMP
9225,DRAMP33452,XXWXXXWWX,9,Not available,Not available,Tumor cells: AT84 (IC50=154 ± 29 µM); A20 (IC50=67.7 ± 13.2 µM),Linear,Free,Amidation,"X=Dab ((S)-2,4-diaminobutyric acid)",L,DRAMP
9226,DRAMP33453,XXWXXXWWX,9,Not available,Not available,Tumor cells: A20 (IC50=21.7 ± 2.5 µM); MT-1 (IC50=216 ± 36 µM); AT84 (IC50=23.0 ± 3.6 µM); HT-29 (IC50=248 ± 5 µM); Kelly (IC50=78 ± 7 µM),Linear,Free,Amidation,"X=Dap ((S)-2,3-diaminopropionic acid)",L,DRAMP
9227,DRAMP33454,XXWXXXWWX,9,Not available,Not available,Tumor cells: AT84 (IC50=14.3 ± 1.2 µM); A20 (IC50=8.3 ± 0.6 µM),Linear,Free,Amidation,"X=Dap ((S)-2,3-diaminopropionic acid)",L,DRAMP
9228,DRAMP33455,XXWXXXWWX,9,Not available,Not available,Tumor cells: AT84 (IC50=154 ± 29 µM); A20 (IC50=67.7 ± 13.2 µM),Linear,Free,Amidation,"X=Dap ((S)-2,3-diaminopropionic acid)",L,DRAMP
9229,DRAMP33456,RRWXRRWWR,9,Not available,Not available,Tumor cells: IGROV-1 (IC50=11.1 ± 3.4 µM); AT84 (IC50=11.3 ± 2.1 µM); MCF-7  (IC50=5.5 ± 0.9 µM); IGROV-1/CDDP (IC50=5.5 ± 2.2 µM); HL-60/ADR (IC50=6.0 ± 4.5 µM); MCF-7/mdr (IC50=6.6 ± 2.8 µM); A20 (IC50=6.7 ± 1.2 µM); HL-60 (IC50=6.7 ± 3.7 µM); K562 (IC50=7.0 ± 0.8 µM); K562/Gleevec (IC50=7.7 ± 1.6 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9230,DRAMP33457,kkWXkkWWk,9,Not available,Not available,Tumor cells: AT84 (IC50=113 ± 10 µM); A20 (IC50=134 ± 13 µM),Linear,Free,Amidation,k=D-Lys; X=Dip (Diphenylalanine),Mix,DRAMP
9231,DRAMP33458,KWWKKWXK,8,Not available,Not available,Tumor cells: A20 (IC50=13.5 ± 0.9 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9232,DRAMP33459,WWKKWXK,7,Not available,Not available,Tumor cells: A20 (IC50=20.3 ± 2.9 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9233,DRAMP33460,WKKWXK,6,Not available,Not available,Tumor cells: A20 (IC50=247 ± 13 µM),Linear,Free,Amidation,X=Dip (Diphenylalanine),L,DRAMP
9234,DRAMP33461,GLPVCGETCVGGTCYTPGCTCSWPVCTRN,29,Not available,Not available,Tumor cells: MM96L (CC50=12.3±0.6 μM); K562 (CC50=3.2±0.1 μM); HeLa  (CC50=8.1±0.4 μM),Cyclic,Free,Free,None,L,DRAMP
9235,DRAMP33462,GLPVCGETCVGGTCDTPGCTCSWPVCTRN,29,Not available,Not available,Tumor cells: HeLa  (Not active up to 60 µM); K562 (Not active up to 60 µM); MM96L (Not active up to 60 µM),Cyclic,Free,Free,None,L,DRAMP
9236,DRAMP33463,GLPVCGETCVGGTCNYPGCTCSWPVCTRN,29,Not available,Not available,Tumor cells: HeLa  (Not active up to 60 µM); K562 (Not active up to 60 µM); MM96L (Not active up to 60 µM),Cyclic,Free,Free,None,L,DRAMP
9237,DRAMP33464,GLPVCGETCVGGTCNSPGCTCSWPVCTRN,29,Not available,Not available,Tumor cells: HeLa  (CC50=43.8±0.5 μM),Cyclic,Free,Free,None,L,DRAMP
9238,DRAMP33465,GLPVCGETCVGGTCNTPGCTCSYPVCTRN,29,Not available,Not available,Tumor cells: HeLa  (Not active up to 60 µM); K562 (Not active up to 60 µM); MM96L (Not active up to 60 µM),Cyclic,Free,Free,None,L,DRAMP
9239,DRAMP33466,GLPVCGETCVGGTCNTPGCTCSWWPVCTRN,30,Not available,Not available,Tumor cells: MM96L (CC50=12.2±0.6 μM); HeLa  (CC50=9.8±0.5 μM),Cyclic,Free,Free,None,L,DRAMP
9240,DRAMP33467,KKLIKVWAKGFKKAKKLFKGIG,22,Not available,Not available,Tumor cells: HeLa  (21% Cytotoxicity=15 µM),Linear,Free,Free,None,L,DRAMP
9241,DRAMP33468,KKLIKVFAKGWKKAKKLFKGIG,22,Not available,Not available,Tumor cells: HeLa  (52% Cytotoxicity=15 µM),Linear,Free,Free,None,L,DRAMP
9242,DRAMP33469,KKLIKVFAKGFKKAKKLWKGIG,22,Not available,Not available,Tumor cells: HeLa  (52% Cytotoxicity=15 µM),Linear,Free,Free,None,L,DRAMP
9243,DRAMP33470,XXLIXVWAXGFXXAXXLFXGIG,22,Not available,Not available,Tumor cells: HeLa  (8% Cytotoxicity=15 µM),Linear,Free,Free,X=Diaminopropionic acid,L,DRAMP
9244,DRAMP33471,KKAAKAWAKGAKKAKKLAKGAG,22,Not available,Not available,Tumor cells: HeLa  (12% Cytotoxicity=15 µM),Linear,Free,Free,None,L,DRAMP
9245,DRAMP33472,WLlXNG,6,Not available,Not available,Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM),Cyclic,Free,Free,X=Allo-Ile,Mix,DRAMP
9246,DRAMP33473,WLlVNG,6,Not available,Not available,Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM),Cyclic,Free,Free,None,Mix,DRAMP
9247,DRAMP33474,WLvXNG,6,Not available,Not available,Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM),Cyclic,Free,Free,X=Allo-Ile; v=D-Val,Mix,DRAMP
9248,DRAMP33475,WLxXNG,6,Not available,Not available,Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM),Cyclic,Free,Free,x=D-Allo-Ile; X=Allo-Ile,Mix,DRAMP
9249,DRAMP33476,WLlXNx,6,Not available,Not available,Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM),Cyclic,Free,Free,X=Allo-Ile; x=D-Orn,Mix,DRAMP
9250,DRAMP33477,WLlVNx,6,Not available,Not available,Tumor cells: HepG2 (IC50=56 µM); NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM),Cyclic,Free,Free,x=D-Orn,Mix,DRAMP
9251,DRAMP33478,GWKDWFRKAKKVGKTVGGLALNHYL,25,Not available,Not available,Tumor cells: HL-60 (50% Cell death=16 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9252,DRAMP33479,GIRKWFKKAAHVGKEVGKVALNACL,25,Not available,Not available,Tumor cells: HL-60 (50% Cell death=128 µg/ml),Linear,Free,Free,None,L,DRAMP
9253,DRAMP33480,GLKKWFKKAVHVGKKVGKVALNAYL,25,Not available,Not available,Tumor cells: HL-60 (50% Cell death=16 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9254,DRAMP33481,GWRKWIKKATHVGKHIGKAALDAYI,25,Not available,Not available,Tumor cells: HL-60 (50% Cell death=32 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9255,DRAMP33482,GCKKWFKKAAHVGKNVGKVALNAYL,25,Not available,Not available,Tumor cells: HL-60 (50% Cell death=32 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9256,DRAMP33483,GIRKWFKKAAHVGKKVGKVALNAYL,25,Not available,Not available,Tumor cells: HL-60 (50% Cell death=64 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9257,DRAMP33484,GrrkrkWLrrIGkGVkIIGGAALDHL,26,Not available,Not available,Tumor cells: HL-60 (50% Cell death>128 µg/ml),Linear,Free,Amidation,r=D-Arg; k=D-Lys,Mix,DRAMP
9258,DRAMP33485,GLVGTLLGHIGKAILG,16,Not available,Not available,Tumor cells: A549 (LC50=80 ± 6 μM ),Linear,Free,Amidation,None,L,DRAMP
9259,DRAMP33486,GLVGTLLGHIGKAILG,16,Not available,Not available,Tumor cells: A549 (LC50>100 μM ),Linear,Free,Amidation,None,L,DRAMP
9260,DRAMP33487,GLVGTLLGHIGKAILS,16,Not available,Not available,Tumor cells: A549 (LC50=65 ± 5 μM ),Linear,Free,Amidation,None,L,DRAMP
9261,DRAMP33488,GLVGTLLGHIGKAILG,16,Not available,Not available,Tumor cells: A549 (LC50=80 ± 6 μM ),Linear,Free,Free,None,L,DRAMP
9262,DRAMP33489,GLVGTLLGHIGKAILG,16,Not available,Not available,Tumor cells: A549 (LC50>100 μM ),Linear,Free,Free,None,L,DRAMP
9263,DRAMP33490,ELLVDLL,7,Not available,Not available,Tumor cells: PC-3 (IC50=10.8 µg/mL); NCI-H23 (IC50=11.2 µg/mL); HCT 15 (IC50=11.4 µg/mL); ACHN (IC50=11.5 µg/mL); NUGC-3 (IC50=11.8 µg/mL); MDA-MB-231 (IC50=14.9 µg/mL),Linear,3-β-hydroxy-11-methyltridecanoic,Free,None,L,DRAMP
9264,DRAMP33491,ELLVDLL,7,Not available,Not available,Tumor cells: NCI-H23 (IC50=11.7 µg/mL); NUGC-3 (IC50=13.9 µg/mL); MDA-MB-231 (IC50=16.1 µg/mL); HCT 15 (IC50=18.3 µg/mL); ACHN (IC50=18.4 µg/mL); PC-3 (IC50=19.4 µg/mL),Linear,3-β-hydroxy-11-methyltridecanoic,Free,None,L,DRAMP
9265,DRAMP33492,ELLVDLL,7,Not available,Not available,Tumor cells: NUGC-3 (IC50=10.5 µg/mL); NCI-H23 (IC50=10.9 µg/mL); MDA-MB-231 (IC50=11.2 µg/mL); PC-3 (IC50=11.7 µg/mL); ACHN (IC50=12.3 µg/mL); HCT 15 (IC50=23.2 µg/mL),Linear,3-β-hydroxy-11-methyltridecanoic,Free,None,L,DRAMP
9266,DRAMP33493,ELLVDLL,7,Not available,Not available,Tumor cells: PC-3 (IC50=10.8 µg/mL); NCI-H23 (IC50=11.2 µg/mL); HCT 15 (IC50=11.4 µg/mL); ACHN (IC50=11.5 µg/mL); NUGC-3 (IC50=11.8 µg/mL); MDA-MB-231 (IC50=14.9 µg/mL),Linear,"3-β-hydroxy-9,11-dimethyltridecanoic acids",Free,None,L,DRAMP
9267,DRAMP33494,ELLVDLL,7,Not available,Not available,Tumor cells: NCI-H23 (IC50=11.7 µg/mL); NUGC-3 (IC50=13.9 µg/mL); MDA-MB-231 (IC50=16.1 µg/mL); HCT 15 (IC50=18.3 µg/mL); ACHN (IC50=18.4 µg/mL); PC-3 (IC50=19.4 µg/mL),Linear,"3-β-hydroxy-9,11-dimethyltridecanoic acids",Free,None,L,DRAMP
9268,DRAMP33495,ELLVDLL,7,Not available,Not available,Tumor cells: NUGC-3 (IC50=10.5 µg/mL); NCI-H23 (IC50=10.9 µg/mL); MDA-MB-231 (IC50=11.2 µg/mL); PC-3 (IC50=11.7 µg/mL); ACHN (IC50=12.3 µg/mL); HCT 15 (IC50=23.2 µg/mL),Linear,"3-β-hydroxy-9,11-dimethyltridecanoic acids",Free,None,L,DRAMP
9269,DRAMP33496,ELLVDLL,7,Not available,Not available,Tumor cells: PC-3 (IC50=10.8 µg/mL); NCI-H23 (IC50=11.2 µg/mL); HCT 15 (IC50=11.4 µg/mL); ACHN (IC50=11.5 µg/mL); NUGC-3 (IC50=11.8 µg/mL); MDA-MB-231 (IC50=14.9 µg/mL),Linear,"(E)-7,9-dimethylundec-2-enoic acid",Free,None,L,DRAMP
9270,DRAMP33497,ELLVDLL,7,Not available,Not available,Tumor cells: NCI-H23 (IC50=11.7 µg/mL); NUGC-3 (IC50=13.9 µg/mL); MDA-MB-231 (IC50=16.1 µg/mL); HCT 15 (IC50=18.3 µg/mL); ACHN (IC50=18.4 µg/mL); PC-3 (IC50=19.4 µg/mL),Linear,"(E)-7,9-dimethylundec-2-enoic acid",Free,None,L,DRAMP
9271,DRAMP33498,ELLVDLL,7,Not available,Not available,Tumor cells: NUGC-3 (IC50=10.5 µg/mL); NCI-H23 (IC50=10.9 µg/mL); MDA-MB-231 (IC50=11.2 µg/mL); PC-3 (IC50=11.7 µg/mL); ACHN (IC50=12.3 µg/mL); HCT 15 (IC50=23.2 µg/mL),Linear,"(E)-7,9-dimethylundec-2-enoic acid",Free,None,L,DRAMP
9272,DRAMP33499,GIMDTIKGAAKDLAGQLLDKLKCKITKC,28,Not available,Not available,Tumor cells: HepG2 (LC50=30 µM ),Cyclic,Free,Free,None,L,DRAMP
9273,DRAMP33500,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9274,DRAMP33501,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9275,DRAMP33502,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9276,DRAMP33503,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9277,DRAMP33504,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9278,DRAMP33505,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9279,DRAMP33506,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9280,DRAMP33507,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9281,DRAMP33508,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9282,DRAMP33509,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9283,DRAMP33510,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9284,DRAMP33511,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9285,DRAMP33512,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9286,DRAMP33513,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9287,DRAMP33514,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9288,DRAMP33515,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9289,DRAMP33516,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9290,DRAMP33517,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9291,DRAMP33518,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9292,DRAMP33519,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9293,DRAMP33520,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9294,DRAMP33521,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9295,DRAMP33522,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9296,DRAMP33523,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9297,DRAMP33524,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9298,DRAMP33525,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9299,DRAMP33526,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9300,DRAMP33527,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9301,DRAMP33528,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9302,DRAMP33529,VKRFKKFFRKLKKSV,15,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9303,DRAMP33530,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9304,DRAMP33531,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9305,DRAMP33532,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9306,DRAMP33533,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9307,DRAMP33534,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,None,L,DRAMP
9308,DRAMP33535,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9309,DRAMP33536,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9310,DRAMP33537,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9311,DRAMP33538,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9312,DRAMP33539,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,None,L,DRAMP
9313,DRAMP33540,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9314,DRAMP33541,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9315,DRAMP33542,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9316,DRAMP33543,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9317,DRAMP33544,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Linear,"CH3(CH2)12CO, Myristic acid",Amidation,None,L,DRAMP
9318,DRAMP33545,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9319,DRAMP33546,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9320,DRAMP33547,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9321,DRAMP33548,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9322,DRAMP33549,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9323,DRAMP33550,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9324,DRAMP33551,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9325,DRAMP33552,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9326,DRAMP33553,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9327,DRAMP33554,GGVKRFKKFFRKLKKSV,17,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,None,L,DRAMP
9328,DRAMP33555,inlkalaalakkil,14,Not available,Not available,Tumor cells: HeLa  (IC50=10 µM); U-373MG (LD50=45.92 μM),Linear,Free,Amidation,None,D,DRAMP
9329,DRAMP33556,LIKKALAALAKLNI,14,Not available,Not available,Tumor cells: U-373MG (LD50=95.46 μM),Linear,Free,Amidation,None,L,DRAMP
9330,DRAMP33557,likkalaalaklni,14,Not available,Not available,Tumor cells: U-373MG (LD50=80.40 μM),Linear,Free,Amidation,None,D,DRAMP
9331,DRAMP33558,INLKKLAKLXKKIL,14,Not available,Not available,Tumor cells: U-373MG (LD50=9.44 μM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
9332,DRAMP33559,inlkklaklXkkil,14,Not available,Not available,Tumor cells: U-373MG (LD50=13.95 μM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),Mix,DRAMP
9333,DRAMP33560,LIKKXLKALKKLNI,14,Not available,Not available,Tumor cells: U-373MG (LD50>100 μM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),L,DRAMP
9334,DRAMP33561,likkXlkalkklni,14,Not available,Not available,Tumor cells: U-373MG (LD50=67.15 μM),Linear,Free,Amidation,X=AIB (Aminoisobutyric acid),Mix,DRAMP
9335,DRAMP33562,GNNKPVYRPQPRPPHPRL,18,Not available,Not available,Tumor cells: A431 (30% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM),Linear,Free,Free,None,L,DRAMP
9336,DRAMP33563,VDKGSYRPRPTPPKPIYNRN,20,Not available,Not available,Tumor cells: A431 (<10% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM),Linear,Free,Free,None,L,DRAMP
9337,DRAMP33564,VDKPPYLPRPRPPRXIYNX,19,Not available,Not available,Tumor cells: HeLa  (Not active up to 600 µg/ml); HepG2 (Not active up to 600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml),Linear,Free,Amidation,X=Orn,L,DRAMP
9338,DRAMP33565,VRKPPYLPRPRWPRXIYNX,19,Not available,Not available,Tumor cells: SH-SY5Y (<5% Cytotoxicity=600 µg/ml); HeLa  (25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Linear,Free,Amidation,X=Orn,L,DRAMP
9339,DRAMP33566,VXKPPYLPRPRWPRXIYNX,19,Not available,Not available,Tumor cells: SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Linear,Free,Amidation,X=Orn,L,DRAMP
9340,DRAMP33567,VrKPPYLPRPRWPRXIYNX,19,Not available,Not available,Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml),Linear,Free,Amidation,r=D-Arg; X=Orn,Mix,DRAMP
9341,DRAMP33568,VDKPPYLPRPRPxRxXYNX,19,Not available,Not available,Tumor cells: SH-SY5Y (<5% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Linear,Free,Amidation,x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn,Mix,DRAMP
9342,DRAMP33569,VRKPPYLPRPRWxRxjYNX,19,Not available,Not available,Tumor cells: HepG2 (<10% Cytotoxicity=600 µg/ml); HeLa  (10-20% Cytotoxicity=600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml),Linear,Free,Amidation,x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn,Mix,DRAMP
9343,DRAMP33570,VXKPPYLPRPRWxRxjYNX,19,Not available,Not available,Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (10-20% Cytotoxicity=600 µg/ml),Linear,Free,Amidation,x=trans-4-hydroxyproline; X(16)=tert-Leu; X(2/19)=Orn,Mix,DRAMP
9344,DRAMP33571,VrKPPYLPRPRWxRxjYNX,19,Not available,Not available,Tumor cells: HeLa  (10-20% Cytotoxicity=600 µg/ml); SH-SY5Y (5% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Linear,Free,Amidation,r=D-Arg; x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn,Mix,DRAMP
9345,DRAMP33572,VRKPPYLPRPRWPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (50-60% Cytotoxicity=600 µg/ml),Linear,Free,Amidation,r=D-Arg,Mix,DRAMP
9346,DRAMP33573,VXKPPYLPRPRWPRrIYNr,19,Not available,Not available,Tumor cells: SH-SY5Y (<10% Cytotoxicity=600 µg/ml); HepG2 (10% Cytotoxicity=600 µg/ml); HeLa  (40% Cytotoxicity=601 µg/ml),Linear,Free,Amidation,r=D-Arg; X=Orn,Mix,DRAMP
9347,DRAMP33574,VrKPPYLPRPRWPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (<10% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (50-60% Cytotoxicity=600 µg/ml),Linear,Free,Amidation,r=D-Arg,Mix,DRAMP
9348,DRAMP33575,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)12CO, Myristic acid",Free,None,L,DRAMP
9349,DRAMP33576,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml),Cyclic,"CH3(CH2)12CO, Myristic acid",Free,None,L,DRAMP
9350,DRAMP33577,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)12CO, Myristic acid",Free,None,L,DRAMP
9351,DRAMP33578,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml),Cyclic,"CH3(CH2)12CO, Myristic acid",Free,None,L,DRAMP
9352,DRAMP33579,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml),Cyclic,"CH3(CH2)12CO, Myristic acid",Free,None,L,DRAMP
9353,DRAMP33580,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)11CO, Tridecanoic acid",Free,None,L,DRAMP
9354,DRAMP33581,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml),Cyclic,"CH3(CH2)11CO, Tridecanoic acid",Free,None,L,DRAMP
9355,DRAMP33582,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)11CO, Tridecanoic acid",Free,None,L,DRAMP
9356,DRAMP33583,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml),Cyclic,"CH3(CH2)11CO, Tridecanoic acid",Free,None,L,DRAMP
9357,DRAMP33584,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml),Cyclic,"CH3(CH2)11CO, Tridecanoic acid",Free,None,L,DRAMP
9358,DRAMP33585,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)10CO, Dodecanoic acid",Free,None,L,DRAMP
9359,DRAMP33586,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml),Cyclic,"CH3(CH2)10CO, Dodecanoic acid",Free,None,L,DRAMP
9360,DRAMP33587,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)10CO, Dodecanoic acid",Free,None,L,DRAMP
9361,DRAMP33588,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml),Cyclic,"CH3(CH2)10CO, Dodecanoic acid",Free,None,L,DRAMP
9362,DRAMP33589,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml),Cyclic,"CH3(CH2)10CO, Dodecanoic acid",Free,None,L,DRAMP
9363,DRAMP33590,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)9CO, Undecanoic acid",Free,None,L,DRAMP
9364,DRAMP33591,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml),Cyclic,"CH3(CH2)9CO, Undecanoic acid",Free,None,L,DRAMP
9365,DRAMP33592,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)9CO, Undecanoic acid",Free,None,L,DRAMP
9366,DRAMP33593,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml),Cyclic,"CH3(CH2)9CO, Undecanoic acid",Free,None,L,DRAMP
9367,DRAMP33594,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml),Cyclic,"CH3(CH2)9CO, Undecanoic acid",Free,None,L,DRAMP
9368,DRAMP33595,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)8CO, Decanoic acid",Free,None,L,DRAMP
9369,DRAMP33596,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml),Cyclic,"CH3(CH2)8CO, Decanoic acid",Free,None,L,DRAMP
9370,DRAMP33597,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml),Cyclic,"CH3(CH2)8CO, Decanoic acid",Free,None,L,DRAMP
9371,DRAMP33598,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml),Cyclic,"CH3(CH2)8CO, Decanoic acid",Free,None,L,DRAMP
9372,DRAMP33599,KIVPAMICAVTKKC,14,Not available,Not available,Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml),Cyclic,"CH3(CH2)8CO, Decanoic acid",Free,None,L,DRAMP
9373,DRAMP33600,GLLKKLLKKLLKKL,14,Not available,Not available,Tumor cells: HL-60 (>80% Killing=50 µM); HeLa  (70% Killing=50 µM),Linear,Free,Amidation,None,L,DRAMP
9374,DRAMP33601,GXXKKXXKKXXKKX,14,Not available,Not available,Tumor cells: HL-60 (>80% Killing=50 µM); HeLa  (60% Killing=50 µM),Linear,Free,Amidation,X=Norleucine,L,DRAMP
9375,DRAMP33602,GVVKKVVKKVVKKV,14,Not available,Not available,Tumor cells: HeLa  (<10% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,None,L,DRAMP
9376,DRAMP33603,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,X=Orn,L,DRAMP
9377,DRAMP33604,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,X=Orn,L,DRAMP
9378,DRAMP33605,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,X=Orn,L,DRAMP
9379,DRAMP33606,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,"X=Dab ((S)-2,4-diaminobutyric acid)",L,DRAMP
9380,DRAMP33607,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,"X=Dab ((S)-2,4-diaminobutyric acid)",L,DRAMP
9381,DRAMP33608,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,"X=Dab ((S)-2,4-diaminobutyric acid)",L,DRAMP
9382,DRAMP33609,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,"X=Dap ((S)-2,3-diaminopropionic acid)",L,DRAMP
9383,DRAMP33610,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,"X=Dap ((S)-2,3-diaminopropionic acid)",L,DRAMP
9384,DRAMP33611,GIIXXIIXXIIXXI,14,Not available,Not available,Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM),Linear,Free,Amidation,"X=Dap ((S)-2,3-diaminopropionic acid)",L,DRAMP
9385,DRAMP33612,AEEASKKAEEASKKAEEASKKAEEASKKAEEASKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50=2.38±0.9 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9386,DRAMP33613,VEEVSKKVEEVSKKVEEVSKKVEEVSKKVEEVSKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50=74.5±6.8 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9387,DRAMP33614,FEEFSKKFEEFSKKFEEFSKKFEEFSKKFEEFSKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50>100 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9388,DRAMP33615,YEEYSKKYEEYSKKYEEYSKKYEEYSKKYEEYSKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50=19.8±1.6 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9389,DRAMP33616,LEELSKKLEELSKKLEELSKKLEELSKKLEELSKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50=4.04±0.4 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9390,DRAMP33617,IEEISKKIEEISKKIEEISKKIEEISKKIEEISKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50=88.8±28 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9391,DRAMP33618,IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50>100 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9392,DRAMP33619,IEEIWKKIEEIWKKIEEIWKKIEEIWKKIEEIWKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50>100 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9393,DRAMP33620,IEEIHKKIEEIHKKIEEIHKKIEEIHKKIEEIHKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50>100 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9394,DRAMP33621,IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50>100 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9395,DRAMP33622,IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50=4.54±0.6 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9396,DRAMP33623,IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKKXK,37,Not available,Not available,Tumor cells: Huh-7 (CC50>100 µM ),Linear,Acetylation,"CH3(CH2)14CONH2, Hexadecanamide",X= β-Ala,L,DRAMP
9397,DRAMP33624,FLWIKLGKLAGAVLKLILGLKKVV,24,Not available,Not available,Tumor cells: MCF-7  (EC50=4.4 ± 1.3 µM ); A549 (EC50=8.3 ± 2.0 µM),Linear,Free,Amidation,None,L,DRAMP
9398,DRAMP33625,GLWAIAVKAGKVILKLIVFIWIRV,24,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7  (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9399,DRAMP33626,GLLDIAGGNAETLAGHAV,18,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9400,DRAMP33627,GLFDVIGSQAGGAAPHFLG,19,Not available,Not available,Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9401,DRAMP33628,KWVKKVHNWLRRWIKVFEALFG,22,Not available,Not available,Tumor cells: A549 (EC50=18.4 ± 0.7 µM); MCF-7 (EC50=7.0 ± 0.5 µM),Linear,Free,Amidation,None,L,DRAMP
9402,DRAMP33629,KIFKKFKTIIKKVWRIFGRF,20,Not available,Not available,Tumor cells: MCF-7 (EC50=5.7 ± 0.7 µM); A549 (EC50=9.3 ± 1.5 µM),Linear,Free,Amidation,None,L,DRAMP
9403,DRAMP33630,AFRHSVKEELNYIRRRLERFPNRL,24,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9404,DRAMP33631,RIENGLRKRLQSIYRHLEE,19,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9405,DRAMP33632,KWVRIWIKVLRGLFVWVWFF,20,Not available,Not available,Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9406,DRAMP33633,AWLKRIKKFLKALFWVWVW,19,Not available,Not available,Tumor cells: MCF-7 (EC50=19.0 ± 1.8 µM); A549 (EC50>50 µM),Linear,Free,Amidation,None,L,DRAMP
9407,DRAMP33634,KVVDNFENILII,12,Not available,Not available,Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9408,DRAMP33635,RVNAAIPNIIV,11,Not available,Not available,Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM ),Linear,Free,Amidation,None,L,DRAMP
9409,DRAMP33636,RVFKKFHPIYHRVWRLWGHL,20,Not available,Not available,Tumor cells: MCF-7 (EC50=27.4 ± 0.5 µM); A549 (EC50=49 ± 2 µM),Linear,Free,Free,None,L,DRAMP
9410,DRAMP33637,HIIKKIRTWYRKAWHVLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=10 ± 2 µM); A549 (EC50=17.0 ± 0.6 µM),Linear,Free,Free,None,L,DRAMP
9411,DRAMP33638,KLYKKFRHILKKVWHYVGKI,20,Not available,Not available,Tumor cells: MCF-7 (EC50=10 ± 1 µM); A549 (EC50=14 ± 3 µM),Linear,Free,Free,None,L,DRAMP
9412,DRAMP33639,KYIRHLKTWFKKVFKLIGEV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=11 ± 2 µM); A549 (EC50=15.0 ± 0.1 µM),Linear,Free,Free,None,L,DRAMP
9413,DRAMP33640,KIFKKFKDFLKKIFQYLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=12.4 ± 0.4 µM); A549 (EC50=17.4 ± 0.1 µM),Linear,Free,Free,None,L,DRAMP
9414,DRAMP33641,HIFKKVKTYWKKLFRILGRF,20,Not available,Not available,Tumor cells: MCF-7 (EC50=12 ± 3 µM); A549 (EC50=18 ± 2 µM),Linear,Free,Free,None,L,DRAMP
9415,DRAMP33642,RLIKRLKTFVRKTWKWVGHF,20,Not available,Not available,Tumor cells: MCF-7 (EC50=39 ± 3 µM); A549 (EC50=52 ± 2 µM),Linear,Free,Free,None,L,DRAMP
9416,DRAMP33643,RFLKHFKTVYKRYWKVLGRL,20,Not available,Not available,Tumor cells: MCF-7 (EC50=11.9 ± 0.1 µM); A549 (EC50=17 ± 4 µM),Linear,Free,Free,None,L,DRAMP
9417,DRAMP33644,KLIHRLKTVFKKVWHFLGHL,20,Not available,Not available,Tumor cells: MCF-7 (EC50=18.9 ± 0.2 µM); A549 (EC50=22 ± 4 µM),Linear,Free,Free,None,L,DRAMP
9418,DRAMP33645,HRIRQLKTTIKKFWEIWPKI,20,Not available,Not available,Tumor cells: MCF-7 (EC50=56 ± 5 µM); A549 (EC50=83 ± 11 µM),Linear,Free,Free,None,L,DRAMP
9419,DRAMP33646,QVFKKFRPFYRRPWELFGKL,20,Not available,Not available,Tumor cells: MCF-7 (EC50=91 ± 2 µM); A549 (EC50>100 µM),Linear,Free,Free,None,L,DRAMP
9420,DRAMP33647,QIIKKIRTWYRKAWHVLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=11.6 ± 0.8 µM); A549 (EC50=20 ± 1 µM),Linear,Free,Free,None,L,DRAMP
9421,DRAMP33648,TLYKKFRHFLKKPWHVVGKI,20,Not available,Not available,Tumor cells: MCF-7 (EC50=65 ± 3 µM); A549 (EC50>100 µM),Linear,Free,Free,None,L,DRAMP
9422,DRAMP33649,HYIRHLKTWFHKPFKLIGKV,20,Not available,Not available,Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM),Linear,Free,Free,None,L,DRAMP
9423,DRAMP33650,KIFKKFKDWFKKAFHVLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=10.4 ± 0.8 µM); A549 (EC50=14.8 ± 0.7 µM),Linear,Free,Free,None,L,DRAMP
9424,DRAMP33651,QIFKKVKTWYKKAFQILGRL,20,Not available,Not available,Tumor cells: A549 (EC50=12.4 ± 0.1 µM); MCF-7 (EC50=9.3 ± 0.2 µM),Linear,Free,Free,None,L,DRAMP
9425,DRAMP33652,RLIKRIKTWYRKAWKVVGKF,20,Not available,Not available,Tumor cells: MCF-7 (EC50=11.2 ± 0.7 µM); A549 (EC50=15 ± 1 µM),Linear,Free,Free,None,L,DRAMP
9426,DRAMP33653,RFLKHLHTYYERAWHVIGHL,20,Not available,Not available,Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM),Linear,Free,Free,None,L,DRAMP
9427,DRAMP33654,HLIHRLHTYWHKPWHYLGKL,20,Not available,Not available,Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM),Linear,Free,Free,None,L,DRAMP
9428,DRAMP33655,QRIRQLHTWIKKAWHIWPKI,20,Not available,Not available,Tumor cells: MCF-7 (EC50=28.6 ± 0.1 µM); A549 (EC50=40 ± 2 µM),Linear,Free,Free,None,L,DRAMP
9429,DRAMP33656,QVVKKIRTWYHKAWHVLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=76 ± 15 µM); A549 (EC50>100 µM),Linear,Free,Free,None,L,DRAMP
9430,DRAMP33657,QLIHKIRTWYRKAWHVLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=13 ± 1 µM); A549 (EC50=20 ± 2 µM),Linear,Free,Free,None,L,DRAMP
9431,DRAMP33658,HLLKKWRTWLRKAWHIVGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=7 ± 1 µM); A549 (EC50=9 ± 1 µM),Linear,Free,Free,None,L,DRAMP
9432,DRAMP33659,QVLKKVRTWYRKAFHVIGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=68 ± 5 µM),Linear,Free,Free,None,L,DRAMP
9433,DRAMP33660,QLLKKVRTWYRKAWHLYGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=16 ± 2 µM); A549 (EC50=29.3 ± 0.9 µM),Linear,Free,Free,None,L,DRAMP
9434,DRAMP33661,QLIKKLRTWYRKAWHVLGKL,20,Not available,Not available,Tumor cells: A549 (EC50=10.6 ± 0.8 µM); MCF-7 (EC50=6.5 ± 0.2 µM),Linear,Free,Free,None,L,DRAMP
9435,DRAMP33662,QIIKKVRTWIKKAWHLIGKI,20,Not available,Not available,Tumor cells: A549 (EC50=12 ± 2 µM); MCF-7 (EC50=8 ± 1 µM),Linear,Free,Free,None,L,DRAMP
9436,DRAMP33663,QYLRRVRTWLRRAWHILGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=11.0 ± 0.2 µM); A549 (EC50=16.5 ± 0.2 µM),Linear,Free,Free,None,L,DRAMP
9437,DRAMP33664,QLLKKIRTWYRKAWHVYGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=13 ± 1 µM); A549 (EC50=28 ± 3 µM),Linear,Free,Free,None,L,DRAMP
9438,DRAMP33665,QIYKKYRTWYRKAWKVLGKV,20,Not available,Not available,Tumor cells: MCF-7 (EC50=16.9 ± 0.8 µM); A549 (EC50=36 ± 7 µM),Linear,Free,Free,None,L,DRAMP
9439,DRAMP33666,CXGRCLLIIKLAKLAKKLAKLAK,23,Not available,"AMPs containing CisoDGRC selectively kill CD13-/αvβ3+ breast cancer cells by inducing apoptosis and inhibiting proliferation. Furthermore, the vivo experiments showed that AMPs containing CisoDGRC could significantly inhibited CD13-/αvβ3+ tumor progression and angiogenesis.",Tumor cells: MCF-7  (IC50=190 µg/ml); MDA-MB-231 (IC50=212 µg/ml),Cyclic,Free,Free,X=iso-Asp,L,DRAMP
9440,DRAMP33667,RFRLPFRRIHPPPFVRIHPPPFYRRFL,27,Not available,Not available,Tumor cells: U-937 (IC50=4.5 ± 1.6 μM); K562 (IC50=8.4 ± 1.1 μM),Linear,Free,Amidation,None,L,DRAMP
9441,DRAMP33668,RFRLPFRRIHPPPFVRIHPPPFYRRFL,27,Not available,Not available,Tumor cells: K562 (IC50=16.5 ± 1.3 μM); U-937 (IC50=9.8 ± 0.5 μM),Linear,Free,Amidation,None,L,DRAMP
9442,DRAMP33669,RFRLPFRRIHPPPFVRIHPPPFYRRFL,27,Not available,Not available,Tumor cells: U-937 (IC50=4.5 ± 1.6 μM); K562 (IC50=8.4 ± 1.1 μM),Linear,Free,Free,None,L,DRAMP
9443,DRAMP33670,RFRLPFRRIHPPPFVRIHPPPFYRRFL,27,Not available,Not available,Tumor cells: K562 (IC50=16.5 ± 1.3 μM); U-937 (IC50=9.8 ± 0.5 μM),Linear,Free,Free,None,L,DRAMP
9444,DRAMP33671,RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL,30,Not available,Not available,Tumor cells: K562 (IC50=20.0 ± 3.4 μM); U-937 (IC50=3.2 ± 0.4 μM),Linear,Free,Amidation,None,L,DRAMP
9445,DRAMP33672,RFRLPFRRPWPIRIHPPPFYPWPFRRFL,28,Not available,Not available,Tumor cells: K562 (IC50=13.7 ± 2.3 μM); U-937 (IC50=4.1 ± 0.3 μM),Linear,Free,Free,None,L,DRAMP
9446,DRAMP33673,RFRLPFRRPPIRIPPPFYPPFRRFL,25,Not available,Not available,Tumor cells: U-937 (IC50=11.5 ± 0.5 μM); K562 (IC50=25.0 ± 3.5 μM),Linear,Free,Amidation,None,L,DRAMP
9447,DRAMP33674,RIHPPPFYPPFRRFL,15,Not available,Not available,Tumor cells: U-937 (IC50=17.0 ± 1.1 μM); K562 (IC50=39.4 ± 2.3 μM),Linear,Free,Amidation,None,L,DRAMP
9448,DRAMP33675,RFRLPFRRPPIRIHPPPFY,19,Not available,Not available,Tumor cells: K562 (IC50=28.0 ± 6.5 μM); U-937 (IC50>64 μM),Linear,Free,Amidation,None,L,DRAMP
9449,DRAMP33676,RFRLPFRRPPIRIH,14,Not available,Not available,Tumor cells: K562 (IC50=33.6 ± 4.1 μM); U-937 (IC50>64 μM),Linear,Free,Amidation,None,L,DRAMP
9450,DRAMP33677,RFRRFRLPFRRPPIRIH,17,Not available,Not available,Tumor cells: K562 (IC50=39.4 ± 6.6 μM); U-937 (IC50>64 μM),Linear,Free,Amidation,None,L,DRAMP
9451,DRAMP33678,FTILKKLKSFIK,12,Not available,Not available,Tumor cells: A549 (CC50>200 μM ),Linear,Free,Free,None,L,DRAMP
9452,DRAMP33679,KLVKKLLKKYITF,13,Not available,Not available,Tumor cells: A549 (CC50=200 μM ),Linear,Free,Free,None,L,DRAMP
9453,DRAMP33680,LARFVLRILKYGFK,14,Not available,Not available,Tumor cells: A549 (CC50=12.5 μM); CaCo-2 (CC50=25 μM),Linear,Free,Free,None,L,DRAMP
9454,DRAMP33681,IPLLRKGKKIIWW,13,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Linear,Free,Free,None,L,DRAMP
9455,DRAMP33682,GLKKVIKLLRPLL,13,Not available,Not available,Tumor cells: A549 (CC50=50 μM),Linear,Free,Free,None,L,DRAMP
9456,DRAMP33683,ILKPKLWKLTVVARKIIK,18,Not available,Not available,Tumor cells: A549 (CC50=200 μM),Linear,Free,Free,None,L,DRAMP
9457,DRAMP33684,IVIKSLGKFLKNVGGFAG,18,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Linear,Free,Free,None,L,DRAMP
9458,DRAMP33685,FKLVWKLLKKLALKL,15,Not available,Not available,Tumor cells: CaCo-2 (CC50=12.5 μM); A549 (CC50=25 μM),Linear,Free,Free,None,L,DRAMP
9459,DRAMP33686,ITKWLLNAIKKGFKL,15,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Linear,Free,Free,None,L,DRAMP
9460,DRAMP33687,IHKLVKLWLNLGKKF,15,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Linear,Free,Free,None,L,DRAMP
9461,DRAMP33688,LFSIIWKLNRKLIKA,15,Not available,Not available,Tumor cells: A549 (CC50>200 μM); CaCo-2 (CC50>200 μM),Linear,Free,Free,None,L,DRAMP
9462,DRAMP33689,KKK,3,Not available,Not available,Tumor cells: HeLa  (IC50=3.9 ± 1.1 μg/mL),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9463,DRAMP33690,CKKKKC,6,Not available,Not available,Tumor cells: HeLa  (IC50=17.9 ± 2.1 μg/mL),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9464,DRAMP33691,KRKK,4,Not available,Not available,Tumor cells: HeLa  (IC50=3.0 ± 0.6 μg/mL),Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9465,DRAMP33692,CKRKKC,6,Not available,Not available,Tumor cells: HeLa  (IC50=27.5 ± 3.4 μg/mL),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9466,DRAMP33693,CRRKKC,6,Not available,Not available,Tumor cells: HeLa  (IC50=20.9 ± 2.1 μg/mL),Cyclic,"CH3(CH2)14CO, Palmitic acid",Amidation,None,L,DRAMP
9467,DRAMP33694,FPVTWRWWKWWKGKFPVTWRWWKWWKG,27,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=32 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9468,DRAMP33695,RRRRWRWWRWWRR,13,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=250 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9469,DRAMP33696,RKRWWRWWKWWKR,13,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=32 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9470,DRAMP33697,RKrWWrWwkWWkR,13,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=125 μg/mL),Linear,Free,Amidation,r=D-Arg; w=D-Trp,Mix,DRAMP
9471,DRAMP33698,RWWKWW,6,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50>250 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9472,DRAMP33699,RWWKWWK,7,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50>250 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9473,DRAMP33700,WRWWKWW,7,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=250 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9474,DRAMP33701,WrWwkWW,7,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=125 μg/mL),Linear,Free,Amidation,r=D-Arg; w=D-Trp,Mix,DRAMP
9475,DRAMP33702,WRWWKWWK,8,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=250 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9476,DRAMP33703,WWRWWKWW,8,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=250 μg/mL),Linear,Free,Amidation,None,L,DRAMP
9477,DRAMP33704,WWrWwkWW,8,Not available,"Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.",Tumor cells: HeLa  (IC50=125 μg/mL),Linear,Free,Amidation,r=D-Arg; w=D-Trp,Mix,DRAMP
9478,DRAMP33705,AFALIAGALYRIFHRR,16,Not available,Not available,Tumor cells: C666-1 (IC50=18.27 μM ); MGC-803 (IC50=31.55 μM ); HCT 116 (IC50=40.83 μM ),Linear,Free,Free,None,L,DRAMP
9479,DRAMP33706,GARELRRLERELRRLEGGGGGGGKLAALKFKLLWLKLAC,39,Not available,"(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.",Tumor cells: MDA-MB-231 (CC50=15.9 ± 2.3 μM); MCF-7  (CC50=16.0 ± 0.5 μM); MM96L (CC50=5.4 ± 0.3 μM ); MDA-MB-435S (CC50=5.7 ± 0.4 μM ); K562 (CC50=8.2 ± 0.4 μM),Cyclic,"CAA, Chloroacetic acid",Free,None,L,DRAMP
9480,DRAMP33707,GARELRRLERELRRLEKGGGGGGKLAALKFKLLWLKLAC,39,Not available,"(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.",Tumor cells: MM96L (CC50=5.3 ± 0.5 μM ); MDA-MB-435S (CC50=7.1 ± 0.6 μM ),Cyclic,"CAA, Chloroacetic acid",Free,None,L,DRAMP
9481,DRAMP33708,GARELRRLERELRRLEKGGGGGGKLAALTFEHYWAQLTSC,40,Not available,"(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.",Tumor cells: K562 (CC50>64 μM); MCF-7  (CC50>64 μM); MDA-MB-435S (CC50>64 μM); MM96L (CC50>64 μM),Cyclic,"CAA, Chloroacetic acid",Free,None,L,DRAMP
9482,DRAMP33709,GARELRRLERELRRLEGGGGGGGKLAALKAKLLWLKLAC,39,Not available,"(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.",Tumor cells: K562 (CC50=36.7 ± 1.9 μM); MDA-MB-435S (CC50>32 μM); MCF-7  (CC50>64 μM); MDA-MB-231 (CC50>64 μM); MM96L (CC50>64 μM),Cyclic,"CAA, Chloroacetic acid",Free,None,L,DRAMP
9483,DRAMP33710,GLAKVMREVLGYERNSYKKFFLR,23,Not available,Not available,Tumor cells: HeLa  (8% Killing=16 µM),Linear,Free,Amidation,None,L,DRAMP
9484,DRAMP33711,KVMREVLGYERNSYKKFFLR,20,Not available,Not available,Tumor cells: HeLa  (19% Killing=128 µM),Linear,Free,Amidation,None,L,DRAMP
9485,DRAMP33712,GLHKVMRKVLGYLRNVYK,18,Not available,Not available,Tumor cells: HeLa  (24% Killing=1 µM),Linear,Free,Amidation,None,L,DRAMP
9486,DRAMP33713,GLAKVMRKVLGYLRNVYK,18,Not available,Not available,Tumor cells: HeLa  (28% Killing=2-4 µM),Linear,Free,Amidation,None,L,DRAMP
9487,DRAMP33714,KVMRKVLGYLRNVYK,15,Not available,Not available,Tumor cells: HeLa  (19% Killing=2 µM),Linear,Free,Amidation,None,L,DRAMP
9488,DRAMP33715,GLHKVMREVLGY,12,Not available,Not available,Tumor cells: HeLa  (27% Killing=128 µM),Linear,Free,Amidation,None,L,DRAMP
9489,DRAMP33716,YERNSYKKFFLR,12,Not available,Not available,Tumor cells: HeLa  (28% Killing=128 µM),Linear,Free,Amidation,None,L,DRAMP
9490,DRAMP33717,GLHKVMREVLGYERNSYK,18,Not available,Not available,Tumor cells: HeLa  (13% Killing=128 µM),Linear,Free,Amidation,None,L,DRAMP
9491,DRAMP33718,KVMREVLGYERNSYK,15,Not available,Not available,Tumor cells: HeLa  (3% Killing=128 µM),Linear,Free,Amidation,None,L,DRAMP
9492,DRAMP33719,REVLGYERNSYK,12,Not available,Not available,Tumor cells: HeLa  (15% Killing=128 µM),Linear,Free,Amidation,None,L,DRAMP
9493,DRAMP33720,LKRIVQRIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=33.7 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9494,DRAMP33721,FKRIVQRILDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=3.9 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9495,DRAMP33722,FXRIVQRILDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=10.7 μg/ml),Linear,Acetylation,Amidation,X=Sialic acid-Lys,L,DRAMP
9496,DRAMP33723,FKRIVQRIRDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=56 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9497,DRAMP33724,FKRIVQRIRDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=12.5 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9498,DRAMP33725,FKRIVQRIRDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=56 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9499,DRAMP33726,FKRIVQRIRDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=12.5 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9500,DRAMP33727,FKRIVQKIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=145.1 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9501,DRAMP33728,FKRIVQLIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=18.9 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9502,DRAMP33729,FKRIVQLIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=13.9 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9503,DRAMP33730,FKRIVQLIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=18.9 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9504,DRAMP33731,FKRIVQLIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=13.9 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9505,DRAMP33732,FKRIVQRIKDLLR,13,Not available,Not available,Tumor cells: A549 (IC50=75 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9506,DRAMP33733,FKRIVQRIKDLLR,13,Not available,Not available,Tumor cells: A549 (IC50=45.5 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9507,DRAMP33734,FKRIVQRIKDLLR,13,Not available,Not available,Tumor cells: A549 (IC50=75 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9508,DRAMP33735,FKRIVQRIKDLLR,13,Not available,Not available,Tumor cells: A549 (IC50=45.5 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9509,DRAMP33736,FKRIVQIIKKFLR,13,Not available,Not available,Tumor cells: A549 (IC50=20 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9510,DRAMP33737,FKRIVQIIKKFLR,13,Not available,Not available,Tumor cells: A549 (IC50=12.9 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9511,DRAMP33738,FKRIVQIIKKFLR,13,Not available,Not available,Tumor cells: A549 (IC50=20 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9512,DRAMP33739,FKRIVQIIKKFLR,13,Not available,Not available,Tumor cells: A549 (IC50=12.9 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9513,DRAMP33740,FKRIVQLLKKLLR,13,Not available,Not available,Tumor cells: A549 (IC50=12.8 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9514,DRAMP33741,FKRIVQLLKKLLR,13,Not available,Not available,Tumor cells: A549 (IC50=9.8 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9515,DRAMP33742,FKRIVQLLKKLLR,13,Not available,Not available,Tumor cells: A549 (IC50=12.8 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9516,DRAMP33743,FKRIVQLLKKLLR,13,Not available,Not available,Tumor cells: A549 (IC50=9.8 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9517,DRAMP33744,FKRILQRIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=19.2 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9518,DRAMP33745,FKRILQRIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=29.2 μg/ml),Linear,Free,Amidation,None,L,DRAMP
9519,DRAMP33746,FKRILQRIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=19.2 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9520,DRAMP33747,FKRILQRIKDFLR,13,Not available,Not available,Tumor cells: A549 (IC50=29.2 μg/ml),Linear,Acetylation,Amidation,None,L,DRAMP
9521,DRAMP33748,GXFKKTFHKVSHAVKSGIHAGQRGCSALGF,30,Not available,Not available,Tumor cells: THP-1 (50% Killing=100 mg/L),Linear,Free,Free,X=Br-Trp,L,DRAMP
9522,DRAMP33749,GWFKKTFHKVSHAVKSGIHA,20,Not available,Not available,Tumor cells: THP-1 (Weak active up to 125 mg/L),Linear,Free,Free,None,L,DRAMP
9523,DRAMP33750,GWFKKTFHKVSHAVKSGIHAGQRGSSALGF,30,Not available,Not available,Tumor cells: THP-1 (Weak active up to 125 mg/L),Linear,Free,Free,None,L,DRAMP
9524,DRAMP33752,IKLXKEXKKXLKKVLKGXIKGXIAVAKMV,29,Not available,Not available,Tumor cells: A549 (IC50=1.10±0.31 μM); HCT 116 (IC50=1.65±0.28 μM); HepG2 (IC50=2.71±0.05 μM),Linear,Free,Free,X(4)=Ser-GlcNAc; X(7)=Thr-GlcNAc; X(10)=Asn-GlcNAc; X(18/22)=(S)-N-Fmoc-2-(4′-pentenyl)alanine,L,DRAMP
9525,DRAMP33753,IKLXKKXKKXLKKVLKGXIKGXIAVAKMV,29,Not available,Not available,Tumor cells: A549 (IC50=0.62±0.12 μM); HCT 116 (IC50=1.29±0.08  μM); HepG2 (IC50=2.13±0.07 μM),Linear,Free,Free,X(4)=Ser-GlcNAc; X(7)=Thr-GlcNAc; X(10)=Asn-GlcNAc; X(18/22)=(S)-N-Fmoc-2-(4′-pentenyl)alanine,L,DRAMP
9526,DRAMP33754,ALWMTLLKKVLKAAAKAALNAVLVGA,26,Not available,Not available,Tumor cells: SW620 (42.19±24.29% Cytotoxicity=256 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9527,DRAMP33755,ALWMTLLKKVLKAAAKAALNAVLV,24,Not available,Not available,Tumor cells: SW620 (71.48±4.81% Cytotoxicity=256 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9528,DRAMP33756,ALWMTLLKKVLKAAAKAALNAV,22,Not available,Not available,Tumor cells: SW620 (66.21±20.07% Cytotoxicity=256 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9529,DRAMP33757,WMTLLKKVLKAAAKAALNAVLVGANA,26,Not available,Not available,Tumor cells: SW620 (54.02±3.37% Cytotoxicity=256 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9530,DRAMP33758,LKKVLKAAAKAALNAVLVGANA,22,Not available,Not available,Tumor cells: SW620 (35.72±18.49% Cytotoxicity=256 µg/ml),Linear,Free,Amidation,None,L,DRAMP
9531,DRAMP33759,GLRKRLRKFFNKIKEK,16,Not available,Not available,Tumor cells: MCF-7  (<20% Killing=40 µM); HeLa  (Not active up to 40 µM),Linear,Free,Amidation,None,L,DRAMP
9532,DRAMP33760,GLRKRLRKFRNKIKFK,16,Not available,Not available,Tumor cells: HeLa  (Not active up to 40 µM); MCF-7  (Not active up to 40 µM),Linear,Free,Amidation,None,L,DRAMP
9533,DRAMP33761,GLRKRLRKFRNKIKEF,16,Not available,Not available,Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (<20% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9534,DRAMP33762,GLEKRKRKFFNKIKFK,16,Not available,Not available,Tumor cells: MCF-7 (60% Killing=40 µM); HeLa  (75% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9535,DRAMP33763,GLRKRLRKFFNKIKEF,16,Not available,Not available,Tumor cells: MCF-7 (>50% Killing=40 µM); HeLa  (40% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9536,DRAMP33764,GLRKRLRKFRNKIKFF,16,Not available,Not available,Tumor cells: MCF-7 (40% Killing=40 µM); HeLa  (80% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9537,DRAMP33765,GLRKRLRKFFNKIKFF,16,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (80% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9538,DRAMP33766,GLRKRLRKFRNKIKK,15,Not available,Not available,Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (35% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9539,DRAMP33767,GLRKRLRKFFNKIKF,15,Not available,Not available,Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,None,L,DRAMP
9540,DRAMP33768,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=4-F-Phe,L,DRAMP
9541,DRAMP33769,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=4-F-Phe,L,DRAMP
9542,DRAMP33770,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=4-F-Phe,L,DRAMP
9543,DRAMP33771,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=2-F-Phe,L,DRAMP
9544,DRAMP33772,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=2-F-Phe,L,DRAMP
9545,DRAMP33773,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=2-F-Phe,L,DRAMP
9546,DRAMP33774,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=5-F-Phe,L,DRAMP
9547,DRAMP33775,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=5-F-Phe,L,DRAMP
9548,DRAMP33776,GLRKRLRKFXNKIKX,15,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Linear,Free,Amidation,X=5-F-Phe,L,DRAMP
9549,DRAMP33777,PWIPLTPL,8,Not available,Not available,Tumor cells: P388 (IC50=8.5 μM),Cyclic,Free,Free,None,L,DRAMP
9550,DRAMP33778,PFDSRAVTY,9,Not available,Not available,Tumor cells: BEL-7402 (IC50=14.3 μM); P388 (IC50=5.4 μM),Cyclic,Free,Free,None,L,DRAMP
9551,DRAMP33779,PWVPLIPI,8,Not available,Not available,Tumor cells: P388 (Not active up to 100 µg/ml),Cyclic,Free,Free,None,L,DRAMP
9552,DRAMP33780,PYPIFPI,7,Not available,Not available,Tumor cells: HCT 116 (IC50=3.9 μM ); K562 (IC50=33 μM); SNU-638 (IC50=37 μM); A549 (IC50=6.7 μM ); SK-HEP-1 (IC50=7.7 μM); MDA-MB-231 (IC50=9.1 μM); P388 (Not active up to 100 µg/ml),Cyclic,Free,Free,None,L,DRAMP
9553,DRAMP33781,IPWFPLTP,8,Not available,Not available,Tumor cells: A549 (IC50=0.44 µM); HT-29 (IC50=0.462 µM); MDA-MB-231 (IC50=0.515 µM),Cyclic,Free,Free,None,L,DRAMP
9554,DRAMP33782,PFNAXAI,7,Not available,Not available,Tumor cells: K562 (IC50=11 µM); HCT 116 (IC50=12 µM); MDA-MB-231 (IC50=12 µM); SNU-638 (IC50=12 µM); SK-HEP-1 (IC50=13 µM); A549 (IC50=15 µM),Cyclic,Free,Free,X=Methionine sulfone,L,DRAMP
9555,DRAMP33783,PPXFELPPYI,10,Not available,Not available,Tumor cells: SK-HEP-1 (IC50=0.041 µM); HCT 116 (IC50=0.14 µM); SNU-638 (IC50=0.16 µM); K562 (IC50=0.17 µM); A549 (IC50=0.19 µM); MDA-MB-231 (IC50=0.4 µM),Cyclic,Free,Free,X=Methionine sulfone,L,DRAMP
9556,DRAMP33784,PPXFELPPYI,10,Not available,Not available,Tumor cells: SNU-638 (IC50=0.01 µM); HCT 116 (IC50=0.011 µM); SK-HEP-1 (IC50=0.014 µM); K562 (IC50=0.021 µM); A549 (IC50=0.023 µM); MDA-MB-231 (IC50=0.35 µM),Cyclic,Free,Free,X=Methionine sulfone,L,DRAMP
9557,DRAMP33785,PPXFELPPYI,10,Not available,Not available,Tumor cells: SK-HEP-1 (IC50=0.041 µM); HCT 116 (IC50=0.14 µM); SNU-638 (IC50=0.16 µM); K562 (IC50=0.17 µM); A549 (IC50=0.19 µM); MDA-MB-231 (IC50=0.4 µM),Cyclic,Free,Free,X=Methionine sulfone,L,DRAMP
9558,DRAMP33786,PPXFELPPYI,10,Not available,Not available,Tumor cells: SNU-638 (IC50=0.01 µM); HCT 116 (IC50=0.011 µM); SK-HEP-1 (IC50=0.014 µM); K562 (IC50=0.021 µM); A549 (IC50=0.023 µM); MDA-MB-231 (IC50=0.35 µM),Cyclic,Free,Free,X=Methionine sulfone,L,DRAMP
9559,DRAMP33787,IxPYPFP,7,Not available,Not available,Tumor cells: A549 (IC50=0.66 µM); HCT 116 (IC50=0.71 µM); SK-HEP-1 (IC50=0.77 µM); MDA-MB-231 (IC50=1.3 µM); SNU-638 (IC50=1.6 µM); A2780 (IC50=28.27 µg/ml (DMSO); IC50=2.72 µg/ml (MeOH)); K562 (IC50=3.2 µM),Cyclic,Free,Free,x=D-Allo-Ile,Mix,DRAMP
9560,DRAMP33788,PtPfiFS,7,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=10 µM); SNU-638 (IC50=24 µM); K562 (IC50=30 µM); HCT 116 (IC50=4.5 µM); SK-HEP-1 (IC50=7.2 µM); A549 (IC50=7.4 µM),Cyclic,Free,Free,t=D-Thr; f=D-Phe; i=D-Ile,Mix,DRAMP
9561,DRAMP33789,lPPYvPPXfv,10,Not available,Not available,Tumor cells: HCT 116 (IC50=1 µM); K562 (IC50=1.1 µM); A549 (IC50=1.4 µM); SK-HEP-1 (IC50=12 µM); SNU-638 (IC50=2.2 µM); MDA-MB-231 (IC50=8.6 µM),Cyclic,Free,Free,X=Allo-Ile,Mix,DRAMP
9562,DRAMP33790,QPFPfifp,8,Not available,Not available,Tumor cells: P388 (ED50=0.2 µg/ml); HCT 116 (IC50=1.6 µM); SK-HEP-1 (IC50=1.7 µM); A549 (IC50=2.8 µM); MDA-MB-231 (IC50=3.2 µM); K562 (IC50=5.6 µM); SNU-638 (IC50=6.9 µM),Cyclic,Free,Free,f=D-Phe; i=D-Ile,Mix,DRAMP
9563,DRAMP33791,IFVLPPYIPP,10,Not available,Not available,Tumor cells: HCT 116 (IC50=0.1 µM); K562 (IC50=0.29 µM); A549 (IC50=0.54 µM); SNU-638 (IC50=1.7 µM); SK-HEP-1 (IC50=2.3 µM); MDA-MB-231 (IC50=2.5 µM),Cyclic,Free,Free,None,L,DRAMP
9564,DRAMP33792,ANPRYPYT,8,Not available,Not available,Tumor cells: A549 (IC50>50 µM); HCT 116 (IC50>50 µM); K562 (IC50>50 µM); MDA-MB-231 (IC50>50 µM); SK-HEP-1 (IC50>50 µM); SNU-638 (IC50>50 µM),Cyclic,Free,Free,None,L,DRAMP
9565,DRAMP33793,IPYVPLTP,8,Not available,Not available,Tumor cells: P388 (ED50=2.1 µg/ml),Cyclic,Free,Free,None,L,DRAMP
9566,DRAMP33794,AIPFNAM,7,Not available,Not available,Tumor cells: DU145 (GI50=0.14-0.74 μg/mL); KM20L2 (GI50=0.14-0.74 μg/mL); NCI-H460 (GI50=0.14-0.74 μg/mL); OVCAR-3 (GI50=0.14-0.74 μg/mL); P388 (GI50=0.14-0.74 μg/mL); SF295 (GI50=0.14-0.74 μg/mL); SK-MEL-5 (GI50=0.14-0.74 μg/mL),Cyclic,Free,Free,None,L,DRAMP
9567,DRAMP33795,PIPIFPY,7,Not available,Not available,Tumor cells: P388 (ED50=7.5 μg/mL),Cyclic,Free,Free,None,L,DRAMP
9568,DRAMP33796,PFGPTIX,7,Not available,Not available,Tumor cells: P388 (ED50=0.33 μg/mL),Cyclic,Free,Free,X=Photo-Trp,L,DRAMP
9569,DRAMP33797,PFPWLPI,7,Not available,Not available,Tumor cells: P388 (ED50=0.18 μg/mL),Cyclic,Free,Free,None,L,DRAMP
9570,DRAMP33798,PPIFALPPYI,10,Not available,Not available,Tumor cells: P388 (ED50=3.2 μg/mL),Cyclic,Free,Free,None,L,DRAMP
9571,DRAMP33799,PPIFTLPPYI,10,Not available,Not available,Tumor cells: P388 (ED50=2.8 μg/mL),Cyclic,Free,Free,None,L,DRAMP
9572,DRAMP33800,AIPFXAX,7,Not available,Not available,Tumor cells: P388 (ED50=0.0042 μg/mL),Cyclic,Free,Free,X(5)=β-OMe-Asp; X(7)=Met(SO),L,DRAMP
9573,DRAMP33801,XP,2,Not available,Not available,Tumor cells: K562 (IC50=21.1 μM); A2780 (IC50=82.8 μM); A2780-cisR (IC50=85.9 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9574,DRAMP33802,XP,2,Not available,Not available,Tumor cells: A2780 (IC50=100 μM); K562 (IC50=40.4 μM); A2780-cisR (IC50=87.8 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9575,DRAMP33803,XG,2,Not available,Not available,Tumor cells: K562 (IC50=16.7 μM); A2780 (IC50=82.4 μM); A2780-cisR (IC50=85.2 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9576,DRAMP33804,XL,2,Not available,Not available,Tumor cells: K562 (IC50=30.1 μM); A2780-cisR (IC50=75 μM); A2780 (IC50=92.6 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9577,DRAMP33805,XW,2,Not available,Not available,Tumor cells: K562 (IC50=29.8 μM); A2780-cisR (IC50=80.8 μM); A2780 (IC50=89.7 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9578,DRAMP33806,XY,2,Not available,Not available,Tumor cells: K562 (IC50=31.6 μM); A2780-cisR (IC50=83.3 μM); A2780 (IC50=89.8 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9579,DRAMP33807,XF,2,Not available,Not available,Tumor cells: K562 (IC50=70.4 μM); A2780-cisR (IC50=81.6 μM); A2780 (IC50=87 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9580,DRAMP33808,Xp,2,Not available,Not available,Tumor cells: A2780 (IC50=106 μM); K562 (IC50=34.7 μM); A2780-cisR (IC50=92 μM),Cyclic,Free,Free,X=Prenylated-Trp,Mix,DRAMP
9581,DRAMP33809,Xp,2,Not available,Not available,Tumor cells: K562 (IC50=30.9 μM); A2780-cisR (IC50=85.6 μM); A2780 (IC50=93.1 μM),Cyclic,Free,Free,X=Prenylated-Trp,Mix,DRAMP
9582,DRAMP33810,XP,2,Not available,Not available,Tumor cells: K562 (IC50=21.1 μM); A2780 (IC50=82.8 μM); A2780-cisR (IC50=85.9 μM),Cyclic,Free,Free,x=Prenylated-D-Trp,L,DRAMP
9583,DRAMP33811,XP,2,Not available,Not available,Tumor cells: A2780 (IC50=100 μM); K562 (IC50=40.4 μM); A2780-cisR (IC50=87.8 μM),Cyclic,Free,Free,x=Prenylated-D-Trp,L,DRAMP
9584,DRAMP33812,Xp,2,Not available,Not available,Tumor cells: A2780 (IC50=106 μM); K562 (IC50=34.7 μM); A2780-cisR (IC50=92 μM),Cyclic,Free,Free,x=Prenylated-D-Trp,Mix,DRAMP
9585,DRAMP33813,Xp,2,Not available,Not available,Tumor cells: K562 (IC50=30.9 μM); A2780-cisR (IC50=85.6 μM); A2780 (IC50=93.1 μM),Cyclic,Free,Free,x=Prenylated-D-Trp,Mix,DRAMP
9586,DRAMP33814,XA,2,Not available,Not available,Tumor cells: K562 (IC50=35.2 μM); A2780-cisR (IC50=82.2 μM); A2780 (IC50=89.8 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9587,DRAMP33815,Xa,2,Not available,Not available,Tumor cells: K562 (IC50=34.5 μM); A2780-cisR (IC50=77 μM); A2780 (IC50=77.2 μM),Cyclic,Free,Free,X=Prenylated-Trp,Mix,DRAMP
9588,DRAMP33816,xa,2,Not available,Not available,Tumor cells: K562 (IC50=34.7 μM); A2780-cisR (IC50=81.1 μM); A2780 (IC50=85 μM),Cyclic,Free,Free,x=Prenylated-D-Trp,D,DRAMP
9589,DRAMP33817,xA,2,Not available,Not available,Tumor cells: K562 (IC50=35.3 μM); A2780-cisR (IC50=84.3 μM); A2780 (IC50=86.2 μM),Cyclic,Free,Free,x=Prenylated-D-Trp,Mix,DRAMP
9590,DRAMP33818,XH,2,Not available,Not available,Tumor cells: K562 (IC50=32.2 μM); A2780-cisR (IC50=91.7 μM); A2780 (IC50=91.8 μM),Cyclic,Free,Free,X=Prenylated-Trp,L,DRAMP
9591,DRAMP33819,GL,2,Not available,Not available,Tumor cells: HeLa  (12.58±1.23% Inhibition=10 µM ; 28.64 ± 1.51% Inhibition=100 µM ); MCF-7  (19.50 ± 1.34% Inhibition=10 µM; 27.49 ± 2.68% Inhibition=100 µM); HT-29 (21.55 ± 1.93% Inhibition=10 µM; 17.25 ± 1.66% Inhibition=100 µM),Cyclic,Free,Free,None,L,DRAMP
9592,DRAMP33820,GV,2,Not available,Not available,Tumor cells: HeLa  (12.58 ± 1.23% Inhibition=10 µM ; 23.46 ± 2.04% Inhibition=100 µM); HT-29 (6.87 ± 0.67% Inhibition=10 µM; 23.90 ± 2.25% Inhibition=100 µM); MCF-7  (7.00 ± 0.56% Inhibition=10 µM; 21.19 ± 2.04% Inhibition=100 µM),Cyclic,Free,Free,None,L,DRAMP
9593,DRAMP33821,Gv,2,Not available,Not available,Tumor cells: HT-29 (14.29 ± 1.40% Inhibition=10 µM; 16.78 ± 1.65% Inhibition=100 µM); HeLa  (19.61 ± 0.82% Inhibition=10 µM ; 20.55 ± 2.03% Inhibition=100 µM); MCF-7  (19.78 ± 1.86% Inhibition=10 µM; 21.94 ± 2.17% Inhibition=100 µM),Cyclic,Free,Free,None,Mix,DRAMP
9594,DRAMP33822,GC,2,Not available,Not available,Tumor cells: HT-29 (30.56 ± 0.03% Inhibition=10 µM; 51.29 ± 0.01% Inhibition=100 µM); MCF-7  (36.49 ± 0.02% Inhibition=10 µM; 56.08 ± 0.01% Inhibition=100 µM); HeLa  (43.92 ± 0.02% Inhibition=10 µM ; 57.79 ± 0.02% Inhibition=100 µM),Cyclic,Free,Free,None,L,DRAMP
9595,DRAMP33823,YC,2,Not available,Not available,Tumor cells: HT-29 (32.41 ± 0.03% Inhibition=10 µM; 52.27 ± 0.02% Inhibition=100 µM); MCF-7  (35.15 ± 0.01% Inhibition=10 µM; 56.08 ± 0.01% Inhibition=100 µM); HeLa  (54.61 ± 0.02% Inhibition=10 µM ; 57.79 ± 0.02% Inhibition=100 µM),Cyclic,Free,Free,None,L,DRAMP
9596,DRAMP33824,VWKPPYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (40% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9597,DRAMP33825,VDRPPYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9598,DRAMP33826,VDKKPYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (50% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9599,DRAMP33827,VDKFPYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (39% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9600,DRAMP33828,VDKYPYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (30% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9601,DRAMP33829,VDKPFYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9602,DRAMP33830,VDKPYYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (35% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9603,DRAMP33831,VDKPHYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9604,DRAMP33832,VDKPRYLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (40% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9605,DRAMP33833,VDKPPWLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9606,DRAMP33834,VDKPPFLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (44% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9607,DRAMP33835,VDKPPHLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9608,DRAMP33836,VDKPPXLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (58% Killing=600 µg/ml),Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,DRAMP
9609,DRAMP33837,VDKPPXLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (54% Killing=600 µg/ml),Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,DRAMP
9610,DRAMP33838,VDKPPXLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (58% Killing=600 µg/ml),Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,DRAMP
9611,DRAMP33839,VDKPPXLPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (54% Killing=600 µg/ml),Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,DRAMP
9612,DRAMP33840,VDKPPYXPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,X=nor-Leu,Mix,DRAMP
9613,DRAMP33841,VDKPPYXPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Linear,Free,Amidation,X=nor-Leu,Mix,DRAMP
9614,DRAMP33842,VDKPPYXPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,X=tert‐Leu,Mix,DRAMP
9615,DRAMP33843,VDKPPYXPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Linear,Free,Amidation,X=tert‐Leu,Mix,DRAMP
9616,DRAMP33844,VDKPPYRPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (42% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9617,DRAMP33845,VDKPPYMPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9618,DRAMP33846,VDKPPYFPRPRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (32% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9619,DRAMP33847,VDKPPYLPRWRPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9620,DRAMP33848,VDKPPYLPRPWPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (44% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9621,DRAMP33849,VDKPPYLPRPHPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9622,DRAMP33850,VDKPPYLPRPKPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (58% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9623,DRAMP33851,VDKPPYLPRPFPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (50% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9624,DRAMP33852,VDKPPYLPRPXPPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Linear,Free,Amidation,X=Homoarginine,Mix,DRAMP
9625,DRAMP33853,VDKPPYLPRPRPPRrIXNr,19,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,DRAMP
9626,DRAMP33854,VDKPPYLPRPRPPRrIXNr,19,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,DRAMP
9627,DRAMP33855,VDKPPYLPRPRPPRrIXNr,19,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,DRAMP
9628,DRAMP33856,VDKPPYLPRPRPPRrIXNr,19,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,DRAMP
9629,DRAMP33857,VDKPPYLPRPRWPRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9630,DRAMP33858,VDKPPYLPRPRWERrIYNr,19,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9631,DRAMP33859,VDKPPYLPRPRWRRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9632,DRAMP33860,VDKPPYLPRPRWWRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (64% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9633,DRAMP33861,VDKPPYLPRPRWKRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (48% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9634,DRAMP33862,VDKPPYLPRPRWHRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (51% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9635,DRAMP33863,VDKPPYLPRPRWIRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (56% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9636,DRAMP33864,VDKPPYLPRPRWFRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (61% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9637,DRAMP33865,VDKPPYLPRPRWLRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (50% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9638,DRAMP33866,VDKPPYLPRPRWARrIYNr,19,Not available,Not available,Tumor cells: HepG2 (48% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9639,DRAMP33867,VDKPPYLPRPRWNRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (54% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9640,DRAMP33868,VDKPPYLPRPRWVRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (25% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9641,DRAMP33869,VDKPPYLPRPRWGRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (27% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9642,DRAMP33870,VDKPPYLPRPRWSRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9643,DRAMP33871,VDKPPYLPRPRWQRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (41% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9644,DRAMP33872,VDKPPYLPRPRWYRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (30% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9645,DRAMP33873,VDKPPYLPRPRWDRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (28% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9646,DRAMP33874,VDKPPYLPRPRWTRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (22% Killing=600 µg/ml),Linear,Free,Amidation,None,Mix,DRAMP
9647,DRAMP33875,VDKPPYLPRPRWXRrIYNr,19,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Linear,Free,Amidation,X=Orn,Mix,DRAMP
9648,DRAMP33876,VLPILLLVL,9,Not available,Not available,Tumor cells: HepG2 (IC50=12.22 μM); SMMC-7721 (IC50=6.38 μM ),Cyclic,Free,Free,None,L,DRAMP
9649,DRAMP33877,VLPILLLVA,9,Not available,Not available,Tumor cells: HepG2 (IC50=38.64 μM); SMMC-7721 (IC50=38.92 μM ),Cyclic,Free,Free,None,L,DRAMP
9650,DRAMP33878,VLPILLLAL,9,Not available,Not available,Tumor cells: HepG2 (IC50=40.46 μM); SMMC-7721 (IC50=47.37 μM),Cyclic,Free,Free,None,L,DRAMP
9651,DRAMP33879,VLPILLAVL,9,Not available,Not available,Tumor cells: HepG2 (IC50=31.84 μM); SMMC-7721 (IC50=47.37 μM),Cyclic,Free,Free,None,L,DRAMP
9652,DRAMP33880,VLPILALVL,9,Not available,Not available,Tumor cells: SMMC-7721 (IC50=42.81 μM); HepG2 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
9653,DRAMP33881,VLPIALLVL,9,Not available,Not available,Tumor cells: SMMC-7721 (IC50=29.8 μM); HepG2 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
9654,DRAMP33882,VLPALLLVL,9,Not available,Not available,Tumor cells: SMMC-7721 (IC50=36.08 μM); HepG2 (IC50=55.61 μM),Cyclic,Free,Free,None,L,DRAMP
9655,DRAMP33883,VAPILLLVL,9,Not available,Not available,Tumor cells: HepG2 (IC50=39.37 μM); SMMC-7721 (IC50=48.48 μM),Cyclic,Free,Free,None,L,DRAMP
9656,DRAMP33884,ALPILLLVL,9,Not available,Not available,Tumor cells: SMMC-7721 (IC50=29.94 μM); HepG2 (IC50=29.95 μM),Cyclic,Free,Free,None,L,DRAMP
9657,DRAMP33885,VLPILLLV,8,Not available,Not available,Tumor cells: HepG2 (IC50=51.72 μM); SMMC-7721 (IC50=73.93 μM),Cyclic,Free,Free,None,L,DRAMP
9658,DRAMP33886,VLPILLL,7,Not available,Not available,Tumor cells: HepG2 (IC50>100 μM); SMMC-7721 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
9659,DRAMP33887,VLPILL,6,Not available,Not available,Tumor cells: HepG2 (IC50>100 μM); SMMC-7721 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
9660,DRAMP33888,VLPIL,5,Not available,Not available,Tumor cells: HepG2 (IC50>100 μM); SMMC-7721 (IC50>100 μM),Cyclic,Free,Free,None,L,DRAMP
9661,DRAMP33889,EQWAREIGAQLRRMADDLNA,20,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=1.006 ± 0.337 μM); OCI-Ly1 (Bcl-2 dependent) (EC50=1.967 ± 0.48 μM),Linear,Free,Free,None,L,DRAMP
9662,DRAMP33890,RPEIWYAQGLKRFGDEFNAYYAR,23,Not available,Not available,Tumor cells: OCI-Ly1 (Bcl-2 dependent) (EC50=228 ± 56 nM); MDA-MB-231 (Bc1-xL dependent) (EC50=50 ± 16 nM),Linear,Free,Free,None,L,DRAMP
9663,DRAMP33891,RPEIWYAQWLKRFGDQFNAYYAR,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9664,DRAMP33892,RPEIWIAQGLKRFGDEFNAYYAR,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9665,DRAMP33893,RPEIWYAQELKRFGDEFNAYYAR,23,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=12 ± 4 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=37 ± 9 nM),Linear,Free,Free,None,L,DRAMP
9666,DRAMP33894,RPEIWYAQGLRRFGDEFNAYYAR,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9667,DRAMP33895,RPEIWYAQGLKRIGDEFNAYYAR,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9668,DRAMP33896,RPEIWYAQGLKRFGDEFNAYKAR,23,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=82 ± 27 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=911 ± 222 nM),Linear,Free,Free,None,L,DRAMP
9669,DRAMP33897,IWYAQGLKRFGDEFNAYK,18,Not available,Not available,Tumor cells: OCI-Ly1 (Bcl-2 dependent) (EC50=3.325 ± 0.812 μM); MDA-MB-231 (Bc1-xL dependent) (EC50=847 ± 284 nM),Linear,Free,Free,None,L,DRAMP
9670,DRAMP33898,RPEIWYAQGLKRFGDEFNAYK,21,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=159 ± 53 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=3.435 ± 0.839 μM),Linear,Free,Free,None,L,DRAMP
9671,DRAMP33899,LRPEIRYAQELRRIGDEFNE,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9672,DRAMP33900,LWAAIRIAQELRRIGDEFNE,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9673,DRAMP33901,LRPEIRIARELRRIGDEFNE,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9674,DRAMP33902,LRPEIRIAQELRRMGDEFNE,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9675,DRAMP33903,LRPEIRYARELRRIGDEFNE,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9676,DRAMP33904,LRPEIRYAQELRRMGDEFNE,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9677,DRAMP33905,PQMVILQLLRFIFRLVWRRH,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9678,DRAMP33906,PQMVELQLLRFIFRLVWRRH,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9679,DRAMP33907,PQMVILQLERFIFRLVWRRH,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9680,DRAMP33908,PQMVILQLLRFEFRLVWRRH,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9681,DRAMP33909,PQMVILQLLRFIFRLEWRRH,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9682,DRAMP33910,PQMVILQLLAFIFALVWRRH,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9683,DRAMP33911,IWIAQELRRIGDEFNA,16,Not available,Not available,Tumor cells: U-937 (18% Killing= 50 μM); HL-60 (23% Killing= 50 μM); K562 (25% Killing= 50 μM),Linear,Acetylation,Amidation,None,L,DRAMP
9684,DRAMP33912,IWIAQELRRIGDEF,14,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9685,DRAMP33913,IAQELRRIGDEFNA,14,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9686,DRAMP33914,WIAQELRRIGDEFN,14,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9687,DRAMP33915,IAQELRRIGDEF,12,Not available,Not available,Tumor cells: HL-60 (21% Killing= 50 μM); K562 (26% Killing= 50 μM); U-937 (40% Killing= 50 μM),Linear,Acetylation,Amidation,None,L,DRAMP
9688,DRAMP33916,IAQELRRIGDEF,12,Not available,Not available,Tumor cells: K562 (20% Killing= 50 μM); HL-60 (23% Killing= 50 μM); U-937 (45% Killing= 50 μM),Linear,Acetylation,Amidation,None,L,DRAMP
9689,DRAMP33917,IAQELRRIGDEF,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9690,DRAMP33918,IAQELRRIGDEF,12,Not available,Not available,Tumor cells: HL-60 (21% Killing= 50 μM); K562 (26% Killing= 50 μM); U-937 (40% Killing= 50 μM),Linear,"Pal, CH3(CH2)14CO",Amidation,None,L,DRAMP
9691,DRAMP33919,IAQELRRIGDEF,12,Not available,Not available,Tumor cells: K562 (20% Killing= 50 μM); HL-60 (23% Killing= 50 μM); U-937 (45% Killing= 50 μM),Linear,"Pal, CH3(CH2)14CO",Amidation,None,L,DRAMP
9692,DRAMP33920,IAQELRRIGDEF,12,Not available,Not available,Not available,Linear,"Pal, CH3(CH2)14CO",Amidation,None,L,DRAMP
9693,DRAMP33921,IAQELRRIGDEF,12,Not available,Not available,Tumor cells: HL-60 (21% Killing= 50 μM); K562 (26% Killing= 50 μM); U-937 (40% Killing= 50 μM),Linear,"mPEG, CH3(OCH2CH2)4OCH2CO",Amidation,None,L,DRAMP
9694,DRAMP33922,IAQELRRIGDEF,12,Not available,Not available,Tumor cells: K562 (20% Killing= 50 μM); HL-60 (23% Killing= 50 μM); U-937 (45% Killing= 50 μM),Linear,"mPEG, CH3(OCH2CH2)4OCH2CO",Amidation,None,L,DRAMP
9695,DRAMP33923,IAQELRRIGDEF,12,Not available,Not available,Not available,Linear,"mPEG, CH3(OCH2CH2)4OCH2CO",Amidation,None,L,DRAMP
9696,DRAMP33924,EIWIAQELRRRGDSFNAYYAR,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9697,DRAMP33925,EIWIAQELRRRGDXFNAYYAR,21,Not available,Not available,Not available,Linear,Free,Free,X=Phosphorylated-Ser,L,DRAMP
9698,DRAMP33926,EIWIAQELRRRGDAFNAYYAR,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9699,DRAMP33927,EIWIAQELRSRGDSFNAYYAR,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9700,DRAMP33928,EIWIAQELRSRGDXFNAYYAR,21,Not available,Not available,Not available,Linear,Free,Free,X=Phosphorylated-Ser,L,DRAMP
9701,DRAMP33929,EIWIAQELRRIGDSFNAYYAR,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9702,DRAMP33930,LWAAQRYGRELRRMSDEFEGSFKGL,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9703,DRAMP33931,RPEIWMTQGLRRLGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9704,DRAMP33932,RPEIWLTQSLQRLGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9705,DRAMP33933,RPEIWLTQHLQRLGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9706,DRAMP33934,RPEIWMGQGLRRLGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9707,DRAMP33935,RPEIWLGQSLQRLGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9708,DRAMP33936,RPEIWLGQHLQRLGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9709,DRAMP33937,AELPPEFAAQLRKIGDKVYC,20,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9710,DRAMP33938,RPEIWIAQELRRIGDEFNAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9711,DRAMP33939,RPEIWITQELRRIGDEFNAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9712,DRAMP33940,RPEIWMTQELRRIGDEFNAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9713,DRAMP33941,RPEIWITQGLRRIGDEFNAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9714,DRAMP33942,RPEIWITQELRRLGDEFNAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9715,DRAMP33943,RPEIWITQELRRIGDEINAYYAR,23,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,None,L,DRAMP
9716,DRAMP33944,RPEIWLAQYLRRLGDQINAYYAR,23,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9717,DRAMP33945,RPEIWMAQVLRRFGDLLNAYYAR,23,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
9718,DRAMP33946,RPEIWIAQELRRAGDVLNAYYAR,23,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9719,DRAMP33947,RPEIWIAQGLRRIGDTWNAYYAR,23,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
9720,DRAMP33948,MRPEIWIAQELRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9721,DRAMP33949,MRPEIWIAQELRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9722,DRAMP33950,MRPEIWIAQELRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9723,DRAMP33951,MRPEIWIAQELRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9724,DRAMP33952,MRPEIWIAQELRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9725,DRAMP33953,MRPEIWIAQELRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9726,DRAMP33954,MRPEIWIAQELRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9727,DRAMP33955,MRPEIWIAQELRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9728,DRAMP33956,MRPEIWIAQELRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9729,DRAMP33957,MRPEIWIAQELRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9730,DRAMP33958,MRPEIWIAQELRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9731,DRAMP33959,MRPEIWIAQELRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9732,DRAMP33960,MRPEIWIAQELRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9733,DRAMP33961,MRPEIWIAQELRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9734,DRAMP33962,MRPEIWIAQELDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9735,DRAMP33963,MRPEIWIAQELDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9736,DRAMP33964,MRPEIWIAQELDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9737,DRAMP33965,MRPEIWIAQELDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9738,DRAMP33966,MRPEIWIAQELDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9739,DRAMP33967,MRPEIWIAQELDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9740,DRAMP33968,MRPEIWIAQELDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9741,DRAMP33969,MRPEIWIAQELDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9742,DRAMP33970,MRPEIWIAQELDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9743,DRAMP33971,MRPEIWIAQELDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9744,DRAMP33972,MRPEIWIAQELDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9745,DRAMP33973,MRPEIWIAQELDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9746,DRAMP33974,MRPEIWIAQELDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9747,DRAMP33975,MRPEIWIAQELDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9748,DRAMP33976,MRPEIWIAQELDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9749,DRAMP33977,MRPEIWIAQEIRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9750,DRAMP33978,MRPEIWIAQEIRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9751,DRAMP33979,MRPEIWIAQEIRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9752,DRAMP33980,MRPEIWIAQEIRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9753,DRAMP33981,MRPEIWIAQEIRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9754,DRAMP33982,MRPEIWIAQEIRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9755,DRAMP33983,MRPEIWIAQEIRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9756,DRAMP33984,MRPEIWIAQEIRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9757,DRAMP33985,MRPEIWIAQEIRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9758,DRAMP33986,MRPEIWIAQEIRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9759,DRAMP33987,MRPEIWIAQEIRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9760,DRAMP33988,MRPEIWIAQEIRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9761,DRAMP33989,MRPEIWIAQEIRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9762,DRAMP33990,MRPEIWIAQEIRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9763,DRAMP33991,MRPEIWIAQEIRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9764,DRAMP33992,MRPEIWIAQEIDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9765,DRAMP33993,MRPEIWIAQEIDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9766,DRAMP33994,MRPEIWIAQEIDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9767,DRAMP33995,MRPEIWIAQEIDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9768,DRAMP33996,MRPEIWIAQEIDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9769,DRAMP33997,MRPEIWIAQEIDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9770,DRAMP33998,MRPEIWIAQEIDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9771,DRAMP33999,MRPEIWIAQEIDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9772,DRAMP34000,MRPEIWIAQEIDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9773,DRAMP34001,MRPEIWIAQEIDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9774,DRAMP34002,MRPEIWIAQEIDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9775,DRAMP34003,MRPEIWIAQEIDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9776,DRAMP34004,MRPEIWIAQEIDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9777,DRAMP34005,MRPEIWIAQEIDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9778,DRAMP34006,MRPEIWIAQEIDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9779,DRAMP34007,MRPEIWIAQEFRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9780,DRAMP34008,MRPEIWIAQEFRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9781,DRAMP34009,MRPEIWIAQEFRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9782,DRAMP34010,MRPEIWIAQEFRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9783,DRAMP34011,MRPEIWIAQEFRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9784,DRAMP34012,MRPEIWIAQEFRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9785,DRAMP34013,MRPEIWIAQEFRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9786,DRAMP34014,MRPEIWIAQEFRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9787,DRAMP34015,MRPEIWIAQEFRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9788,DRAMP34016,MRPEIWIAQEFRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9789,DRAMP34017,MRPEIWIAQEFRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9790,DRAMP34018,MRPEIWIAQEFRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9791,DRAMP34019,MRPEIWIAQEFRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9792,DRAMP34020,MRPEIWIAQEFRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9793,DRAMP34021,MRPEIWIAQEFRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9794,DRAMP34022,MRPEIWIAQEFDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9795,DRAMP34023,MRPEIWIAQEFDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9796,DRAMP34024,MRPEIWIAQEFDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9797,DRAMP34025,MRPEIWIAQEFDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9798,DRAMP34026,MRPEIWIAQEFDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9799,DRAMP34027,MRPEIWIAQEFDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9800,DRAMP34028,MRPEIWIAQEFDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9801,DRAMP34029,MRPEIWIAQEFDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9802,DRAMP34030,MRPEIWIAQEFDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9803,DRAMP34031,MRPEIWIAQEFDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9804,DRAMP34032,MRPEIWIAQEFDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9805,DRAMP34033,MRPEIWIAQEFDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9806,DRAMP34034,MRPEIWIAQEFDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9807,DRAMP34035,MRPEIWIAQEFDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9808,DRAMP34036,MRPEIWIAQEFDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9809,DRAMP34037,MRPEIWIAQEARRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9810,DRAMP34038,MRPEIWIAQEARRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9811,DRAMP34039,MRPEIWIAQEARRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9812,DRAMP34040,MRPEIWIAQEARRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9813,DRAMP34041,MRPEIWIAQEARRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9814,DRAMP34042,MRPEIWIAQEARRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9815,DRAMP34043,MRPEIWIAQEARRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9816,DRAMP34044,MRPEIWIAQEARRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9817,DRAMP34045,MRPEIWIAQEARRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9818,DRAMP34046,MRPEIWIAQEARRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9819,DRAMP34047,MRPEIWIAQEARRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9820,DRAMP34048,MRPEIWIAQEARRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9821,DRAMP34049,MRPEIWIAQEARRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9822,DRAMP34050,MRPEIWIAQEARRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9823,DRAMP34051,MRPEIWIAQEARRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9824,DRAMP34052,MRPEIWIAQEADRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9825,DRAMP34053,MRPEIWIAQEADRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9826,DRAMP34054,MRPEIWIAQEADRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9827,DRAMP34055,MRPEIWIAQEADRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9828,DRAMP34056,MRPEIWIAQEADRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9829,DRAMP34057,MRPEIWIAQEADRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9830,DRAMP34058,MRPEIWIAQEADRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9831,DRAMP34059,MRPEIWIAQEADRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9832,DRAMP34060,MRPEIWIAQEADRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9833,DRAMP34061,MRPEIWIAQEADRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9834,DRAMP34062,MRPEIWIAQEADRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9835,DRAMP34063,MRPEIWIAQEADRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9836,DRAMP34064,MRPEIWIAQEADRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9837,DRAMP34065,MRPEIWIAQEADRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9838,DRAMP34066,MRPEIWIAQEADRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9839,DRAMP34067,MRPEIWAAQELRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9840,DRAMP34068,MRPEIWAAQELRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9841,DRAMP34069,MRPEIWAAQELRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9842,DRAMP34070,MRPEIWAAQELRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9843,DRAMP34071,MRPEIWAAQELRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9844,DRAMP34072,MRPEIWAAQELRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9845,DRAMP34073,MRPEIWAAQELRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9846,DRAMP34074,MRPEIWAAQELRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9847,DRAMP34075,MRPEIWAAQELRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9848,DRAMP34076,MRPEIWAAQELRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9849,DRAMP34077,MRPEIWAAQELRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9850,DRAMP34078,MRPEIWAAQELRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9851,DRAMP34079,MRPEIWAAQELRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9852,DRAMP34080,MRPEIWAAQELRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9853,DRAMP34081,MRPEIWAAQELRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9854,DRAMP34082,MRPEIWAAQELDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9855,DRAMP34083,MRPEIWAAQELDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9856,DRAMP34084,MRPEIWAAQELDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9857,DRAMP34085,MRPEIWAAQELDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9858,DRAMP34086,MRPEIWAAQELDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9859,DRAMP34087,MRPEIWAAQELDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9860,DRAMP34088,MRPEIWAAQELDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9861,DRAMP34089,MRPEIWAAQELDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9862,DRAMP34090,MRPEIWAAQELDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9863,DRAMP34091,MRPEIWAAQELDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9864,DRAMP34092,MRPEIWAAQELDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9865,DRAMP34093,MRPEIWAAQELDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9866,DRAMP34094,MRPEIWAAQELDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9867,DRAMP34095,MRPEIWAAQELDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9868,DRAMP34096,MRPEIWAAQELDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9869,DRAMP34097,MRPEIWAAQEIRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9870,DRAMP34098,MRPEIWAAQEIRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9871,DRAMP34099,MRPEIWAAQEIRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9872,DRAMP34100,MRPEIWAAQEIRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9873,DRAMP34101,MRPEIWAAQEIRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9874,DRAMP34102,MRPEIWAAQEIRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9875,DRAMP34103,MRPEIWAAQEIRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9876,DRAMP34104,MRPEIWAAQEIRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9877,DRAMP34105,MRPEIWAAQEIRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9878,DRAMP34106,MRPEIWAAQEIRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9879,DRAMP34107,MRPEIWAAQEIRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9880,DRAMP34108,MRPEIWAAQEIRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9881,DRAMP34109,MRPEIWAAQEIRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9882,DRAMP34110,MRPEIWAAQEIRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9883,DRAMP34111,MRPEIWAAQEIRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9884,DRAMP34112,MRPEIWAAQEIDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9885,DRAMP34113,MRPEIWAAQEIDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9886,DRAMP34114,MRPEIWAAQEIDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9887,DRAMP34115,MRPEIWAAQEIDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9888,DRAMP34116,MRPEIWAAQEIDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9889,DRAMP34117,MRPEIWAAQEIDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9890,DRAMP34118,MRPEIWAAQEIDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9891,DRAMP34119,MRPEIWAAQEIDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9892,DRAMP34120,MRPEIWAAQEIDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9893,DRAMP34121,MRPEIWAAQEIDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9894,DRAMP34122,MRPEIWAAQEIDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9895,DRAMP34123,MRPEIWAAQEIDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9896,DRAMP34124,MRPEIWAAQEIDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9897,DRAMP34125,MRPEIWAAQEIDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9898,DRAMP34126,MRPEIWAAQEIDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9899,DRAMP34127,MRPEIWAAQEFRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9900,DRAMP34128,MRPEIWAAQEFRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9901,DRAMP34129,MRPEIWAAQEFRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9902,DRAMP34130,MRPEIWAAQEFRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9903,DRAMP34131,MRPEIWAAQEFRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9904,DRAMP34132,MRPEIWAAQEFRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9905,DRAMP34133,MRPEIWAAQEFRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9906,DRAMP34134,MRPEIWAAQEFRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9907,DRAMP34135,MRPEIWAAQEFRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9908,DRAMP34136,MRPEIWAAQEFRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9909,DRAMP34137,MRPEIWAAQEFRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9910,DRAMP34138,MRPEIWAAQEFRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9911,DRAMP34139,MRPEIWAAQEFRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9912,DRAMP34140,MRPEIWAAQEFRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9913,DRAMP34141,MRPEIWAAQEFRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9914,DRAMP34142,MRPEIWAAQEFDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9915,DRAMP34143,MRPEIWAAQEFDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9916,DRAMP34144,MRPEIWAAQEFDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9917,DRAMP34145,MRPEIWAAQEFDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9918,DRAMP34146,MRPEIWAAQEFDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9919,DRAMP34147,MRPEIWAAQEFDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9920,DRAMP34148,MRPEIWAAQEFDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9921,DRAMP34149,MRPEIWAAQEFDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9922,DRAMP34150,MRPEIWAAQEFDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9923,DRAMP34151,MRPEIWAAQEFDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9924,DRAMP34152,MRPEIWAAQEFDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9925,DRAMP34153,MRPEIWAAQEFDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9926,DRAMP34154,MRPEIWAAQEFDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9927,DRAMP34155,MRPEIWAAQEFDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9928,DRAMP34156,MRPEIWAAQEFDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9929,DRAMP34157,MRPEIWAAQEARRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9930,DRAMP34158,MRPEIWAAQEARRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9931,DRAMP34159,MRPEIWAAQEARRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9932,DRAMP34160,MRPEIWAAQEARRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9933,DRAMP34161,MRPEIWAAQEARRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9934,DRAMP34162,MRPEIWAAQEARRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9935,DRAMP34163,MRPEIWAAQEARRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9936,DRAMP34164,MRPEIWAAQEARRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9937,DRAMP34165,MRPEIWAAQEARRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9938,DRAMP34166,MRPEIWAAQEARRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9939,DRAMP34167,MRPEIWAAQEARRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9940,DRAMP34168,MRPEIWAAQEARRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9941,DRAMP34169,MRPEIWAAQEARRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9942,DRAMP34170,MRPEIWAAQEARRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9943,DRAMP34171,MRPEIWAAQEARRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9944,DRAMP34172,MRPEIWAAQEADRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9945,DRAMP34173,MRPEIWAAQEADRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9946,DRAMP34174,MRPEIWAAQEADRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9947,DRAMP34175,MRPEIWAAQEADRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9948,DRAMP34176,MRPEIWAAQEADRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9949,DRAMP34177,MRPEIWAAQEADRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9950,DRAMP34178,MRPEIWAAQEADRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9951,DRAMP34179,MRPEIWAAQEADRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9952,DRAMP34180,MRPEIWAAQEADRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9953,DRAMP34181,MRPEIWAAQEADRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9954,DRAMP34182,MRPEIWAAQEADRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9955,DRAMP34183,MRPEIWAAQEADRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9956,DRAMP34184,MRPEIWAAQEADRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9957,DRAMP34185,MRPEIWAAQEADRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9958,DRAMP34186,MRPEIWAAQEADRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9959,DRAMP34187,MRPEIWFAQELRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9960,DRAMP34188,MRPEIWFAQELRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9961,DRAMP34189,MRPEIWFAQELRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9962,DRAMP34190,MRPEIWFAQELRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9963,DRAMP34191,MRPEIWFAQELRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9964,DRAMP34192,MRPEIWFAQELRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9965,DRAMP34193,MRPEIWFAQELRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9966,DRAMP34194,MRPEIWFAQELRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9967,DRAMP34195,MRPEIWFAQELRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9968,DRAMP34196,MRPEIWFAQELRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9969,DRAMP34197,MRPEIWFAQELRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9970,DRAMP34198,MRPEIWFAQELRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9971,DRAMP34199,MRPEIWFAQELRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9972,DRAMP34200,MRPEIWFAQELRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9973,DRAMP34201,MRPEIWFAQELRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9974,DRAMP34202,MRPEIWFAQELDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9975,DRAMP34203,MRPEIWFAQELDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9976,DRAMP34204,MRPEIWFAQELDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9977,DRAMP34205,MRPEIWFAQELDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9978,DRAMP34206,MRPEIWFAQELDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9979,DRAMP34207,MRPEIWFAQELDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9980,DRAMP34208,MRPEIWFAQELDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9981,DRAMP34209,MRPEIWFAQELDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9982,DRAMP34210,MRPEIWFAQELDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9983,DRAMP34211,MRPEIWFAQELDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9984,DRAMP34212,MRPEIWFAQELDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9985,DRAMP34213,MRPEIWFAQELDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9986,DRAMP34214,MRPEIWFAQELDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9987,DRAMP34215,MRPEIWFAQELDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9988,DRAMP34216,MRPEIWFAQELDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9989,DRAMP34217,MRPEIWFAQEIRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9990,DRAMP34218,MRPEIWFAQEIRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9991,DRAMP34219,MRPEIWFAQEIRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9992,DRAMP34220,MRPEIWFAQEIRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9993,DRAMP34221,MRPEIWFAQEIRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9994,DRAMP34222,MRPEIWFAQEIRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9995,DRAMP34223,MRPEIWFAQEIRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9996,DRAMP34224,MRPEIWFAQEIRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9997,DRAMP34225,MRPEIWFAQEIRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9998,DRAMP34226,MRPEIWFAQEIRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
9999,DRAMP34227,MRPEIWFAQEIRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10000,DRAMP34228,MRPEIWFAQEIRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10001,DRAMP34229,MRPEIWFAQEIRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10002,DRAMP34230,MRPEIWFAQEIRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10003,DRAMP34231,MRPEIWFAQEIRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10004,DRAMP34232,MRPEIWFAQEIDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10005,DRAMP34233,MRPEIWFAQEIDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10006,DRAMP34234,MRPEIWFAQEIDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10007,DRAMP34235,MRPEIWFAQEIDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10008,DRAMP34236,MRPEIWFAQEIDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10009,DRAMP34237,MRPEIWFAQEIDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10010,DRAMP34238,MRPEIWFAQEIDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10011,DRAMP34239,MRPEIWFAQEIDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10012,DRAMP34240,MRPEIWFAQEIDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10013,DRAMP34241,MRPEIWFAQEIDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10014,DRAMP34242,MRPEIWFAQEIDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10015,DRAMP34243,MRPEIWFAQEIDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10016,DRAMP34244,MRPEIWFAQEIDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10017,DRAMP34245,MRPEIWFAQEIDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10018,DRAMP34246,MRPEIWFAQEIDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10019,DRAMP34247,MRPEIWFAQEFRRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10020,DRAMP34248,MRPEIWFAQEFRRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10021,DRAMP34249,MRPEIWFAQEFRRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10022,DRAMP34250,MRPEIWFAQEFRRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10023,DRAMP34251,MRPEIWFAQEFRRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10024,DRAMP34252,MRPEIWFAQEFRRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10025,DRAMP34253,MRPEIWFAQEFRRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10026,DRAMP34254,MRPEIWFAQEFRRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10027,DRAMP34255,MRPEIWFAQEFRRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10028,DRAMP34256,MRPEIWFAQEFRRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10029,DRAMP34257,MRPEIWFAQEFRRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10030,DRAMP34258,MRPEIWFAQEFRRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10031,DRAMP34259,MRPEIWFAQEFRRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10032,DRAMP34260,MRPEIWFAQEFRRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10033,DRAMP34261,MRPEIWFAQEFRRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10034,DRAMP34262,MRPEIWFAQEFDRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10035,DRAMP34263,MRPEIWFAQEFDRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10036,DRAMP34264,MRPEIWFAQEFDRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10037,DRAMP34265,MRPEIWFAQEFDRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10038,DRAMP34266,MRPEIWFAQEFDRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10039,DRAMP34267,MRPEIWFAQEFDRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10040,DRAMP34268,MRPEIWFAQEFDRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10041,DRAMP34269,MRPEIWFAQEFDRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10042,DRAMP34270,MRPEIWFAQEFDRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10043,DRAMP34271,MRPEIWFAQEFDRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10044,DRAMP34272,MRPEIWFAQEFDRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10045,DRAMP34273,MRPEIWFAQEFDRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10046,DRAMP34274,MRPEIWFAQEFDRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10047,DRAMP34275,MRPEIWFAQEFDRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10048,DRAMP34276,MRPEIWFAQEFDRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10049,DRAMP34277,MRPEIWFAQEARRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10050,DRAMP34278,MRPEIWFAQEARRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10051,DRAMP34279,MRPEIWFAQEARRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10052,DRAMP34280,MRPEIWFAQEARRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10053,DRAMP34281,MRPEIWFAQEARRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10054,DRAMP34282,MRPEIWFAQEARRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10055,DRAMP34283,MRPEIWFAQEARRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10056,DRAMP34284,MRPEIWFAQEARRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10057,DRAMP34285,MRPEIWFAQEARRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10058,DRAMP34286,MRPEIWFAQEARRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10059,DRAMP34287,MRPEIWFAQEARRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10060,DRAMP34288,MRPEIWFAQEARRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10061,DRAMP34289,MRPEIWFAQEARRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10062,DRAMP34290,MRPEIWFAQEARRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10063,DRAMP34291,MRPEIWFAQEARRAGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10064,DRAMP34292,MRPEIWFAQEADRIGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10065,DRAMP34293,MRPEIWFAQEADRIGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10066,DRAMP34294,MRPEIWFAQEADRIGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10067,DRAMP34295,MRPEIWFAQEADRFGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10068,DRAMP34296,MRPEIWFAQEADRFGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10069,DRAMP34297,MRPEIWFAQEADRFGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10070,DRAMP34298,MRPEIWFAQEADRDGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10071,DRAMP34299,MRPEIWFAQEADRDGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10072,DRAMP34300,MRPEIWFAQEADRDGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10073,DRAMP34301,MRPEIWFAQEADRNGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10074,DRAMP34302,MRPEIWFAQEADRNGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10075,DRAMP34303,MRPEIWFAQEADRNGDENNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10076,DRAMP34304,MRPEIWFAQEADRAGDEFNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10077,DRAMP34305,MRPEIWFAQEADRAGDEVNAYYARRVZ,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10078,DRAMP34306,LKlLKkLlkKLLkLL,15,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10079,DRAMP34307,GYPICGESCVGGICNIPGCSCSWPVCTTN,29,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10080,DRAMP34308,rlylriGrr,9,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10081,DRAMP34309,rlrlriGrr,9,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10082,DRAMP34310,alylairrr,9,Not available,Not available,Not available,Linear,Free,Amidation,None,D,DRAMP
10083,DRAMP34311,rlllriGrr,9,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10084,DRAMP34312,KLWKKWKKWLK,11,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10085,DRAMP34313,GmwskilGhlir,12,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10086,DRAMP34314,GMWSKILGHLIK,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10087,DRAMP34315,Gkwmsllkhilk,12,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10088,DRAMP34316,fPFfNQYVXL,10,4M6E,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10089,DRAMP34317,FKRiVQRiKDFlRNLV,16,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10090,DRAMP34318,vnwkkilGkiikvvk,15,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10091,DRAMP34319,vnwkkllGkllkvvk,15,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10092,DRAMP34320,GfGmalkllkkvl,13,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10093,DRAMP34321,RRQRRTSKLMKRGGKLAKLAKKLAKLAK,28,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10094,DRAMP34322,ILGKLLSTAWGLLSkL,16,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10095,DRAMP34323,GFSSIFRGVAKFASKGLGKDLAKLGVDLVA,30,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10096,DRAMP34324,KFASKGLGKDLAKLGVDLVACKISKQC,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10097,DRAMP34325,gwgsffkkaahvgkhvgkaalthyl,25,Not available,Not available,Tumor cells: Calu-3 (IC50=41.9 ± 1.8 μg/ml); HeLa (IC50=47.1 ± 2.1 μg/ml); A549 (IC50=79.3 ± 7.2 μg/ml),Linear,Free,Amidation,None,D,DRAMP
10098,DRAMP34326,GlpvcGetcvGGtcntpGctcswpvctrn,29,2JUE,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10099,DRAMP34327,RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP,35,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10100,DRAMP34328,RRIRPRPPRLPRPRPRPLPFPRP,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10101,DRAMP34329,WaxVlL,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10102,DRAMP34330,RAGLQFPVGRLLRRLLR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10103,DRAMP34331,ILPIRSLIKKLL,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10104,DRAMP34332,FLPLKKLRFGLL,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10105,DRAMP34333,MRKWFHNVLSSGQLLADKWPAWDYNWK,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10106,DRAMP34334,fPFfNQYVKL,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10107,DRAMP34335,fPWfNQYVXL,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10108,DRAMP34336,fPWfNQYVKL,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10109,DRAMP34337,fPWwNQYVXL,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10110,DRAMP34338,fPWwNQYVKL,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10111,DRAMP34339,YPLPFIP,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10112,DRAMP34340,KWXWKXVKXAK,11,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
10113,DRAMP34341,KAXWKXVKXAK,11,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
10114,DRAMP34342,KWXWKXAKXAK,11,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
10115,DRAMP34343,QSHLSMCSVCCNCCKNYKGCGFCCRF,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10116,DRAMP34344,MGSSHHHHHHSSGLVPRGSHMIPVNGVTELEEAASNDTPVAARHEMSMQSWMMPNHIREKRQSHLSMCSVCCNCCKNYKGCGFCCRF,87,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10117,DRAMP34345,RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR,45,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10118,DRAMP34346,yf,2,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10119,DRAMP34347,pF,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10120,DRAMP34348,PF,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10121,DRAMP34349,VXVXXVXVXTVX,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10122,DRAMP34350,LV,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10123,DRAMP34351,pf,2,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10124,DRAMP34352,AXEGSnXX,8,Not available,Not available,Not available,Linear,3-OH-Me-C16,Free,None,Mix,DRAMP
10125,DRAMP34353,DKPKKKPPPPAGPPPPPPPPPGPPPPGP,28,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10126,DRAMP34354,KPKGMTSSQWFKIQHMQPSPQASNSAMKNINKHTKRSKDLNTFLH,45,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10127,DRAMP34355,WP,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10128,DRAMP34356,WY,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10129,DRAMP34357,WL,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10130,DRAMP34358,WF,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10131,DRAMP34359,NGVQPKYRWWRWWRRWW,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10132,DRAMP34360,KESRAKKFQRQHMDSDSSPSSSSTYSNQMMRRRNMTQGRSKPVNTFVH,48,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10133,DRAMP34361,KPPQFTWAQWFETQHINMTSQQSTNAMQVINNYQRRSKNQNTFLL,45,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10134,DRAMP34362,QDGMYQRFLRQHVHPEETGGSDRYSNLMMQRRKMTLYHSKRFNTFIH,47,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10135,DRAMP34363,QDNSRYTHFLTQHYDAKPQGRDDRYSESIMRRRGLTSPSKDINTFIH,47,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10136,DRAMP34364,WPKRLTKAHWFEIQHIQPSPLQSNRAMSGINNYTQHSKHQNTFLH,45,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10137,DRAMP34365,KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH,45,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10138,DRAMP34366,RAGLQFPVGRVHRLLRK,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10139,DRAMP34367,VIHRAGLQFPVGRVHRLLRK,20,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10140,DRAMP34368,RCpGRTRQIGTIFpGRIKCRSW,22,Not available,Not available,Not available,Linear,Acetylation,Free,None,Mix,DRAMP
10141,DRAMP34369,GG,2,Not available,Not available,Not available,Linear,DiMIQ,Free,None,L,DRAMP
10142,DRAMP34370,GP,2,Not available,Not available,Not available,Linear,DiMIQ,Free,None,L,DRAMP
10143,DRAMP34371,KWKVFKKIEKMGRNIRNGIVKAGPKWKVFKKIEK,34,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10144,DRAMP34372,CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV,35,2MFS,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10145,DRAMP34373,KGK,3,Not available,Not available,Not available,Linear,3-OH-C16,Amidation,None,L,DRAMP
10146,DRAMP34374,kQrWlWlW,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10147,DRAMP34375,ILPIIGKILSTIFGK,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10148,DRAMP34376,GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC,37,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10149,DRAMP34377,LLCIALRKK,9,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10150,DRAMP34378,YPFX,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10151,DRAMP34379,RRRRWWWW,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10152,DRAMP34380,CNGRCGGKLAKLAKKLAKLAK,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10153,DRAMP34381,LRLKSIVSYAKKVL,14,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10154,DRAMP34382,KGIRGYKGGYCKGAFKQTCKCY,22,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10155,DRAMP34383,KGIRGYKGGYKGAFKQTKY,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10156,DRAMP34384,"ELLVDLL,ELLVDLL",15,Not available,Not available,Not available,Linear,"3-OH-Me-C13,3-OH-DiMe-C13",Free,None,Mix,DRAMP
10157,DRAMP34385,KWKSFLKTFKSAKKTVLHTAAKAISS,26,Not available,Not available,Tumor cells: NCI-H1299 (IC50=15.6 μmol/L); A-375 (IC50=59.8 μmol/L); B16 (IC50=63.5 μmol/L); HeLa (IC50=64.7 μmol/L); MCF-7 (IC50=70.8 μmol/L); A549 (IC50=71 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L),Linear,Acetylation,Amidation,None,L,DRAMP
10158,DRAMP34386,KWKSFLKTFKSAKKTVLHTAAKAISS,26,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
10159,DRAMP34387,GLPLCGETCVGGTCNTPGCSCGWPVCVRN,29,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10160,DRAMP34388,DEDDD,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10161,DRAMP34389,HTASDAAAAAALTAANAAAAAAASMA,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10162,DRAMP34390,GIGAVLKVLTTGLPALKSWIKRKRQQ,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10163,DRAMP34391,IIGAVLKVLTTGLPALISWIKRKRQQ,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10164,DRAMP34392,GWWRRTVDKVRNAGRKVAGFASKACGALGH,30,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10165,DRAMP34393,PMLRVRLASHLRKLRKRLLR,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10166,DRAMP34394,LRVRLASHLRKLRKRLLR,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10167,DRAMP34395,MPRRRRSSSRPVRRRRRPRVSRRRRRRGGRRR,32,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10168,DRAMP34396,GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ,31,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10169,DRAMP34397,GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI,33,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10170,DRAMP34398,RGSALTHLP,9,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10171,DRAMP34399,"KKKFPWWWPFKKKC,KKKFPWWWPFKKKC",29,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10172,DRAMP34400,"KKKFPWWWPFKKK,KKKFPWWWPFKKKK",28,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10173,DRAMP34401,FLPAALAGIGGILGKLF,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10174,DRAMP34402,ffflsrif,8,Not available,Not available,Not available,Linear,Free,Amidation,None,D,DRAMP
10175,DRAMP34403,firslfff,8,Not available,Not available,Not available,Linear,Free,Amidation,None,D,DRAMP
10176,DRAMP34404,FIRSLFFF,8,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10177,DRAMP34405,FFFLRRIF,8,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10178,DRAMP34406,XFFLSRIF,8,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10179,DRAMP34407,FXFLRRIF,8,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10180,DRAMP34408,ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEWGGPCQL,53,6LWZ,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10181,DRAMP34409,"KRFKKFFKKVKKSV,KKRLKKIFKKPMVIGVTIPF",35,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10182,DRAMP34410,KWRRWIRWL,9,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10183,DRAMP34411,IKIPSFFrNILKKVGKEAVSLIAGALKQS,29,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10184,DRAMP34412,GSPE,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10185,DRAMP34413,GYPFV,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.66 ± 0.0007 μg/mL); HT-29 (IC50=10.45 ± 0.0042 μg/mL),Linear,Free,Free,None,L,DRAMP
10186,DRAMP34414,fkklkklfsklwnwk,15,Not available,Not available,Tumor cells: SGC-7901 (IC50=10.42±0.30 μM ); B16 (IC50=19.16±0.38 μM ); PC-3 (IC50=21.38±0.56 μM ); BGC-823 (IC50=8.65 ±0.38 μM ),Linear,Acetylation,Amidation,None,D,DRAMP
10187,DRAMP34415,fkklkklfsklwnwk,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,D,DRAMP
10188,DRAMP34416,ADMDFTGIAESIIKKIKETNAKPPA,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10189,DRAMP34417,GrkkrrqrrrGGwmwvtnlrtd,22,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10190,DRAMP34418,KWKSFLKTFKSAKkTVLHTALKAISS,26,Not available,Not available,Tumor cells: HeLa (IC50=15.6 ± 4.1μM ); MIA PaCa-2 (IC50=17.9 ± 2.3μM); Bxpc-3 (IC50=20.0 ± 0.8μM); HPAC (IC50=7.2 ± 5.2μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10191,DRAMP34419,KWKSFLKTFKsAKkTVLHTALKAISS,26,Not available,Not available,Tumor cells: Bxpc-3 (IC50=22.4 ± 2.3μM); HPAC (IC50=25.5 ± 0.5	μM); HeLa (IC50=30.6 ± 0.5μM ); MIA PaCa-2 (IC50=41.3 ± 2.6μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10192,DRAMP34420,KWKSFLKTFKSAKktVLHTALKAISS,26,Not available,Not available,Tumor cells: HPAC (IC50=22.5 ± 0.5μM); Bxpc-3 (IC50=24.1 ± 5.5μM); HeLa (IC50=31.6 ± 2.1μM); MIA PaCa-2 (IC50=47.1 ± 5.3μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10193,DRAMP34421,KWKSFLKTFKsAKktVLHTALKAISS,26,Not available,Not available,Tumor cells: HeLa (IC50=41.1 ± 0.5μM); Bxpc-3 (IC50=45.5 ± 5.6μM); HPAC (IC50=54.2 ± 1.2μM); MIA PaCa-2 (IC50=56.8 ± 3.3μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10194,DRAMP34422,KWKSFLKTFKSaKKTVLHTALKAISS,26,Not available,Not available,Tumor cells: HPAC (IC50=15.5 ± 1.7μM); HeLa (IC50=28.8 ± 0.8	μM); MIA PaCa-2 (IC50=29.9 ± 4.8μM); Bxpc-3 (IC50=45.1 ± 1.0μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10195,DRAMP34423,KWKSFLKTfKSaKKTVLHTALKAISS,26,Not available,Not available,Tumor cells: Bxpc-3 (IC50=125.0 ± 3.7μM); MIA PaCa-2 (IC50=38.8 ± 2.9	μM); HPAC (IC50=42.4 ± 3.0μM); HeLa (IC50=59.8 ± 0.5μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10196,DRAMP34424,KWKSFLKTFKSaKKTvLHTALKAISS,26,Not available,Not available,Tumor cells: Bxpc-3 (IC50=125.0 ± 5.9μM); HPAC (IC50=41.4 ± 1.4μM); MIA PaCa-2 (IC50=46.2 ± 3.0μM); HeLa (IC50=60.1 ± 1.2μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10197,DRAMP34425,KWKSFLKTfKSaKKTvLHTALKAISS,26,Not available,Not available,Tumor cells: Bxpc-3 (IC50=125.0 ± 1.8μM); HeLa (IC50=125.0 ± 3.4μM); MIA PaCa-2 (IC50=57.9 ± 2.8μM); HPAC (IC50=95.6 ± 1.8μM),Linear,Acetylation,Amidation,None,Mix,DRAMP
10198,DRAMP34426,XRWRWRW,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10199,DRAMP34427,XGX,3,Not available,Not available,Not available,Linear,C20,Amidation,None,L,DRAMP
10200,DRAMP34428,LIXFXPx,7,Not available,Not available,Not available,Linear,Boc,OMe,None,Mix,DRAMP
10201,DRAMP34429,XFXILxP,7,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10202,DRAMP34430,XFXVLxP,7,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10203,DRAMP34431,XFXXLxP,7,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10204,DRAMP34432,XAaQyI,6,Not available,Not available,Tumor cells: L5178Y (IC50=5.71μM); PC12 (IC50=9.55μM),Linear,3-OH-4-Me-C15,Free,X=Allo-Thr,Mix,DRAMP
10205,DRAMP34433,GLGKAQCAALWLQCASGGTIGXGGGAVACQNYRQFCR,37,2MIJ,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10206,DRAMP34434,CKILSKTIKCRIPCGRRKEY,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10207,DRAMP34435,KRCKNKMEGDDVAVSGRGARKAAKK,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10208,DRAMP34436,EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF,30,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10209,DRAMP34437,ALWKSLLKNVGKAAGKAALNAVTDMVNQ,28,Not available,Not available,Tumor cells: PC-3 (IC50=3.21μM); H157 (IC50=8.43μM),Linear,Free,Amidation,None,L,DRAMP
10210,DRAMP34438,GRKKRRQRRRGALWKSLLKNVGKA,24,Not available,Not available,Tumor cells: H157 (IC50=21.6μM); PC-3 (IC50=6.75μM),Linear,Free,Amidation,None,L,DRAMP
10211,DRAMP34439,AAAARRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10212,DRAMP34440,YYYYRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10213,DRAMP34441,FFFFRRRR,8,Not available,Not available,Not available,Cyclic,Free,Free,None,L,DRAMP
10214,DRAMP34442,FFFFRRRR,8,Not available,Not available,Not available,Cyclic,Free,Free,None,L,DRAMP
10215,DRAMP34443,IIIIRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10216,DRAMP34444,LLLLRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10217,DRAMP34445,LYPFA,5,Not available,Not available,Tumor cells: HepG2 (IC50=8.76 ± 0.0035 μg/mL); HT-29 (IC50=12.33 ± 0 μg/mL),Linear,Free,Free,None,L,DRAMP
10218,DRAMP34446,GLRKRLRKFRNK,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10219,DRAMP34447,KCVRQNNKRVCK,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10220,DRAMP34448,KCVRQNNKRVCKGLRKRLRKFRNK,24,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10221,DRAMP34449,"GLRKRLRKFRNKIKEK,GLRKRLRKFRNKIKEK",33,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10222,DRAMP34450,GLLEALAELLEGLRKRLRKFRNKIKEK,27,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10223,DRAMP34451,GLLEALAELLEGRKKRRQRRRPPQ,24,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10224,DRAMP34452,"GLLEALAELLEKFHTFPQTAIGVGAP,KKRKAPKKKRKFA",40,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10225,DRAMP34453,ALWKTMLKKLGTVALHAGKAALGAVADTISQ,31,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10226,DRAMP34454,PKILNKILGKILRLAAAFK,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10227,DRAMP34455,LVPFIGRTLGGLLARF,16,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10228,DRAMP34456,LLGAALSALSSVIPSVISWFQK,22,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10229,DRAMP34457,rGDFV,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10230,DRAMP34458,SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD,43,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10231,DRAMP34459,CGESCVWIPCISSAIGCSCKSKVCYRNGIP,30,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10232,DRAMP34460,"TvXXX,XvXXX",11,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10233,DRAMP34461,RQIKIWFQNRRMKWK,15,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10234,DRAMP34462,CHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYM,34,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10235,DRAMP34463,FDIVKKVVGTIAGL,14,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10236,DRAMP34464,MDAQTRRRERRAEKQAQWKAANGC,24,Not available,Not available,Not available,Linear,Free,Conjugation with fluorescein by C-terminal Gly Cys amide,None,L,DRAMP
10237,DRAMP34465,RKKRRQRR,8,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10238,DRAMP34466,TSPLNIHNGQKL,12,Not available,Not available,Not available,Not available,fluorescein/ FITC/texas red,Amidation,None,L,DRAMP
10239,DRAMP34467,CELDENNTPMC,11,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10240,DRAMP34468,XXPXxX,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10241,DRAMP34469,IFSPIPL,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10242,DRAMP34470,GIGVLLSAGKAALKGLAKVLAEKYAN,26,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10243,DRAMP34471,AKVKDEPQRRSARLSAKPAPPKPEPKPKKAPAKK,34,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10244,DRAMP34472,ALWKTLLKKVLKAPKKKRKV,20,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10245,DRAMP34473,VQRKRQKLMP,10,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10246,DRAMP34474,LXIGxP,6,Not available,Not available,Not available,Linear,2-OH-ME-C5,OMe,None,Mix,DRAMP
10247,DRAMP34475,GRKKRRQRRRPP,12,Not available,Not available,Not available,Linear,fluorescein,Free,None,L,DRAMP
10248,DRAMP34476,RGGRLSYSRRRFSTSTGR,18,Not available,Not available,Not available,Linear,NBD and TAMRA,Free,None,L,DRAMP
10249,DRAMP34477,RHIKIWFQNRRMKWKK,16,Not available,Not available,Not available,Linear,FITC,Free,None,L,DRAMP
10250,DRAMP34478,KLLKKPLKLKL,11,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10251,DRAMP34479,XFXFLPX,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10252,DRAMP34480,MFTLKKSLLLLFFLGTISSSLCEQERDSDDEDQGEVTEQVVKRLVRGCWTKSYPPKPCFVRG,62,2M3N,Not available,Not available,,Free,Free,None,L,DRAMP
10253,DRAMP34481,VRLPPP,6,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10254,DRAMP34482,VCIIIIC,7,Not available,Not available,Not available,Linear,Free,PEA,None,L,DRAMP
10255,DRAMP34483,CGNKRTRGC,9,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10256,DRAMP34484,GLFDIVKKVVGTIAGL,16,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10257,DRAMP34485,HHPHG,5,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10258,DRAMP34486,HHPHGHHPHGHHPHG,15,Not available,Not available,Not available,,Free,Acetylation,None,L,DRAMP
10259,DRAMP34487,HF,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10260,DRAMP34488,GPFYVI,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10261,DRAMP34489,AAWIPPG,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10262,DRAMP34490,RKKRRRESRKKRRRES,16,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10263,DRAMP34491,AXQNMEILEXTPLTXVX,17,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10264,DRAMP34492,RQIKIWFQNRRMKWKKTYADFIASGRTGRRNAI,33,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10265,DRAMP34493,fXXXXXNfPPR,11,Not available,Not available,Not available,Linear,MeOAc,Free,None,Mix,DRAMP
10266,DRAMP34494,YTAIAWVKAFIRKLRK,16,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10267,DRAMP34495,GIPCGESCVWIPCISSAIGCSCXSXVCYRN,30,Not available,Not available,Tumor cells: U-937/GTB (IC50=2.3(2.0-2.5)μM),Linear,Free,Free,X=Lys(Ac)2,L,DRAMP
10268,DRAMP34496,GIPCGESCVWIPCISSAIGCSCKSKVCYXN,30,Not available,Not available,Tumor cells: U-937/GTB (IC50=0.95(0.82-1.1)μM),,Free,Free,X=ARG(CHD),L,DRAMP
10269,DRAMP34497,KSGIACFL,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10270,DRAMP34498,VNADIKATTVFGGKYVSLTTP,21,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10271,DRAMP34499,FKRIVQRIKDFLX,13,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10272,DRAMP34500,XXVXXV,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10273,DRAMP34501,NQL,3,Not available,Not available,Not available,Linear,C8,Free,None,L,DRAMP
10274,DRAMP34502,YRXG,4,Not available,Not available,Not available,,Free,Free,"X=Cα -dialkylated glycine (Aaa2,2 )",L,DRAMP
10275,DRAMP34503,HG,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10276,DRAMP34504,MLLLTRRRST,10,Not available,Not available,Not available,Linear,Biotinylation or Conjugation with TMR,Free,None,L,DRAMP
10277,DRAMP34505,VRRFKWWWKFLRR,13,Not available,Not available,Tumor cells: HeLa (IC50=24μM),Linear,Free,Amidation,None,L,DRAMP
10278,DRAMP34506,CTTHWGFTLC,10,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10279,DRAMP34507,YLKNYRIATFKNWPF,15,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10280,DRAMP34508,GPFHFYQFLFPPV,13,Not available,Not available,Not available,Linear,FITC,Free,None,L,DRAMP
10281,DRAMP34509,AAXGVL,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10282,DRAMP34510,LIRLWSHLIHIWFQNRRLKWKKK,23,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10283,DRAMP34511,MVTVLFRRLRIRRACGPPRVRV,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10284,DRAMP34512,MVTVLFRRLRIRRACGPPRVRV,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10285,DRAMP34513,vrlpppvrlpppvrlppp,18,Not available,Not available,Not available,Linear,Fluorescein,Free,None,D,DRAMP
10286,DRAMP34514,CNSCWSDK,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10287,DRAMP34515,GlXGVY,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10288,DRAMP34516,MVRRFLVTLRIRRACGPPRVRV,22,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10289,DRAMP34517,GYVPLWP,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10290,DRAMP34518,LLPFPYPTPF,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10291,DRAMP34519,AFPGLSF,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10292,DRAMP34520,XxXxXxXx,8,Not available,Not available,Not available,Linear,Free,Free,"X=MeLeu; x=D-HIV, 2-d-hydroxyisovaleric acid ",Mix,DRAMP
10293,DRAMP34521,VG,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10294,DRAMP34522,KLKNFAKGVAQSLLNKASCKLSGQC,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10295,DRAMP34523,TPFVXV,6,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10296,DRAMP34524,vTVvpXxxxvFXV,13,Not available,Not available,Not available,Linear,5-ME-C6,Free,None,Mix,DRAMP
10297,DRAMP34525,AAPFLECQGRQGTCHFFAN,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10298,DRAMP34526,MAFLKKSLFLVLFLALVPLSICEEKKSEEENEEKQEDDQSEEKRGLVTSLIKGAGKLLGGLFGSVTGGQS,70,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10299,DRAMP34527,KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK,46,1ORL,Not available,Not available,,Free,Free,None,L,DRAMP
10300,DRAMP34528,GSGKKGGKKHCQKY,14,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10301,DRAMP34529,XXPXXV,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10302,DRAMP34530,AFXGVL,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10303,DRAMP34531,CGETCTLGTCYTAGCSCSWPVCTRNGVPI,29,3E4H,Not available,Not available,,Free,Free,None,L,DRAMP
10304,DRAMP34532,xVXvxVXvxVXv,12,Not available,Not available,Not available,Linear,Free,Free,x(1/9)=2R-hydroxy-3S-methyl-valeryl-R-valine; x(5)=2R-hydroxy-4-methyl-valeryl-R-valine; X=S-lactic acid-S-Val,Mix,DRAMP
10305,DRAMP34533,xVXvxVXvxVXv,12,Not available,Not available,Not available,Linear,Free,Free,x(1/9)=2R-hydroxy-3S-methyl-valeryl-R-valine; x(5)=2R-hydroxy-4-methyl-valeryl-R-valine; X=S-lactic acid-S-Val,Mix,DRAMP
10306,DRAMP34534,xVXvxVXvxVXv,12,Not available,Not available,Not available,Linear,Free,Free,x(1/9)=2R-hydroxy-3S-methyl-valeryl-R-valine; x(5)=2R-hydroxy-4-methyl-valeryl-R-valine; X=S-lactic acid-S-Val,Mix,DRAMP
10307,DRAMP34535,xVXvxVXvxVXv,12,Not available,Not available,Not available,Cyclic,Free,Free,x=2R-hydroxy-3S-methyl-valeryl-R-valine; X=S-lactic acid-S-Val,Mix,DRAMP
10308,DRAMP34536,xVXvxVXvxVXv,12,Not available,Not available,Not available,Cyclic,Free,Free,x=2R-hydroxy-3S-methyl-valeryl-R-valine; X=S-lactic acid-S-Val,Mix,DRAMP
10309,DRAMP34537,xVXvxVXvxVXv,12,Not available,Not available,Not available,Cyclic,Free,Free,x=2R-hydroxy-3S-methyl-valeryl-R-valine; X=S-lactic acid-S-Val,Mix,DRAMP
10310,DRAMP34538,crkkrrqrrr,10,Not available,Not available,Not available,Linear,Insulin,Free,None,D,DRAMP
10311,DRAMP34539,PVVXY,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10312,DRAMP34540,MFTLKKSLLLLFFLGTINLSLCEEERDADEEERRDDPEERAVEVEKRFVDLKKIANIINSIFGK,64,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10313,DRAMP34541,FXX,3,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10314,DRAMP34542,WEAALAEALAEALAEHLAEALAEALEALAA,30,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10315,DRAMP34543,HARIKPTFRRLKWKYKGKFW,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10316,DRAMP34544,CLGENVPCDKDRPNCCSRYECLEPTGYGWWYASYYCYKKRS,41,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10317,DRAMP34545,ALWKEVLKNAGKAALNEINNLV,22,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10318,DRAMP34546,HARIKpTFRRlKWKYKGKFW,20,Not available,Not available,Not available,Linear,Acetylation,Free,None,Mix,DRAMP
10319,DRAMP34547,"WKLLSKAQEKFGKNKSR,RYGTXIYQXRLWAFSK",34,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10320,DRAMP34548,IETFLKQLRSAANKIVGL,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10321,DRAMP34549,GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK,33,6HN9,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10322,DRAMP34550,GFWSSVWDGAKNVGTAI,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10323,DRAMP34551,GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC,49,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10324,DRAMP34552,TRGRWGRFKRRAGRFIRRNRWQIISTGLKLIG,32,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10325,DRAMP34553,FLSLLPHIASGIASLVSKF,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10326,DRAMP34554,FLSLIPHIASGIASLVKNF,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10327,DRAMP34555,RWCRRYRVRVRGVLVYAYVCW,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10328,DRAMP34556,RWRPPIRRPPIRPPFYP,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10329,DRAMP34557,CVRRFPWWWPFLRRC,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10330,DRAMP34560,"XvXXX,TvXXX",11,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10331,DRAMP34561,RQIKIWFQNRRMKW,14,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10332,DRAMP34562,RQIKIWFQNRRMK,13,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10333,DRAMP34563,RQIKIWFQNRRM,12,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10334,DRAMP34564,RQIKIWFQNRR,11,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10335,DRAMP34565,RQIKIWFQNR,10,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10336,DRAMP34566,RQIKIWFQN,9,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10337,DRAMP34567,RQIKIWFQ,8,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10338,DRAMP34568,RQIKIW,6,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10339,DRAMP34569,QIKIWFQNRRMKWKK,15,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10340,DRAMP34570,IKIWFQNRRMKWKK,14,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10341,DRAMP34571,IWFQNRRMKWKK,12,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10342,DRAMP34572,WFQNRRMKWKK,11,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10343,DRAMP34573,QNRRMKWKK,9,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10344,DRAMP34574,NRRMKWKK,8,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10345,DRAMP34575,RMKWKK,6,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10346,DRAMP34576,AQIKIWFQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10347,DRAMP34577,RAIKIWFQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10348,DRAMP34578,RQAKIWFQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10349,DRAMP34579,RQIAIWFQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10350,DRAMP34580,RQIKAWFQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10351,DRAMP34581,RQIKIAFQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10352,DRAMP34582,RQIKIWAQNRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10353,DRAMP34583,RQIKIWFANRRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10354,DRAMP34584,RQIKIWFQARRMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10355,DRAMP34585,RQIKIWFQNARMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10356,DRAMP34586,RQIKIWFQNRAMKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10357,DRAMP34587,RQIKIWFQNRRAKWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10358,DRAMP34588,RQIKIWFQNRRMAWKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10359,DRAMP34589,RQIKIWFQNRRMKAKK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10360,DRAMP34590,RQIKIWFQNRRMKWAK,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10361,DRAMP34591,RQIKIWFQNRRMKWKA,16,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,None,L,DRAMP
10362,DRAMP34592,CRQIKIWFPNRRMKWKKC,18,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-Ahx),Unknown,None,L,DRAMP
10363,DRAMP34593,PSSSSSSRIGDP,12,Not available,Not available,Not available,Linear,EGFP,Free,None,L,DRAMP
10364,DRAMP34594,RKKRRQR,7,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10365,DRAMP34595,KKRRQRRR,8,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10366,DRAMP34596,KRRQRRR,7,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10367,DRAMP34597,rkkrrqrrr,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,D,DRAMP
10368,DRAMP34598,rrrqrrkkr,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,D,DRAMP
10369,DRAMP34599,AKKRRQRRR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10370,DRAMP34600,RAKRRQRRR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10371,DRAMP34601,RKARRQRRR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10372,DRAMP34602,RKKARQRRR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10373,DRAMP34603,RKKRAQRRR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10374,DRAMP34604,RKKRRARRR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10375,DRAMP34605,RKKRRQARR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10376,DRAMP34606,RKKRRQRAR,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10377,DRAMP34607,RKKRRQRRA,9,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10378,DRAMP34608,RRRRRR,6,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,L,DRAMP
10379,DRAMP34609,rrrrr,5,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,D,DRAMP
10380,DRAMP34610,rrrrrrr,7,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,D,DRAMP
10381,DRAMP34611,CQNHHAKHGKVC,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10382,DRAMP34612,KCGHKHQCAVHN,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10383,DRAMP34613,LVPLPKIKNSTFT,13,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10384,DRAMP34614,MEPECNLNCTD,11,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10385,DRAMP34615,NITVTLKKFPL,11,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10386,DRAMP34616,RPFVEMYSEIPE,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10387,DRAMP34617,SPNITVTLKKFPL,13,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10388,DRAMP34618,STNITVTLKKFPL,13,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10389,DRAMP34619,akvkdepqrrsarlsakpappkpepkpkkapakk,34,Not available,Not available,Not available,Linear,fluorescein with 6-aminohexanoic acid (Ahx) spacer,Free,None,D,DRAMP
10390,DRAMP34620,PKKKRKVALWKTLLKKVLKA,20,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10391,DRAMP34621,VKRKKKPALWKTLLKKVLKA,20,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10392,DRAMP34622,RQARRNRRRALWKTLLKKVLKA,22,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10393,DRAMP34623,RQARRNRRRC,10,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10394,DRAMP34624,GRKKRRQRRRPPQC,14,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10395,DRAMP34625,SKKKKTKV,8,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10396,DRAMP34626,GKKKKRKREKL,11,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10397,DRAMP34627,ERKKRRRE,8,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10398,DRAMP34628,FKKFRKF,7,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10399,DRAMP34629,rggrlsysrrrfststgr,18,Not available,Not available,Not available,Linear,NBD,Free,None,D,DRAMP
10400,DRAMP34630,RRLSYSRRRF,10,Not available,Not available,Not available,Linear,NBD and TAMRA,Free,None,L,DRAMP
10401,DRAMP34631,rrlsysrrrf,10,Not available,Not available,Not available,Linear,NBD,Free,None,D,DRAMP
10402,DRAMP34632,RGGRLAYLRRRWAVLGR,17,Not available,Not available,Not available,Linear,NBD and TAMRA,Free,None,L,DRAMP
10403,DRAMP34633,KPLLKKLLKKL,11,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10404,DRAMP34634,KWKKLLKKPLKLKL,14,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10405,DRAMP34635,KWKLKPLLKKLLKKL,15,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10406,DRAMP34636,XFXFLXX,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10407,DRAMP34637,VRLPPPVRLPPP,12,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10408,DRAMP34638,VRLPPPVRLPPPVRLPPP,18,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10409,DRAMP34639,VHLPPP,6,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10410,DRAMP34640,VHLPPPVHLPPP,12,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10411,DRAMP34641,VHLPPPVHLPPPVHLPPP,18,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10412,DRAMP34642,VKLPPP,6,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10413,DRAMP34643,VKLPPPVKLPPP,12,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10414,DRAMP34644,VKLPPPVKLPPPVKLPPP,18,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10415,DRAMP34645,MAFLKKSLFLVLFLGLVSLSICEKEKRQNEEDEDENEAANHEEGSEEKRGLFDIVKKVVGAFGSLGKRNDLE,72,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10416,DRAMP34646,MAFLKKSLFLVLFLGLVSLSICEKEKRQNEEDEDENEAANHEEGSEEKRGLFDIVKKVVGALGSLGKRNDLE,72,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10417,DRAMP34647,MAFLKKSLFLVLFLGLVSLSICEKEKRQNGEDEDENEAANHEEGSEEKRGLFDIVKKVVGAIGSLGKRNDVE,72,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10418,DRAMP34648,GLLSVLGSVAKHVLGHVVGVIAEHL,25,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10419,DRAMP34649,HHPHGHHPHG,10,Not available,Not available,Not available,,Free,Acetylation,None,L,DRAMP
10420,DRAMP34650,HY,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10421,DRAMP34651,GSLPPIF,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10422,DRAMP34652,GPISFV,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10423,DRAMP34653,GRPRESGKKRKRKRLKP,17,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10424,DRAMP34654,GKRKKKGKLGKKRPRSR,17,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10425,DRAMP34655,RKKRRRESRRARRSPRHL,18,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10426,DRAMP34656,SRRARRSPRESGKKRKRKR,19,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10427,DRAMP34657,VKRGLKLRHVRPRVTRMDV,19,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10428,DRAMP34658,SRRARRSPRHLGSG,14,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10429,DRAMP34659,LRRERQSRLRRERQSR,16,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10430,DRAMP34660,GAYDLRRRERQSRLRRRERQSR,22,Not available,Not available,Not available,Linear,Cys addition,Free,None,L,DRAMP
10431,DRAMP34661,XXEXXXFLIILG,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10432,DRAMP34662,GRKKRRQRRRPPQTYADFIASGRTGRRNAI,30,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10433,DRAMP34663,AGYLLGKINLKALAALAKKILTYADFIASGRTGRRNAI,38,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10434,DRAMP34664,RRRRRRRRRRRTYADFIASGRTGRRNAI,28,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10435,DRAMP34665,IAWVKAFIRKLRKGPLG,17,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10436,DRAMP34666,GIPCGXSCVWIPCISSAIGCSCKSKVCYRN,30,2KNN,Not available,Tumor cells: U-937/GTB (IC50=36(32-40)μM),Linear,Free,Free,X=Glu(Me),L,DRAMP
10437,DRAMP34667,GIPCGESCVWIPCISSAIGCSCXSXVCYXN,30,Not available,Not available,Tumor cells: U-937/GTB (IC50=5.1(4.8-5.5)μM),,Free,Free,X(24)=Lys(Ac)2; X(28)=ARG(CHD),L,DRAMP
10438,DRAMP34668,GIACFLKE,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10439,DRAMP34669,CWQVKWQL,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10440,DRAMP34670,NTKNDKQM,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10441,DRAMP34671,SARNSCWS,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10442,DRAMP34672,RNSCWSKD,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10443,DRAMP34673,GKYVSLTTPKNPTKRRITPKDV,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10444,DRAMP34674,TKRRITPKDVIDVRSVTTEINT,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10445,DRAMP34675,RSVTTEINTLFQTLTSIAEKVDP,23,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10446,DRAMP34676,VNADIKATTVFGGKYVSLTTPKNPTKRRITPKDVIDVRSVTTEINTLFQTLTSIAEKVDP,60,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10447,DRAMP34677,AEKVDPVKLNLTLSAAAEALTGLGDK,26,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10448,DRAMP34678,GLGDKFGESIVNANTVLDDLNSRMPQSRHDIQQL,34,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10449,DRAMP34679,GDVYADAAPDLFDFLDSSVTTARTINA,27,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10450,DRAMP34680,ARTINAQQAELDSALLAAAGFGNTTADVFDRG,32,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10451,DRAMP34681,ADVFDRGGPYLQRGVADLVPTATLLDTYSP,30,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10452,DRAMP34682,LDTYSPELFCTIRNFYDADRPDRGAAA,27,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10453,DRAMP34683,TKRRITPDDVIDVRSVTTEINT,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10454,DRAMP34684,TKRRITPKKVIDVRSVTTEINT,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10455,DRAMP34685,TKRRITPKDVIDVRSVTTKINT,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10456,DRAMP34686,TKRRITPKDVIDV,13,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10457,DRAMP34687,TKRRITPKDVIDVESVTTEINT,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10458,DRAMP34688,TARRITPKDVIDVRSVTTEINT,22,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10459,DRAMP34689,TKAARITPKDVIDVRSVTTEINT,23,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10460,DRAMP34690,HHHHHHTKRRITPKDVIDVRSVTTEINT,28,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,None,L,DRAMP
10461,DRAMP34691,YSX,3,Not available,Not available,Not available,,Free,Free,"X=Cα -dialkylated glycine (Aaa2,2 )",L,DRAMP
10462,DRAMP34692,YSXG,4,Not available,Not available,Not available,,Free,Free,"X=Cα -dialkylated glycine (Aaa2,2 )",L,DRAMP
10463,DRAMP34693,YXGFM,5,Not available,Not available,"Tumor cells: HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,2 )",L,DRAMP
10464,DRAMP34694,YXGFM,5,Not available,Not available,"Tumor cells: HEp-2 (13.7% inhibition at 1μM, 25.8% inhibition at 10μM, 34.7% inhibition at 100μM, 44.5% inhibition at 1000μM); HT-29 (16.2% inhibition at 1μM, 6.6% inhibition at 10μM, 5.1% inhibition at 100μM, 14.5% inhibition at 1000μM); CaCo-2 (17.7% inhibition at 1μM, 10.9% inhibition at 10μM, 12.1% inhibition at 100μM, 8.1% inhibition at 1000μM); HBL (2.4% inhibition at 1μM, 4.5% inhibition at 10μM, 11.4% inhibition at 100μM, 23.2% inhibition at 1000μM); SW620 (26.4% inhibition at 1μM, 13.1% inhibition at 10μM, 14.6% inhibition at 100μM, 38.4% inhibition at 1000μM); HeLa (8.5% inhibition at 1μM, 9.5% inhibition at 10μM, 15.4% inhibition at 100μM, 24.1% inhibition at 1000μM); MCF-7 (9.6% inhibition at 100μM, 29.9% inhibition at 100μM)",Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,2 )",L,DRAMP
10465,DRAMP34695,YXGFM,5,Not available,Not available,Not available,Linear,Free,Free,"X=Cα -dialkylated glycine (Aaa2,2 )",L,DRAMP
10466,DRAMP34696,CDSDSDITWDQLWDLMK,17,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10467,DRAMP34697,FLKDHRISTFKNWPF,15,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10468,DRAMP34698,RGdFV,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10469,DRAMP34699,RGDfV,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10470,DRAMP34700,RGDFv,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10471,DRAMP34701,GRGDS,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10472,DRAMP34702,GSPWGLQHHPPRT,13,Not available,Not available,Not available,Linear,FITC,Free,None,L,DRAMP
10473,DRAMP34703,RCSCWSDK,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10474,DRAMP34704,RKSCWSKD,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10475,DRAMP34705,RNDCWSKD,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10476,DRAMP34706,RNLCWSKD,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10477,DRAMP34707,RNNCWSKD,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10478,DRAMP34708,RNSCRSKD,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10479,DRAMP34709,RNSCWSKN,8,Not available,Induce cell death,Not available,Linear,Free,Free,None,L,DRAMP
10480,DRAMP34710,FVTRGCPRRLVARLIRVMVPRR,22,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10481,DRAMP34711,VRRFLVTLRIRRA,13,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10482,DRAMP34712,RVRILARFLRTRV,13,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10483,DRAMP34713,RVRVFVVHIPRLT,13,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10484,DRAMP34714,VIRVHFRLPVRTV,13,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10485,DRAMP34715,MVRRFLVTLRIRRACGPPRVRVFVVHIPRLTGEWAAP,37,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10486,DRAMP34716,FRVPLRIRPCVVAPRLVMVRHTFGRIARWVAGPLETR,37,Not available,Not available,Not available,Linear,fluorescein,Amidation,None,L,DRAMP
10487,DRAMP34717,FC,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10488,DRAMP34718,ASWSACSVSCGGGARQRTR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10489,DRAMP34719,ATPFIECSGARGTCHYFAN,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10490,DRAMP34720,FCNINNVCNFASRNDYSYW,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10491,DRAMP34721,GPWAPCSASCGGGSQSRS,18,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10492,DRAMP34722,GPWEDCSVSCGGGEQLRSR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10493,DRAMP34723,GPWEPCSVTCSKGTRTRRR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10494,DRAMP34724,GPWERCTAQCGGGIQARRR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10495,DRAMP34725,GPWGDCSRTCGGGVQFSSR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10496,DRAMP34726,GPWGPCSGSCGPGRRLRRR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10497,DRAMP34727,LPRFSTMPFIYCNINEVCHY,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10498,DRAMP34728,LPVFSTLPFAYCNIHQVCH,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10499,DRAMP34729,LRRFSTMPFMFCNINNVCNF,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10500,DRAMP34730,QPWGTCSESCGKGTQTRAR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10501,DRAMP34731,QPWSQCSATCGDGVRERRR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10502,DRAMP34732,SAPFIECHGRGTCNYYANS,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10503,DRAMP34733,SAWRACSVTCGKGIQKRSR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10504,DRAMP34734,SEWSDCSVTCGKGMRTRQR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10505,DRAMP34735,SKWSECSRTCGGGVKFQER,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10506,DRAMP34736,SPWSKCSAACGQTGVQTRTR,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10507,DRAMP34737,SPWSPCSGNCSTGKQQRTR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10508,DRAMP34738,SPWSPCSTSCGLGVSTR,17,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10509,DRAMP34739,SPWSQCSVRCGRGQRSRQVR,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10510,DRAMP34740,SPWSQCTASCGGGVQTR,17,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10511,DRAMP34741,SPWTKCSATCGGGHYMRTR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10512,DRAMP34742,SQWSPCSRTCGGGVSFRER,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10513,DRAMP34743,TAWGPCSTTCGLGMATRV,18,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10514,DRAMP34744,TEWSACNVRCGRGWQKRSR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10515,DRAMP34745,TEWSACSKTCGMGISTRV,18,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10516,DRAMP34746,TEWSVCNSRCGRGYQKRTR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10517,DRAMP34747,TEWTACSKSCGMGFSTRV,18,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10518,DRAMP34748,TKWTPCSRTCGMGISNRV,18,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10519,DRAMP34749,TLPFAYCNIHQVCHYAQRNDRSYWL,25,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10520,DRAMP34750,TQWTSCSKTCNSGTQSRHR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10521,DRAMP34751,TSWSPCSASCGGGHYQRTR,19,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10522,DRAMP34752,TSWSQCSKTCGTGISTRV,18,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10523,DRAMP34753,WTRCSSSCGRGVSVRSR,17,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10524,DRAMP34754,YCNINEVCHYARRNDKSYWL,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10525,DRAMP34755,KKKFPWWWPFKKKKKKFPWWWPFKKKK,27,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10526,DRAMP34756,GSGKKGGKKICQKY,14,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10527,DRAMP34757,xVXvxVXvxVXv,12,Not available,Not available,Not available,Linear,Free,Free,x=R-Hiv; X=S-lactic acid-S-Val,Mix,DRAMP
10528,DRAMP34758,xVXvxVXvxVXv,12,Not available,Not available,Not available,Linear,Free,Free,x=R-Hiv; X=S-lactic acid-S-Val,Mix,DRAMP
10529,DRAMP34759,xVXvxVXvxVXv,12,Not available,Not available,Not available,Linear,Free,Free,x=R-Hiv; X=S-lactic acid-S-Val,Mix,DRAMP
10530,DRAMP34760,XTXPX,5,Not available,Not available,Not available,Linear,DiMe-C8,Free,None,L,DRAMP
10531,DRAMP34761,FFSLLPSLIGGLVSAIK,17,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10532,DRAMP34762,YTMNPRKLFDY,11,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10533,DRAMP34763,FPVPLPI,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10534,DRAMP34764,TRQARRNRRRRWRERQRGC,19,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,DRAMP
10535,DRAMP34765,RRRRNRTRRNRRRVRGC,17,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,DRAMP
10536,DRAMP34766,KMTRAQRRAAARRNRWTARGC,21,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,DRAMP
10537,DRAMP34767,TRRQRTRRARRNRGC,15,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,DRAMP
10538,DRAMP34768,RIKAERKRMRNRIAASKSRKRKLERIARGC,30,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,DRAMP
10539,DRAMP34769,KRRIRRERNKMAAAKSRNRRRELTDTGC,28,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,DRAMP
10540,DRAMP34770,GGGARKKAAKAARKKAAKAARKKAAKAARKKAAKA,35,Not available,Not available,Not available,Linear,Free,GFP,None,L,DRAMP
10541,DRAMP34771,ATPFVPP,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10542,DRAMP34772,LFPXSXP,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10543,DRAMP34773,FPXFSPX,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10544,DRAMP34774,WPISFVP,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10545,DRAMP34775,IIILPPXP,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10546,DRAMP34776,AXXlXX,6,Not available,Not available,Not available,Linear,PivOH,Free,None,Mix,DRAMP
10547,DRAMP34777,XsfATX,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10548,DRAMP34778,KCFQWQRNMRKVRGPPVSC,19,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10549,DRAMP34779,KCFQWQRNMRKVRGPPVSSIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10550,DRAMP34780,KCFQWQRNMRKVR,13,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10551,DRAMP34781,QWQRNMRKVRGPPVSCIKR,19,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10552,DRAMP34782,QWQRNMRKVR,10,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10553,DRAMP34783,KCFMWQEMLNKAGVPKLRCARK,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10554,DRAMP34784,KLWMRWYSPTTRRYG,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10555,DRAMP34785,RTLVNEYKNTLKFSK,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10556,DRAMP34786,IPSRWKDQFWKRWHY,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10557,DRAMP34787,GYGNCRHFKQKPRRD,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10558,DRAMP34788,KNAWKHSSCHHRHQI,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10559,DRAMP34789,RVREWWYTITLKQES,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10560,DRAMP34790,QQHLLIAINGYPRYN,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10561,DRAMP34791,WKCRRQCFRVLHHWN,15,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,None,L,DRAMP
10562,DRAMP34792,AAQYVXX,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10563,DRAMP34793,DDDDDNDKIPDDRDN,15,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10564,DRAMP34794,KWFETWFTEWPKKRK,15,Not available,Not available,Not available,Linear,Acetylation,Cysteamide,None,L,DRAMP
10565,DRAMP34795,GLWWRLWWRLRSWFRLWFRA,20,Not available,Not available,Not available,Linear,Acetylation,Cysteamide,None,L,DRAMP
10566,DRAMP34796,ECKFTVKPYLKRFQVYYKGRMWCP,24,Not available,"SALF can induce apoptotic gene expressions, enhance antitumor activity of cisplatin in vitro, and inhibit tumor growth in nude mice.",Tumor cells: HeLa (65% Inhibition=100μg/ml),Cyclic,Acetylation,Amidation,None,L,DRAMP
10567,DRAMP34797,IVRRADRAAVP,11,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10568,DRAMP34798,XIIFPXPLPINAI,13,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10569,DRAMP34799,XLPFFPPVPIIG,12,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10570,DRAMP34800,XLPPPPLPFFF,11,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10571,DRAMP34801,XVPVFPPLFI,10,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10572,DRAMP34802,XVPVFPPLPI,10,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10573,DRAMP34803,YRIPIVRRLQRR,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10574,DRAMP34804,YTYGLCTSSR,10,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10575,DRAMP34805,TPATPTVAQFVIQGSTICLVC,21,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10576,DRAMP34806,VPTLK,5,Not available,Not available,Not available,Linear,Fluorescein,Free,None,L,DRAMP
10577,DRAMP34807,VELPPPVELPPPVELPPP,18,Not available,Not available,Not available,Linear,Fluorescein/ Rhodamine B,Free,None,L,DRAMP
10578,DRAMP34808,MIIYRDLISH,10,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10579,DRAMP34809,MIIYRDLISH,10,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10580,DRAMP34810,MIIYRDLIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10581,DRAMP34811,MIIYRDLI,8,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10582,DRAMP34812,IIYRDLISH,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10583,DRAMP34813,MIIYRDL,7,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10584,DRAMP34814,MIIYRD,6,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10585,DRAMP34815,IYRDLISH,8,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10586,DRAMP34816,AIIYRDLIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10587,DRAMP34817,MAIYRDLIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10588,DRAMP34818,MIAYRDLIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10589,DRAMP34819,MIIARDLIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10590,DRAMP34820,MIIYADLIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10591,DRAMP34821,MIIYRALIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10592,DRAMP34822,MIIYRDAIS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10593,DRAMP34823,MIIYRDLAS,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10594,DRAMP34824,MIIYRDLIA,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,L,DRAMP
10595,DRAMP34825,MIIYRDLISKK,11,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10596,DRAMP34826,MIIYRDKKSH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10597,DRAMP34827,MIIFRDLISH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10598,DRAMP34828,MIISRDLISH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10599,DRAMP34829,QIISRDLISH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10600,DRAMP34830,CIISRDLISH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10601,DRAMP34831,MIIYRALISHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10602,DRAMP34832,MIIYRIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10603,DRAMP34833,MIIRRDLISE,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10604,DRAMP34834,MIIYRAEISH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10605,DRAMP34835,MIIYARRAEE,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10606,DRAMP34836,MIIFRIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10607,DRAMP34837,MIIFRALISHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10608,DRAMP34838,MIIFRAAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10609,DRAMP34839,FIIFRIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10610,DRAMP34840,LIIFRIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10611,DRAMP34841,WIIFRIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10612,DRAMP34842,WIIFRAAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10613,DRAMP34843,WIIFRALISHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10614,DRAMP34844,MIIFRIAAYHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10615,DRAMP34845,WIIFRIAAYHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10616,DRAMP34846,MIIFRIAATHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10617,DRAMP34847,WIIFRIAATHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10618,DRAMP34848,MIIFKIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10619,DRAMP34849,WIIFKIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10620,DRAMP34850,MIIFAIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10621,DRAMP34851,LIIFRILISHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10622,DRAMP34852,MIIFRILISHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10623,DRAMP34853,LIIFRILISHRR,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10624,DRAMP34854,LIIFRILISHHH,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10625,DRAMP34855,LIIFRILISHK,11,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10626,DRAMP34856,LIIFRILISHR,11,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10627,DRAMP34857,LIIFRILISH,10,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10628,DRAMP34858,LIIFAIAASHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10629,DRAMP34859,LIIFAILISHKK,12,Not available,Not available,Not available,Linear,FITC,Amidation,None,L,DRAMP
10630,DRAMP34860,ANIKLSVQMKLFKRHLKWKIIVKLNDGRELSLDA,34,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10631,DRAMP34861,ARPAKAAATQKKVERKAPDA,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10632,DRAMP34862,CETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSFMTSFSK,50,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10633,DRAMP34863,DFKLFAVTIKYR,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10634,DRAMP34864,DFKLFAVYIKYR,12,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10635,DRAMP34865,DPFFKVPVNKLAAAVSNFGYDLYRVRSSTSPTTN,34,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10636,DRAMP34866,DPFFKVPVNKLAAVSNFGYDLYRVRSSMSPTTN,33,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10637,DRAMP34867,EDMNQKLFDLRGKFKRPPLRRVRMSADAML,30,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10638,DRAMP34868,EVHHQKLVFF,10,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10639,DRAMP34869,FLSSRLQDLYSIVRRADRAA,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10640,DRAMP34870,HTHQDFQPVLHLVALNTPLSGGMRGIR,27,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10641,DRAMP34871,KSVRGKGKGQKRKRKKSRYK,20,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10642,DRAMP34872,NGREACLDPEAPMVQKIVQKMLKG,24,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10643,DRAMP34873,NGRKISLDLRAPLYKKIIKKLLES,24,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10644,DRAMP34874,NVLLSPLSVATALSALSLGAEQRTES,26,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10645,DRAMP34875,TGALVEEEDPF,11,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10646,DRAMP34876,TSLDASIIWAMMQN,14,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10647,DRAMP34877,KWKKLLKKPLLKKLLKKL,18,Not available,Not available,Not available,,Free,Acetylation,None,L,DRAMP
10648,DRAMP34878,NXV,3,Not available,Not available,Not available,Linear,3-OH-C14,Free,None,L,DRAMP
10649,DRAMP34879,NXL,3,Not available,Not available,Not available,Linear,3-OH-C14,Free,None,L,DRAMP
10650,DRAMP34880,RXRXRXRXRXRXRXRXB,17,Not available,Not available,Not available,Linear,Free,Free,X=6-aminohexanoic acid (Ahx); B=Beta-Alanine,L,DRAMP
10651,DRAMP34881,RXRRXRRXRRXRXB,14,Not available,Not available,Not available,Linear,Free,Free,X=6-aminohexanoic acid (Ahx); B=Beta-Alanine,L,DRAMP
10652,DRAMP34882,RXRRBRRXRRBRXB,14,Not available,Not available,Not available,Linear,Free,Free,X=6-aminohexanoic acid (Ahx); B=Beta-Alanine,L,DRAMP
10653,DRAMP34883,GXVFXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10654,DRAMP34884,GXVXXPV,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10655,DRAMP34885,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10656,DRAMP34886,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10657,DRAMP34887,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10658,DRAMP34888,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10659,DRAMP34889,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10660,DRAMP34890,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10661,DRAMP34891,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10662,DRAMP34892,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10663,DRAMP34893,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10664,DRAMP34894,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10665,DRAMP34895,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10666,DRAMP34896,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)",L,DRAMP
10667,DRAMP34897,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)",L,DRAMP
10668,DRAMP34898,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)",L,DRAMP
10669,DRAMP34899,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)",L,DRAMP
10670,DRAMP34900,GXVXXPI,7,Not available,Not available,Not available,Cyclic,Free,Free,"X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)",L,DRAMP
10671,DRAMP34901,RKKRRQRRRHRRKKR,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10672,DRAMP34902,rrrrrrrrr,9,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,None,D,DRAMP
10673,DRAMP34903,rqikiwfqnrrmkwkk,16,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,D,DRAMP
10674,DRAMP34904,KCFQWQRNMRKVRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10675,DRAMP34905,kcfqwqrnmrkvrgppvscikr,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,D,DRAMP
10676,DRAMP34906,GGVCPKILAACRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Not available,Cyclic,Alexa-488,Cyclization,None,L,DRAMP
10677,DRAMP34907,GGVCPAILKKCRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Not available,Cyclic,Alexa-488,Cyclization,None,L,DRAMP
10678,DRAMP34908,GGVCPKILAKCRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Not available,Cyclic,Alexa-488,Cyclization,None,L,DRAMP
10679,DRAMP34909,GGVCPKILKACRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Not available,Cyclic,Alexa-488,Cyclization,None,L,DRAMP
10680,DRAMP34910,GLPVCGETCVGGTCNTPGCKCSWPVCTRN,29,Not available,Not available,Not available,Cyclic,Alexa-488,Cyclization,None,L,DRAMP
10681,DRAMP34911,GLPVCGETCVGGTCNTPGCTCSWPKCTRN,29,Not available,Not available,Not available,Cyclic,Alexa-488,Cyclization,None,L,DRAMP
10682,DRAMP34912,KLALKLALKALKAALKLAGC,20,Not available,Not available,Not available,Linear,Acetylation,fluorescein,None,L,DRAMP
10683,DRAMP34913,KLULKLULKULKAULKLUGC,20,Not available,Not available,Not available,Linear,Acetylation,fluorescein,"U=Aib, α-aminoisobutyric acid",L,DRAMP
10684,DRAMP34914,WKLFDDGV,8,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10685,DRAMP34915,CGETCVGGTCNTPGCTCSWPVCTRNGLNPV,30,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10686,DRAMP34916,GIIKKI,6,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10687,DRAMP34917,GLRKRLRKFRNKIKEK,16,Not available,Not available,Not available,Linear,Carboxyfluorescein ,Free,None,L,DRAMP
10688,DRAMP34918,BGLRKXRLRKFRNKIKEK,18,Not available,Not available,Not available,Linear,Amidation,Free,"B=Beta-Alanine; X=NIA, 2-(2-nitroimidazol-1-yl)acetic acid",L,DRAMP
10689,DRAMP34919,KAAKKWAKAAKKWAKAWKKAA,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10690,DRAMP34920,KAAKKAWKAWKKAAKAWKKAA,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10691,DRAMP34921,KAAKKAWKAAKKAWKAWKKAA,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10692,DRAMP34922,KWAKKAAKWAKKAAKWAKKAA,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10693,DRAMP34923,KAWKKAWKAAKKAWKAAKKAA,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10694,DRAMP34924,AAKKWAKAKKWAKAKKWAKAA,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10695,DRAMP34925,MAMPGEPRRANVMAHKLEPASLQLRNSCA,29,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10696,DRAMP34926,MAPQRDTVGGRTTPPSWGPAKAQLRNSCA,29,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10697,DRAMP34927,KKALLAHALHLLALLALHLAHALKKA,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10698,DRAMP34928,LSQETFSDLWKLLPEN,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10699,DRAMP34938,xi,2,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10700,DRAMP34939,FLHHIVGLIHHGLSLFGDRAD,21,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10701,DRAMP34940,MTLTG,5,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10702,DRAMP34941,XrXrXr,6,Not available,Not available,Not available,Linear,Free,Free,"X=Fx, cyclohexylalanine",Mix,DRAMP
10703,DRAMP34942,XrXrXrXr,8,Not available,Not available,Not available,Linear,Free,Free,"X=Fx, cyclohexylalanine",Mix,DRAMP
10704,DRAMP34943,XrXrXrXrXr,10,Not available,Not available,Not available,Linear,Free,Free,"X=Fx, cyclohexylalanine",Mix,DRAMP
10705,DRAMP34944,XrXrXrXrXrXr,12,Not available,Not available,Not available,Linear,Free,Free,"X=Fx, cyclohexylalanine",Mix,DRAMP
10706,DRAMP34945,RRRRRRRRRGPGVTWTPQAWFQWV,24,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10707,DRAMP34946,HEHEHEHEHEHEHEHEHEHEGGGGGKLALKLALKALKAALKLA,43,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10708,DRAMP34947,LX,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10709,DRAMP34948,RRR,3,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10710,DRAMP34949,FFLIPKGRRRRRRRR,15,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10711,DRAMP34950,LILIGRRRRRRRRGC,15,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10712,DRAMP34951,FFGRRRRRRR,10,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10713,DRAMP34952,FFFFGRRRRRRRR,13,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10714,DRAMP34953,FFFFFFGRRRRRRRR,15,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10715,DRAMP34954,fflipkgrrrrrrrr,15,Not available,Not available,Not available,Linear,Free,Amidation,None,D,DRAMP
10716,DRAMP34955,ffffgrrrrrrrr,13,Not available,Not available,Not available,Linear,Free,Amidation,None,D,DRAMP
10717,DRAMP34956,NNXnyNQP,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10718,DRAMP34957,GCGGGYGRKKRRQRRR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10719,DRAMP34958,YGRKKRRQRRRGTALDWSWLQTE,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10720,DRAMP34959,CGNVVRQGCGYGRKKRRQRRRGTALDWSWLQTE,33,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10721,DRAMP34960,Wp,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10722,DRAMP34961,wp,2,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10723,DRAMP34962,Wa,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10724,DRAMP34963,wa,2,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10725,DRAMP34964,wA,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10726,DRAMP34965,WH,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10727,DRAMP34966,XFXPXLV,7,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10728,DRAMP34967,SRRRRRRRRR,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10729,DRAMP34968,CHHHHHRRRRRRRRRHHHHHC,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10730,DRAMP34969,FFLIPKGRRRRRRRRR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10731,DRAMP34970,CGGGYGRKKRRQRRR,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10732,DRAMP34971,GLWWKAWWKAWWKSLWWRKRKRKA,24,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10733,DRAMP34972,AGYLLGKLLOOLAAAALOOLL,21,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
10734,DRAMP34973,YGRKKRPQRRR,11,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10735,DRAMP34974,DSLKSYWYLQKFSWR,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10736,DRAMP34975,KLWMRWWSPTTRRYG,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10737,DRAMP34976,RLWMRWYSPWTRRWG,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10738,DRAMP34977,RLIMRIYAPTTRRYG,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10739,DRAMP34978,RLYMRYYSPTTRRYG,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10740,DRAMP34979,RLWMRWYSPRTRAYG,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10741,DRAMP34980,KRPTMRFRYTWNPMK,15,Not available,Resisting chymotrypsin hydrolysis,Not available,Linear,Free,Free,None,L,DRAMP
10742,DRAMP34981,WKCRRQAFRVLHHWN,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10743,DRAMP34982,WKARRQCFRVLHHWN,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10744,DRAMP34983,STRUCTUREGIVEN,14,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10745,DRAMP34984,rRRRRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10746,DRAMP34985,rRrRRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10747,DRAMP34986,rRrRrRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10748,DRAMP34987,rRrRrRrR,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10749,DRAMP34988,rrrRrRrR,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10750,DRAMP34989,rrrrrrrr,8,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10751,DRAMP34990,XXXXXXXX,8,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=Nbtg,L,DRAMP
10752,DRAMP34991,ZBBZBBZBB,9,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine",L,DRAMP
10753,DRAMP34992,ZBBZBBZBBZBB,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine",L,DRAMP
10754,DRAMP34993,ZXXZXXZXXZXX,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Npm from benzylamine (1-phenylethylamine)",L,DRAMP
10755,DRAMP34994,ZXXZXXZXXZXX,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Npm from benzylamine (1-phenylethylamine)",L,DRAMP
10756,DRAMP34995,ZXXZXXZXXZXX,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Nssb from (S)-(sec-butyl)amine",L,DRAMP
10757,DRAMP34996,ZXXZXXZXXZXX,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Nssb from (S)-(sec-butyl)amine",L,DRAMP
10758,DRAMP34997,ZZBZZBZZBZZB,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine",L,DRAMP
10759,DRAMP34998,ZZZZZZZZBBBB,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(2-phenylethyl)amine",L,DRAMP
10760,DRAMP34999,ZZZZZZZZXXXXX,13,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=NLeu from isobutylamine",L,DRAMP
10761,DRAMP35000,XBBXBBXBBXBB,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine",L,DRAMP
10762,DRAMP35001,XXBXXBXXBXXB,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(2-phenylethyl)amine",L,DRAMP
10763,DRAMP35002,RRRRRHHH,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10764,DRAMP35003,RRRRRRHHH,9,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10765,DRAMP35004,RRRRRRRHHH,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10766,DRAMP35005,RRRRRRRRHHH,11,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10767,DRAMP35006,RRRRRRRRRHHH,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10768,DRAMP35007,BENPESILDEHVQRVM,16,Not available,Inhibit wnt/β-catenin signaling pathway,Not available,Linear,FITC,Amidation,B=β-Ala,L,DRAMP
10769,DRAMP35022,WX,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10770,DRAMP35023,FX,2,Not available,Not available,Not available,,OMe,Free,X=Sar,L,DRAMP
10771,DRAMP35024,FX,2,Not available,Not available,Not available,,OMe,Free,X=Sar,L,DRAMP
10772,DRAMP35025,GF,2,Not available,Not available,Not available,,OtBu,"Boc=Tert-Butyloxycarbonyl, Sar",,L,DRAMP
10773,DRAMP35026,VF,2,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10774,DRAMP35027,VKX,3,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10775,DRAMP35028,VV,2,Not available,Not available,Not available,,Free,"Boc=Tert-Butyloxycarbonyl, Sar",,L,DRAMP
10776,DRAMP35029,Vx,2,Not available,Not available,Not available,,Free,Free,None,Mix,DRAMP
10777,DRAMP35030,zV,2,Not available,Not available,Not available,,OtBu,"Boc=Tert-Butyloxycarbonyl, Sar",,Mix,DRAMP
10778,DRAMP35031,YGRKKRRQRRRX,12,Not available,Not available,Not available,Linear,Free,Free,"X=acp, Epsilon-aminocaproic acid",L,DRAMP
10779,DRAMP35032,YGRKKRRQRRRENAEYLR,18,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,DRAMP
10780,DRAMP35033,YGRKKRRQRRRQNAQYLR,18,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,DRAMP
10781,DRAMP35034,YGRKKRRQRRRDYQQD,16,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,DRAMP
10782,DRAMP35035,YGRKKRRQRRRNYQQN,16,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,DRAMP
10783,DRAMP35036,NOTAVAILABLE,12,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10784,DRAMP35037,rrrrrrrrrcqcrrkn,16,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
10785,DRAMP35038,CALNNYGRKKRRQRRR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10786,DRAMP35039,AGYLLGXLLOOLAAAALOOLL,21,Not available,Not available,Not available,Linear,Stearylation,Amidation,"X=Lys(ε-Mtt), Trifluoromethylquinoline moietie is added at amino froup of Lys7",L,DRAMP
10787,DRAMP35040,WRWRW,5,Not available,Not available,Not available,Linear,RuC(O),Amidation,None,L,DRAMP
10788,DRAMP35041,GXFKKTFHKVSHAVKSGIHA,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10789,DRAMP35042,CRGDKGPDC,9,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10790,DRAMP35043,MIIYRDLISH,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10791,DRAMP35044,MIIYRDLISH,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10792,DRAMP35045,RRRRRRRGGIYLATALAKWALKQGF,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10793,DRAMP35046,IYLATALAKWALKQGFGGRRRRRRR,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10794,DRAMP35047,RRRRRRRGGIYLATALAKWALKQ,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10795,DRAMP35048,IYLATALAKWALKQGGRRRRRRR,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10796,DRAMP35049,RRRRRRRGGKLAKLAKKLAKLAK,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10797,DRAMP35050,KLAKLAKKLAKLAKGGRRRRRRR,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10798,DRAMP35051,RGDXRRRRRRRR,12,Not available,Not available,Not available,Linear,Free,Free,X=12-aminododecanoic acid (ADDA),L,DRAMP
10799,DRAMP35052,RGDXRRRRRRRR,12,Not available,Not available,Not available,Linear,Free,Free,X=12-aminododecanoic acid (ADDA),L,DRAMP
10800,DRAMP35053,RGDXRRRRRRRR,12,Not available,Not available,Not available,Linear,Free,Free,"X=6-aminohexanoic acid, Ahx",L,DRAMP
10801,DRAMP35054,RGDXRRRRRRRR,12,Not available,Not available,Not available,Linear,Free,Free,"X=6-aminohexanoic acid, Ahx",L,DRAMP
10802,DRAMP35055,RGDRRRRRRRR,11,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10803,DRAMP35056,GIGKFLHSAKKFGKAFVGEIMNSGGKKWKMRRNQFWVKVQRG,42,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10804,DRAMP35057,WRWRWRWRW,9,Not available,Not available,Not available,,Free,"Dox, Doxorubicin",None,L,DRAMP
10805,DRAMP35058,WRWKKKKA,8,Not available,Not available,Not available,Cyclic,Free,Free,None,L,DRAMP
10806,DRAMP35059,RKKRRQRRRGC,11,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10807,DRAMP35060,DGRCLLIIKLAKLAKKLAKLAK,22,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10808,DRAMP35061,NHQQQNPHQPPM,12,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,None,L,DRAMP
10809,DRAMP35062,LLIILRRRIRKQAHAHSKNHQQQNPHQPPM,30,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,None,L,DRAMP
10810,DRAMP35063,NHQQQNPHQPPMLLIILRRRIRKQAHAHSK,30,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,None,L,DRAMP
10811,DRAMP35064,CLLIILRRRIRKQAHAHSKNHQQQNPHQPPM,31,Not available,Not available,Not available,Linear,Succinimidyl-4-(N-mal-eimidomethyl) cyclohexane-1-carboxylate (SMCC),Amidation,None,L,DRAMP
10812,DRAMP35065,AGYLLGXINLKALAALAKKIL,21,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,DRAMP
10813,DRAMP35066,AGYLLGXINLKALAALAKKIL,21,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,DRAMP
10814,DRAMP35067,AGYLLGXINLKALAALAKKIL,21,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,DRAMP
10815,DRAMP35068,AGYLLGXINLKALAALAKKIL,21,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,DRAMP
10816,DRAMP35069,RLLRLLRRLLRLLRRLLRC,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10817,DRAMP35070,RGDRGDRRDLRLDRGDLRC,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10818,DRAMP35071,RGDRLDRRDLRLDRRDLRC,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10819,DRAMP35072,RGERGERRELRLERGELRC,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10820,DRAMP35073,RGERLERRELRLERRELRC,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10821,DRAMP35074,CGETCVGGTCNTPGCTCSWPVCTRNGLPV,29,1ZNU##2JUE##1NB1,Not available,Not available,,Free,Free,None,L,DRAMP
10822,DRAMP35075,NYRWRCKNQN,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10823,DRAMP35076,NYQRRCKNQN,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10824,DRAMP35077,NYQWRCKNQN,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10825,DRAMP35078,NYRRRCKNQN,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10826,DRAMP35079,YRWRCKNQN,9,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10827,DRAMP35080,NYRWRCKNQ,9,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10828,DRAMP35081,YRWRCKNQ,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10829,DRAMP35082,NYRWRCKN,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10830,DRAMP35083,RWRCKNQN,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10831,DRAMP35084,NYRWRCK,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10832,DRAMP35085,GRKKRRQRRRP,11,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10833,DRAMP35086,KLAKLAKKLAKLAKGRKKRRQRRRP,25,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10834,DRAMP35087,KLAKLAKKLAKLAKNYRWRCKNQN,24,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10835,DRAMP35088,KETWWETWWTEWSQPKKKRKVC,22,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10836,DRAMP35089,RRRRR,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10837,DRAMP35090,GLKKLAELFHKLLKLG,16,Not available,Not available,Not available,Linear,"TAMRA, 5-(and-6)-carboxytetramethylrhodamine",Amidation,None,L,DRAMP
10838,DRAMP35091,GLKKLAELFHKLLKLG,16,Not available,Not available,Not available,Linear,"TAMRA, 5-(and-6)-carboxytetramethylrhodamine",Amidation,None,L,DRAMP
10839,DRAMP35092,LKKLAELAHKLLKLG,15,Not available,Not available,Not available,Linear,TAMRA,Amidation,None,L,DRAMP
10840,DRAMP35093,GLKKLAELFHKLLKLG,16,Not available,Not available,Not available,Linear,Conjugated to nanoparticles,Amidation,None,L,DRAMP
10841,DRAMP35094,GLKKLAELFHKLLKLG,16,Not available,Not available,Not available,Linear,Conjugated to nanoparticles,Amidation,None,L,DRAMP
10842,DRAMP35095,GLKKLAELAHKLLKLG,16,Not available,Not available,Not available,Linear,Conjugated to nanoparticles,Amidation,None,L,DRAMP
10843,DRAMP35096,BRRRRRRR,8,Not available,Not available,Not available,Linear,Free,Amidation,B=Beta-Alanine,L,DRAMP
10844,DRAMP35097,BRRRRRRRRR,10,Not available,Not available,Not available,Linear,Lauroylation,Amidation,B=Beta-Alanine,L,DRAMP
10845,DRAMP35098,Brrrrrrr,8,Not available,Not available,Not available,Linear,Lauroylation,Amidation,B=Beta-Alanine,Mix,DRAMP
10846,DRAMP35099,BrrrrrRRRR,10,Not available,Not available,Not available,Linear,Lauroylation,Amidation,B=Beta-Alanine,Mix,DRAMP
10847,DRAMP35100,BRRRRrrrrr,10,Not available,Not available,Not available,Linear,Lauroylation,Amidation,B=Beta-Alanine,Mix,DRAMP
10848,DRAMP35101,BRRRRRRRRRRR,12,Not available,Not available,Not available,Linear,Myrsitoylation,Amidation,B=Beta-Alanine,L,DRAMP
10849,DRAMP35102,Brrrrrrrrrrr,12,Not available,Not available,Not available,Linear,Myrsitoylation,Amidation,B=Beta-Alanine,Mix,DRAMP
10850,DRAMP35103,DEVD,4,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10851,DRAMP35104,YGRKKRRQRRREILSRXPAYRKIL,24,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,X=ATP-binding site inhibitors,L,DRAMP
10852,DRAMP35105,YGRKKRRQRRREILSRXPAYRKIL,24,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,X=ATP-binding site inhibitors,L,DRAMP
10853,DRAMP35106,YGRKKRRQRRREILSRXPAYRKIL,24,Not available,Not available,Not available,Linear,Acetylation,Free,X=ATP-binding site inhibitors,L,DRAMP
10854,DRAMP35107,YGRKKRRQRRREILSRXPAYRKIL,24,Not available,Not available,Not available,Linear,Acetylation,Free,X=ATP-binding site inhibitors,L,DRAMP
10855,DRAMP35108,KKWKMRRNQFWIKIQREILSRXPAYRKIL,29,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,X=ATP-binding site inhibitors,L,DRAMP
10856,DRAMP35109,KKWKMRRNQFWIKIQREILSRXPAYRKIL,29,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,X=ATP-binding site inhibitors,L,DRAMP
10857,DRAMP35110,KKWKMRRNQFWIKIQREILSRXPAYRKIL,29,Not available,Not available,Not available,Linear,Acetylation,Free,X=ATP-binding site inhibitors,L,DRAMP
10858,DRAMP35111,KKWKMRRNQFWIKIQREILSRXPAYRKIL,29,Not available,Not available,Not available,Linear,Acetylation,Free,X=ATP-binding site inhibitors,L,DRAMP
10859,DRAMP35112,CRGDK,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10860,DRAMP35113,AYLLGKINLKALAALAKKIL,20,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,None,L,DRAMP
10861,DRAMP35114,AXLYLLGKINLKALAALAKKIL,22,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"X=L-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",L,DRAMP
10862,DRAMP35115,AGYXLGKINLKALAALAKKIL,21,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"X=L-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",L,DRAMP
10863,DRAMP35116,axlyllgkinlkalaalakkil,22,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"x=D-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",D,DRAMP
10864,DRAMP35117,agyxlgkinlkalaalakkil,21,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"x=D-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",D,DRAMP
10865,DRAMP35118,"IGGYCSWLRL,IGGYCSWLRL",21,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
10866,DRAMP35119,CLLFVY,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10867,DRAMP35120,Xaix,4,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10868,DRAMP35121,VGAlAvVvWlWlWlWbAGSGPKKKRKVC,28,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10869,DRAMP35122,AGYLLGHINLHHLAHLHHILC,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10870,DRAMP35123,AGYLLGHINLHHLAHLHHIL,20,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10871,DRAMP35124,AGYLLGKINLKKLAKLLLIL,20,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10872,DRAMP35125,KILRGVAKKILRTFLRRISKDILTGKK,27,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
10873,DRAMP35126,TPWWRLWTKWHHKRRDLPRKPEGC,24,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10874,DRAMP35129,LTFEHYWAQLTS,12,Not available,Not available,Tumor cells:  -- (IC50 for MDM2=0.29 µM);  -- (IC50 for MDMX-p53=1.6 µM),Linear,Acetylation,Amidation,None,L,DRAMP
10875,DRAMP35130,LTFEHYWAQLTS,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
10876,DRAMP35136,LSTAADMQGVVTDGMASGLDKDYLKPDD,28,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10877,DRAMP35137,Pr,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
10878,DRAMP35138,RXRRXRILFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10879,DRAMP35139,RXRRXRYQFLIRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10880,DRAMP35140,RXRRXRFLQIYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10881,DRAMP35141,RXRRXRAAAAARXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10882,DRAMP35142,RXRRXRIKFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10883,DRAMP35143,RXRRXRIEFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10884,DRAMP35144,RXRRXRIWFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10885,DRAMP35145,RXRRXRIPFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10886,DRAMP35146,KXRKXRILFQYKXRKXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10887,DRAMP35147,HXRHXRILFQYHXRHXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10888,DRAMP35148,SXRSXRILFQYSXRSXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10889,DRAMP35149,EXREXRILFQYEXREXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10890,DRAMP35150,RMKWKKILFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10891,DRAMP35151,RXRRXRILFQYRMKWKK,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10892,DRAMP35152,KKWKMRILFQYRXRRXR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10893,DRAMP35153,RXRRXRILFQYKKWKMR,17,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,DRAMP
10894,DRAMP35154,YGRKKRRQRRRREADFFWSLCTADMS,26,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10895,DRAMP35155,KLULKLULKULKAULKLU,18,Not available,Not available,Not available,Linear,Acetylation,Amidation,U=α-amino isobutyric acid (Aib),L,DRAMP
10896,DRAMP35156,RKKRRQRRRGGG,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10897,DRAMP35157,RKKRRQRRRGGGKLLKLLLKLLLKLLK,27,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
10898,DRAMP35161,XVTXVXVXXVXV,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10899,DRAMP35162,KCFQAQRNMRKVRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10900,DRAMP35163,KCFQWARNMRKVRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10901,DRAMP35164,KCFQWQRNARKVRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10902,DRAMP35165,KCFQWQRNMRKVRGAPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10903,DRAMP35166,KCFQWQRNMRKRRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10904,DRAMP35167,KCFQWQANMRKVRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10905,DRAMP35168,KCFQWQRNMRKVAGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10906,DRAMP35169,KCFQWQANMRKRRGPPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10907,DRAMP35170,KCFQWQRNMRKVAGRPVSCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10908,DRAMP35171,KCFRWQRNRRKVRGRPVRCIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10909,DRAMP35172,KRFRWQRNMRKVRGRPVRSIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10910,DRAMP35173,RCFQWQRNMRRVRGPPVSCIRR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10911,DRAMP35174,KCFQWQKNMKKVKGPPVSCIKK,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,None,L,DRAMP
10912,DRAMP35175,KXFQWQRNMRKVRGPPVSXIKR,22,Not available,Not available,Not available,Linear,Fluorescein,Amidation,"X=Hcy, homocysteine in which the side chain is one methylene group longer than in cysteine",L,DRAMP
10913,DRAMP35176,GALFLAFLAAALSLMGLWSQPKKKRKV,27,Not available,Not available,Not available,Linear,Acetylation,Cysteamide group,None,L,DRAMP
10914,DRAMP35177,KLPVM,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10915,DRAMP35178,KLFMALVAFLRFLTIPPTAGILKRWGTI,28,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10916,DRAMP35179,LKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR,35,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
10917,DRAMP35180,CETPSKHFNGLCIRSSNCASVCHGEHFTDGRCQGVRRRCMCLKPC,45,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
10918,DRAMP35181,CELAGIGILTVRKKRRQRRR,20,Not available,Not available,Not available,Linear,Conjugation with Alexa488 C5 maleimide,Free,None,L,DRAMP
10919,DRAMP35182,CELAGIGILTVKKKKKQKKK,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10920,DRAMP35183,RIMRILRILKLAR,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10921,DRAMP35184,GRGDSPRR,8,Not available,Not available,Not available,Linear,Acetylation,Free,Phosphorylation,L,DRAMP
10922,DRAMP35185,GRGDSPRRSPRR,12,Not available,Not available,Not available,Linear,Acetylation,Free,Phosphorylation,L,DRAMP
10923,DRAMP35186,GRGDSPRRKKKKSPRRKKKKSPRR,24,Not available,Not available,Not available,Linear,Acetylation,Free,Phosphorylation,L,DRAMP
10924,DRAMP35187,GRGDGPRRKKKKGPRRKKKKGPRR,24,Not available,Not available,Not available,Linear,Acetylation,Free,None,L,DRAMP
10925,DRAMP35188,XPX,3,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10926,DRAMP35189,CGGKDCERRFSRSDQLKRHQRRHTGVKPFQ,30,Not available,Not available,Not available,Linear,Biotinylation,Amidation,None,L,DRAMP
10927,DRAMP35190,KDCERRFSRSDQLKRHQRRHTGVKPFQK,28,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10928,DRAMP35191,YGRGGRRGRRR,11,Not available,Not available,Not available,Linear,ELPBC,Free,None,L,DRAMP
10929,DRAMP35192,RRRRRRRRRGDfK,13,Not available,Not available,Not available,Linear,Free,Free,Cysteine modified octa-arginine conjugated to the branch of lysine,Mix,DRAMP
10930,DRAMP35193,BRRXRRXRRX,10,Not available,Not available,Not available,Linear,"FAM, fluorescein",Amidation,B=Beta-Alanine; X=α-amino isobutyric acid,L,DRAMP
10931,DRAMP35194,BrrXrrXrrX,10,Not available,Not available,Not available,Linear,"FAM, fluorescein",Amidation,B=Beta-Alanine; X=α-amino isobutyric acid,Mix,DRAMP
10932,DRAMP35195,BRrXRrXRrX,10,Not available,Not available,Not available,Linear,"FAM, fluorescein",Amidation,B=Beta-Alanine; X=α-amino isobutyric acid,Mix,DRAMP
10933,DRAMP35196,BXRXRXXRXRXXRXRX,16,Not available,Not available,Not available,Linear,"FAM, fluorescein",Amidation,B=Beta-Alanine; X=α-amino isobutyric acid,L,DRAMP
10934,DRAMP35197,LPIP,4,Not available,Not available,Tumor cells: HepG2 (IC50=26.6µM); HeLa (IC50=34.7µM),Cyclic,Free,Free,None,L,DRAMP
10935,DRAMP35198,FPYG,4,Not available,Not available,Tumor cells: HepG2 (IC50=38.2µM); HeLa (IC50=46.1µM),Cyclic,Free,Free,None,L,DRAMP
10936,DRAMP35199,GGGGRRRRRRRRRLLLL,17,Not available,Not available,Not available,Linear,Maleimide addition,Free,None,L,DRAMP
10937,DRAMP35200,CGGGRRRRRRRRRLLLL,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10938,DRAMP35201,XACSGSGSGCGSGSGSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10939,DRAMP35202,XACSGRGSGCGSGRGSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10940,DRAMP35203,XACRGSGRGCGRGSGRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10941,DRAMP35204,XACSGRGRGCGRGRGSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10942,DRAMP35205,XACRGRGRGCGRGRGRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10943,DRAMP35206,XACGRGRGRCRGRGRGCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10944,DRAMP35207,XACRGRGRGCRGRGRGCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10945,DRAMP35208,XACGRGRGRCGRGRGRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10946,DRAMP35209,XACRGRRRGCGRRRGRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10947,DRAMP35210,XACRRSRRGCGRRSRRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10948,DRAMP35211,XACRRSRRGCGRRSRRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10949,DRAMP35212,XACSDRFRNCPADEALCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10950,DRAMP35213,XACRDRFRNCPADEALCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10951,DRAMP35214,XACRDRFRNCPADERLCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10952,DRAMP35215,XACRDRFRRCPADERLCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10953,DRAMP35216,XACRDRFRRCPADRRLCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10954,DRAMP35217,XACSGRGRGCGSGSGSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10955,DRAMP35218,XACRGRGRGCGSGSGSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10956,DRAMP35219,XACRGRGRGCGSGSRSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10957,DRAMP35220,XACRGRGRRCGSGSRSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10958,DRAMP35221,XACRGRGRRCGSGRRSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10959,DRAMP35222,XACRGRGRRCGSGRRSCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10960,DRAMP35223,XARCSGSGSGCGSGSGSCGR,20,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10961,DRAMP35224,XARRCSGSGSGCGSGSGSCGRR,22,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10962,DRAMP35225,XARRRCSGSGSGCGSGSGSCGRRR,24,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10963,DRAMP35226,XARRRRCSGSGSGCGSGSGSCGRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10964,DRAMP35227,XACSGSGSGCGSGSGSCGRRRRRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10965,DRAMP35228,XACSGSGSGCGSGSGSCGRRRRRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10966,DRAMP35229,XARCSDRFRNCPADEALCGR,20,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10967,DRAMP35230,XARRCSDRFRNCPADEALCGRR,22,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10968,DRAMP35231,XARRRCSDRFRNCPADEALCGRRR,24,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10969,DRAMP35232,XARRRRCSDRFRNCPADEALCGRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10970,DRAMP35233,XACSDRFRNCPADEALCGRRRRRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10971,DRAMP35234,XACSDRFRNCPADEALCGRRRRRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10972,DRAMP35235,XACRRSRRGCGRRSRRCG,18,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10973,DRAMP35236,XACRRSRRGCGRRSRRCG,18,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10974,DRAMP35237,XACRGRGRRCGSGRRSCG,18,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10975,DRAMP35238,XACRGRGRRCGSGRRSCG,18,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10976,DRAMP35239,XACSGSGSGCGSGSGSCGRRRRRRRR,26,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10977,DRAMP35240,XACSGSGSGCGSGSGSCGRRRRRRRR,26,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10978,DRAMP35241,XACSDRFRNCPADEALCGRRRRRRRR,26,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10979,DRAMP35242,XACSDRFRNCPADEALCGRRRRRRRR,26,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10980,DRAMP35243,XACSHSGHGCGHGSHSCGRRRRRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10981,DRAMP35244,XACSHSGWGCGHGSWSCGRRRRRRRR,26,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10982,DRAMP35245,XACHGRRWGCGRHRGRCG,18,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
10983,DRAMP35246,HEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG,37,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10984,DRAMP35247,HEHEHEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG,41,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10985,DRAMP35248,HEHEHEHEHEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG,45,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10986,DRAMP35249,HEHEHEHEHEHEHEHEEFGGGGGYGRRRRRRGGGGGG,37,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10987,DRAMP35250,HEHEHEHEHEHEHEHEHEHEEFGGGGGYGRRRRRRGGGGGG,41,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10988,DRAMP35251,HEHEHEHEHEHEHEHEHEHEHEHEEFGGGGGYGRRRRRRGGGGGG,45,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10989,DRAMP35252,HEHEHEHEHEHEHEHEHEHEHEHEEFGGGGGYGRKKRRQRRR,42,Not available,Not available,Not available,Linear,Glutathione S-transferase,Free,None,L,DRAMP
10990,DRAMP35253,IPLVVPLC,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10991,DRAMP35254,IPLVVPLRRRRRRRRC,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10992,DRAMP35255,PKKKRKVAGYLLGKINLKALAALAKKILPQMQQNVFQYPGAGMVPQGEANF,51,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10993,DRAMP35256,PKKKRKVRRRRRRRYSQTSHKLVQLLTTAEQQ,32,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10994,DRAMP35257,PKKKRKVRRRRRRRPQMQQNVFQYPGAGMVPQGEANF,37,Not available,Not available,Not available,Linear,NLS,Free,None,L,DRAMP
10995,DRAMP35258,AYGRKKRRQRRR,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10996,DRAMP35259,WELVVLGKLYGRKKRRQRRR,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10997,DRAMP35260,ELVVLGKLYGRKKRRQRRR,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10998,DRAMP35261,LVVLGKLYGRKKRRQRRR,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
10999,DRAMP35262,VVLGKLYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11000,DRAMP35263,WELVVLGKYGRKKRRQRRR,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11001,DRAMP35264,WELVVLGYGRKKRRQRRR,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11002,DRAMP35265,WELVVLYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11003,DRAMP35266,WELVVLYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11004,DRAMP35267,WELVVYGRKKRRQRRR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11005,DRAMP35268,WELVYGRKKRRQRRR,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11006,DRAMP35269,WELYGRKKRRQRRR,14,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11007,DRAMP35270,WEYGRKKRRQRRR,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11008,DRAMP35271,WELVVAYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11009,DRAMP35272,WEAVVLYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11010,DRAMP35273,WEAVVAYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11011,DRAMP35274,WELVVLYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Acetylation,Free,None,L,DRAMP
11012,DRAMP35275,WELVVLYGRKKRRQRRR,17,Not available,Not available,Not available,Linear,Acetylation,Free,None,L,DRAMP
11013,DRAMP35276,YARVRRRGPRR,11,Not available,Not available,Not available,Linear,6-histidine tag,Free,None,L,DRAMP
11014,DRAMP35277,CRQIKIWFQNRRMKWKK,17,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11015,DRAMP35278,CRQIKIWFQNRRMKWKKKLAKLAKKLAKLAK,31,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11016,DRAMP35279,LCLRPVG,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11017,DRAMP35280,LCLRP,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11018,DRAMP35281,LCLR,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11019,DRAMP35282,LLR,3,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11020,DRAMP35283,LLLR,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11021,DRAMP35284,LLLLR,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11022,DRAMP35285,LLLRR,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11023,DRAMP35286,IIIR,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11024,DRAMP35287,VVVR,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11025,DRAMP35288,LCLK,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11026,DRAMP35289,LCLH,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11027,DRAMP35290,LCLE,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11028,DRAMP35291,LCLN,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11029,DRAMP35292,LCLQ,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11030,DRAMP35293,lclrpvg,7,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11031,DRAMP35294,lclrp,5,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11032,DRAMP35295,lclr,4,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11033,DRAMP35296,lcl,3,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11034,DRAMP35297,icir,4,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11035,DRAMP35298,vcvr,4,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11036,DRAMP35299,vlclr,5,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11037,DRAMP35300,CRRLRHLRHHYRRRWHRFRC,20,Not available,Not available,Not available,Linear,Free,Free,Addition of cysteine in Mgpe3 sequence makes Mgpe9,L,DRAMP
11038,DRAMP35301,CLLYWFRRRHRHHRRRHRRC,20,Not available,Not available,Not available,Linear,Free,Free,Addition of cysteine in Mgpe4 sequence makes Mgpe10,L,DRAMP
11039,DRAMP35302,RRLRHLRHHYRRRWHRFR,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11040,DRAMP35303,LLYWFRRRHRHHRRRHRR,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11041,DRAMP35304,GLKKLARLFHKLLKLGC,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11042,DRAMP35305,GLKKLAELFHKLLKLGC,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11043,DRAMP35306,GLKKLARLAHKLLKLGC,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11044,DRAMP35307,GLKKLAELAHKLLKLGC,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11045,DRAMP35308,YGRKKRRQRRRGC,13,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11046,DRAMP35309,RLRLRLRLRLRLRLRLKRLKRLKRLKRLKKKKKKKGYK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11047,DRAMP35310,RLRLRLRLRLRLRLRLKLLKLLKLLKLLKKKKKKKGYK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11048,DRAMP35311,RLRLRLRLRLRLRLRLKNNKNNKNNKNNKKKKKKKGYK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11049,DRAMP35312,GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11050,DRAMP35313,GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11051,DRAMP35314,GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11052,DRAMP35315,GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11053,DRAMP35316,ALALALALALALALALKIKKIKKIKKIKKLAKLAKKIK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11054,DRAMP35317,LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11055,DRAMP35318,LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11056,DRAMP35319,LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11057,DRAMP35320,LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11058,DRAMP35321,IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11059,DRAMP35322,IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11060,DRAMP35323,IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11061,DRAMP35324,IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11062,DRAMP35325,LALALALALALALALAKIKKIKKIKKIKKLAKLAKKIK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11063,DRAMP35326,LALALALALALALAKLAKLAKLAKLAKIKKIKKKIK,36,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11064,DRAMP35327,LALALALALALALALAKLAKLAKLAKLAKLAKKIK,35,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11065,DRAMP35328,LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11066,DRAMP35329,LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK,38,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11067,DRAMP35330,LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11068,DRAMP35331,LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK,38,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11069,DRAMP35332,XGLFGCGRKKRRQRRRPPQ,19,Not available,Not available,Not available,Linear,Free,Amidation,X=Doxorubicin,L,DRAMP
11070,DRAMP35333,(XGLFGC)(XGLFGC)KGRKKRRQRRRPPQ,26,Not available,Not available,Not available,Linear,Free,Amidation,X=Doxorubicin,L,DRAMP
11071,DRAMP35334,[(XGLFGC)(XGLFGC)K][(XGLFGC)(XGLFGC)K]KGRKKRRQRRRPPQ,40,Not available,Not available,Not available,Linear,Free,Amidation,X=Doxorubicin,L,DRAMP
11072,DRAMP35335,XCGRKKRRQRRRPPQ,15,Not available,Not available,Not available,Linear,Free,Amidation,X=Doxorubicin,L,DRAMP
11073,DRAMP35336,XGLFGXGRKKRRQRRRPPQ,19,Not available,Not available,Not available,Linear,Free,Amidation,"X(1)=Doxorubicin; X(6)=(C16)Cys, Cys-Palmitoylation",L,DRAMP
11074,DRAMP35337,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"Rho, rhodamine B",Φ=L-2-naphthylalanine,L,DRAMP
11075,DRAMP35338,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"Rho, rhodamine B",Φ=L-2-naphthylalanine,L,DRAMP
11076,DRAMP35339,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"Rho, rhodamine B",Φ=L-2-naphthylalanine,L,DRAMP
11077,DRAMP35340,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"Dex, dexamethasone",Φ=L-2-naphthylalanine,L,DRAMP
11078,DRAMP35341,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"Dex, dexamethasone",Φ=L-2-naphthylalanine,L,DRAMP
11079,DRAMP35342,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"Dex, dexamethasone",Φ=L-2-naphthylalanine,L,DRAMP
11080,DRAMP35343,KXGRKKRRQRRRPPQY,16,Not available,Not available,Not available,Linear,Free,Amidation,"X=Dex, dexamethasone",L,DRAMP
11081,DRAMP35344,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"FITC, fluorescein isothiocyanate",Φ=L-2-naphthylalanine,L,DRAMP
11082,DRAMP35345,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"FITC, fluorescein isothiocyanate",Φ=L-2-naphthylalanine,L,DRAMP
11083,DRAMP35346,FΦRRRRQKX,9,Not available,Not available,Not available,Cyclic,Free,"FITC, fluorescein isothiocyanate",Φ=L-2-naphthylalanine,L,DRAMP
11084,DRAMP35347,FΦRRRRQRRRRRKX,14,Not available,Not available,Not available,Cyclic,Free,"Rho, rhodamine B",Φ=L-2-naphthylalanine,L,DRAMP
11085,DRAMP35348,FΦRRRRQAAAAAKX,14,Not available,Not available,Not available,Cyclic,Free,"Rho, rhodamine B",Φ=L-2-naphthylalanine,L,DRAMP
11086,DRAMP35349,FΦRRRRQFFFFKX,13,Not available,Not available,Not available,Cyclic,Free,"Rho, rhodamine B",Φ=L-2-naphthylalanine,L,DRAMP
11087,DRAMP35350,FΦRRRRQXDEXLI,13,Not available,Not available,Not available,Cyclic,Free,Amidation,"Φ=L-2-naphthylalanine; X(8)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(11)=Pcap, phosphocoumaryl aminopropionic acid",L,DRAMP
11088,DRAMP35351,RRRRRRRRRXDEXLI,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,"Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid",L,DRAMP
11089,DRAMP35352,RKKRRQRRRXDEXLI,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,"Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid",L,DRAMP
11090,DRAMP35353,RQIKIWFQNRRMKWKKXDEXLI,22,Not available,Not available,Not available,Linear,Acetylation,Amidation,"Φ=L-2-naphthylalanine; X(17)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(20)=Pcap, phosphocoumaryl aminopropionic acid",L,DRAMP
11091,DRAMP35354,XAAAAAKRRRRΦFXKX,16,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B",Mix,DRAMP
11092,DRAMP35355,XAAAAAAAKRRRRΦFXKX,18,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(16)=L-2,3-diaminopropionic acid; X(18)=Rho, rhodamine B",Mix,DRAMP
11093,DRAMP35356,XRARARKRRRRΦFXKX,16,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B",Mix,DRAMP
11094,DRAMP35357,XDADADKRRRRΦFXKX,16,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B",Mix,DRAMP
11095,DRAMP35358,AAAAARRRRΦFKX,13,Not available,Not available,Not available,Cyclic,Free,Amidation,"Φ=L-2-naphthylalanine; X=Rho, rhodamine B",Mix,DRAMP
11096,DRAMP35359,AAAAAAARRRRΦFKX,15,Not available,Not available,Not available,Cyclic,Free,Amidation,"Φ=L-2-naphthylalanine; X=Rho, rhodamine B",Mix,DRAMP
11097,DRAMP35360,YGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRR,33,Not available,Not available,Not available,Linear,Coupled to signal peptide,mCherry,None,L,DRAMP
11098,DRAMP35361,CKYGRKKRRQRRR,13,Not available,Not available,Not available,Linear,Extra Cys and Lys added for labeling of TMR,Free,None,L,DRAMP
11099,DRAMP35362,CKYGRKKRRQRRR,13,Not available,Not available,Not available,Linear,Extra Cys and Lys added for labeling of TMR,Free,None,L,DRAMP
11100,DRAMP35363,RRRQRRKKRGYCKCKYGRKKRRQRRR,26,Not available,Not available,Not available,Linear,Extra Cys and Lys added for labeling of TMR and dimerization,Free,None,L,DRAMP
11101,DRAMP35364,RRRQRRKKRGYCKCKYGRKKRRQRRR,26,Not available,Not available,Not available,Linear,Extra Cys and Lys added for labeling of TMR and dimerization,Free,None,L,DRAMP
11102,DRAMP35365,CKYGRKKRRQRRR,13,Not available,Not available,Not available,Linear,Acetamidation,Free,None,L,DRAMP
11103,DRAMP35366,CKYGRKKRRQRRR,13,Not available,Not available,Not available,Linear,Acetamidation,Free,None,L,DRAMP
11104,DRAMP35367,RRRQRRKKRGYCKCKYGRKKRRQRRR,26,Not available,Not available,Not available,Linear,bis(maleimido)ethane added,Free,None,L,DRAMP
11105,DRAMP35368,RRRQRRKKRGYCKCKYGRKKRRQRRR,26,Not available,Not available,Not available,Linear,bis(maleimido)ethane added,Free,None,L,DRAMP
11106,DRAMP35369,RKWWK,5,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11107,DRAMP35370,PKKKRKVWKLLQQFFGLM,18,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11108,DRAMP35371,PKKKRKVWKLLQQFFGLM,18,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11109,DRAMP35372,PKKKRKVWKLLQQFFGLM,18,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11110,DRAMP35373,PKKKRKVWKLLQQFFGLM,18,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11111,DRAMP35374,CSKSSDYQC,9,Not available,Not available,Not available,Cyclic,Free,Free,"Coupling to polyoxyethylene (40) steartae (SA-PEG2000), peptide ligand modified salmon calcitonin (sCT)-loaded SLNs",L,DRAMP
11112,DRAMP35375,CSKSSDYQC,9,Not available,Not available,Not available,Cyclic,Free,Free,"Coupling to polyoxyethylene (40) steartae (SA-PEG2000), peptide ligand modified salmon calcitonin (sCT)-loaded SLNs",L,DRAMP
11113,DRAMP35376,IRQRRRR,7,Not available,Not available,Not available,Linear,Free,Conjugation to solid lipid nanoparticle,None,L,DRAMP
11114,DRAMP35377,CSKSSDYQC,9,Not available,Not available,Not available,Linear,Free,Conjugation to solid lipid nanoparticle,None,L,DRAMP
11115,DRAMP35378,CSKSSDYQC,9,Not available,Not available,Not available,Linear,Free,Conjugation to solid lipid nanoparticle,None,L,DRAMP
11116,DRAMP35379,GGVCPKILKKCRRDSDCPGACICRGNGWCGSGSD,34,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11117,DRAMP35380,GGVCPKILRRCRRDSDCPGACICRGNGYCGSGSD,34,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11118,DRAMP35381,GGVCPKILRRCRRDSDCPGACICRGNGWCGSGSD,34,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11119,DRAMP35382,GGVCPKILRRCRRDSDCPGACICRGNGYCGSGSR,34,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11120,DRAMP35383,GGVCPRILRRCRRDSDCPGACICRGNGYCGSGSK,34,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11121,DRAMP35384,GRCTKSIPPICFPD,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11122,DRAMP35385,grctksippicfpd,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,D,DRAMP
11123,DRAMP35386,GACTKSIPPICFPD,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11124,DRAMP35387,GRCTKSIPPICFPA,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11125,DRAMP35388,GRCTKSIPPICWPD,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11126,DRAMP35389,GRCTKSIPPICWPK,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11127,DRAMP35390,GRCTRSIPPKCWPD,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11128,DRAMP35391,GRXTKSIPPIXFPD,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,"X=Abu, α-aminobutyric acid",L,DRAMP
11129,DRAMP35392,GRXTKSIPPIXFPD,14,Not available,Not available,Not available,Cyclic,Conjugation with Alexa Flour 488,Free,"X=Abu, α-aminobutyric acid",L,DRAMP
11130,DRAMP35393,GRXTKSIPPIXFPD,14,Not available,Not available,Not available,Linear,Conjugation with Alexa Flour 488,Free,"X=Abu, α-aminobutyric acid",L,DRAMP
11131,DRAMP35394,GRXTKSIPPIXFPD,14,Not available,Not available,Not available,Linear,Conjugation with Alexa Flour 488,Free,"X=Abu, α-aminobutyric acid",L,DRAMP
11132,DRAMP35395,YGRKKRRQRRRPPQG,15,Not available,Not available,Not available,Linear,Conjugation with Alexa Flour 488,Free,None,L,DRAMP
11133,DRAMP35396,EEEEEEEEPLGLAGRRRRRRRRN,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11134,DRAMP35397,VSRRRRRRGGRRRR,14,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11135,DRAMP35398,LKKLCKLLKKLCKLAG,16,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11136,DRAMP35399,FSGSGSGSGRRRRRRRRGC,19,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11137,DRAMP35400,GSGSGSGSGRRRRRRRRGC,19,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11138,DRAMP35401,FSGSGSGSGRQIKIWFQNRRMKWKKGC,27,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11139,DRAMP35402,GSGSGSGSGRQIKIWFQNRRMKWKKGC,27,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11140,DRAMP35403,FSGSGSGSGAGYLLGKINLKALAALAKKILGC,32,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11141,DRAMP35404,GSGSGSGSGAGYLLGKINLKALAALAKKILGC,32,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11142,DRAMP35405,AGYLLGKTNLKALAALAKKIL,21,Not available,Not available,Not available,Linear,"Stearylation,  CH3(CH2)16CO",Amidation,None,L,DRAMP
11143,DRAMP35406,VTPHHVLVDEYTGEWVDSQFK,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11144,DRAMP35407,RLLRLLRLL,9,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,None,L,DRAMP
11145,DRAMP35408,RLLRLLRLX,9,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=1-aminocyclopentane-1-carboxylic acids (Ac5c),L,DRAMP
11146,DRAMP35409,RLLRLXRLX,9,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=1-aminocyclopentane-1-carboxylic acids (Ac5c),L,DRAMP
11147,DRAMP35410,RLXRLXRLX,9,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=1-aminocyclopentane-1-carboxylic acids (Ac5c),L,DRAMP
11148,DRAMP35411,RLXRLXRXX,9,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=1-aminocyclopentane-1-carboxylic acids (Ac5c),L,DRAMP
11149,DRAMP35412,RLXRXRXX,8,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=1-aminocyclopentane-1-carboxylic acids (Ac5c),L,DRAMP
11150,DRAMP35413,RXXRXRXX,8,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,X=1-aminocyclopentane-1-carboxylic acids (Ac5c),L,DRAMP
11151,DRAMP35414,HHHHHHHHRRRRRRRR,16,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11152,DRAMP35415,HHHHHHHHRRRRRRRRRRRRRRR,23,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11153,DRAMP35416,HHHHHHHHRRRRRRRRRRRRRRR,23,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11154,DRAMP35417,HHHHHHHHRRRRRRRRRRRRRRR,23,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11155,DRAMP35418,HHHHHHHHRRRRRRRRRRRRRRR,23,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11156,DRAMP35419,HHHHHHHHHHHHRRRRRRRRRRRRRRR,27,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11157,DRAMP35420,HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR,31,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11158,DRAMP35421,HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR,31,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11159,DRAMP35422,HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR,31,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11160,DRAMP35423,HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR,31,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11161,DRAMP35424,HHHHHHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR,35,Not available,Not available,Not available,Linear,Stearylation,Amidation,None,L,DRAMP
11162,DRAMP35425,MAARLCCQLDPARDVLCLRP,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11163,DRAMP35426,MAARLCCQLDPARDV,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11164,DRAMP35427,MAARLCCQ,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11165,DRAMP35428,MAARL,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11166,DRAMP35429,XFrFKFrFK,9,Not available,Not available,Not available,Linear,Amidation,Amidation,"X=Ahx, 6-aminohexanoic acid",Mix,DRAMP
11167,DRAMP35430,XGLXGGLXGI,10,Not available,Not available,Not available,Linear,C8,OMe,X=AIB (Aminoisobutyric acid),L,DRAMP
11168,DRAMP35431,XGLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),OMe,X=Aib,L,DRAMP
11169,DRAMP35432,XGLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),OMe,X=Aib,L,DRAMP
11170,DRAMP35433,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM),Linear,Acetylization,Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11171,DRAMP35434,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Acetylization,Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11172,DRAMP35435,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM),Linear,Acetylization,Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11173,DRAMP35436,XGLXGGLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM),Linear,Acetylization,Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11174,DRAMP35437,XGLXGGLXGIX,11,Not available,Not available,Not available,Linear,Acetylization,Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11175,DRAMP35438,XKLXGGLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11176,DRAMP35439,XKLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),OMe,X=Aib,L,DRAMP
11177,DRAMP35440,XKLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),OMe,X=Aib,L,DRAMP
11178,DRAMP35441,XKLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),COOH,X=Aib,L,DRAMP
11179,DRAMP35442,XKLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),COOH,X=Aib,L,DRAMP
11180,DRAMP35443,XGLXGKLXGIX,11,Not available,Not available,Tumor cells: HeLa  (EC50=2 μM); T67 (EC50=4 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11181,DRAMP35444,XGLXGKLXGIX,11,Not available,Not available,Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM),Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11182,DRAMP35445,XGLXGKLXGIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11183,DRAMP35446,XGLXGKLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),OMe,X=Aib,L,DRAMP
11184,DRAMP35447,XGLXGGLXKIX,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol),L,DRAMP
11185,DRAMP35448,XGLXGGLXKIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),OMe,X=Aib,L,DRAMP
11186,DRAMP35449,FLFKLIPKAIKGLLKAFK,18,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11187,DRAMP35450,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=Ahx-FITC(Ahx, ε-aminocaproic acid; FITC, fluorescein isothiocyanate)",Mix,DRAMP
11188,DRAMP35451,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=Ahx-FITC(Ahx, ε-aminocaproic acid; FITC, fluorescein isothiocyanate)",Mix,DRAMP
11189,DRAMP35452,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=Ahx-FITC(Ahx, ε-aminocaproic acid; FITC, fluorescein isothiocyanate)",Mix,DRAMP
11190,DRAMP35453,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=RhB, rhodamine B",Mix,DRAMP
11191,DRAMP35454,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=RhB, rhodamine B",Mix,DRAMP
11192,DRAMP35455,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=RhB, rhodamine B",Mix,DRAMP
11193,DRAMP35456,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=PA-RhB, photoactivatable rhodamine B derivative",Mix,DRAMP
11194,DRAMP35457,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=PA-RhB, photoactivatable rhodamine B derivative",Mix,DRAMP
11195,DRAMP35458,MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR,33,Not available,Not available,Not available,Linear,Free,Free,"X=PA-RhB, photoactivatable rhodamine B derivative",Mix,DRAMP
11196,DRAMP35459,KKKKKKNKKLQQRGD,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11197,DRAMP35460,RGDGPRRRPRKRRGR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11198,DRAMP35461,RRRQKRIVVRRRLIR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11199,DRAMP35462,RRVWRRYRRQRWCRR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11200,DRAMP35463,RRARRPRRLRPAPGR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11201,DRAMP35464,LLRARWRRRRSRRFR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11202,DRAMP35465,RGPRRQPRRHRRPRR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11203,DRAMP35466,RRWRRWNRFNRRRCR,15,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,None,L,DRAMP
11204,DRAMP35467,RKKRRQRRRRKKRRQRRR,18,Not available,Not available,Not available,Linear,FITC,Natamycin,None,L,DRAMP
11205,DRAMP35468,AKKRRQRRRAKKRRQRRR,18,Not available,Not available,Not available,Linear,FITC,Natamycin,None,L,DRAMP
11206,DRAMP35469,XNIIXPLLXPIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11207,DRAMP35470,XNIIXPLLAPIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11208,DRAMP35471,ANIIXPLLXPIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11209,DRAMP35472,XNIIAPLLXPIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11210,DRAMP35473,XNIIXXLLXXIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11211,DRAMP35474,XNIIXPLLXXIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11212,DRAMP35475,XNIIXXLLXPIC,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,"X=Aib, α-amino isobutyric acid",L,DRAMP
11213,DRAMP35476,CAYGRKKRRQRRR,13,Not available,Not available,Not available,Linear,Cysteine addition,Rhodamine LP,None,L,DRAMP
11214,DRAMP35477,CHAIYPRH,8,Not available,Not available,Not available,Linear,Free,Rhodamine LP,None,L,DRAMP
11215,DRAMP35478,XXXXXXXAXXX,11,Not available,Not available,Not available,Linear,Free,Free,"X(1)=Me2Val; X(2)=Hva, α-Hydroxyisovaleric acid; X(3)=Me2Ser; X(4)=MeLeu; X(5)=MeThr(Trt); X(6)=MeSer(Me); X(7)=MeIle; M(9)=MeLeu; X(10)=MeTyr; X(11)=MeAla",L,DRAMP
11216,DRAMP35479,XXXXXXXAXXx,11,Not available,Not available,Not available,Linear,Free,Free,"X(1)=Me2Val; X(2)=Hva, α-Hydroxyisovaleric acid; X(3)=Me2Ser; X(4)=MeLeu; X(5)=MeThr(Trt); X(6)=MeSer(Me); X(7)=MeIle; M(9)=MeLeu; X(10)=MeTyr; X(12)=D-MeAla",Mix,DRAMP
11217,DRAMP35480,PNVIPLL,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11218,DRAMP35481,PIFYLPL,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11219,DRAMP35482,PIFPIYF,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11220,DRAMP35483,PFPFIFP,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11221,DRAMP35484,PLWPVIPI,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11222,DRAMP35485,FyXrXGeX,8,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11223,DRAMP35486,GWTLNSAGYLLGXINLKALAALAKKIL,27,Not available,Not available,Not available,Linear,Free,Amidation,X=Lys-Biotinylation,L,DRAMP
11224,DRAMP35487,KWSFRVSYRGISYRRSRGK,19,Not available,Not available,Not available,Linear,Biotinylation,Free,None,L,DRAMP
11225,DRAMP35488,KWFRVYRGIYRRRGK,15,Not available,Not available,Not available,Linear,Biotinylation,Free,None,L,DRAMP
11226,DRAMP35489,KWCFAVCYAGICYAACAGK,19,Not available,Not available,Not available,Linear,Biotinylation,,None,L,DRAMP
11227,DRAMP35490,rRrGrKkRr,9,Not available,Not available,Not available,Cyclic,Free,GFP,None,Mix,DRAMP
11228,DRAMP35491,rRrGrKkRr,9,Not available,Not available,Not available,Cyclic,Free,GFP,None,Mix,DRAMP
11229,DRAMP35492,rRrGrKkRr,9,Not available,Not available,Not available,Linear,Free,GFP,None,Mix,DRAMP
11230,DRAMP35493,rRrGrKkRr,9,Not available,Not available,Not available,Linear,Free,GFP,None,Mix,DRAMP
11231,DRAMP35494,RRGRRG,6,Not available,Not available,Not available,Linear,Conjugated to FITC modified folding domain via β-alanine–glycine– glycine linker,Amidation,None,L,DRAMP
11232,DRAMP35495,HHHRRRRRRRR,11,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11233,DRAMP35496,HHHRRRRRRRR,11,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11234,DRAMP35497,HHHRRRRRRRR,11,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,None,L,DRAMP
11235,DRAMP35498,HHHRRRRRRRR,11,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,None,L,DRAMP
11236,DRAMP35499,YKQCHKKGGXKKGSG,15,Not available,Not available,Not available,Linear,Rhodamine B,Free,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
11237,DRAMP35500,ykqchkkGGkkGsG,14,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,Mix,DRAMP
11238,DRAMP35501,YKQSHKKGGKKGSG,14,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
11239,DRAMP35502,YRQSHRRGGRRGSG,14,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
11240,DRAMP35503,WKQSHKKGGKKGSG,14,Not available,Not available,Not available,Linear,Rhodamine B,Free,None,L,DRAMP
11241,DRAMP35504,XRRRRRR,7,Not available,Not available,Not available,Linear,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11242,DRAMP35505,XRRRRRRR,8,Not available,Not available,Not available,Linear,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11243,DRAMP35506,XRRRRRRRR,9,Not available,Not available,Not available,Linear,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11244,DRAMP35507,XRRRRRRRRR,10,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,DRAMP
11245,DRAMP35508,XKRRRRE,7,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11246,DRAMP35509,XKRRRRRRE,9,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11247,DRAMP35510,XKRRRRRRRE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11248,DRAMP35511,XKRRRRRRRRE,11,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11249,DRAMP35512,XKRRRRRRRRRE,12,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11250,DRAMP35513,XKrrrrrrrE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,Mix,DRAMP
11251,DRAMP35514,XKrrrrrrrrE,11,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,Mix,DRAMP
11252,DRAMP35515,XKrrrrrrrrrE,12,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,Mix,DRAMP
11253,DRAMP35516,XKRrRrRrE,9,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,Mix,DRAMP
11254,DRAMP35517,XKrRrRrRrE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,Mix,DRAMP
11255,DRAMP35518,XKRrRrRrRrE,11,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,Mix,DRAMP
11256,DRAMP35519,XERRRKKRRRE,11,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11257,DRAMP35520,XERRRKXKRRRE,12,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11258,DRAMP35521,XERRRKXXKRRRE,13,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11259,DRAMP35522,XERRRKXXXKRRRE,14,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11260,DRAMP35523,XRRRRKRRRE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11261,DRAMP35524,XRRRKRRRRE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11262,DRAMP35525,XRRKRRRRRE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11263,DRAMP35526,XRKRRRRRRE,10,Not available,Not available,Not available,Cyclic,FITC,Amidation,X=Beta-Alanine,L,DRAMP
11264,DRAMP35527,XxXAlV,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11265,DRAMP35528,"PF,PY,PV",8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11266,DRAMP35529,FCTCNVKGFNAKNKRGIIYP,20,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
11267,DRAMP35530,XXKKWRKWLAKK,12,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11268,DRAMP35531,IIKKIIKKIIKKI,13,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11269,DRAMP35532,GIIKKIIKKIIKK,13,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11270,DRAMP35533,IIKKIIKKIIKK,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11271,DRAMP35534,XHXLLPPVPLFG,12,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
11272,DRAMP35535,XIXIILPPLPII,12,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
11273,DRAMP35536,XIXVILPPLPIFG,13,Not available,Not available,Not available,,Free,Amidation,None,L,DRAMP
11274,DRAMP35537,VRKPPYLPRPRWXRXXYNX,19,Not available,Not available,Tumor cells: HeLa (15% loss of viability=600μg/mL),Linear,Free,Amidation,None,L,DRAMP
11275,DRAMP35538,VXKPPYLPRPRWXRXXYNX,19,Not available,Not available,Tumor cells: HeLa (15% loss of viability=600μg/mL),Linear,Free,Amidation,None,L,DRAMP
11276,DRAMP35539,VrKPPYLPRPRWXRXXYNX,19,Not available,Not available,Tumor cells: HeLa (15% loss of viability=600μg/mL),Linear,Free,Amidation,None,Mix,DRAMP
11277,DRAMP35540,"XRPDKPRPYLPRPRPPRPVR,XRPDKPRPYLPRPRPPRPVR,XRPDKPRPYLPRPRPPRPVRXC,XRPDKPRPYLPRPRPPRPVRXC",87,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11278,DRAMP35541,ARCCLVMPVPPFACVKFCS,19,2MTM,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11279,DRAMP35542,XGLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X=Aib,L,DRAMP
11280,DRAMP35543,XGLXGGLXGIL,11,Not available,Not available,Not available,Linear,Oct (Fatty acid 1-Octanoyl),Free,X=Aib,L,DRAMP
11281,DRAMP35544,DDEKEQFLYHLLSFNAV,17,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Linear,Fluorescein-O2OC-,Free,None,L,DRAMP
11282,DRAMP35545,DDEⓍEQFⓍYHLLSFNAV,17,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Cyclic (Stapled),Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,DRAMP
11283,DRAMP35546,DDEⓍEQFⓍYHLLSFNAV,17,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Cyclic (Stapled),Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,DRAMP
11284,DRAMP35547,DDEⓍEQFⓍYHLLSFNAV,17,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Linear,Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,DRAMP
11285,DRAMP35548,DDEⓍEQFⓍYHLLSFNAV,17,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Linear,Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,DRAMP
11286,DRAMP35601,GSTLLSLL,8,Not available,Not available,Not available,Linear,C16,Free,None,L,DRAMP
11287,DRAMP35602,ALXGVl,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11288,DRAMP35603,AYXGVl,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11289,DRAMP35604,AMXGVl,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11290,DRAMP35605,FX,2,Not available,Not available,Not available,Linear,Free,Free,X=Hyp,L,DRAMP
11291,DRAMP35606,FX,2,Not available,Not available,Not available,Linear,Free,Free,X=Hyp,L,DRAMP
11292,DRAMP35607,ELLSRVD,7,Not available,Not available,Not available,Linear,C14H24O2,Free,None,L,DRAMP
11293,DRAMP35608,XLFXL,5,Not available,Not available,Not available,Linear,Free,Free,X=METH-Leu,L,DRAMP
11294,DRAMP35609,XLfXL,5,Not available,Not available,Not available,Linear,Free,Free,X=METH-Leu,L,DRAMP
11295,DRAMP35610,XLFxL,5,Not available,Not available,Not available,Linear,Free,Free,X(1)=METH-Leu; x(4)=D-METH-Leu,Mix,DRAMP
11296,DRAMP35611,XLFXl,5,Not available,Not available,Not available,Linear,Free,Free,X=METH-Leu,L,DRAMP
11297,DRAMP35612,xLFXL,5,Not available,Not available,Not available,Linear,Free,Free,x(1)=D-METH-Leu; X(4)=METH-Leu,Mix,DRAMP
11298,DRAMP35613,XlFXL,5,Not available,Not available,Not available,Linear,Free,Free,X=METH-Leu,L,DRAMP
11299,DRAMP35614,GGGGGGGRGDLPETGGS,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11300,DRAMP35615,GGGGRGDRGDLPETGGS,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11301,DRAMP35616,GRGDRGDRGDLPETGGS,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11302,DRAMP35617,RRRQRRKKRGGGDTRLNTVWMW,22,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
11303,DRAMP35618,GGKKLFKKILKYL,13,Not available,Not available,Not available,Linear,C18,Amidation,None,L,DRAMP
11304,DRAMP35619,LPGP,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11305,DRAMP35620,DYVP,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11306,DRAMP35621,MRLLVLSSLLCILLLCFSIFSTEGKRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV,81,Not available,Not available,Not available,,Free,Free,None,L,DRAMP
11307,DRAMP35622,LXFX,4,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11308,DRAMP35623,KP,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11309,DRAMP35624,YLARAIRRTLARLLL,15,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11310,DRAMP35625,SWKKFFKKARSLPKLF,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11311,DRAMP35626,INLKKLAKLXKKIS,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11312,DRAMP35627,INLKKLAXLXKKIS,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11313,DRAMP35628,INLKKLAKLXKKIT,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11314,DRAMP35629,KRIVARIKAFLR,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11315,DRAMP35630,KRIVKRIKKFLR,12,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11316,DRAMP35631,"GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQX",54,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11317,DRAMP35632,"WKLLSKAQEKFGKNKSRC,RYGTCIYQXRLWAFS",34,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11318,DRAMP35633,XCRRLCYRNRCVTYCRGR,18,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11319,DRAMP35634,ECRRLCYKQRCVTYCRGR,18,1KFP,Not available,Not available,,Amidation,Amidation,None,L,DRAMP
11320,DRAMP35635,RQIKIWFQNRRMKWKKAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKT,53,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11321,DRAMP35636,RQIKIWFQNRRMKWKKAKLNAEKLKDFKIRLQYFARGGQVYIRQGRLALQGKT,53,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11322,DRAMP35637,AWIWLV,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11323,DRAMP35638,LESLASSAVRTANKARAKL,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11324,DRAMP35639,XTXCXfXRXc,10,Not available,Not available,Not available,Linear,C12,Free,None,Mix,DRAMP
11325,DRAMP35640,XTXCXxXXXc,10,Not available,Not available,Not available,Linear,C12,Free,None,Mix,DRAMP
11326,DRAMP35641,FLFKLIPKAIKGLIKAFK,18,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11327,DRAMP35642,IP,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11328,DRAMP35643,XI,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11329,DRAMP35644,FFFFRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11330,DRAMP35645,FFFFRRRR,8,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11331,DRAMP35646,IKNAKVCVYAVCVSHK,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11332,DRAMP35647,KKWRKWLKWLAKK,13,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11333,DRAMP35648,KKPSKKPKPQAMTFPKVTVEYFPASFSTAALTVPED,36,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11334,DRAMP35649,GLFDIVKKVLKLLK,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11335,DRAMP35650,GLFDIVKKVLRLLK,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11336,DRAMP35651,GWFDILKHVFRLLK,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11337,DRAMP35652,GWYEIIKKIYKWLK,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11338,DRAMP35653,VKAWAKVLKGFGKLLKGFGKL,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11339,DRAMP35654,FHAWAKLLKGVGRFFKGIGRW,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11340,DRAMP35655,IRAWAKVLKGVGKILKGVGRW,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11341,DRAMP35656,WRAWAKIYHGVGKLLKGVGRW,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11342,DRAMP35657,NVlLWK,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11343,DRAMP35658,XXXAXLX,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11344,DRAMP35659,AFXGVl,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11345,DRAMP35660,FLSLIPHIVSGVAALANHL,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11346,DRAMP35661,GLPLLISWIKRKRQQAGPGSKKPVPIIYCNRRTGKCQRM,39,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11347,DRAMP35662,RGDfK,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11348,DRAMP35663,FIVPSIFLLKKAFCIALKKC,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11349,DRAMP35664,KKLRLKIAFK,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11350,DRAMP35665,RTCQSQSHRFRGPCLRRSNCANVCRTEGFPGGRCRGFRRRCFCTTHC,47,6DMZ,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11351,DRAMP35666,RRSRFGRFFKKVRKQLGRVLRHSRITVGGRMRF,33,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11352,DRAMP35667,GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC,33,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11353,DRAMP35668,RRWCVYAYVRVRGVRVYAYVCW,22,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11354,DRAMP35669,WCRRYRVLVRGVLVRYRRCW,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11355,DRAMP35670,"RWCVYAYVRVXX,RWCVYAYVRV",23,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11356,DRAMP35671,"WCRRYRVLVXX,WCRRYRVLV",21,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11357,DRAMP35672,RFCVYAYVRVRGVLVRYRRCF,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11358,DRAMP35673,RWXVYAYVRVRGVLVRYRRXW,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11359,DRAMP35674,SRSSRAGLQFPVGRIHRLLRK,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11360,DRAMP35675,SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC,37,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11361,DRAMP35676,RKKRRQRRRCWTKSIPPKPC,20,Not available,Not available,Tumor cells: H157 (50% viability=100μM); H460 (50% viability=100μM),Linear,Free,Free,None,L,DRAMP
11362,DRAMP35677,RKKAIKLVKKLVKKLKKALK,20,Not available,Not available,Not available,Linear,,,None,L,DRAMP
11363,DRAMP35678,FLKAIKKFGKEFKKIGAKLK,20,Not available,Not available,Not available,Linear,,,None,L,DRAMP
11364,DRAMP35679,RWCFRVCYRGICYRKCRG,18,6PIO,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11365,DRAMP35680,KWCFRVCYRGICYRKCRG,18,6PIP,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11366,DRAMP35681,CFQWKRAMRKVR,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11367,DRAMP35682,FLSGIVaMLaKLF,13,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11368,DRAMP35683,FLSaIVGMLaKLF,13,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11369,DRAMP35684,FLSAIVGMLAKLF,13,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11370,DRAMP35685,LSYXXxXWXXASpP,14,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11371,DRAMP35686,WCVASpPLSYCGXTXXXlLXXT,22,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11372,DRAMP35687,RFRWPIRRPPIRPPFYP,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11373,DRAMP35688,RFRPPIRRPPIRPPWYP,17,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11374,DRAMP35689,GYPFA,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.77 ± 0.0007 μg/mL); HT-29 (IC50=11.4 ± 0 μg/mL),Linear,Free,Free,None,L,DRAMP
11375,DRAMP35690,AYPFG,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.53 ± 0.0014 μg/mL); HT-29 (IC50=10.78 ± 0.0021 μg/mL),Linear,Free,Free,None,L,DRAMP
11376,DRAMP35691,FSPFG,5,Not available,Not available,Tumor cells: HepG2 (IC50=8.99 ± 0.0014 μg/mL); HT-29 (IC50=10.97 ± 0.0049 μg/mL),Linear,Free,Free,None,L,DRAMP
11377,DRAMP35692,VYPIA,5,Not available,Not available,Tumor cells: HepG2 (IC50=10.98 ± 0.0014 μg/mL); HT-29 (IC50=12.31 ± 0.0063 μg/mL),Linear,Free,Free,None,L,DRAMP
11378,DRAMP35693,PYVFA,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.6 ± 0.0007 μg/mL); HT-29 (IC50=9.78 ± 0.0212 μg/mL),Linear,Free,Free,None,L,DRAMP
11379,DRAMP35694,FYPVG,5,Not available,Not available,Tumor cells: HepG2 (IC50=10.35 ± 0.0014 μg/mL); HT-29 (IC50=12.88 ± 0.0014 μg/mL),Linear,Free,Free,None,L,DRAMP
11380,DRAMP35695,FYPFV,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.33 ± 0.0007 μg/mL); HT-29 (IC50=10.44 ± 0.5536 μg/mL),Linear,Free,Free,None,L,DRAMP
11381,DRAMP35696,FYPFA,5,Not available,Not available,Tumor cells: HepG2 (IC50=10.5 ± 0.0014 μg/mL); HT-29 (IC50=10.5 ± 0.0007 μg/mL),Linear,Free,Free,None,L,DRAMP
11382,DRAMP35697,TVPFA,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.56 ± 0.0021 μg/mL); HT-29 (IC50=11.67 ± 0.0014 μg/mL),Linear,Free,Free,None,L,DRAMP
11383,DRAMP35698,FYPFI,5,Not available,Not available,Tumor cells: HepG2 (IC50=11.32 ± 0.0014 μg/mL); HT-29 (IC50=14.2 ± 0.0014 μg/mL),Linear,Free,Free,None,L,DRAMP
11384,DRAMP35699,VTPFL,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.26 ± 0.0028 μg/mL); HT-29 (IC50=17.2 ± 0.0014 μg/mL),Linear,Free,Free,None,L,DRAMP
11385,DRAMP35700,PYFFL,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.67 ± 0.0007 μg/mL); HT-29 (IC50=9.12 ± 0.0042 μg/mL),Linear,Free,Free,None,L,DRAMP
11386,DRAMP35701,PYGFV,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.44 ± 0 μg/mL); HT-29 (IC50=10.55 ± 0.0989 μg/mL),Linear,Free,Free,None,L,DRAMP
11387,DRAMP35702,FTPFV,5,Not available,Not available,Tumor cells: HepG2 (IC50=11.1 ± 0.0007 μg/mL); HT-29 (IC50=12.11 ± 0.0056 μg/mL),Linear,Free,Free,None,L,DRAMP
11388,DRAMP35703,FSPFA,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.33 ± 0.0007 μg/mL); HT-29 (IC50=11.33 ± 0.0035 μg/mL),Linear,Free,Free,None,L,DRAMP
11389,DRAMP35704,FSPAG,5,Not available,Not available,Tumor cells: HepG2 (IC50=10.33 ± 0.0007 μg/mL); HT-29 (IC50=10.2 ± 0.0014 μg/mL),Linear,Free,Free,None,L,DRAMP
11390,DRAMP35705,FYPFG,5,Not available,Not available,Tumor cells: HepG2 (IC50=9.18 ± 0.0014 μg/mL); HT-29 (IC50=9.61 ± 0.0007 μg/mL),Linear,Free,Free,None,L,DRAMP
11391,DRAMP35706,FLFKLIKHAIKGLIKAFK,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11392,DRAMP35707,LRKVRRLLRRL,11,Not available,Not available,Tumor cells: HeLa (10% Killing=100µM),Linear,Free,Amidation,None,L,DRAMP
11393,DRAMP35708,LRKVWRWLRRL,11,Not available,Not available,Tumor cells: HeLa (80% Killing=100µM),Linear,Free,Amidation,None,L,DRAMP
11394,DRAMP35709,LRKFRRLLRRL,11,Not available,Not available,Tumor cells: HeLa (0% Killing=100µM),Linear,Free,Amidation,None,L,DRAMP
11395,DRAMP35710,LRRLRRLLRRL,11,Not available,Not available,Tumor cells: HeLa (85% Killing=100µM),Linear,Free,Amidation,None,L,DRAMP
11396,DRAMP35712,FWRIRIRRPRRIRIRWF,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11397,DRAMP35713,PFWRIRIRRPFWRIRIRR,18,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11398,DRAMP35714,PWRIRIRRPRRIRIWP,16,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11399,DRAMP35715,PWRIRIRRRRIRIRWPPWRIRIRR,24,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11400,DRAMP35716,RRWFWRRRRWFWRR,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11401,DRAMP35717,AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,32,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11402,DRAMP35718,AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG,32,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11403,DRAMP35719,HHHH,4,Not available,Not available,Not available,Linear,C12,C12,None,L,DRAMP
11404,DRAMP35720,VKRTKRGARRGLTKVLKKIFGSIVKKAVSKGV,32,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11405,DRAMP35721,WYQLIRTFGNLIHQKYRKLLEAYRKLRD,28,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11406,DRAMP35722,VRRSKRGIKVPSFVKKVLKDVVSESIS,27,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11407,DRAMP35723,KRWKKFFRKVIKFF,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11408,DRAMP35724,KRLKKIFKKMIKIF,14,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11409,DRAMP35730,XXXXKKK,7,Not available,Not available,Tumor cells: HepG2 (IC50=355µM),Linear,Free,Amidation,None,L,DRAMP
11410,DRAMP35731,KKLKXFX,7,Not available,Not available,Tumor cells: HeLa (IC50=462µM),Linear,Free,Amidation,None,L,DRAMP
11411,DRAMP35732,XFXLKKK,7,Not available,Not available,Tumor cells: HeLa (IC50=783µM),Linear,Free,Amidation,None,L,DRAMP
11412,DRAMP35733,WG,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11413,DRAMP35734,WW,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11414,DRAMP35735,EKKRLLKWWR,10,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11415,DRAMP35736,KWWKLLRKKR,10,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11416,DRAMP35737,FLSLIPKIAGGIAALVKNL,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11417,DRAMP35738,KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,34,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11418,DRAMP35739,EGCNILCLLKRKVKAVKNVVKNVVKSVVG,29,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11419,DRAMP35740,IFWLFRGKADVAL,13,7JGX,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11420,DRAMP35741,IFGTILGFLKGL,12,7JHF,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11421,DRAMP35742,GWGSFFRRAAHVGRHVGRAALTHYL,25,6RSF,Not available,Tumor cells: HeLa (IC50=30.7 ± 2.6 μg/ml),Linear,Free,Amidation,None,L,DRAMP
11422,DRAMP35743,gwgsffrraahvgrhvgraalthyl,25,Not available,Not available,Tumor cells: HeLa (IC50=25.3 ± 2.2 μg/ml); Calu-3 (IC50=39.1 ± 1.8 μg/ml); A549 (IC50=56.5 ± 4.5 μg/ml),Linear,Free,Amidation,None,D,DRAMP
11423,DRAMP35744,GWGSFFKKAAHAGKHAGKAALTHYL,25,6RSG,Not available,Tumor cells: HeLa (IC50>400 μg/ml),Linear,Free,Amidation,None,L,DRAMP
11424,DRAMP35745,gwgsffkkaahagkhagkaalthyl,25,Not available,Not available,Tumor cells: HeLa (IC50=198.2 ± 10.2 μg/ml); A549 (IC50>250 μg/ml); Calu-3 (IC50>250 μg/ml),Linear,Free,Amidation,None,D,DRAMP
11425,DRAMP35746,GSRGWGFEPGVRCLIWCD,18,6XTH,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11426,DRAMP35747,GGGGRGYEYNKQCLIFC,17,6XTI,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11427,DRAMP35748,"GSRGWGFEPGVRCLIWCD,GGGGRGYEYNKQCLIFC",36,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11428,DRAMP35752,LWKIWKKIWRVGWNWR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11429,DRAMP35753,LWKIWKKIWRVWKNWR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11430,DRAMP35754,LWKIGKKIWRVLWNWR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11431,DRAMP35755,LWKIWWKIWRVWKNWR,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11432,DRAMP35756,KVNHAACAAHCLLKRKRGGYCNKRRICVCRN,31,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11433,DRAMP35757,ELlVDlL,7,Not available,Not available,Not available,Linear,3-OH-Me-C14,Free,None,Mix,DRAMP
11434,DRAMP35758,ExYxEaPQyI,10,Not available,Not available,Not available,Linear,3-OH-C16,Free,None,Mix,DRAMP
11435,DRAMP35759,nnsNXNQPy,9,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11436,DRAMP35760,"ELlVDlL,ExYxEaPQyI",18,Not available,Not available,Not available,Linear,"3-OH-Me-C14,3-OH-C16",Free,None,Mix,DRAMP
11437,DRAMP35761,ALWKDLLKNVGIAAGKAALNKVTDMVNQ,28,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11438,DRAMP35762,GKLRLIKKLWVKKWKKKGWKA,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11439,DRAMP35763,PFRLRLRL,8,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11440,DRAMP35764,PWRLRLRL,8,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11441,DRAMP35765,RLMRIFRILKLAR,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11442,DRAMP35766,RMMRIFWVIKLAR,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11443,DRAMP35767,PI,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11444,DRAMP35768,NynQPnS,7,Not available,"Iturin A significantly inhibited the growth of tumor cells, induce apoptosis, autophagy and paraptosis.",Tumor cells: HepG2 (10% viability=75μM),Linear,Free,β-amino fatty acid with a-(CH2)10CH3 group,None,Mix,DRAMP
11445,DRAMP35769,GIINTLQKYYCRVRGGRCAVLSCRSQEYRIGRCSTRGRKCCRRKK,45,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11446,DRAMP35770,IRIILRAQGALKI,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11447,DRAMP35771,NLRTYKKRYMFY,12,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11448,DRAMP35772,YNKKYMKHLKPCKKA,15,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11449,DRAMP35773,YNKKYRYHLKSCKKADK,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11450,DRAMP35774,nfwxXGxWTIGS,12,Not available,Not available,Not available,Linear,4-ME-C6,Free,None,Mix,DRAMP
11451,DRAMP35775,nywxXGxWTIGS,12,Not available,Not available,Not available,Linear,4-ME-C6,Free,None,Mix,DRAMP
11452,DRAMP35776,KWWKKWKKWW,10,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11453,DRAMP35777,XLXVVVKVVKYLX,13,Not available,Not available,Not available,Linear,2-OH-ME-C5,Free,None,L,DRAMP
11454,DRAMP35778,XLXIIVKIVKYLX,13,Not available,Not available,Not available,Linear,2-OH-ME-C5,Free,None,L,DRAMP
11455,DRAMP35779,XLXIIVKVVKYLX,13,Not available,Not available,Not available,Linear,2-OH-ME-C5,Free,None,L,DRAMP
11456,DRAMP35780,XLXIVVKVVKYLX,13,Not available,Not available,Not available,Linear,2-OH-ME-C5,Free,None,L,DRAMP
11457,DRAMP35781,KKMMKKGGKFGTFMAIGMGIR,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11458,DRAMP35782,KKMMKKGGKFGTFMAIGGIR,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11459,DRAMP35783,RSKKWRKIEKRVKKIFEKTKEALPVIQGVATIVGAVGR,38,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11460,DRAMP35784,GSKRWRKFEKRVKKIFEETKEALPVIQGVATIVGAVGR,38,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11461,DRAMP35785,LKTKALNKLKQKLQAVGNLIGSVIKG,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11462,DRAMP35786,LKLKLKLTGKLKLKL,15,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11463,DRAMP35787,LKLKLKVpPTKLKLKL,16,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11464,DRAMP35788,LKLKLKpGKLKLKL,14,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11465,DRAMP35789,LKLKLKINGKKLKLKL,16,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11466,DRAMP35790,LKLKLKpNKLKLKL,14,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11467,DRAMP35791,LCXIIKKIIKKIIKKII,17,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11468,DRAMP35792,KWKLFKKIGAVLKVLC,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11469,DRAMP35793,KWKLFKKLGAVLKVLC,16,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11470,DRAMP35794,GLRRALLRLLRSLRRLLLRAC,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11471,DRAMP35795,GLARALTRLLRQLTRQLTRAC,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11472,DRAMP35796,FfXTG,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11473,DRAMP35797,FxTkVf,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11474,DRAMP35798,FxTxVf,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11475,DRAMP35799,FkTrVf,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11476,DRAMP35800,FrTrVf,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11477,DRAMP35801,wSxXxSwF,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11478,DRAMP35802,xXxFfF,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11479,DRAMP35803,vTxXxWavvF,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11480,DRAMP35804,AvVWXyWS,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11481,DRAMP35805,VxvvXtKf,8,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11482,DRAMP35806,WFkXxFf,7,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11483,DRAMP35807,xTxXwTavvF,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11484,DRAMP35808,fXaTlF,6,Not available,Not available,Not available,Linear,Free,Free,X=Enduracididine,Mix,DRAMP
11485,DRAMP35809,vLnSxF,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11486,DRAMP35810,VrTtFf,6,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11487,DRAMP35811,fVrtF,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11488,DRAMP35812,WkTkVwWava,10,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11489,DRAMP35813,VRKPPYLPRPRPPRrIYNr,19,Not available,Not available,Not available,Linear,Free,Amidation,None,Mix,DRAMP
11490,DRAMP35814,GMFTNMLKGIGKLAGKAALGAVKTLA,26,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11491,DRAMP35815,GFGCPWNAYECDRHCVSKGYTGGNCRGKIRQTCHCY,36,2RU0,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11492,DRAMP35816,WNWTKRF,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11493,DRAMP35817,GLWSKIKNVAAAAGKAALGAL,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11494,DRAMP35818,GLWKKIKNVAAAAGKAALGAL,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11495,DRAMP35819,GLWKKIKNVAKAAGKAALGAL,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11496,DRAMP35820,GLWKKIKNVAKAAGKAAKGAL,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11497,DRAMP35821,WLWKKIKNVAKAAGKAAKGAL,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11498,DRAMP35822,Gikefkrivqrikdflrnlv,20,Not available,Not available,Tumor cells: HeLa (50% Cytotoxicity=18.9µM),Linear,Free,Amidation,None,Mix,DRAMP
11499,DRAMP35823,GVITDTLKGVAKTVAAELLRKAHCKLTNSC,30,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11500,DRAMP35829,WA,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11501,DRAMP35830,WS,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11502,DRAMP35831,ws,2,Not available,Not available,Not available,Linear,Free,Free,None,D,DRAMP
11503,DRAMP35832,wS,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11504,DRAMP35833,Ws,2,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11505,DRAMP35834,WT,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11506,DRAMP35835,WE,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11507,DRAMP35836,WK,2,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11508,DRAMP35837,SYEKKINRHFKILKKNLKKK,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11509,DRAMP35838,XLLXL,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11510,DRAMP35839,LXLPL,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11511,DRAMP35840,LPLPL,5,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11512,DRAMP35841,lPLPL,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11513,DRAMP35842,LPlPL,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11514,DRAMP35843,LPLPl,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11515,DRAMP35844,lPLPl,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11516,DRAMP35845,LPlPl,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11517,DRAMP35846,lPlPl,5,Not available,Not available,Not available,Linear,Free,Free,None,Mix,DRAMP
11518,DRAMP35847,FKGLAKLLKIGLKALAKVIQ,9,Not available,Not available,Not available,Linear,,,None,Mix,DRAMP
11519,DRAMP35848,NKGLAKLLKIGLKALESVIQ,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11520,DRAMP35856,RRIRIRPPRLPRPRPRPYFMPRP,23,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11521,DRAMP35857,GLLGKILGAGKKVLCGVSGLC,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11522,DRAMP35858,GLLGKILGAGKKVLLGVSGLL,21,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11523,DRAMP35859,MKKLLLILFCLALALAGCKKAP,22,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11524,DRAMP35860,VLGLALIVGGALLIKKKQAKS,21,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11525,DRAMP35861,WKRFHPFRVVRKIFRRRIKR,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11526,DRAMP35862,rlfrrvkkvagkiakriwk,19,Not available,Not available,Not available,Linear,Free,Amidation,None,D,DRAMP
11527,DRAMP35863,KLLPSVVGLFKKKKQ,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11528,DRAMP35864,KLLKKVVKLFKKKKK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11529,DRAMP35865,KLLKKVVKLFKKLLK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11530,DRAMP35866,KLLKKLLKLLKKLLK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11531,DRAMP35867,KIIKKIIKIIKKIIK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11532,DRAMP35868,KVVKKVVKVVKKVVK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11533,DRAMP35869,KIIKKIKKKIKKIIK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11534,DRAMP35870,KLLKKLKKKLKKLLK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11535,DRAMP35871,KVVKKVKKKVKKVVK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11536,DRAMP35872,IKKIIKIIKKIIKKI,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11537,DRAMP35873,IIIKKIKKKIKKIII,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11538,DRAMP35874,KIIIKIKKKIKIIIK,15,Not available,Not available,Not available,Linear,Acetylation,Amidation,None,L,DRAMP
11539,DRAMP35875,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11540,DRAMP35876,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11541,DRAMP35877,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11542,DRAMP35878,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11543,DRAMP35879,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11544,DRAMP35880,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11545,DRAMP35881,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11546,DRAMP35882,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11547,DRAMP35883,TSFAEYWALLSXLAXYXP,18,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Linear,Acetylation,Amidation,"X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,DRAMP
11548,DRAMP35904,LAKKLKEYLEKLV,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11549,DRAMP35905,LIKKLKEYLKKLI,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11550,DRAMP35906,LAKKLAKYLKKAL,13,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11551,DRAMP35907,TEFQTNLVP,9,Not available,Not available,Not available,Linear,"FITC, 5(6)-carboxy fluorescence",Free,None,L,DRAMP
11552,DRAMP35908,FRRKAFLHWYTG,12,Not available,Not available,Tumor cells: MCF-7  (IC50=271.59 ± 76.41 μM),Linear,"FITC, 5(6)-carboxy fluorescence",Free,None,L,DRAMP
11553,DRAMP35909,VPKDVNAAIA,10,Not available,Not available,Not available,Linear,"FITC, 5(6)-carboxy fluorescence",Free,None,L,DRAMP
11554,DRAMP35910,VPELTQQMF,9,Not available,Not available,Not available,Linear,"FITC, 5(6)-carboxy fluorescence",Free,None,L,DRAMP
11555,DRAMP35911,NEALYDICFR,10,Not available,Not available,Not available,Linear,"FITC, 5(6)-carboxy fluorescence",Free,None,L,DRAMP
11556,DRAMP35933,RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN,30,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11557,DRAMP35934,RRRRRRRRGGMWKGFILTVVELRVPTDLTL,30,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11558,DRAMP35935,RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ,30,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11559,DRAMP35936,RRRRRRRRGGQGLTIYFYNSNRDFQ,25,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11560,DRAMP35937,RRRRRRRRGGQGLTIYFYNSNR,22,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11561,DRAMP35938,RRRRRRRRGGQGLTIYFY,18,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11562,DRAMP35939,RRRRRRRRGGGLTIYFYN,18,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11563,DRAMP35940,RRRRRRRRGGGLTIYFY,17,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11564,DRAMP35941,RRRRRRRRGGVVELRVPTDLTLLPGHLYMM,30,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11565,DRAMP35942,RRRRRRRRGGILTVVELRVP,20,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Linear,Free,Free,None,L,DRAMP
11566,DRAMP35943,GIFDVLKNLAKGVITSLAS,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11567,DRAMP35944,GIFKVLKNLAKGVITSLAS,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11568,DRAMP35945,GIFDVLKNLAKGVITSLKS,19,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11569,DRAMP35946,GIFKVLKNLAKGVITSLKS,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11570,DRAMP35947,FSLVNADQTT,10,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11571,DRAMP35948,FAKKLAKLKKKLAKLALAL,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11572,DRAMP35949,FAKKLAKLKKKLAKLAKKR,19,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11573,DRAMP35950,CFETLRGEERILSILRHQNLLKELQD,26,Not available,Not available,Not available,Linear,Free,Amidation,None,L,DRAMP
11574,DRAMP35953,CIRLDLELINFQSDLQHELLKTRLRG,26,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11575,DRAMP35954,NAVPNLRGDLQVLAQKVART,20,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11576,DRAMP35955,RSHRLRLH,8,Not available,"CD9-BP impaired CD9-related functions by adversely affecting the formation of tetraspanin webs—networks composed of CD9 and its partner proteins. The anti-cancer metastasis effect of CD9-BP was evidenced by the in vitro inhibition of cancer cell migration and invasion as well as exosome secretion and uptake, which are essential processes during metastasis. ",Not available,Linear,Free,Free,None,L,DRAMP
11577,DRAMP35956,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H358  (EC50=34nM); H1993  (EC50=37nM); H1299 (EC50=38nM); H2009  (EC50=38nM),Linear,Acetylization,Free,None,L,DRAMP
11578,DRAMP35957,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H358  (EC50=3.9nM); H1993  (EC50=4nM); H1299 (EC50=5.8nM); H2009  (EC50=6.8nM),Linear,Acetylization,Free,None,L,DRAMP
11579,DRAMP35958,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H1993  (EC50=1.5nM); H1299 (EC50=2.5nM); H2009  (EC50=3.4nM); H358  (EC50=3.5nM),Linear,Acetylization,Free,None,L,DRAMP
11580,DRAMP35959,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H358  (EC50=34nM); H1993  (EC50=37nM); H1299 (EC50=38nM); H2009  (EC50=38nM),Dimer,Free,Free,None,L,DRAMP
11581,DRAMP35960,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H358  (EC50=3.9nM); H1993  (EC50=4nM); H1299 (EC50=5.8nM); H2009  (EC50=6.8nM),Dimer,Free,Free,None,L,DRAMP
11582,DRAMP35961,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H1993  (EC50=1.5nM); H1299 (EC50=2.5nM); H2009  (EC50=3.4nM); H358  (EC50=3.5nM),Dimer,Free,Free,None,L,DRAMP
11583,DRAMP35962,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H358  (EC50=34nM); H1993  (EC50=37nM); H1299 (EC50=38nM); H2009  (EC50=38nM),Tetramer,Free,Free,None,L,DRAMP
11584,DRAMP35963,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H358  (EC50=3.9nM); H1993  (EC50=4nM); H1299 (EC50=5.8nM); H2009  (EC50=6.8nM),Tetramer,Free,Free,None,L,DRAMP
11585,DRAMP35964,FHAVPQSFYT,10,Not available,Not available,Tumor cells: H1993  (EC50=1.5nM); H1299 (EC50=2.5nM); H2009  (EC50=3.4nM); H358  (EC50=3.5nM),Tetramer,Free,Free,None,L,DRAMP
11586,DRAMP35965,ANGRGD,6,Not available,The perceived cancer cell-selective killing of both peptides P1 and P2 seems to stalk from cationic peptides and the electrostatic interactions between the anionic lipids of cancer cells on account of specific binding between integrins proteins and N (APN/CD13) ligand-receptor on the cancer cell membrane and the presence of binding RGD and NGR motifs in peptides.,Tumor cells: HepG2 (IC50=11.53µg/mL); MCF-7  (IC50=15.73µg/mL); HEp-2 (IC50=17.84µg/mL); A375 (IC50=69.87µg/mL),Linear,"1-oxo-1H-phenalene-2,3-carbonitrile (Ar)",Amidation,None,L,DRAMP
11587,DRAMP35966,KRGDKA,6,Not available,The perceived cancer cell-selective killing of both peptides P1 and P2 seems to stalk from cationic peptides and the electrostatic interactions between the anionic lipids of cancer cells on account of specific binding between integrins proteins and N (APN/CD13) ligand-receptor on the cancer cell membrane and the presence of binding RGD and NGR motifs in peptides.,Tumor cells: HepG2 (IC50=10.92µg/mL); HEp-2 (IC50=11.38µg/mL); MCF-7  (IC50=38.53µg/mL); A375 (IC50=91.28µg/mL),Linear,"α-(2,5,7-tri-tert-butyl) tryptophan (W*)",Amidation,None,L,DRAMP
11588,DRAMP35967,KLWCKSSQVPQSR,13,Not available,Not available,Tumor cells: HT-29 (55.3 ± 2.7% cell viability=200µM); A549  (59.7 ± 1.1% cell viability=200µM),Linear,Free,Free,None,L,DRAMP
11589,DRAMP35968,FLPLLAGLAANFLPQIICKIARKC,24,Not available,Not available,Tumor cells: H838 (IC50=32.15µM); PC-3 (IC50=33.46µM); U251MG (IC50=33.56µM),Linear,Free,Free,None,L,DRAMP
11590,DRAMP35969,FLPLLAGLAANFLPKIICKIARKC,24,Not available,Not available,Tumor cells: U251MG (IC50=3.86µM); PC-3 (IC50=4.283µM); H838 (IC50=5.15µM),Linear,Free,Free,None,L,DRAMP
11591,DRAMP35970,IWDTIEK,7,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11592,DRAMP35971,WWSDHR,6,Not available,Not available,Not available,Linear,Free,Free,None,L,DRAMP
11593,DRAMP35972,RIIDRLWLVRRPOKPKFVLVWVL,23,Not available,"A unique structure with an amphipathic N-helix, a central hinge, and a hydrophobic C-helix is responsible for bactericidal and anticancer activity of PMAP-NC. ",Tumor cells: MDA361 (IC50=6.4µM); A549 (IC50=7.1µM),Linear,Free,Free,None,L,DRAMP
11594,DRAMP35973,TKEQKEQIAKATGLTTKQVRNWYVQLNASIKVCMCSC,37,Not available,Not available,Tumor cells: SNU449 (4.8% viability=162 μM); SNU449 (52.8% viability=71 μM),Linear,Free,Free,None,L,DRAMP
11595,DRAMP35974,LLLLLLLLLLLLLL,14,Not available,Not available,Tumor cells: C26 (IC50=175µg/mL),Linear,C6,Free,None,L,DRAMP
11596,DRAMP35975,LLLLLLLLLLLLLL,14,Not available,Not available,Tumor cells: C26 (IC50=12µg/mL),Linear,C6,Free,None,L,DRAMP
11597,DRAMP35976,LLLLLLLLLLLLLLLLLLLLLLLLL,25,Not available,Not available,Tumor cells: C26 (IC50=41µg/mL),Linear,C6,Free,None,L,DRAMP
11598,DRAMP35977,LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL,40,Not available,Not available,Tumor cells: C26 (IC50=115µg/mL),Linear,C6,Free,None,L,DRAMP
11599,DRAMP35978,LLLLLLLLLLLLL,13,Not available,Not available,Tumor cells: C26 (IC50=10µg/mL),Linear,C12,Free,None,L,DRAMP
11600,DRAMP35979,LLLLLLLLLLLLLLLLLLLLLLLLLL,26,Not available,Not available,Tumor cells: C26 (IC50=15µg/mL),Linear,C12,Free,None,L,DRAMP
11601,DRAMP35980,LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL,37,Not available,Not available,Tumor cells: C26 (IC50=14µg/mL),Linear,C12,Free,None,L,DRAMP
11602,DRAMP35981,LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL,37,Not available,Not available,Tumor cells: C26 (IC50=22µg/mL),Linear,C12,Free,None,L,DRAMP
11603,DRAMP35982,LLLLLLLLLLLLLL,14,Not available,Not available,Tumor cells: C26 (IC50=175µg/mL),Linear,C16,Free,None,L,DRAMP
11604,DRAMP35983,LLLLLLLLLLLLLL,14,Not available,Not available,Tumor cells: C26 (IC50=12µg/mL),Linear,C16,Free,None,L,DRAMP
11605,DRAMP35984,LLLLLLLLLLLLLLLLLLLLLLLL,24,Not available,Not available,Tumor cells: C26 (IC50=25µg/mL),Linear,C16,Free,None,L,DRAMP
11606,DRAMP35985,LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL,38,Not available,Not available,Tumor cells: C26 (IC50=44µg/mL),Linear,C16,Free,None,L,DRAMP
11607,DRAMP35986,LLLLLLLLLLL,11,Not available,Not available,Tumor cells: C26 (IC50=10µg/mL),Linear,C18,Free,None,L,DRAMP
11608,DRAMP35987,LLLLLLLLLLLLLLLLLLLLLLL,23,Not available,Not available,Tumor cells: C26 (IC50=25µg/mL),Linear,C18,Free,None,L,DRAMP
11609,DRAMP35988,LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL,37,Not available,Not available,Tumor cells: C26 (IC50=14µg/mL),Linear,C18,Free,None,L,DRAMP
11610,DRAMP35989,LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL,37,Not available,Not available,Tumor cells: C26 (IC50=22µg/mL),Linear,C18,Free,None,L,DRAMP
11611,DRAMP35990,GAGIVVASIDTGVRVSHE,18,Not available,"GE18 affects the cellular morphology, which triggers the cells to undergo apoptosis for biological cellular elimination",Tumor cells: MCF-7  (IC50=29.06μM); MCF-7  (IC50=35.34μM),Linear,Amidation,Acetylation,None,L,DRAMP
